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Abstract 
 
This thesis describes advances in the development of a divergent synthetic 
route towards the isodomoic acids, employing a dearomatising cyclisation 
reaction as a key step. 
 
The dearomatising cyclisation of methoxy substituted benzamides A, are 
discussed in section 2.1 along with the extensive work on the optimisation of 
these reactions. 
O
N
Ph
A
MeO R
 
To obtain a divergent synthesis a common late stage intermediate is 
considered in the form of alkyne B. Section 2.2 describes a synthetic route 
towards this intermediate via an Eschenmoser fragmentation reaction to introduce 
the alkyne functionality. Conditions are developed to overcome problems in 
chemoselectivity of an amide protection and arene oxidation issues surrounding a 
resistant aromatic ring are achieved. 
B
NP
CO2R
H
RO2C
H
 
Section 2.3 discusses an alternative route towards alkyne B using a 
regioselective Baeyer-Villiger oxidation reaction to introduce further 
functionality. 
 
Finally, in section 2.4 a strategy towards alkyne B involving a silicon-
mediated fragmentation is explored. Successful optimisation of a silylcupration is 
described, as well as addressing problems surrounding the fragmentation. 
Advances in the alkyne functionalisation and side chain couplings are also 
covered.  
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quant.   Qantitative 
R, R′  unspecified substituents 
Rf  retention factor 
RL, RS  large/small substituents 
Red Al. sodium bis(2-methoxyethoxy)aluminumhydride 
R.T.  room temperature 
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s  secondary 
sat.  Saturated 
SEM  2-(trimethylsilyl)ethoxy]methyl 
soln.  solution 
Super-H Lithium triethylborohydride 
t  tertiary 
TBAF  tetrabutylammonium fluoride 
TBAT  Tetrabutylammonium triphenyldifluorosilicate 
TBDMS tert-butyldimethylsilyl 
TBDPS tert-butyldiphenylsilyl 
tert  tertiary 
Tf  trifluoromethanesulfonyl 
TFA  trifluoroacetic acid 
THF  tetrahydrofuran 
TIPS  triisopropylsilyl 
TLC  thin layer chromatography 
TMS  tetramethylsilane; trimethylsilyl 
Tol.  Toluene 
triflate  trifluoromethanesulfonate 
Triton B benzyl(trimethyl)azanium hydroxide 
Ts  Tosyl 
UV  ultraviolet 
VT  Variable Temperature 
wt%  weight percentage
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Chapter 1: Introduction. 
1.1 The Kainoid Family. 
 
The kainoid family is a group of structurally related compounds 
containing a functionalised pryrrolidine dicarboxylic nucleus with three 
contiguous stereogenic centres (Fig. 1).1 
N
H
R
HO2C
HO2C
2
3 4
 
Figure 1: Core Structure of the Kainoid Family 
 
The parent member, kainic acid 1 (originally known as digenic acid), was 
first isolated from a Japanese marine alga, Digenea simplex, in 1953 (Fig. 2).2 The 
C4 epimer of kainic acid, (+)-allokainic acid 2, was also isolated from this alga. 
(–)-Domoic acid 3 was isolated in 1958 from the Japanese marine warm 
water alga, Chondria armata3 and was later found to be present in Pseudo - 
nitzschia.4 Domoic acid differs from kainic acid by possessing an octadienoic side 
chain (containing a (cis -, trans -) diene5) at the C4 position on the pyrrolidine 
ring.6 This warm watered alga has also been proven to be the source of a number 
other members of the kainoid family, including isodomoic acids A to F (5 - 10),7 
domoilactones A and B (13 and 14)8, nordomoic acid (lacking the C5′ methyl 
group) and the C5′ domoic acid diastereomer 4.9 Diatoms have also recently been 
found to be responsible for production of isodomoic acids A and B (Nitzschia 
navis-varingica) and isodomoic acid C (Phragmites australis). 
The acromelic acids A 15 and B 16 were isolated from a poisonous 
Japanese mushroom, Clitocybe acromelalga, in 1983.10 The quantities of these 
acids were low and therefore only 1H NMR, C.D and UV spectral data was 
acquired for characterisation. Synthesis has since confirmed the structure of these 
acids. Seven years later the acromelic acids C, D and E (17 – 19), were isolated 
from the same alga.11 
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Identifying remaining members of the kainoid family proved difficult until 
1989.12 It was in this year that a reverse-phase HPLC analysis reported rapid, 
sensitive identification of the kainoids.13 Other techniques surfaced, including 
LC-MS,14 GC-MS15 and electrophoresis16 that were also able to successfully 
identify the kainoid amino acid series in various shellfish and phytoplankton. 
These techniques enabled the discovery of isodomoic acids E and F (9 and 10) 
from the edible mussels Mytilus edulis from Canadian waters in 1990,17 and 
isodomoic acids G and H (11 and 12) from re-examination of Chondria armata in 
1997.18  192021222324 
N
H
HO2C CO2H
HO2C
N
H
HO2C
HO2C CO2H
N
H
HO2C
HO2C CO2H
N
H
HO2C
HO2C CO2H
N
H
HO2C
HO2C CO2H
N
H
HO2C
HO2C
CO2H
N
H
HO2C
HO2C CO2H
N
H
HO2C
HO2C
CO2H
N
H
HO2C
HO2C
CO2H
N
H
HO2C
HO2C
domoic acid, 3
Isolated in 19583
First total synthesis:
Ohfune and Tomita in 198251
2
3 4
1' 2'
3'
4'
5'
kainic acid, 1
Isolated in 19532
First total synthesis:
Oppolzer and Thirring in 198219
2
3 4
N
H
HO2C
HO2C
(+)-allokainic acid, 2
Isolated in 19532
First total synthesis:
Oppolzer and Robiani in 198420
2
3 4
N
H
HO2C CO2H
HO2C
C5' domoic acid diastereomer, 4
Isolated in 199421
5'
isodomoic acid A, 5
Isolated in 19867b
isodomoic acid B, 6
Isolated in 19867b
isodomoic acid C, 7
Isolated in 19867b
First total synthesis:
Clayden et. al. in 200577
isodomoic acid D, 8
Isolated in 19857a
isodomoic acid E, 9
Isolated in 199017
isodomoic acid F, 10
Isolated in 199017
isodomoic acid G, 11
Isolated in 199718
First total synthesis:
Mongomery et. al. in 200358
isodomoic acid H, 12
Isolated in 199718
First total synthesis:
Denmark et. al. in 200959
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N
H
HO2C
HO2C
O
OHO N
H
HO2C
HO2C
O
OHO
N
H
HO2C
HO2C
NH
O
N
H
HO2C
HO2C
NH
CO2H
O
CO2H
N
H
HO2C
HO2C
NH
O
N
H
HO2C
HO2C
NH
CO2H
N
H
HO2C
HO2C
NH
CO2H
domoilactone A, 13
Isolated in 19878
domoilactone B, 14
Isolated in 19878
acromelic acid A, 15
Isolated in 198310
First total synthesis:
Takano et. al. in 198722
acromelic acid B, 16
Isolated in 198310
First total synthesis:
Matsumoto et. al. in 198623
acromelic acid E, 19
Isolated in 199211
First total synthesis:
Shirahama et. al. in 199324
acromelic acid D, 18
Isolated in 199211
acromelic acid C, 17
Isolated in 199211
 
 
Figure 2: Kainoid Amino Acid Family 
1.2 Biological Properties.25 
 
A considerable amount of interest has been drawn to the kainoid amino 
acids due to their insecticidal,7,26 anthelmintic (anti-intestinal worm)3,27 and 
neuroexcitatory properties.28 
Insecticidal properties of domoic acid and kainic acid have been utilised 
for fly-killing purposes in Yakushima Island, Japan. Research has reported that 
domoic acid and isodomoic acids A-C are the most potent insecticides and that 
the potency is dependent on the nature of the octadienoic side chain at the C4 
position.26 
Digenea simplex was used for eliminating parasites from humans and 
animals (anthelmintic properties) for thousands of years in Japan before it was 
discovered that the potent component was kainic acid.28a The cis-stereochemistry 
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of the C3 and C4 substituents appears to be a contributing factor as comparison 
with the C4 epimer, allokainic acid 2, shows weaker anthelmintic effects.27 
Most investigations have concentrated on the neuroexcitatory properties of 
the kainoid family.28 The amino acids have been shown to stimulate nerve cells in 
the mammalian central nervous system (CNS) which results in symptoms that 
mimic those of Alzheimer’s disease, epilepsy,29 Huntington’s Chorea28(a),30 and 
senile dementia.31 This means that the kainoids are a powerful tool in 
neuropharmacology to study the neurochemical pathways to the brain.  The mode 
of biological action is thought to be due to their conformationally restricted 
structural similarity to glutamic acid, 20,32 a major excitatory neurotransmitter in 
the mammalian CNS (Fig. 3).33 Although L-glutamic acid does not have a 
pyrrolidine ring or additional stereochemistry at C3 and C4, it is thought that 
these additional features assist in extra binding ability to the receptor site. It is 
also thought that the ring pre-orders the molecule, therefore reducing the entropy 
lost upon binding. 
N
H
R
HO
O
O
HO
Kainoid
amino acid
NH2
OHO
HO
O
glutamic acid, 20
 
 
Figure 3: Structural Similarity Between Kainoids and Glutamic Acid 
 
Structural-activity investigations have confirmed the C4 
stereochemistry32(b) the nature of the C4 substituent26,28(c),32(c) and the molecular 
confirmation32(c) plays a crucial role in binding and activation at the recognition 
site. Alkene configuration in the C4 side-chain seems to be particularly critical, 
with the Z-configuration of a C1′ mono-alkene 400 times more active than the E-
configuration, and the potency of domoic acid more than 5,000 times that of 
tetrahydrodomoic acid.34,35,36 
Domoic acid bioaccumulates in marine organisms that feed on the 
phytoplankton, such as shellfish, anchovies, and sardines.37 The toxin does not 
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bioaccumulate in the classic sense because it is quickly excreted by fish and 
shellfish that ingest it. It only accumulates in high numbers in these plankton 
feeders when the diatom itself is high in number in the surrounding waters.25 An 
outbreak of ‘amnesic shellfish poisoning’ in Prince Edward Island, Canada in 
1987 was due to high levels of domoic acid in the edible blue mussels, Mytilus 
edulis.38,39 This resulted in three deaths and 153 casualties suffering from 
symptoms of nausea, vomiting, headaches, diarrhoea and memory loss. Canadian 
scientists discovered that domoic acid (which is more potent than kainic acid) had 
entered the food chain when the mussels fed on a toxic algal bloom of the pinnate 
diatom Pseudonitzschia pungenst forma multiseries.40,41  
As a result of this outbreak, extensive monitoring techniques have been 
introduced to analyse levels of domoic acid so that it does not exceed the legal 
limit, 20 mg/kg. This legal limit has since been employed in Europe, as domoic 
acid and its analogues have been discovered in Scottish waters,42 Irish waters43 
and waters surrounding Portugal.44 This can also be a perennial problem in areas 
of the world’s oceans where essential nutrients are brought up from deep water to 
levels penetrated by light, such as the western coast of North America.31 Other 
methods of protection employed by the shellfish industry include delaying mussel 
harvest until after ice-cover in Canada,45 processing shellfish with constant water 
changes and the ongoing research into isolation of bacteria that can break down 
domoic acid.46 
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1.3 Biosynthesis of Domoic Acid. 
 
Wright et. al. worked on the biosynthesis of domoic acid using 13C 
labelling experiments.47 They showed that a geranyl diphosphate derivative 21 
and an activated glutamic acid derivative performed a condensation reaction that 
yields a precursor to the cyclisation to give a proline ring (Scheme 1). 
H
PPO
Glutamic acid
derivative
Geranyl diphosphate intermediate
H
N CO2H
CO2H
H
N
H CO2H
CO2H
H+
21
N
H
HO2C CO2H
HO2C
domoic acid, 3
 
Scheme 1: Biosynthesis of Domoic Acid 
 
During their research they discovered that a sample from the cultured 
mussel Mytilus edulis L. contained more than 90% domoic acid, with isodomoic 
acids D, E and F at just 5%, 2% and 1% respectively.48 They were able to make 
more of these isomers by exposing a dilute aqueous sample of domoic acid to 254 
nm light for nine to twelve minutes. This yielded domoic acid and isodomoic 
acids D, E and F in a 0.28: 0.12: 0.27: 0.13 ratio respectively per unit of starting 
material. This finding may suggest that only domoic acid is biosynthesised by the 
mollusc and that the isodomoic acids present are the result of later processes. 
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1.4 Previous Domoic Acid Synthesis. 
 
The synthetic challenge of the kainoid family is to address the formation 
of a pyrrolidine-2-carboxylic acid with defined stereochemistry at three adjacent 
centres with additional attention to the cis- stereochemistry. There have been 
numerous approaches to the synthesis of kainic acid and allokainic acid,49 
including ene reactions,50 Claisen rearrangements,51 free-radical cyclisations,52 
azomethane ylide cycloadditions,53 Pauson-Khand cyclisations54 and imminiun 
ion cyclisations.55  
Domoic acid has only been previously synthesised once, by Ohfune and 
Tomita in 1982,56 aiming to prove the absolute stereochemistry. The synthesis 
began with an advanced N-tert-butoxycarbonyl-L-pyroglutamic acid intermediate 
23, a derivative of (L)-glutamic acid (Scheme 2), performing a Diels-Alder 
reaction with diene 22 to yield the bicyclic product 24. 
NBoc
O
OTBDMS
Me3SiO
NBoc
OTBDMS
O
Me3SiO
H
H
+
23 24
a
22
 
Reagents and conditions: (a) 135 ºC, sealed tube, 3 days 
Scheme 2: Diels-Alder Reaction to Form Pyrrolidinone Core 
 
This key step was used to set the stereochemistry at the C3 and C4 
positions and this is achieved remarkably well by the favoured steric and 
electronic interactions between the starting materials. The reaction is consistent 
with the Woodward-Hoffmann rules, along with second order effects.57 
Stereochemistry of the ring junction is set by the endo rule relative to the methyl 
group on the six membered ring. The diene approaches from above 23 to avoid 
steric interactions with the bulky tert-butyldimethylsilyl group. Finally 
regiochemistry was set by the favourd diene-dienophile orbital overlap resulting 
in the trimethylsilyl group in the para position. 
Adduct 24 without isolation was treated to ozonolysis to open the six-
membered ring. The carboxylic acid was converted to the ester and the aldehyde 
was protected as the ethylene ketal (25) in subsequent steps (Scheme 3). The 
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amide and the ester were reduced using borane-dimethyl sulphide complex. The 
TBDMS was selectively deprotected and the diol was oxidised using pyridinium 
dichromate and then converted to the diester 27 with diazomethane. 
NBoc
OTBDMS
O
Me3SiO
H
H
24
a
40%
NBoc
OTBDMS
OH H
HMeO2C
O
O
b
70%
NBoc
OTBDMS
H H
H
O
O
HO
NBoc
CO2Me
H H
HMeO2C
O
O
c
70%
25
2627
 
Reagents and conditions: (a) i. O3, DCM, -78 ºC, DMS, R.T.; ii. CH2N2; iii. 2-methyl-2-ethyl-1,3-dioxolane, 
p-TsOH, R.T.;  (b) BH3.DMS, 70%;  (c) i. MeOH, p-TsOH, ii. PDC, DMF, iii. CH2N2. 
Scheme 3: Towards the Total Synthesis of Domoic Acid 
 
Treating 27 with acetic acid yielded the unprotected aldehyde 28. It was 
reported that under these condtions the compound epimerised at the C1′ centre to 
give a 1:1 mixture of products (Scheme 4). Wittig chemistry was used to 
introduce the methoxy methylene group to give 29, then hydroxyselenation to 
produce α-selenoaldehyde 30. 
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NBoc
CO2Me
H H
HMeO2C
O
O
27
a
64%
NBoc
CO2Me
H
HMeO2C
O
28
H
b
NBoc
CO2Me
H
HMeO2C
29
O
c
90% (2 Steps)
NBoc
CO2MeMe2OC
30
O
PhSe
H
H
H
 
Reagents and conditions: (a) 60% AcOH; (b) Ph3P(Cl)CH2OCH3, t-AmONa, benzene; (c) PhSeCl, THF, 
Et3N, H2O. 
Scheme 4: Towards the Total Synthesis of Domoic Acid 
 
Two methods were developed for the production of the enal 31 (Scheme 
5), both of which give moderate yields and control of stereochemistry (Table 1). 
NBoc
CO2Me
OHC
PhSe
MeO2C
NBoc
CO2MeMeO2C
OHCNBoc
CO2MeMeO2C
OHC
30
a
Z-31E-31
+
H
H
H
H
H
H
 
Reagents and conditions: (a) see table 1 
Scheme 5: Towards the Total Synthesis of Domoic Acid 
 
Entry Conditions Total Yield 
of 31 
Ratio 
E-31 : Z-31 
1 O3, DCM, –78 ºC; Et3N 33% 10 : 1 
2 NBS, THF, R.T., 2 min; NaOAc 
(aq.), 15 min 
67% 1 : 2 
 
Table 1: Conditions for Deselenation 
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A Wittig reaction was used to introduce the side chain with the C5' 
stereocentre (Scheme 6). Jones’ reagent was used to oxidise the alcohol and then 
diazomethane was used for the formation of the methyl ester. These steps yielded 
the protected products (E, E, S)-32 and (E, E, R)-32 which did not correspond to 
the 360 MHz 1H NMR spectroscopic data of the protected (–)-domoic acid. X-ray 
crystallography experiments were then performed on (–)-domoic acid which 
showed that the side chain is in fact (Z, E, R). The synthesis was modified to 
obtain the correct stereochemistry. 
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NBoc
CO2MeMeO2C
OHC
NBoc
CO2MeMeO2C
OHC
Ph3P OH Ph3P OH
NBoc
CO2MeMeO2C
MeO2C S
NBoc
CO2MeMeO2C
MeO2C R
NBoc
CO2MeMeO2C
CO2MeR
OO
O
N CN
Ph
NH
CO2HHO2C
CO2HR
E
Z
E E E E
E
Z
E
Z
(-)-domoic acid, 3
E-31 Z-31
(E,E,S)-32 (E,E,R)-32
(Z,E,R)-32
34
(S)-33 (R)-33
a, c, d b, c, d b, c, d
g, he, f
35%
100%
H
H
H
H
H
H
H
H H
H
H
H
 
Reagents and conditions: (a) (S)-33, n-BuLi (2 eq.), THF, -78 ºC, 2 min; 0 ºC, 10 min; (b) (R)-33, n-BuLi  
(2 eq.), THF, –78 ºC, 2 min; 0 ºC, 10 min; (c) Jones’ reagent, 0 ºC, 1 h; (d) CH2N2; (e) Boc-ON (34), Et3N;  
(f) CH2N2; (g) 2.5 % KOH (aq.), R.T., 24 h; (h) TFA, R.T., 15 min; NaOH (1 eq.) 
 
Scheme 6: Towards the Total Synthesis of Domoic Acid 
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1.5 Semisynthesis: Isopropenyl Extension of Kainic 
Acid. 
 
Mertes et. al. investigated how the substitution of the isopropenyl ring of 
kainic acid would affect the binding ability to the kainate receptor site.58 Utilising 
a previous synthesis of kainic acid1 and employing a metal-coupling reaction to 
introduce a number of different side chains (Scheme 7) would be an attractive 
way of making other members of the kainoid family. 
 
N
H
CO2H
CO2H
kainic acid, 1
N
H
CO2H
CO2H
alkenyl
metal coupling
domoic acid family
 
 
Scheme 7: Semi-Synthesis of the Kainoid Family 
 
Mertes et al. only studied aryl couplings to the isopropenyl group, 
resulting in low yields and a mixture of isomers (Scheme 8).  
N CO2Me
CO2Me
CO2Et
N CO2Me
CO2Me
CO2Et
NO2
Z-36
E-36
5%
10%
a
35
 
Reagents and conditions: (a) Pd(OAc)2, 3-nitroaniline, MeCN, 60 ºC; t-butylnitrite, 60 ºC, portionwise over  
3 h; 60 ºC, 4 h; 25 ºC, o/n; Pd(OAc)2, 3-nitroaniline, t-butylnitrite, 60 ºC, 2 h; 25 ºC, 2 days 
Scheme 8: Isopropenyl Aryl Coupling Reactions 
 
Investigations into the side chain additions were also reported. They 
discovered that the π-allyl palladium complex 37 intermediate was susceptible to 
nucleophilic attack (Scheme 9).  
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N CO2Me
CO2Me
CO2Et
N CO2Me
CO2Me
CO2Et
Cl2Pd
N CO2Me
CO2Me
CO2Et
R
O
38 R = SPh        16%
39 R = CO2tBu  60%
35 37, 74%
a, b c
 
Reagents and conditions: (a) Pd(OCOCF3)2, EtOAc, R.T., o/n; (b) n-Bu4NCl, R.T., 24 h;  
(c) t-butylacetoacetate or phenylthioacetone, NaH, THF; Ph3P, THF, 25 ºC, o/n (38) or 38 h (39) 
Scheme 9: Methyl Group Additions Reactions 
 
Since this publication there have been no attempts to apply this chemistry 
to the synthesis of domoic acid or the isodomoic acids. It is thought that due to the 
low yields, lack of selectivity and sensitivity to the aryl-coupled substituent the 
route to the kainoid amino acids would not be efficient. 
1.6 Isodomoic Acid G and H Synthesis. 
 
The first total synthesis and stereochemical definition of isodomoic acid G 
was achieved by Montgomery et. al in 2003.59 The approach was to utilise a 
previous synthesis to kainic acid and introduce a key nickel-catalysed alkyne-
alkenylzirconium coupling of 41 with 42 (Scheme 10). This key step enabled the 
formation of the exocyclic double bond, characteristic of isodomoic acids G and 
H and also complete control of the stereochemistry at the C2 and C3 positions.  
O
N
NO
OO
O
OTIPS OTIPS
ClCp2Zr
O
N
O
OTIPS
N
O
O
O
42
4140
43, 74%
a b
2
3 E
Ph
Ph
 
Reagents and conditions: (a) Cp2ZrHCl, THF, R.T.; (b) Ni(COD)2 (10 mol %), ZnCl2 (20 mol %), THF, 0 ºC 
Scheme 10: Towards the Total Synthesis of Isodomoic Acid G 
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The selective formation of compound 44 as a single isomer proved 
difficult by partial epimerisation at the C2 centre in an earlier step. This was 
resolved by using a chiral oxazolidinone so that the two epimers could be 
separated (Scheme 11).  
Deprotection using tetrabutylammonium fluoride and oxazolidinone 
opening followed to yield diol 45, which was oxidised to the corresponding diacid 
with Dess-Martin periodinane and NaClO2. Ion-exchange chromatography was 
used to separate the products and afford 5'(R)-isodomoic acid G in 38% yield. 
Experimental data was compared with that of isodomoic acid G’s original 
isolation report from Arakawa which confirmed the structure. 
O
N
O
OTIPS
N
O
O
O
2
3 E
Ph
O
N
O
OTIPS
O
2
3 E
O
N
O
OH
O
2
3 E
O
HO
O
N
H
OH
O
2
3 E
HO
O
HO
O
a
80%
           b
95% (2 Steps)
c
38% from 44
5'(R)-isodomoic acid G, 11
single isomer
43 44 45
 
Reagents and conditions: (a) MeOMgBr, MeOH, R.T, 80%; (b) i. MeONa, MeOH, R.T.; ii. TBAF, THF, 
R.T.; (c) i. Dess-Martin periodinane, DCM, R.T.; ii. NaClO2, NaH2PO4, 2-methyl-2-butene, t-BuOH, H2O, 
R.T.; iii. NaOH, MeOH, H2O, R.T; (iv) ion-exchange chromatography. 
Scheme 11: Towards the Total Synthesis of Isodomoic Acid G 
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The synthesis was modified to synthesise 5′ (S) isodomoic acid G, 48 
(Scheme 12). 
O
OH
N
H
OH
O
2
3 EHO NH2
O O
N O
O
O
HO
O
5' (S) isodomoic acid G, 48
46 47
 
 
Scheme 12: Modified Synthesis Towards 5' (S) Isodomoic Acid G 
 
In 2009, Denmark et. al. published a general approach to both isodomoic 
acids G and H using a stereodivergent alkenylsilane iodination which allows the 
preparation of both exocyclic alkene isomers.60 
The synthesis begins with the formation of the alkyne 52, the precursor to 
the key carbonylative silylcarbocyclization (Scheme 13). Lactone 49, which is 
derived by L-methionine, was opened using TMSI and after esterification and N-
alkynylation gives the iodinated amino ester, which is converted to the 
corresponding selenium substrate 50 using sodium phenylselenide. N-alkylation 
followed by oxidative elimination then gave the N-methylpropargyl L-
vinylglycine ester 52. 
O
OH
NTs
O
OMe
H
NTs
SePH
a, b
O
OMeNTs
SePH
  c
93%
  d
95%
N Ts
CO2Me
49
50 51
52
 
Reagents and conditions: (a) i. TMSI; ii. SOCl2, MeOH 90%; (b) NaBH4, Ph2Se2 88%; (c) 2-butyn-1-ol, 
PPh3, DEAD; (d) 30% H2O2. 
Scheme 13: Towards the Total Synthesis of Isodomoic Acid H 
 
 
Performing a carbonylative silylcarboncyclisation using Rh(acac)(CO)2 on 
alkyne 52 gave the cyclised product 53 as an inseparable mixture of 2,3-trans and 
2,3-cis-diasteroisomer in an 8:1 ratio. To obtain the desired trans isomer it was 
necessary to reduce the aldehyde using NaBH4, which enabled the separation of 
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the two diasteroisomers in 85% yield of the desired trans diasteroisomer 53 
(Scheme 14). 
N Ts
CO2Me
52
 a, b
N
PhMe2Si
CO2Me
Ts
HO
 c
81%
N
PhMe2Si
CO2Me
Ts
MeO2C
d
86%
N
I
CO2Me
Ts
MeO2C
N
CO2Me
Ts
MeO2C
MeO2C
 e
92%
 f
56%
isodomoic acid H, 12
53 54
55
56
CO2Me
HOMe2Si
57
H H
HHN
H
HO2C
HO2C
HO2C
H
Reagents and conditions: (a) HSiMe2Ph, Rh(acac)(CO)2 (5 mol %), CO (500 psi), 120 °C, 77%, trans/cis 8:1; 
(b) NaBH4 85%; (c) i. CrO3, H5IO6; ii, CH2N2 81%; (d) IC1, 86%; (e) 57, Pd2(dba)3, CHCl3 (5 mol %), 
TBAF.8H2O, 92%; (f) i. LiOH,; ii. 20% Na/Hg, NaH2PO4. 
Scheme 14: Total Synthesis of Isodomoic Acid H 
 
Alcohol 53 was converted to the methyl ester 54 using CrO3 and CH2N2, 
followed by the iododesilylation using IC1 resulting in the complete inversion of 
the double bond configuration to afford Z-alkenyl iodide 55 in 86% yield. The 
sterochemical outcome was rationalised by an anchimeric participation of the C7 
carbonyl group trapping the iodonium ion intermediate which enables bond 
rotation making the silyl group antiperiplanar to the oxocarbenium CO bond. 
Cross-coupling of vinyl silyl 57 using Pd2(dba)3.CHCl3 and TBAF.8H2O 
resulted in 92% yield of the protected (–)-isodomoic acid H 56 which was 
deprotected over two steps to give (–)-isodomoic acid H, 12 in 56% yield. 
The synthesis was modified to make the iodination retentive by employing 
a nonparticipating substrate in the C7 position. Alcohol 53 was protected with 
TIPSCl and the iodination reaction became retentive, therefore making it possible 
to synthesise (–)-isodomoic acid G, 11 (Scheme 15). 
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MeO2C
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CO2HHO2C
HO2C
isodomoic acid G, 11
59
CO2Me
HOMe2Si
57
H H
58
H
H
7
Reagents and conditions: (a) TIPSCl, imidazole, 91%; (b) i. IC1, ii. HF, 73%; (c) i. CrO3, H5IO6, ii. CH2N2 
79%; (d) 57, Pd2(dba)3.CHCl3 (5 mol %), TBAF.8H2O; (e) LiOH ; (f) 20% Na/Hg, NaH2PO4 . 
Scheme 15: Modification Towards the Synthesis of Isodomoic Acid G 
 
In 2009, Montgomery et. al. published a full paper of the previously 
discussed total synthesis of (–)-isodomoic acid G which included a modification 
enabling the synthesis of (–)-isodomoic acid H.61 The article describes that it was 
necessary to convert the vinyl zirconium reagent 41 to the E-vinyl iodide, 60, 
using N-iodosuccinimide to obtain the desired stereochemistry (Scheme 16). 
OTIPS OTIPS
ClCp2Zr
4140
a
I
OTIPS
60
 
Reagents and conditions: (a) Cp2ZrHCl, THF, R.T.; and then N-iodosuccinimide, 71%. 
Scheme 16: Towards the Synthesis of Isodomoic Acid H 
A Sonogashira coupling of vinyl iodide 60 and terminal alkyne 61 
proceeds in 83% yield giving conjugate enyne 62 which when exposed to 
dimethylzinc with 10% mol Ni(COD)2 cyclises to give 63 in 77% as a single 
isomer (Scheme 17).  
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Reagents and conditions: (a) Pd(PPh3)2Cl2, CuI, iPr2NH, THF, 0 °C, 83%; (b) Ni(COD)2, Me2Zn, THF, 0 °C, 
77%; (c) MeOMgBr, MeOH, R.T., 70%; then MeONa, MeOH, R.T.; and then TBAF, THF, R.T., 75% over 
two steps; (d) Dess-Martin periodinane, CH2Cl2, R.T.; and then NaClO2, NaH2PO4, 2-methyl-2-butene, t-
BuOH, H2O, R.T.; and then NaOH, MeOH, H2O, R.T.; ion-exchange chromatography, 21%. 
Scheme 17: Total Synthesis of Isodomoic Acid H 
After assembly of the key pyrrolidine framework the protecting 
oxazolidinones and TIPS groups were removed giving ester 64 in 75% yield over 
two steps. Oxidation using Dess-Martin periodinane and a global deprotection 
completed the synthesis of (–)-isodomoic acid H, 12. 
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1.7 Domoic Acid Analogue Synthesis: Cobalt-
Mediated Cyclisation.62 
 
Baldwin et. al. used a cobalt-mediated radical cyclisation, which has been 
previously used for the synthesis for kainic acid,63 to form an analogue of domoic 
acid structurally similar to isodomoic acid C, 7. The cyclisation involves 
homolysis followed by β-elimination of the cobalt species to form the pyrrole ring 
(Scheme 18). 
N R
R1
R2
N R
R1
R2
N R
R1
R2
N R
R1
R2
N R
R1
R2
CoIII
N R
R1
R2
-CoIII (Homolysis)a
-HCoIII
x =halogen
65
66
A
B
CD
X CoIII
 
Reagents and conditions: (a) Co(I), MeOH (cobolt in the form of a colboloxime (I) solution) 
Scheme 18: Cobolt-Mediated Radical Cyclisation Reaction 
 
The synthesis begins with the introduction of the side chain to 67 by a 
reductive amination with citral 68 which was then protected with phenyl 
chlorofomate to form carbamate 70. DIBAlH was used for the reduction of the 
ester to the aldehyde, which was converted to alcohol 71 by addition of tert-
butyllithioacetate (Scheme 19). 
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TBDMSO CO2Me
NH2
TBDMSO CO2Me
NH
CHO
N OPh
Oa
c
67
68
69
70
MeO2C OTBDMS
b
N OPh
O
OTBDMSt-BuO2C OH
71
75% 90%
52%
Reagents and conditions: (a) NaBH4; (b) PhOCOCl; (c) i. DIBAlH; ii. LiCH2CO2t-Bu. 
Scheme 19: Towards the Synthesis of a Domoic acid Analogue 
 
 Alcohol 71 was converted to oxazolidinone 72 in 56% yield, prior to the 
secondary alcohol displacement with iodine as an undesired cyclisation reaction 
were observed with the amide (Scheme 20). The free alcohol was then converted 
to the iodine using triflic anhydride and sodium iodide yielding precursor 73. The 
alkene configuration of 73 was a cis, trans mixture due to the configuration of 
citral 68, which is only available as a 95:5 mixture. However, this was shown to 
have little effect on the cyclisation in model studies.  
N OPh
O
OTBDMStBuO2C OH
71
N O
O
tBuO2C OH
72
H
a
56%
b
60%
N O
O
tBuO2C I
H
73
 
Reagents and conditions: (a) i. p-TsOH, MeOH; ii. K2CO3, H2O, MeOH; (b) (CF3SO2)2O, NaI 
 
Scheme 20: Towards the Synthesis of a Domoic Acid Analogue 
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The key cobalt-mediated cyclisation step results in a mixture of products. 
The major products being the desired cyclised pyrrolidine 74 and an elimination 
product 75. The remaining products, 76-79, were isolated in a total of 13% yield. 
(Scheme 21). 
N O
O
I
CO2tBu
N
CO2tBu
O
O
a
73
74, 29%
N
CO2tBu
O
O
76
77 78
N
CO2tBu
O
O
79
N O
O
BuO2tC
75, 25%
N O
O
BuO2tC
N O
O
BuO2tC
 
Reagents: (a) Co(I), MeOH 
Scheme 21: Colbolt-Mediated Cyclisation Reaction 
 
Compound 74 was treated with aqueous sodium hydroxide to open the 
carbamate and hydrolyse the ester (Scheme 22). After amine protection with di-
tert-butyl dicarbonate and esterification, the primary alcohol was converted to the 
methyl ester using pyridinium dichromate and diazomethane to give ester 81 in 
61% yield. 
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N
CO2tBu
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O
74
NBoc
CO2Me
80
OH
81
  a
50%
  b
61%
NBoc
CO2Me
CO2Me
Reagents: (a) i. aq. NaOH, ii. Boc2O, iii. CH2N2; (b) i. PCC, ii. CH2N2 
Scheme 22: Towards the Synthesis of a Domoic Acid Analogue 
 
The final stage in the synthesis involves hydrolysis of the ester followed 
by a deprotection (Scheme 23). This yields two products, the desired alkene 82 
that was present in trace amounts and the major product 83 in 72% yield as a 
result of an electrophilic addition with trifluoroacetic acid. 
N
Boc
CO2Me
CO2Me
N
H
CO2H
CO2H
N
H
CO2H
CO2H
HO
+
81
82, trace
83, 72%
a, b
 
Reagents: (a) KOH aq.; (b) TFA 
Scheme 23: Towards the Synthesis of a Domoic Acid Analogue 
 
Baldwin et. al. wanted to apply this chemistry to the synthesis of other 
members of the kainoid amino acid family, however to date there have been no 
developments in the synthesis of other isodomoic acids. Research has 
concentrated on 4-arylsulfanyl analogues 8464 and 4-aryl, alkenyl and alkynyl 
analogues65 of the acromelic acids 15-19 (Fig. 4). 
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Figure 4: Analogues of Acromelic Acids 
 
1.8 Previous Research Within the Clayden Group. 
1.8.1 Anionic Dearomatising Cyclisation Reaction. 
 
In the mid-1990s research was carried out on an anionic dearomatising 
cyclisation reaction of naphthamides and benzamides.66 The cyclisation involves 
the lithiation of a benzamide at the α position followed by a diastereoselective 
dearomatising cyclisation resulting in a product that contains three new 
stereogenic centres.  
Lithiating compound 85 yields two products, 86 as the major compound in 
40% and 87 in 20% yield as a mixture of atropisomers (Scheme 24).67, 68 
NO
Ph
Ph NO
Ph
PhN
O
H
Ph
Ph
a, b
+
85 86 8740% 20%
 
Reagents and conditions: (a) s-BuLi, THF, –78 ºC; (b) MeI 
Scheme 24: Anionic Dearomatising Cyclisation Reaction 
Upon this discovery the scope of the cyclisation reaction was explored 
which revealed that the use tert-butyl group or cumyl groups gave good yields.69 
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Attempts to cyclise tert-butylcarboxylate protected benzamides resulted in a 
rearrangement reaction described by Hamada.70,71 It was also discovered that the 
cyclisation can tolerate either electron-withdrawing (CN) or donating (OMe) 
groups on the dearomatising arene ring (Scheme 25).72 
O
NR
Ph
O
NR
PhLi
NR
OLi
PhH Ph
R''
NR
O
H
R'' = H, Me, Bn or n-Bu
a b c
R = t-Bu, Bn or Cumyl
R' = OMe, Br or CN
88
89 90 91
R' R' R' R'
 
Reagents and conditions: (a) t-BuLi; (b) HMPA; (c) NaH4Cl, MeI, BnBr or n-BuBr 
Scheme 25: General Dearomatising Cyclisation 
 
1.8.2 Mechanism of the Dearomatising Cyclisation. 
 
Mechanistic experiments have suggested that the dearomatising 
cyclisation reaction is pericylic rather than an intramolecular conjugate addition 
process.73,74 As the cyclised products have the aromatic group on the exo face  this 
suggests a conjugate addition process but would be a Baldwin-disfavoured 5-
endo-trig reaction (Scheme 26).75  
MeO
N
O
Ph
Ph
MeO
N
O
Ph
PhLi
N
O
Ph
H Ph
MeO
H
N
O
PhMeO
H
H Ph
92
93 94
95
 
Scheme 26: Intramolecular Addition 5-endo-trig 
 
In a pericyclic cyclisation the phenyl group would have to be trans to the 
cumyl group which could be possible as the cis conformation experiences steric 
interactions (Fig.5). 
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Figure 5: Steric Interactions of the Cyclisation Precursor 
 
To confirm the type of mechanism a modified cyclisation reaction was 
developed in which the starting benzamide 85 was fixed in the cis conformation 
by introducing a small ring (Scheme 27).  
N
O
O
N
O
O
HH
N
O
O
H H
96 97a 97b
a
53%
b
quant.
 
Reagents and conditions: (a) i. s-BuLi, DMPU, THF, -78 ºC to 0 ºC, ii. MeI; (b) 2 M HCl, MeOH;. 
Scheme 27: Modified Dearomatising Cyclisation Reaction 
 
The reaction resulted in the formation of the cis isomer 97a which 
epimerised under mild conditions to give the more stable trans isomer 97b. The 
stereochemistry of the product shows that the reaction is not a conjugate addition 
process and is a result of a thermal electrocyclic six-electron disrotatory ring 
closure according to the Woodward-Hoffman rules (Scheme 28).57  
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OLi
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Reagents and conditions: (a) ortho-lithiation; (b) anion translocation; (c) disrotatory electrocyclic ring 
closure; (d) work-up. 
Scheme 28: Suggested Anionic Dearomatising Cyclisation 
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1.8.3 Synthesis of (±)-Kainic Acid. 
 
Modifications to the dearomatising cyclisation reaction included the 
protecting group of the amide which was changed to a cumyl protecting group as 
tert-butyl group proved difficult to remove.69 Also, by using a methoxy 
substituted benzamide it was possible to produce methyl enol ether products that 
can be hydrolysed to the thermodynamically stable enone without isolation of the 
methyl ether intermediate (Scheme 29).72 
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92 102 103
Ph Ph
Ph
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Reagents and conditions: (a) t-BuLi, HMPA; (b) HCl, H2O–MeOH 
Scheme 29: Dearomatising Cyclisation of Methoxy Substituted Benzamide 
 
                                                                       Chapter 1: Introduction 
  
                                                           
 
47 
Enone 104 was used as an intermediate in the racemic synthesis of kainic 
acid by the Clayden group in 2000 (Scheme 30).71 
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CO2MeH
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(±)-107
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59% 
(from 104)
d
57%
e
76%
f
71%
g, h, i
50%
j
60%
a
(±)-105(±)-104
 
Reagents and conditions: (a) Me2CuLi, TMSCl, THF, –78 ºC, 1 h; (b) TFA, reflux, 6 h, ; (c) Boc2O, Et3N, 
DMAP, DCM; (d) i. NaIO4, cat. RuCl3, 1:1 acetone:H2O; ii. Me3SiCHN2, PhH, MeOH; (e) mCPBA, DCM; 
(f) i. NaOH (2.2 eq.), MeOH, reflux, 2 h; ii. Me3SiCHN2, PhH, MeOH; (g) o-NO2C6H4SeCN, Bu3P, THF, 
R.T.; (h) H2O2, py, THF, –40 ºC; (i) NaBH(OMe)3 (2 eq.), THF, reflux; (j) 10:1 TFA : H2O, reflux, 4 h 
Scheme 30: Total Synthesis of (±)-Kainic Acid 
 
Functionalisation of the bicyclic structure was achieved by a 
regioselective Baeyer-Villiger reaction giving lactone 108 as a single isomer. The 
subsequent steps involved opening the lactone by treatment with sodium 
hydroxide and formation of the isopropenyl group by elimination. The final steps 
required the reduction of the lactam using sodium trimethoxy borohydride and 
finally deprotection to complete the synthesis of (±)-Kainic acid, 1. 
1.8.4 Asymmetric Dearomatising Cyclisation & (–)-
Kainic Acid Synthesis. 
 
The dearomatising cyclisation was developed into an enantioselective 
reaction by introducing a chiral base to perform an asymmetric deprotonation. 
Research into an enantioselective cyclisation highlighted two chiral lithium 
amides (111 and 112) that give good enantioselectivity (Scheme 31).76 
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. 
Reagents and conditions: (a) i. amide 111 or 112, THF, -78 °C - R.T.; ii. NH4Cl; iii. 3M HCl aq. 
Scheme 31: Enantioselective Dearomatising Cyclisation Reaction 
 
Using chiral amide 112 it was possible to obtain an enantiomeric excess of 
73% which after recrystalisation gave enantiopure material with a moderate 34% 
yield.77 Chiral amide 111 gave a good enantiomeric excess of 81% and in an 
improved 52% yield after recrystalisation.78 Therefore amide 111 was chosen for 
the total synthesis of (–)-kainic acid, 1 in 2002.79 
1.8.5 Acromelic Acid Analogue Synthesis. 
 
The Clayden group also published the synthesis of an acromelic acid 
analogue, known to have biological activity, in 2001.80 This synthesis involved 
the same key steps applied to the synthesis of (–)-kainic acid, 1,79 including the 
dearomatising cyclisation and a regioselective Baeyer-Villiger oxidation reaction 
(Scheme 32). 
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Reagents and conditions: (a) i. t-BuLi, THF, -78 °C, ii. DMPU, iii. NH4Cl, H2O, 88%, iv. CF3CO2H, H2O, 
87%; (b) i. Boc2O, DMAP, CH3CN, 80%, ii. RuCl3, NaIO4, H2O, EtOAc, CH3CN, iii. CH2N2, 52%; (c) 
mCPBA, 52%; (d) NaOMe, MeOH, 85% ; (e) i. NaBH(OMe)3, THF, ii. BF3.OEt2, EtSiH, DCM, 25%, iii.  
6M HCl, reflux. quant. 
Scheme 32: Synthesis of an Acromelic Acid Analogue 
 
The aromatic side chain at the C4 position was present in naphthamide 
113 prior to the dearomatising cyclisation with tert-butyllithium. The Baeyer-
Villiger oxidation followed producing lactone 116, which was then opened using 
sodium methoxide in methanol giving alcohol 117. The lactam was reduced in a 
two step process using Na(OMe)3BH and then triethylsilane/boron trifluoride. 
Kainoid 118 was finally synthesised by performing a deprotection using aqueous 
HCl solution. 
1.8.6 Isodomoic Acid C Synthesis. 
 
The synthesis of isodomoic acid C was published by the Clayden group in 
2005.81 This was achieved by employing the developed enantioselective 
dearomatising cyclisation reaction and introducing the characteristic side chain at 
an early stage in the synthesis (Scheme 33). 
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Reagents and conditions: (a) p-anisoyl chloride, Et3N, DCM, 0 ºC, 12 h; (b) BnBr, NaH, DMF; (c) 111, n-
BuLi, THF, –78 ºC - R.T., 5 h; sat. aq. NH4Cl soln.; (d) 3 M aq. HCl soln.; recrystallisation from EtOAc; (e) 
120, Et2O, –78 ºC, 2 h; (f) HCO2H, reflux, 30 min; (g) Boc2O, DMAP, Et3N, DCM, R.T., 18 h; (h) NaIO4, 
RuCl3, MeCN, H2O, EtOAc, R.T., 18 h; (i) TMS–CHN2, PhMe, MeOH, R.T., 5 min; (j) 1 M aq. NaOH, 
MeOH, –78 ºC, 1 h; (k) TBDPSCl, imidazole, DCM, R.T., 18 h; (l) mCPBA, DCM, R.T., 72 h; (m) NaOMe, 
MeOH, –78 ºC; (n) o-NO2C6H4SeCN, n-Bu3P, THF, R.T., 2 h; (o) H2O2, py, THF, –40 ºC to R.T., 12 h; (p) 
DIBAlH, THF, –78 ºC, 1 h; MeOH; (q) Et3SiH, BF3.Et2O, DCM, –78 ºC, 2.5 h; (r) TBAF, THF, R.T., 2 h; (s) 
Dess-Martin periodinane, DCM, R.T., 30 min; (t) 133, DBU, LiCl, MeCN, R.T., 1 h; (u) LiOH, MeOH, 12 h, 
R.T.; (v) TFA, reflux, 2 h 
Scheme 33: Total Synthesis of Isodomoic Acid C 
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After the enantioselective synthesis of enone 104 using chiral amide 111, 
it was necessary to introduce the side chain using a conjugate cuprate addition to 
give compound 121 in 79% yield. The TIPS and cumyl protecting groups were 
unstable during the arene oxidation and so needed to be removed and replaced 
with a formate ester and Boc protecting groups respectively, giving product 123. 
It was then possible to perform the phenyl oxidation and esterification reactions 
using TMS-diazomethane to give methyl ester 124 in 64% yield. The formate 
group was then removed and replace with TBDPS which would be stable for the 
remaining steps in the synthesis. Utilising a regioselective Baeyer-Villiger 
oxidation enabled further functionalisation giving lactone 127 as a single isomer 
in quantitative yield, which was opened with NaOMe to give the corresponding 
primary alcohol 128 in 60%. A selenium-mediated elimination reaction gave the 
desired alkene 130 in 41% yield. The final steps of the synthesis removed the 
TBDPS group and converted the resulting alcohol into the aldehyde 132 in order 
to perform a Wittig reaction using ylid 133 to give the protected (–)-isodomoic 
acid C 134 in 50% yield. A successful deprotection completed the synthesis of (–
)-isodomoic acid C, 7 in 86% yield. 
This was an efficient synthetic route but one that was limited to the 
synthesis of (–)-isodomoic acid C (i.e. the 1, 1-disubstituted alkene) and does not 
tackle the issues of the other isodomoic acids which have trisubstituted alkenes. 
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1.9 Research Towards the Synthesis of Isodomoic 
Acids: Approaches to a Trisubstituted Alkene. 
 
With the successful synthesis of (–)-kainic acid and (–)-isodomoic acid C, 
the Clayden group focused on applying the dearomatising cyclisation to a 
divergent route to multiple members of the kainoid family. The strategy was 
aimed at developing a synthesis that introduces a trisubstituted alkene at the C4 
position, so that it could be functionalised as a late stage intermediate. 
1.9.1 Tin-Mediated Fragmentation. 
 
Initial attempts to develop a route to a trisubstituted alkene were carried 
out by K. Hebditch, based on using a tin-mediated fragmentation to control the 
stereochemistry of a trisubstituted double bond 139 (Scheme 34).82 
NBoc
O
O
CO2MeH
H
NBoc
O
LiO
CO2MeH
HR3Sn
NBoc
O
O
CO2MeH
H
R3Sn
R'
NBoc
O
HO
CO2MeH
H
R3Sn
R'
OHC NBoc
O
CO2MeH
HR'
135
exo-face
nucleophilic
addition of tin
electrophilic
quench on
opposite 
face to tin
fragmentation
136 137
138139
R' = Side chain of desired
        isodomoic acid
 
Scheme 34: Proposed Synthetic Route to Isodomoic Acid B 
 
The proposed route presented a number of chemoselective problems, 
however prior to completing a proposed synthetic route, model systems were used 
to validate the tin-mediated fragmentation. Unfortunately initial experiments 
resulted in poor yields of the desired alkene (Scheme 35).83 
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Reagents and conditions: (a) Pb(OAc)4, PhH, reflux 
Scheme 35: Model Fragmentation Reactions 
 
Stereospecific fragmentations demonstrated by Isoe et. al83(b) were also 
applied to model systems (Scheme 36). As predicted this resulted in an E-alkene 
on treatment with lead tetracetate giving alkene 146. The reaction was faster for 
model 145a and required one equivalent of the oxidant and 145b required 1.25 
equivalents. The higher yields obtainied (up to 47%) were explained by the 
presence of calcium carbonate, which was thought to remove acetic acid and 
prevent decomposition and protodestannylation. 
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Reagents and conditions: (a) Pb(OAc)4, PhH, reflux 
Scheme 36: Model Fragmentation Reactions 
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The stereochemistry of the alkene was characterised by 1H NMR and was 
consistent with anti elimination of tin by a radical84 or an ionic mechanism83(a) 
involving acetate (Scheme 37 and 38). 
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Scheme 37: Radical Fragmentation Mechanism 
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Scheme 38: Ionic Fragmentation Mechanism 
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1.9.2 Oxazolidine Cyclisation Towards the Synthesis 
of Isodomoic Acid B.85 
 
More recent work into the synthesis of isodomoic acids has been carried 
out by B. Read.86 The aim of this project was to extend the work on the N-
benzoyloxazolidine cyclisation87 and continue fragmentation studies towards a 
synthetic route to isodomoic acid B. The proposed route is shown in scheme 39.  
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Reagents and conditions: (a) LiAlH4; (b) (CH2O); (c) p-anisoyl chloride; (d) t-BuLi, DMPU; sat. aq. NH4Cl 
soln. (e) HCl; (f) Me2CuLi; (g) Pd(OAc)2; (h) R′3SnLi or R′3SiLi; (i) RBr; (j) TMSCN; (k) Ca, NH3; (l) 
Boc2O; (m) NaBH4; (n) Pb(OAc)4 (M = Sn) or PhI(OAc)2/I2 (M = Si); (o) NaBH4; (p) base, H2O; (q) 
DIBAlH; (r) Et3SiH, BF3. Et2O; (s) LiHMDS 
Scheme 39: Towards the Total Synthesis of Isodomoic Acid B 
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This route would have been an attractive synthesis towards isodomoic acid 
B as it would avoid the challenging arene oxidation used in previous syntheses. 
Instead it would involve opening of the oxazolidine ring with cyanide which 
could be easily converted into the desired carboxylic acid. 
Large amounts of research centred on the dearomatising cyclisation of 
benzamide 149, the stability of the products formed and the ‘metal’ used for the 
fragmentation. Little success was reported due to difficulties in generating the 
fragmentation precursor and poor results in model fragmentation reactions. 
1.10 Project Aims. 
 
The aim of this project is to extend the work of B. Read86 and K. 
Hebditch82 in the studies towards isodomoic acid series, based on an efficient way 
of diastereoselectively obtaining the desired trisubstituted double bond. Due to the 
little success reported in using a fragmentation reaction, the main aim would be to 
synthesise to a common intermediate that could be regio- and stereoselectively 
functionalised at a late stage to complete the total synthesis of the isodomoic acids 
and numerous ananolgues of the kainoid family. The target would be an alkyne 
intermediate (at the C4 position) which is known to be a good functional group 
for carbometallation chemistry in order to selectively obtain the desired cis and 
trans alkenes (Scheme 40). 
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Scheme 40: Initial Research Points 
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The key step in the synthesis was to apply the unique dearomatising 
cyclisation to the synthesis of an alkyne intermediate. The initial research of the 
project was to concentrate on the dearomatising cyclisation reaction and the 
functional group interconversions to yield the desired alkyne (Scheme 41). This 
included the removal of the protecting group, reduction of a sterically hindered 
amide, oxidation of an aromatic ring and ring cleavage to introduce the required 
ester and alkyne. 
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MeO
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N R2
Ar
N
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O
O
R2
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benzamide
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dearomatised products
 
Scheme 41: Initial Research Points 
 
Once a reliable, robust synthesis to an enantiopure alkyne intermediate 
had been developed, another investigation point was the functionalisation of the 
alkyne.  
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Chapter 2: Research Towards the Synthesis of Domoic 
Acid and the Isodomoic Acid Family. 
 
2.1 Dearomatising Cyclisation Reaction. 
 
As previously discussed, the synthesis of the kainoid family is based 
around a key dearomatising cyclisation to introduce the desired stereochemistry. 
The initial research focussed on benzamides 160, 162 and 165 as these had been 
extensively researched within the Clayden group for the cyclisation reaction 
(Scheme 42). 
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b
OMe
159 160
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163 164 165
 
Reagents and conditions: (a) amine 166, Et3N, DCM; (b) oxalyl chloride, DMF, 12 h 
Scheme 42: Synthesis of Benzamides for the Dearomatising Cyclisation 
 
Sections 2.1.1, 2.1.2 and 2.1.3 detail the previous work with these three 
benzamides and the optimisation of the dearomatising cyclisation reactions. 
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2.1.1 Cyclisation of ortho-Methoxy Benzamides. 
 
The cyclisation reaction using ortho-methoxy benzamide 160 was 
originally studied by K. Hebditch and was reported to result in poor yields of 
166a with trace amounts of the endo epimer 166b and an aromatised by-product 
167 (Scheme 43).82 It was also discovered that the cyclisation would not proceed 
without the presence of DMPU, which was thought to promote anion 
translocation.88 
N
OOMe
Ph
a
N N
O
Ph
H
H
MeO H
H
O
Ph
MeO
N
O
Ph
39% 8% 11%
160
166a 166b 167
 
Reagents and conditions: (a) i. LDA, DMPU, THF, 0 °C, 2 h; ii. NH4Cl. 
Scheme 43: Dearomatising Cyclisation of ortho-Methoxy Benzamide 
  
Attempts to optimise the production of methyl ether 166a by performing 
the reaction under various conditions were unsuccessful in controlling the amount 
of 167 produced, which was throught to be a formed due to regioselectivity issues 
(Scheme 44). 
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168 167
O
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PhO
169
 
Scheme 44: Proposed Mechanism for By-Product Formation 
 
It was possible to hydrolyse the methyl ether 166a by introducing an acid 
wash in the workup procedure, enabling the isolation of enone 170 (Scheme 45). 
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Reagents and conditions: (a) i. LDA, DMPU, THF, 0 °C, 2 h; ii. NH4Cl; iii. 3M HCl aq. 
Scheme 45: Methyl Ether Hydrolysis  
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2.1.2 Cyclisation of para-Methoxy Benzamides. 
 
The cyclisation of para-methoxy benzamide 162 has been reported during 
the research towards the synthesis of (–)-kainic acid and (–)-isodomoic acid C 
(Scheme 46).79,81 
N
O
Ph
N
O
Ph
H
H
N
O
Ph
a
MeO MeOO
162 42% 171 trace 172
 
Reagents and conditions: (a) i. LDA, THF, 0 °C - R.T.; ii. NH4Cl; iii. HCl aq. 
Scheme 46: Dearomatising Cyclisation of para-Methoxy Benzamide 
 
The reaction procedure was repeated a number of times but proved 
difficult to produce consistent yields. Due to the importance of this reaction in the 
synthesis of the kainoid family an optimisation study was carried out at 
AstraZeneca, Loughborough to monitor the reaction profile using a mid-IR probe, 
a UV probe and internal and external temperature probes. The cyclisation studies 
were carried out using para-methoxy benzamide 92 (Scheme 47).  
N
O
Ph
Ph
b
80%
MeO
NH2
a
66%
H
N Ph
Ph Ph
119 173 92
 
Reagents and conditions: (a) K2CO3, DMF, benzyl bromide, 18 h; (b) p-anisoylchloride, Et3N, DCM, 18 h 
Scheme 47: Synthesis of Cumyl Protected Benzamide 
 
Cumylamine was first alkylated with benzylbromide in DMF in 66% yield 
and the resulting amine 173 was coupled with p-anisoylchloride in DCM in 80% 
yield to give benzamide 92. The dearomatising cyclisation was performed using 
LDA at 0 °C and allowed to warm to room temperature over 2 hours, at which 
point the reaction was quenched with saturated ammonium chloride solution. 
Hydrolysis using aqueous HCl solution gave enone 104 in 43% yield with trace 
amounts of the re-aromatised by-product 174 (Scheme 48). 
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Reagents and conditions: (a) i. LDA, THF, 0 °C - R.T. 2 h; ii. NH4Cl; iii. 3M HCl aq. 
Scheme 48: Dearomatising Cyclisation of ortho-Methoxy Benzamide 
 
The data obtained from this reaction showed a number of changes in the 
IR profile, which proved difficult to characterise. The UV spectrum obtained is 
shown in figure 6. 
Figure 6: UV Spectrum Showing the Reaction Profile Between 0 °C and R.T. 
 
The spectra in figure 6 shows a UV scan every minute, represented by the 
different coloured lines. The peak at 431nm developed immediately after adding 
benzamide 92 and was fully formed over thirty minutes. The peak remained until 
the reaction was quenched with ammonium chloride solution. It was proposed that 
the peak at 431nm could be the desired lithium enolate 103 intermediate 
generated after cyclisation.89 To confirm the presence of the lithium enolate 103 
an NMR study was performed on a sample of the reaction at –30 ºC (Fig. 7). 
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Figure 7: Crude 1H NMR Spectrum of the Lithium Enolate Intermediate 
 
1H NMR data shows the resonance at 6.27 (H6), 4.44 (H7), 4.24 (H3), and 
3.26 (H4) ppm, which when compared with predicted ppm data values strongly 
suggests the presence of intermediate 103 (Fig. 8).90 
 
 
 
 
 
 
 
Figure 8: Calculated ppm Values for the Lithium Enolate Intermediate 
 
This sample was allowed to warm slowly to -10 °C recording the 1H NMR 
spectra, which showed minor changes in the aromatic region due to 
conformational effects or restricted rotation of the molecule at lower 
temperatures. 
This initial result suggests that the cyclisation is complete in 30 minutes at 
0 °C as there was no further formation of the lithium enolate intermediate 103. In 
order to investigate the cause for the inconsistent yields the reaction was 
performed at lower temperatures to slow the cyclisation. The reaction was 
repeated at –78 ºC and the temperature was slowly ramped and fixed at 10 ºC 
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intervals until the UV spectrum showed no further formation of the intermediate 
103 at 431nm (Fig. 9, Scheme 48). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: Reaction Profile of the Cyclisation at Various Temperatures 
 
This graph represents the reaction profile at different temperatures which 
shows that the production of the lithium enolate 103 (line of triangles) fits 1º 
kinetics (light blue line) and the rate clearly increases as the temperature 
increases. Based on this data, performing the reaction at -40 ºC was concluded as 
a suitable rate of reaction for the cyclisation to be complete in approximately 2 
hours. The dearomatising cyclisation was repeated at a fixed temperature of -40 
°C and the reaction profile was recorded (Scheme 49, Fig. 10). 
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Figure 10: Reaction Profile of the Cyclisation Performed at -40 °C 
 
The reaction profile shows the cyclisation was complete after 2 hours and 
so was quenched shortly after with saturated ammonium chloride solution. The 
solution yield assay calculated a yield of 94% and after purification it was 
pleasing to obtain a greatly improved 79% yield of the methyl ether 95 with no 
trace of the re-aromatised by-product 174 (Scheme 49). 
N
O
Ph
Ph
a
79%MeO MeO
N
Ph
O
Ph
H
H
92
95
 
Reagents and conditions: (a) i. LDA, THF, -40 °C, 2 h; ii. NH4Cl. 
Scheme 49: Modified Dearomatising Cyclisation Reaction 
 
By introducing a 1M hydrochloric acid wash in the work-up, it is possible 
to perform the hydrolysis and obtain the more stable enone 104 in an excellent 
85% yield from benzamide 92. The amended procedure has been repeated on up 
to a six gram scale using either the cumyl benzamide 92 or the tert-butyl 
benzamide 162 with reproducible yields (Scheme 50). 
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Reagents and conditions: (a) i. LDA, THF, -40 °C, 2 h; ii. NH4Cl; iii. HCl aq. 
Scheme 50: Optimised Dearomatising Cyclisation Reaction 
 
In conclusion, this study has shown that the lithium enolate is an unstable 
species if left for prolonged periods of time at high temperatures and that it is 
possible to obtain a substantial increase in yield with the elimination of re-
aromatisation, by performing the reaction at -40 °C for 2 hours. 
2.1.3 Cyclisation of ortho,para-Methoxy Benzamides. 
 
The dearomatising cyclisation using ortho,para-methoxy benzamide 165 
has been previously reported by K. Hebditch to result in 40% yield of the enone 
177 (Scheme 51).82  
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Reagent and conditions: (a) i. LDA, THF, 0 °C, 2 h; ii. NH4Cl; iii. HCl aq. 
 
Scheme 51: Dearomatising Cyclisation of ortho,para-Methoxy Benzamide 170 
 
The reaction was performed with an internal UV probe using ortho,para-
methoxy benzamide 178. The results showed the progressive formation of the 
intermediate lithium enolate 179, at 401nm, over a 2 hour period giving a yield of 
62% (Scheme 52, fig. 11).  
MeO
N
OLi
Ph
Ph
OMe
H
179
OMe
MeO
N
O
Ph
Ph O
N
O
Ph
Ph
MeO
H
H
62% 180178
a
 
Reagent and conditions: (a) i. LDA, THF, 0 °C, 2 h; ii. NH4Cl; iii. HCl aq. 
 
Scheme 52: Dearomatising Cyclisation of ortho,para-Methoxy Benzamide 
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Figure 11: UV Spectrum for the Dearomatising Cyclisation of ortho,para-Methoxy Benzamide 
 
In an attempt to further optimise the yield of the reaction, various reaction 
temperatures were tested which resulted in poor yields and recovery of the 
starting benzamide 178. This was thought to be due to poor rates of cyclisation (at 
low temperatures) and decomposition of intermediate 179 (at higher 
temperatures).  
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2.2 Eschenmoser Fragmentation Route. 
 
The first strategy towards the alkyne intermediate previously discussed in 
section 1.12, was to employ an Eschenmoser fragmentation reaction to generate 
an alkyne in the C4 position of the pyrrolidine ring. This work has been carried 
out in collaboration with Dr. J. Toueg. 
This strategy had been previously explored by K. Hebditch with limited 
success performing the fragmentation.82 It was reported that under acidic 
conditions no reaction was observed and only starting material was recovered. 
When using basic conditions the reaction resulted in the decomposition of the 
starting epoxide 182 (Scheme 53).  
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36%
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160 181 182 183
 
Reagents and conditions: (a) i. LDA, DMPU, THF, 0°C; ii. NH4Cl; iii. TFA, chloroform, reflux; (b) 5M 
NaOH, H2O2, MeOH; (c) i. mesitylene-2-sulfonyl hydrazine, AcOH, DCM or; ii. 2,4-
dinitrobenzenesulfonylhydrazine, pyridine, THF or; iii. Benzenesulfonyl hydrazine, AcOH, DCM. 
Scheme 53: Previous Attempts to Perform an Eschenmoser Fragmenation 
 
The observed decomposition using basic conditions was thought to be due 
to the acidity of the ring junction hydrogen (highlighted in red) being 
deprotonated prior to fragmentation. Therefore, the initial research of this project 
was aimed at introducing a lactam reduction in order to reduce the acidity at the 
ring junction and prevent decomposition. The retrosynthetic route is shown in 
scheme 54.  
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Scheme 54: Retrosynthetic Route 
 
It was envisaged that alkyne A could be formed from employing the 
fragmentation reaction on the epoxide precursor B. This could be synthesised by 
performing multiple functional group interconversions from enone D, which is 
derived from the dearomatising cyclisation reaction using either ortho-methoxy 
benzamide or ortho,para-methoxy benzamide, F. The plan was to work on two 
synthetic routes. The first route used ortho-methoxybenzamide 160/184 as the 
starting material (Scheme 55).  
N
O
R'
Ph
OMe
N
O O
Ph
H
H
NP
O
Ph
H
H
NP
O
Ph
H
H
O
NP
CO2R
O
H
H
R' = Me (170) or Ph (185)
NP
O
CO2R
H
H
O
a b
c
d
e
fP = Protecting group
R = alkyl chain
186
187 188
189190
R'
NP
R' = Me (160) 
      or Ph (184)
 
Reagents and conditions: (a) dearomatising cyclisation; (b) lactam reduction and alcohol oxidation; (c) 
protecting group removal and replacement; (d) epoxidation; (e) arene oxidation; (f) Eschenmoser 
fragmentation 
Scheme 55: Proposed Synthesis of the Desired Alkyne from ortho-Methoxy Benzamide 
 
 
 
 
                                                      Chapter 2: Results and Discussion 
69 
As discussed in section 2.1.1, it is possible to obtain enone 170/185 by 
performing the cyclisation reaction with an acidic work-up using either the cumyl 
protected benzamide 184 or tert-butyl protected benzamide 160 (step a). 
 Reduction of the lactam could then be attempted followed by oxidation to 
obtain the desired enone functionality. Removal of the protecting group and 
replacement with a more stable group, which is necessary in order to perform the 
arene oxidation could then be completed (steps b - c). Enone 187 could then be 
epoxidised followed by phenyl oxidation to give the ester 189 (Step d - e), which 
using basic conditions should fragment to give the desired alkyne 190 (step f). 
An alternative route was to use ortho,para-methoxy benzamide 165/178 as 
the starting material for the synthesis (Scheme 56). The same or similar steps 
would apply as described previously but the advantage of using enone 177/180 
would be the ability to generate the enone 187 via an elimination reaction after 
lactam reduction. 
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Reagents and conditions: (a) dearomatising cyclisation; (b) lactam reduction; (c) protecting group removal 
and replacement; (d) enone formation; (e) epoxidation; (f) arene oxidation; (g) Eschenmoser fragmentation. 
Scheme 56: Proposed Synthesis of the Desired Alkyne from ortho,para-Methoxy Benzamide 
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2.2.1 Lactam Reduction Attempts. 
 
After successfully synthesising the dearomatised products 166, 170 and 
177 (described in sections 2.1.1 and 2.1.3), several lactam reduction attempts 
were performed. Initial reactions were carried out on methyl ether 166 using the 
conditions detailed in table 2 (Scheme 57). 
N
O
PhH
H
N
PhH
H
MeO
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MeO
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Reagents and conditions: (a) conditions in table 2; ii. Et3SiH, BF3.OEt2, THF, -78 °C, 2 h (entries 1-3 only) 
Scheme 57: Lactam Reduction Attempts 
 
Entry Conditions Temp. Equiv. Time 
(hours) 
Result 
1 BH3, THF Reflux 3 2  166 recovered 
2 BH3. Me2S, THF56 Reflux 2 1  166 recovered 
3 DIBAlH, THF Reflux 4 18  Decomposition 
of 166 
4 LiAlH4, THF -78 ºC 4 18  166 recovered 
5 LiAlH4, AlCl3, THF -10 °C 2 18  166 recovered 
6 AlH3, THF R.T. 2 18  166 recovered 
7 Red Al, Toluene Reflux 2 48 166 recovered 
8 LiAlH4, THF Reflux 5 18 Decomposition 
of 166 
 
Table 2: Lactam Reduction Attempts 
 
The lactam proved resistant to borane reagents and starting material was 
recovered on each attempt (entries 1 and 2). Using harsher conditions, including 
LiAlH4 at reflux, were also unsuccessful causing decomposition of the starting 
material (entries 3, 7 and 8). 
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Various reduction conditions were also used in an attempt to reduce the 
lactam in enone 170 (Scheme 58, table 3). 
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Reagents and conditions: (a) conditions in table 3; ii. Et3SiH, BF3.OEt2, THF, -78 °C, 2 h (entries 1, 5 and 6 
only) 
Scheme 58: Lactam Reduction Attempts 
 
Entry Conditions Temp. Equiv. Time 
(hours) 
Result 
1 DIBAlH, THF -78 ºC 5 18  82% 195 
2 LiAlH4, THF -78 ºC 5 18  66% 195 
3 LiAlH4, THF R.T. 5 18 90% 196 
4 LiAlH4, THF Reflux 5 6 Decomposition 
of 170 
5 BH3, THF Reflux 3 2  Decomposition 
of 170 
6 BH3. Me2S, THF Reflux 3 1  Decomposition 
of 170 
 
Table 3: Lactam Reduction Attempts 
 
Unfortunately, reduction of the lactam was not observed using DIBAlH, 
borane complexes or LiAlH at -78 °C, resulting in the reduction of the alkene to 
give ketone 195 (entry 1 and 2).91  At room temperature, LiAlH4 gave complete 
reduction of the enone and alcohol 196 was isolated in 90% yield (entry 3).90 
Lactam reduction of enone 176 was also researched using the conditions 
detailed in table 4 (Scheme 59). 
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Reagents and conditions: (a) conditions in table 4; ii. Et3SiH, BF3.OEt2, THF, -78 °C, 2 h (used in entries 1, 
2, 3 and 8) 
Scheme 59: Lactam Reduction Attempts 
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Entry Conditions Temp. Equiv. Time 
(hours) 
Result 
1 BH3, THF Reflux 3 2  76% 198 
2 BH3. Me2S, THF Reflux 3 1  82% 198 
3 DIBAlH, THF Reflux 5 6  44% 198 
4 LiAlH4, THF -78 ºC 5 18  62% 198 
5 LiAlH4, THF 0 ºC 5 4 32% 199 
7 LiAlH4, THF Reflux 5 6 Decomposition 
of 176 
8 Super-H, THF Reflux 4 6 Decomposition 
of 176 
 
Table 4: Lactam Reduction Attempts 
 
Lactam reduction in enone 176 was unsuccessful using the conditions 
detailed in table 4. LiAlH4 at -78 °C or borane complexes resulted in the reduction 
of the enone only, giving allylic alcohol 198 (entry 1, 2 and 4). Using LiAlH4 at 0 
°C resulted in the over-reduction of enone 176 giving substrate 199 in 32% yield 
(entry 5). Under harsher conditions, including LiAlH4 or Super-H (LiEt3BH) at 
reflux resulted in complete decomposition of the starting material (entry 7 and 8). 
The limited success in the lactam reduction was thought to be due to the 
substrates considerably confined bicyclic structure preventing initial hydride 
attack, as the hemiaminal was never observed. Literature searches showed that 
there are a limited number of publications reporting lactam reductions in bicyclic 
systems, but this transformation can be made easier by introducing a Boc 
protecting group and reducing a more reactive carbamate protected amide. 
Therefore research concentrated on the cleavage of the protecting group and 
replacement with a Boc group.  
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2.2.1.1 tert-Butyl Group Cleavage. 
 
During the development of the dearomatising cyclisation it became clear 
that for successful results the use of a tert-butyl or a cumyl group was needed as 
the amide protecting group.69 tert-Butylamine was a readily available starting 
material and so methods to cleave the tert-butyl group from the dearomatised 
products were explored.  
A recent publication by Alterman and co-workers92 reported the use of 
scandium triflate to cleave tert-butyl groups from acyclic benzamides (Scheme 
60). 
N
H
O
a NH2
O
96%
200 201
 
Reagents and conditions: (a) Sc(OTf)3 (1.5 eq.), CH3NO2, reflux 
Scheme 60: tert-Butyl Cleavage 
 
These conditions were tested on acyclic benzamide 160 and dearomatised 
products 170 and 176 (Scheme 61).  
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Reagents and conditions: (a) Sc(OTf)3 (1.5 eq.), CH3NO2, reflux 
Scheme 61: tert-Butyl Cleavage Attempts 
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Acyclic benzamide 160 was successfully cleaved with scandium triflate 
and free amide 202 was obtained in 97% yield. However, the bicyclic amides 
were unsuccessfully deprotected and resulted in recovery of the starting material 
or decomposition after prolonged reaction times. 
The publication does not comment on the use of scandium triflate for the 
removal of tert-butyl group from cyclic amide, but it has been shown in our 
bicyclic substrates that it was not possible to cleave the tert-butyl group. 
Other published examples of tert-butyl removal involve harsh acidic 
conditions, including conc. H2SO4, which were tested on enone 176 (Scheme 62 
and table 5). 
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Reagents and conditions: (a) conditions in table 5 
Scheme 62: tert-Butyl Cleavage Attempts 
 
Entry Conditions Temp. Time 
(hours) 
Result 
1 TFA Reflux 16 176 recovered 
2 H2SO493 55 ºC 3 70% 204 
3 HBr R.T. 3 trace 204 
 
Table 5: tert-Butyl Cleavage Attempts 
 
Surprisingly, it was possible to perform the deprotection and isolated 
amide 204 in 70% yield using concentrated sulfuric acid (H2SO4). Due to the 
successful deprotection of enone 176, it was decided to concentrate exclusively on 
the ortho, para-methoxybenzamide 165 route (Section 2.2, Scheme 56). 
2.2.1.2 Reprotection. 
 
It had been decided to introduce a Boc protecting group as it had been 
previously shown to be stable during the phenyl oxidation reaction and it is also 
known that reducing a Boc protected amide requires milder reduction conditions, 
as the protecting group increases the susceptibility of hydride attack. 
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Previous research within the Clayden group has shown that protecting 
these types of substrates using Boc anhydride can be problematic.89 Research 
carried out during the synthesis of α-methyl kainic acid has shown that the 
protection of amide 205 using standard conditions can result in the formation of 
the enol carbamate 206 (Scheme 63). 
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O H Ar
NBoc
O
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205 73% 206 6% 207
 
Reagents and conditions: (a) Boc2O, DCM, Et3N, DMAP, 12 h. 
Scheme 63: Previously Reported Boc Protection 
 
Considering this problem, various conditions were tested in an attempt to 
protect amide 204 with Boc anhydride. Crude 1H NMR analysis was used to 
determine the ratio of the products produced (Scheme 64, table 6). 
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Reagents and conditions: (a) conditions in table 6 
Scheme 64: Boc Protection Attempts 
 
 
Entry Conditions Equiv. of 
Boc2O 
Time 
(hours) 
Ratio by crude 
NMR 
(204:208:209) 
1 Boc2O, NaHCO3, DCM 1.05 18 8:1:1 
2 Boc2O, Et3N, DCM 2 18  5:1:3 
3 Boc2O, DMAP (cat.), CH3CN 1.05 18   6:2:3 
4 Boc2O, DMAP (cat.), DCM, 
Et3N 
0.95 1 5:1:2 
5 Boc2O, NaH, THF 1 2 5:4:1 
 
Table 6: Boc Protection Attempts 
 
The results in table 6 suggest that it would be challenging to obtain the 
desired protected product 208 without the formation of the unwanted enol 
carbamate 209. Using Boc anhydride with triethylamine in DCM suggests the 
preferential formation of the enol carbamate 209 (entries 2 and 4). However, 
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when sodium bicarbonate or catalytic amounts of DMAP are used there is no 
clear favoured formation of the desired product 208 (entries 1 and 3). A good 
ratio of the desired product 208 was obtained when using sodium hydride in THF 
(entry 5). As a result of the improved ratio of products using NaH, a study was 
carried out to determine what effect the reaction time has on the ratio of products. 
Three reactions were performed under the same conditions but with varying 
reaction times (Scheme 65, table 7). 
NH
O
Ph
H
H
MeO
O
NBoc
O
Ph
H
H
MeO
O
a
NBoc
OBoc
PhH
OMe
O
204 208 209
 
Reagents and conditions: (a) Boc2O, NaH, DCM. 
Scheme 65: Boc Protection Attempts 
 
Entry Equiv. 
of NaH 
Equiv. of 
Boc2O 
 
Time 
(mins) 
 
Ratio by crude NMR 
(204:208:209) 
1 1 1 10 8:2:0 
2 1 1 20 5:3:2 
3 1 1 30  3:4:3 
 
Table 7: Boc Protection Attempts 
 
The results suggest that the initial stages of the reaction involve the 
formation of the desired product 208 and once this has formed it then reacts 
further to give the unwanted enol carbamate 209. An explanation for this 
observation was that after the initial protection on the nitrogen the t-butoxide ions 
which are generated as a by-product, could deprotonate the product 208 to form a 
nucleophilic enolate which reacts with remaining Boc anhydride. In an attempt to 
avoid this, the source of the Boc protecting group was changed from Boc 
anhydride to 2-(Boc-oxyimino)-2-phenylacetonitrile 34 (Boc-ON) as this reagent 
generates non-basic by-products. 
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The reaction was repeated with varying equivalents of Boc-ON (34) and 
sodium hydride (Scheme 66, table 8). 
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Reagents and conditions: (a) Boc-ON, NaH, DCM. 
Scheme 66: Boc Protection Attempts using Boc-ON 
 
 
Entry Equiv. 
of NaH 
Equiv. of 
Boc-ON 
Time 
(hours) 
 
Results 
1 1 1 18 40% 204, 48% 208, 0% 209 
2 1.2 1.2 2 15% 204, 59% 208, 10% 209 
3 2.5 5 2 5% 204, 36% 208, 30% 209 
 
Table 8: Boc Protections Attempts using Boc-ON 
 
By using one equivalent of Boc-ON and sodium hydride, 48% of the 
desired product 208 was isolated with recovered starting material (entry 1). 
Unfortunately, attempting to increase the yield by increasing the equivalents of 
either Boc-ON or sodium hydride resulted in formation of the enol carbamate 209 
(entries 2 and 3).  
An alternative explanation for the formation of the enol carbamate was 
that there may only be partial deprotonation of the free amide 204 using sodium 
hydride in solution. This could cause competing deprotonation with the 
preferential formation of the enol carbamate. To ensure complete deprotonation of 
the starting amide 204 a strong, bulky base was employed prior to the addition of 
Boc-ON (Scheme 67, table 9).  
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Reagents and conditions: (a) i. LDA, 0°C, THF, 20 mins; ii. Boc-ON. 
Scheme 67: Boc Protection Attempts using Boc-ON 
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Entry Equiv. 
of LDA 
Equiv. of 
Boc-ON 
Time 
(hours) 
 
Results 
1 1 1 4 60% 204, 30% 208 
2 1.2 1 4 79% 208 
3 1.5 1 2 87% 208 
 
Table 9: Boc Protection Attempts using Boc-ON 
 
Pleasingly, the formation of the enol carbamate was stopped by using 
LDA and the desired product was obtained in 30% yield with 60% recovered 
starting material (entry 1). The reaction was optimised further by using 1.5 
equivalents of base to obtain 87% yield of the desired protected amide 208. These 
results suggest that the use of a sterically hindered base prevents the formation of 
the nucleophilic enolate during the reaction. 
2.2.2 Reduction of Lactam 208. 
 
As previously discussed in section 2.2.1, the reduction of the lactam in 
bicyclic substrates has proved difficult. With the introduction of the Boc 
protecting group, the amide carbonyl group is more electrophilic than the previous 
t-butyl amide, therefore should require milder conditions to reduce. Table 10 
shows the conditions used in an attempt to reduce lactam 208 (Scheme 68). 
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Reagents and conditions: (a) i. conditions in table 10; ii. Et3SiH, BF3.OEt2, THF, -78 °C, 2 h (used in entries 
1-5) 
 
Scheme 68: Lactam Reduction Attempts 
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Entry Conditions Temp./Time (hours) 210 211 212 213 
1 BH3, THF -78 °C to R.T./18 h 0% quant. 0% 0% 
2 BH3.DMS, THF -78 °C to R.T./18 h 0% quant. 0% 0% 
3 DIBAlH, THF -78 °C/1h 0% quant. 0% 0% 
4 DIBAlH, THF -78 °C to R.T./18 h /* /* /* /* 
5 DIBAlH, DCM -78 °C/3 h 0% quant. 0% 0% 
6 LiAlH4, THF -78 °C/1h 0% quant. 0% 0% 
7 LiAlH4, THF 0°C/3 h 0% ¥ ¥ 0% 
8 LiAlH4, THF 0 °C to R.T./24 h 0% 0% quant. 
(crude) 
0% 
9 LiAlH4, THF R.T/24 h - 50 °C/3 h 0% 0% 0% 47% 
* Decomposition of starting material, ¥ Mixture of 211 and 212 
Table 10: Carbamate Reduction Attempts 
 
Enone 208 was resistant to lactam reduction using borane complexes, 
DIBAlH at low temperatures or LiAlH4 at low temperature and only reduction of 
the enone was observed in alcohol 211. However, it was found that using LiAlH4 
at a higher temperature led to the partial reduction of the amide carbonyl resulting 
in a mixture of hemiaminals 212 and 212' (entry 7 and 8). Furthermore, heating 
this reaction to 50 °C led to the complete reduction of the amide but also the 
reduction of the Boc group giving the N-methyl substrate 213 in 47% yield (entry 
9). 
Purification of hemiaminal 212 proved difficult and so an elimination 
reaction was performed on the crude material using mild acidic conditions 
(Scheme 69, table 11). 
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Reagents and conditions: (a) i. LiAlH4, THF, 0 °C- R.T., 24 h; ii. PTSA, conditions in table 11. 
Scheme 69: Elimation Reaction Attempts 
 
Entry Solvent 214 (%) 215 (%) 
1 THF 10 18 
2 MeOH 10 / 
 
Table 11: Elimination Reaction Attempts 
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In THF, the elimination product 214 was observed in 10% yield with the 
formation of an unwanted elimination product 215 in 18% yield (entry 1). To 
avoid the undesired elimination the reaction was repeated in methanol, which was 
successful, however the yield was poor, 10% (entry 2).  
The cause for the poor yields was thought to be the use of LiAlH4 in the 
reduction step, as it proved difficult to remove from the reaction mixture and so 
product may have been lost. The initial reduction was repeated using LiEt3BH 
(Super-H), which was easier to remove from the reation mixture. After 
performing the elimination and the hemiaminal cleavage on the crude material, 
the desired amine 216 was purified in 32% yield over the 3 steps (Scheme 70). 
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Reagents and conditions: (a) i. LiEt3BH, THF, 0°C-R.T., 24 h; ii. PTSA, MeOH; iii. Et3SiH, BF3.OEt2, -78 
°C, 2 h. 
Scheme 70: Optimised Lactam Reduction and Elimination Procedure 
2.2.3 Enone Epoxidation. 
 
The remaining steps to the Eschenmoser precursor include the oxidation of 
a phenyl ring and epoxidation of the enone. The arene oxidation could not be 
performed in the presence of the enone as it would be destroyed by an unwanted 
oxidation. Therefore it was decided to perform the epoxidation prior to the phenyl 
oxidation to prevent unwanted reactions. The Clayden group has previously 
shown that using Sharpless’s oxidation conditions, it was possible to perform an 
arene oxidation reaction in the presence of epoxide functionality.89,94 Enone 216 
was subjected to various epoxidation conditions detailed in table 12 (Scheme 71). 
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Reagents and conditions: (a) conditions in table 12 
Scheme 71: Epoxidation Attempts 
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Entry Oxidant Base 
(equiv.) 
Conditions Yield 
1 H2O2 NaOH  THF, 0°C - R.T., 2 h 216 
2 H2O2 NaOH (1.5) MeOH, -5°C, 0.5 h 42%, 217 
3 H2O2 NaOH 
(0.45) 
MeOH, 0°C, 1.5 h 216 
4 H2O2 K2CO3 (2) THF/MeOH/H2O, 
0°C - R.T., 2 h 
54%, 217 
5 H2O2 K2CO3 (1.1) THF/MeOH/H2O, 
0°C, 0.5 h 
59%, 217 
6 H2O2 Triton B (4) THF, 0°C, 2 h 216 
 
Table 12: Epoxidation Attempts 
 
It was possible to obtain the desired epoxide 217 in a moderate 42% yield 
using hydrogen peroxide with excess NaOH (entry 2). The yield was successfully 
increased to 59% by replacing the base with K2CO3 and performing the reaction in 
a mixed solvent system of THF, methanol and water (entry 5). 
In all the successful examples shown in table 12, the epoxidation was 
diastereoselective with the attack of the oxidant on the exo face. It was possible to 
obtain an X-ray crystal structure to confirm the expoxide configuration. 
 
 
Figure 12: X-ray Crystal Structure 
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2.2.4 Phenyl Oxidation. 
 
With the successful epoxidation of enone 216 it was then possible to perform 
the phenyl oxidation reaction. The oxidation was performed on epoxide 217 using 
Sharpless’s oxidation conditions (Scheme 72).93 
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Reagents and conditions: (a) i. RuCl3, NaIO4, EtOAc/H2O/CH3N, 24 h, R.T.; ii. TMS-CHN2, 
MeOH/Toluene, R.T. 
Scheme 72: Phenyl Oxidation Attempts 
 
The phenyl ring in epoxide 217 proved resistant to the oxidation 
conditions and only starting material was recovered. The reaction was repeated 
with prolonged reaction times and increased equivalents of sodium periodate with 
little success.  
In order to perform the desired oxidation, the arene ring would need to be 
more electron rich making it more susceptible to oxidation.95 Prior to research 
into an appropriate arene ring to perform the oxidation, model studies into 
conditions needed for the Eschenmoser fragmentation using epoxyketone 217 
were explored.  
2.2.5 Eschenmoser Fragmentation Model Studies. 
 
The Eschenmoser fragmentation reaction was first discovered in 1967 by 
Albert Eschenmoser and involves an α, β-epoxy ketone and an aryl 
sulfonylhydrazine to give an alkyne and aldehyde products.96 Under acidic 
conditions the fragmentation is catalysed by electrophilic activation of the 
epoxide and using basic conditions initiate the fragmentation by deprotonation of 
the hydrazone (Scheme 73). 
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Scheme 73: Acid/Base Catalysed Eschenmoser Fragmentation Mechanism 
 
Epoxyketone 217 was subjected to a number of different conditions to 
form the hydrazone, followed by fragmentation (Scheme 74, table 13). 
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Reagents and conditions: (a) conditions in table 13 
Scheme 74: Eschenmoser Fragmenation Attempts 
 
Entry Conditions Temp. Time 
(hours) 
Result/comment 
1 p-nitrobenzenesulfonyl 
hydrazide, pyridine, 
EtOH/THF97 
R.T. 4 217 recovered 
2 TsHN-NH2, EtOH, 
AcOH98 
50 °C 4 Intermediate 224 followed 
by recovery of 217 
3 TsHN-NH2, EtOH, 
Pyridine97 
50 °C 4 Intermediate 224 followed 
by recovery of 217 
4 TsHN-NH2, AcOH, 
DCM97, 99 
R.T. 8 31% 225 
5 Mesitylenesulfonyl 
hydrazide, AcOH100 
R.T. 36 21% 223 
 
Table 13: Eschenmoser Fragmentation Attempts 
 
The results show that using an electron poor p-nitrobenzenesulfonyl 
hydrazine resulted in no reaction (entry 1). Using toluenesulfonyl hydrazine in 
ethanol gave intermediate 224, which when subjected to acidic and basic 
conditions resulted in the regeneration of ketone 217 (entries 2 and 3). To avoid 
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this unwanted intermediate 224, the solvent was changed to DCM and in acidic 
conditions the fragmentation was observed and gave alkyne 225 in 31% yield 
(entry 4). Alkyne 225 bears an unwanted toluenesulfonyl hydrazone and was 
thought to have formed because of competing rates of hydrazone formation 
between the ketone and the newly formed aldehyde. To overcome this problem it 
was decided to use a more hindered hydrazine to slow down the rate of hydrozone 
formation. Mesitylsulfonyl hydrazine gave a successful fragmentation reaction 
and the desired alkyne 223 was isolated in 21% yield (entry 5). 
2.2.6 Arene Oxidation. 
 
As discussed in section 2.2.4, the phenyl ring in epoxyketone 217 proved 
resistant to the oxidation conditions. Previous research within the group has 
shown that increasing the electron density of the arene ring enhances the 
susceptibilty of oxidation and was reported in the synthesis of arylkainoid 229 
(Scheme 75).101 
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Reagents and conditions: (a) i. cat. RuCl3, NaIO4 (100 equiv), EtOAc/H2O/CH3N (1:34:1); ii. TMS-CHN2, 
MeOH/Benzene. 
Scheme 75: Oxidation Reaction of Electron Rich Aromatic Ring 
 
To achieve the desired oxidation, the phenyl group was replaced with 
methoxy-substituted aromatic rings and benzamides 232, 236 and 240 were 
synthesised (Scheme 76). 
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Reagents and conditions: (a) tert-butylamine, K2CO3, DMF, 18 h; (b) 2,4-dimethoxybenzoyl chloride, Et3N, 
DCM, 18 h; (c) i. LDA, 0 °C, THF, 2h; ii. NH4Cl; iii. 1M HCl aq.; (d) cumylamine 119, K2CO3, DMF, 18 h; 
(e) i. tert-butylamine, DCM, AcOH, 2 h; ii. NaBH(OAc)3, 3 d; (f) 2,4-dimethoxybenzoyl chloride, Et3N, 
DCM, 18 h. 
Scheme 76: Synthesis of Electron Rich Benzamides and Dearomatising Cyclisation Reactions 
 
There were concerns that changing the electronic properties of the 
benzamides may affect the dearomatising cyclisation reaction but this was only 
slightly observed in the yields obtained. Using benzamide 232, enone 233 was 
isolated in 37% yield. However, performing the cyclisation with benzamide 236 
resulted in enone 237 in an improved 64% yield. With a highly increased electron 
rich benzamide 240, enone 241 was isolated in a poor 14% yield, which was 
thought to be due to the addition electron density affecting the acidity of the 
benzylic protons (caused by electron donation from the para-methoxy 
substituent).  
The next step in the synthesis was to remove the tert-butyl group with 
conc. H2SO4 but this proved unsuccessful on enone 233. A number of attempts 
were made resulting in decomposition of starting material after prolonged reaction 
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times. This prompted the use of enone 237 as the cyclisation yield was high and 
the cumyl group could be easily removed in 86% yield using TFA (Scheme 77) 
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Reagents and conditions: (a) TFA, reflux, 1.5 h; (b) LDA, Boc-ON, THF, 0 °C, 5 h; (c) i. LiEt3BH, THF, 0 
°C-R.T., 24 h; ii. PTSA, MeOH; iii. Et3SiH, BF3.OEt2, DCM, -78 °C; (d) t-BuOOH, DBU, THF, 0 °C, 30 
mins. 
Scheme 77: Steps Towards the Desired Epoxyketone 
 
The free amide 242 was protected with the optimised Boc-ON conditions 
(discussed in section 2.2.1.2) and successfully gave 243 in 80% yield. Enone 243 
was then subjected to the reduction and elimination procedure developed in 
section 2.2.2, to give amine 244 in an improved 48% yield over 3 steps. 
Performing the epoxidation with hydrogen peroxide gave epoxyketone 245 in a 
reduced yield of 38%. However, performing the epoxidation with tert-BuOOH 
resulted in an improved 68% yield.102 The arene oxidation reaction was then 
attempted using the newly synthesised epoxyketone 245 (Scheme 78, table 14). 
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Reagents and conditions: (a) i. conditions in table 14; ii. TMS-CHN2, toluene/methanol 
Scheme 78: Arene Oxidation Attempts 
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Entry Reagents Temp. Time 
(mins) 
Yield 
1 RuCl3, NaIO4, CH3CN, 
H2O, EtOAc 
R.T 10 1:1 mixture 
218:246 
2 RuCl3, NaIO4, CH3CN, 
H2O, EtOAc 
0 °C 120 42% 218 
 
Table 14: Arene Oxidation Attempts 
 
Epoxyketone 245 was successfully oxidised at room temperature giving 
methyl ester 218 after esterification with TMS-diazomethane. However, an 
undesired product formed which was thought to be an oxidation α to the nitrogen 
in hemiaminal 246, which was inseparable to the product (entry 1).103 This was 
not surprising as it has been reported that these conditions can oxidise at the α 
position to the nitrogen.103 To avoid the undesired oxidation the reaction 
performed at 0 °C which gave the epoxyketone 218 in 42% yield with no traces of 
the undesired hemiaminal 246 (entry 2). 
2.2.7 Eschenmoser Fragmentation Studies. 
 
Having successfully synthesised the desired precursor to the Eschenmoser 
fragmentation95, epoxyketone 218 was subjected to the fragmentation conditions 
discussed in section 2.2.5 (Scheme 79, table 15).  
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Reagents and conditions: (a) i. conditions in table 15 
Scheme 79: Eschenmoser Fragmentation Attempts 
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Entry Ar 
(Hydrazine) 
Solvent Temp. Time Result/Comment 
1 Mes AcOH/DCM R.T. 4 d < 29% 247 
2 Mes AcOH/DCM 40 °C 2h30 3% 247 
3 Mes AcOH R.T. 4 d <21% 247 
4 Mes AcOH R.T. 7 d (to finish 40 °C for 30 
min) <11% 247 
5 Tol AcOH/DCM R.T. 2 d Decomposition of 218 
6 p-NO2Ph THF R.T. 24 h 218 
 
Table 15: Eschenmoser Fragmentation Attempts 
 
Fragmentation was observed using mesitylenesulfonyl hydrazine in acetic 
acid at room temperature but due to purification difficulties the resulting aldehyde 
was isolated in less than 29% yield (entry 1). Different hydrazines were tested, 
including toluenesulfonyl hydrazide (entry 5) and p-nitrobenzenesulfonyl 
hydrazide (entry 6) with no observed fragmentation.  
In an attempt to increase the yield by trapping the apparently unstable 
aldehyde as a hydrazone (cf. 225). The reaction was repeated using an additional 
equivalent of mesitylenesulfonyl hydrazine but resulted in a complex mixture of 
products.104 With little success isolating the hydrazone, reactions were performed 
using the solvent as the trapping agent (Scheme 80, table 16).  
NBoc
H
H
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O
H
H
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CO2Me
NBoc
EtO CO2Me
H
H
EtO
218 248
 
Reagents and conditions: (a) mesitylenesulfonyl hydrazine, EtOH, AcOH, R.T. (see table 16) 
Scheme 80: Fragmentations using a Solvent Trapping Agent 
 
 
Table 16: Eschemoser Fragmenation Attempts 
 
Entry Time 
(hours) 
Additives Conc. Result/Comment  
1 4 N/A 0.1 M 15% 248 
2 22 N/A 0.1 M 11% 248 
3 4 4 Ǻ MS 0.1 M 218 
4 3 AcOH 
(10%) 
0.1 M Mixture of 248 and 247, 
trace 
5 5 N/A 0.5 M 11% 248 
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Performing the reaction for 4 hours at room temperature gave the desired 
product 248 in 15% yield (entry 1). Attempts to increase the yield using additives 
were unsuccessful and resulted in the recovery of starting material (entry 3) or 
low yielding mixtures of the desired 247 and 248 (entry 4). 
2.2.8 Enantioselective Dearomatising Cyclisation. 
 
Previous work within the Clayden group in developing enantioselective 
dearomatising cyclisations has highlighted two chiral lithium amides that give 
good enantioselective reactions (Scheme 81).77,79 
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O
O Ph
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NPh Ph
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(−)-isodomoic acid C
Yield
88%
52%
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81%
99%
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66%
34%
ee
73%
99%
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92
(−)-104
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Reagents and conditions: (a) i. n-BuLi, Chiral amide 111/112, -78 °C - R.T.; ii. NH4Cl; iii. HCl aq; 
Scheme 81: Enantioselective Dearomatising Cyclisations 
 
Developing an enantioselective cyclisation reaction using ortho-
methoxybenzamide 249 has proven difficult using chiral amine 111, obtaining a 
maxiumum e.e. of 48% (Scheme 82).82 
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Reagents and conditions: (a) i. n-BuLi, -78 °C - R.T; ii. HCl aq. 
Scheme 82: Enantioselective Dearomatising Cyclisation using Chiral Amide 111 
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Variable temperature NMR has shown restricted rotation in benzamides 
containing ortho-methoxy substituents, which is observed in the splitting of the 
cumyl methyl peaks (Fig. 13). This rotation was assigned to the CO-Ar bond 
rather than amide bond as the observed splitting was not observed in benzamide 
that did not contain an ortho substituent. 
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1.401.501.601.70
 
Figure 13: VT 1H NMR Spectra of Cumyl Peaks in Benzamide 249 
 
These experiments showed coalescence of the methyl signals between 
338K and 343K. Based on this data, the free energy of activation was calculated 
using Eyring equation (∆G‡ = aTc[10.319+log (Tc/k)) at 340 ± 2 K (Tc) to be ∆G‡ 
= 68.4 ± 0.4 kJmol-1.  
This restricted bond rotation was also observed in ortho, para-
methoxybenzamide 177. The variable temperature spectra shows coalescence of 
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the methyl signals between 308 K and 313 K and the free energy of activation 
was calculated at 311 ± 2 K to be ∆G‡ = 62.4 ± 0.3 kJmol-1 (Fig. 14). 
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Figure 14: VT 1H NMR Spectra of Cumyl Peaks in Benzamide 177 
 
The rational for the lower barrier to rotation was due to the additional 
para-methoxy group providing enhanced stability by resonance and lowering the 
activation energy (Scheme 83). 
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Scheme 83: Resonance Forms for Enhanced Transition State Stability 
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2.2.8.1 Enantiomeric Excess Explanations.  
 
A possible explanation for the poor enantiomeric excess was rationalised 
by restricted rotation at low temperatures. Substrates bearing ortho substituents 
are forced to have undesired dihedral angles due to steric hindrance.105 Therefore 
benzamides 177 and 249 can experience atropisomerism and exist as two amide 
enantiomers at low temperatures (Scheme 84). 
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 Reagents and conditions: (a) n-BuLi, Chiral amine 
Scheme 84: Amide Diastereoisomers 
 
Once asymmetrically deprotonated, the organolithium diastereoisomer B 
can cyclise to give the desired product but diastereoisomer B' cannot cyclise due 
to the ortho-methoxy substituent. This organolithium enantiomer (B') would have 
to epimerise in order to cyclise, therefore giving a poor enantiomeric excess. 
A related explanation for the poor enantiomeric excess is based on a 
“match-missmatch” effect. This theory is based on the chiral base asymmetrically 
deprotonating one amide enantiomer successfully and unable to access the correct 
proton in the remaining enantiomer and is therefore forced to take the undesired 
proton resulting in a poor enantiomeric excess. 
An alternative explanation was that anion epimerisation occurs due to the 
higher activation energy for the cyclisation onto a more electron rich arene ring or 
that the generated amide organolithium is deprotonating starting benzamide 
resulting in the observed poor enantiomeric excess. 
Further studies into the behaviour of ortho substituted benzamide 177 at 
low temperatures (-80 °C) revealed additional restrictions in rotation causing the 
presence of diastereoisomers in NMR analysis. This was not believed to 
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contribute to the poor enantioselectivity as the asymmetric deprotonation does not 
occur at -80 °C. 
Little was understood of the stability of the intermediate amide 
organolithium and the rate of cyclisation. Therefore, the explanations for the 
observed enantiomeric excess were speculative and further experiments, including 
deuterium quenching, would have given a better understating to the reaction 
process. 
2.2.8.2 Enantioselective Dearomatising Cyclisation 
Attempts. 
 
Based on the variable temperature calculations, the ortho, para-methoxy 
benzamide enantiomers (177) racemise more rapidly than the ortho-methoxy 
benzamide enantiomers (249) and so enantioselective dearomatising cyclisation 
reactions were performed using chiral amide 111 (Scheme 85, table 17) 
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Reagents and conditions: (a) i. conditions in table 17 
Scheme 85: Enantioselective Dearomatising Cyclisation Attempts 
 
Entry Conditions e.e. Yield 
1 THF, -78 oC – R.T. 52% 36% 179 
2 THF – 30 oC 14% 15% 179 
3 THF 0 oC 23% 18% 179 
4 THF R.T. 27% 21% 179 
5 Et2O/10%THF -30 oC / 177 
6 Et2O/10%THF 0 oC / 177 
7 Toluene / 177 
 
Table 17: Enantioselective Dearomatising Cyclisation Attempts 
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The results in table 17 show that it would be difficult to obtain high 
enantiomeric ratios using chiral amine 111 as the highest obtained was 52% e.e. 
by performing the reaction in THF at -78 °C and warming to room temperature 
(entry 1).  
Chiral amide 112 was also tested under different conditions (Scheme 86, 
table 18). 
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Reagents and conditions: (a) i. conditions in table 18 
Scheme 86: Enantioselective Dearomatising Cyclisation Attempts 
 
Entry Conditions e.e.  Yield  
1 THF, -78 oC – R.T. 48% 30% 179 
2 THF, - 30  oC, 0.5 equiv of chiral amine 73% 12% 179 
3 THF - 20 oC, 2 h 7% 26% 179 
4 THF 0 oC, 2 h 53% 24% 179 
5 THF 10 oC, 2 h 44% 22% 179 
6 THF R.T., 2 h 23% 18% 179 
8 Et2O/10%THF -30 oC, 2 h <10% 20% 179 
7 THF/Et2O 0 oC, 2h 3% 15% 179 
9 Et2O/10%THF 0 oC, 2 h 20% 12% 179 
10 THF/Toluene 0 oC, 2 h 14% 16% 179 
11 Toluene, 0 oC, 2 h SM / 
 
Table 18: Enantioselective Dearomatising Cyclisation Attempts 
 
Disappointingly, it was not possible to obtain a high e.e using chiral amine 
112. It was possible to obtain a 53% e.e. in 24% yield by performing the reaction 
in THF at 0 °C (entry 4).  
In an attempt to gain a further understanding of the asymmetric 
deprotonation, the reaction was performed with half an equivalent of base. The 
result gave an improved e.e. of 73% suggesting that the chiral amide selectively 
deprotonates the amide enantiomer that can cyclise preferentially. This result 
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would promote the restricted rotation explanation for the observed e.e rather than 
anion epimerisation (see 2.2.8.1). 
As enone 179 was not crystalline, it was not be possible to increase the 
e.e. by recrystalisation and so these results confirmed doubts that it would be 
difficult to obtain a high yielding enantioselective dearomatising cyclisation using 
an ortho substituted benzamides. 
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2.2.9 Summary. 
 
In summary it has been shown that using ortho,para-methoxy benzamide 
177 it was possible to synthesise the desired alkyne 248 using an Eschenmoser 
fragmentation (Scheme 87). 
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Reagents and conditions: (a) 3-methoxybenzyl bromide, K2CO3, DMF, R.T., 18 h; (b) 2,4-dimethoxybenzoyl 
chloride, Et3N, DCM, R.T., 18 h; (c) i. LDA, DMPU, THF, 0 °C; ii. 1M HCl; (d) i. TFA, reflux, 1.5 h, quant; 
ii. LDA, Boc-OH, THF, 0 °C, 5 h; (e) i. Super-H, THF, 0 °C - R.T., 24 h; ii. PTSA, MeOH, R.T., 1.5 h; iii. 
Et3SiH, BF3.OEt2, DCM, -78 °C, 2 h; (f) t-BuOOH, DBU, THF, 0 °C, 30 mins; (g) RuCl3, NaIO4, 
EtOAc/H2O/CH3N, 0 °C, 2 h; (h) mesitylsulfonyl hydrazine, EtOH, reflux, 4 h. 
Scheme 87: Summary of Synthetic Route 
 
However, it was decided to develop an alternative route to the desired 
alkyne intermediate that avoids the use of an ortho-substituted benzamides due to 
the problems encountered with performing an enantioselective reaction. It was 
also decided to avoid using the Eschenmoser fragmentation as only poor, 
irreproducible yields were observed.  
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2.3 Baeyer-Villiger Oxidation Route. 
 
An alternative strategy towards the synthesis of the alkyne intermediate 
was based around introducing functionality using a Baeyer-Villiger oxidation 
reaction. The retrosynthetic route is shown in scheme 88. 
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Scheme 88: Retrosynthetic Route 
 
It was envisaged that alkyne A could be made via a formal 
dehydrogenation of alkene B, which could be synthesised via an elimination 
reaction on primary alcohol C. Primary alcohol C could be the product of 
hydrolysis and lactam reduction reactions of unsaturated lactone D. Lactone D 
can be made by performing a regioselective Baeyer-Villiger oxidation on enone E 
which is the product of the dearomatising cyclisation using para-methoxy 
benzamide F. The proposed synthesis is shown in scheme 89. 
                                                      Chapter 2: Results and Discussion 
98 
NBoc
R'O2C
CO2R'
H
H
NBoc
R'O2C
CO2R'
H
H
NBoc
R'O2C
CO2R'
H
H
HO O
NO
O
OH
H Ph
N
O
Ph
OH
HMeO
N
O
Ph
R = Me (251) or Ph (252)
NBoc (253)
NBoc
R'O2C
CO2R'
H
H
HO
NBocO
O
OH
H Ph
NBocO
O
OH
H CO2R'
a
c
d
e
fgh
i
R = Me (162) or Ph (92)
R' = alkyl group
R b
R = Me (171)
R
or Ph (104)
254
255256257258
190
 
Reagents and conditions: (a) dearomatising cyclisation; (b) Baeyer-Villiger oxidation; (c) protecting group 
removal and replacement; (d) hydrogenation; (e) arene oxidation; (f) methanolysis; (g) lactam reduction; (h) 
elimination; (i) alkyne formation. 
Scheme 89: Proposed Synthesis Towards the Alkyne Intermediate  
 
2.3.1 Baeyer-Villiger Oxidation Studies. 
 
The Baeyer-Villiger oxidation reaction was discovered in 1899 and is an 
oxidative cleavage of a carbon-carbon bond adjacent to a carbonyl, which 
converts a ketone into an ester or a cyclic ketone into a lactone.106 The general 
mechanism is shown in scheme 90. 
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Scheme 90: Baeyer-Villiger Oxidation 
 
Since the discovery in 1899 the reaction has been a regularly used 
transformation in organic synthesis.107 The popularity of the reaction is based on 
the uniqueness of the transformation, the stereospecificity and the predictable 
regioselectivity, which is dependant on the substituents adjacent to the carbonyl 
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group and their ability to migrate. With few exceptions, the literature permits the 
generalisation that substituents that are able to stabilize a developing positive 
charge migrate preferentially.108 Mechanistic studies by W. von E. Doering and L. 
Speers, concluded that the migration aptitude supports a mechanism in which the 
migrating group is electron deficient in the transition state.108 The rearrangement 
requires the correct antiperiplanar alignment of the O-O bond of the leaving group 
and the migrating group (Rm), which is classed as the primary stereoelectronic 
effect. The secondary effect is the antiperiplanar alignment of the migrating group 
(Rm) and the oxygen lone pair (Fig. 15). 
O
RRm
O
OH
Primary effect
Secondary effect
ArO
 
Figure 15: Stereoelectronic Effects in the Baeyer-Villiger Reaction 
 
Counter to the generalised migration argument, Kishi et.al. have explored 
the effects of conformation on the Baeyer-Villiger oxidation in bicyclic structures 
and contend that the bond that is anti-periplanar to the dissociating peroxide bond 
is always and exclusively the bond that migrates, even when electronically 
disfavoured from doing so.109 Despite the many investigations on the mechanism 
of the Baeyer-Villiger oxidation, the migratory pattern and the nature that 
influences migration is still not fully understood. 
The Baeyer-Villiger oxidation reaction was previously shown to be 
regioselective in the total synthesis of (±)-kainic acid published by the Clayden 
group (Scheme 91).76 
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Scheme 91: Baeyer-Villiger Oxidation Reaction Towards the Synthesis of (±)-Kainic Acid 
 
The regioselectivity was explained through an exo-face peracid attack 
together with steric interactions with the axial methyl group favouring the 
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intermediate conformation A (Scheme 91). The more favourable migration was 
where the breaking carbon–carbon bond is antiperiplanar to the breaking oxygen–
oxygen bond (shown as bold bonds). 
There are many examples in the literature involving the regioselective 
oxidation of a cyclic enone to the corresponding lactone.110 The theory for the 
preferential migration of the vinyl group is not fully understood, which is 
presumably due to the undefined reaction mechanism.111 Baeyer-Villiger 
oxidation reactions were performed on enone 104 using a number of different 
oxidants detailed in table 19 (Scheme 92). 
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Reagents and conditions: (a) conditions in table 19 
Scheme 92: Baeyer-Villiger Oxidation Attempts with Different Oxidants 
 
Entry Reagent Equiv. Time 
(hours) 
Result 
1 mCPBA, DCM 1 24 171 recovered 
2 mCPBA, DCM 3 48 20% 265, 60% 251 
3 mCPBA, TsOH, DCM 1.5 24 171 recovered 
4 Peracetic acid, DCM 1.5 24 171 recovered 
5 Ozone, DCM 1.5 24 171 recovered 
6 mCPBA, DCM 1 48 30% 171, 55% 251 
7 mCPBA, DCE (60 ºC) 1.5 24 Decomposition of 171 
 
Table 19: Baeyer-Villiger Oxidation Conditions 
 
The results show that the oxidation can be carried out regioselectively 
using mCPBA. Lactone 251 was obtained in 55% yield using one equivalent of 
mCPBA for 48 hour with 30% recovered starting material, which could be 
recycled (entry 6). Attempting to increase the yield by using excess equivalents of 
oxidant resulted in the epoxidation of the desired lactone 251 giving epoxide 265 
in 20% yield (entry 2).112 
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An X-ray crystal structure of lactone 251 was obtained confirming the 
isomer obtained (Fig 15). 
 
Figure 16: X-ray Crystal Structure 
 
A study was carried out on the Baeyer-Villiger oxidation using substrates 
266 and 268 to determine what effect varying functionality has on the 
regioselectivity of the oxidation (Scheme 93).  
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Reagents and conditions: (a) TFA, reflux, 1 h; (b) mCPBA (1 equiv.), DCM, 48 h.; (c) H2, Pd/C, EtOAc. 
Scheme 93: Baeyer-Villiger Oxidation Model Studies 
 
The results show that performing the oxidation on a free NH 266 does not 
affect the regioselectivity of the oxidation. More interestingly, the oxidation 
reaction using ketone 268 gave a 62% yield of an inseparable mixture of lactone 
isomers 269 and 270, in a 5:1 ratio. With the comparable substitution pattern 
NO
O
H
H Ph
O
251
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adjacent to the ketone, this result suggests that the conformation of the starting 
ketone and steric hindrance is causing preferential formation of isomer 269. 
Substrates 271 and 274 were also synthesised to observe the effect on the 
ratio of products by changing surrounding functionality of ketone 268 (Scheme 
94).  
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Reagents and conditions: (a) i. TFA, reflux, 1 h; ii. Boc2O, DMAP (cat.), DCM, Et3N; (b) mCPBA (1 equiv.), 
DCM, 48 h.; (c) i. RuCl3, NaIO4, EtOAc/H2O/CH3N; ii. TMS-CHN2, MeOH/toluene. 
Scheme 94: Baeyer-Villiger Oxidation Model Studies 
 
Changing the surrounding functional groups in ketone 268 had minimal 
effect on the ratio of products suggesting that they have little effect on the 
conformation of the bicycle. 
This study has shown that there is an inherent preference for the desired 
regioisomer using saturated ketone bicycles, which could be caused by 
conformation and steric hindrance. However, to obtain complete regioselectivity 
the presence of unsaturation is essential. Further understanding of the Baeyer-
Villiger oxidation could be obtained by synthesising the reaction intermediate in a 
stable form and the crystal structure data would suggest reason for the preferential 
formation of isomer 251. 
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A summary of all the Baeyer-Villiger oxidation reactions performed 
within the group with bi-cyclic structures is shown in scheme 95 and table 20. 
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Reagents and conditions: (a) mCPBA, DCM 
Scheme 95: Summary of Baeyer-Villiger Oxidation Within the Clayden Group 
 
Structure R1 R2 R3 Yield Ratio 
A / / / 52% 1:0 
B Cumyl H / 55% 1:0 
B t-butyl H / 54% 1:0 
B t-butyl Me / + 1:1* 
B t-butyl H / 37% 1:0 
C Boc Me CO2Me 88% 1:0 
C Cumyl H Ph + 5:1* 
C Boc H Ph + 3:1* 
C Boc H CO2Me + 3:1* 
C¥ Cumyl SiMe3 Ph 99% 1:0 
C¥ Boc SiMe3 CO2Me 99% 1:0 
D¥ Boc SiMe3 CO2tBu 93% 1:0 
*Ratio of inseparable isomers, determined by 1H NMR; ¥ Reactions discussed in section 2.4; 
+ Yield not determined 
Table 20: Summary of Baeyer-Villiger Oxidations Within the Clayden Group 
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In all the examples shown in table 20 there is a preferencial formation for 
one regioisomer. These results have concluded a generalisation that in order to 
obtain complete regioselectivity in our bicyclic substrates there is a requirement 
of either unsaturation or a substituent β' to the carbonyl group.    
2.3.2 Amide Reduction of Lactone 251. 
 
Attempts were made to chemoselectivily reduce the amide in lactone 251 
without lactone reduction (Scheme 96, table 21). 
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Reagents and conditions: (a) conditions in table 21 
Scheme 96: Lactam Reduction Attempts 
 
Entry Conditions Equiv. Temp. Result 
1 DIBAlH, THF, 2 h 6 -78 ºC 22% 278 
2 BH3.DMS, THF, 2 h 6 -78 ºC 32% 278 
 
Table 21: Lactam Reduction Attempts 
 
The results suggest that it would be challenging to reduce the amide in the 
presence of a reactive lactone. Using either DIBAlH or borane dimethylsulfide 
complex at low temperatures resulted in the reduction of the lactone to give 
alcohol 278 (entries 1 and 2). 
2.3.2.1 Removal of the tert-Butyl Group. 
 
It was previously shown in the Eschenmoser fragmentation route that 
introducing a Boc group increases the reactivity of the lactam, as milder 
conditions are required to reduce carbamate amides (section 2.2.2). Therefore, 
attempts were made to remove the tert-butyl group in enone 171 and lactone 251 
using conc. H2SO4 (Scheme 97, section 2.2.1.1). 
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Reagents and conditions: (a) H2SO4, 55 °C, 30 mins. 
Scheme 97: tert-Butyl Cleavage Attempts 
 
The reaction proved unsuccessful using enone 171 and only starting 
material was recovered. Forcing reaction conditions using higher temperatures 
and prolonged reaction times resulted in complex mixtures of decomposition. tert-
Butyl removal on lactone 251 resulted in decomposition of the starting material 
thought to be caused by hydrolysis of the lactone using acidic conditions. 
Due to the little success in removing the tert-butyl group the cumyl 
protecting group was employed and the Baeyer-Villiger oxidation was performed 
on known enone 104 to give lactone 252 as a single regioisomer in 54% yield 
with 36% recovered starting material that can be recycled (Scheme 98). 
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Reagents and conditions: (a) mCPBA, DCM, 48 h; (b) TFA, reflux, 1 h 
Scheme 98: Cumyl Removal 
 
The cumyl group was successfully removed from lactone 252 using TFA 
giving amide 267 in 89% yield. 
Known enone 104 was also successfully deprotected using TFA at reflux 
to give free amide 266 in quantitative yield (Scheme 99). Performing the reaction 
for prolonged reaction times resulted in trace amounts of isomer 279 which was 
inseparable from the product 266. 
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Reagents and conditions: (a) TFA, reflux, 1 h 
Scheme 99: Cumyl Removal 
 
2.3.2.2 Boc Reprotection. 
 
The next stage in the synthesis was to protect the free amide in preparation 
for the phenyl oxidation and amide reduction. Standard Boc protection conditions 
and Boc-ON conditions (developed in section 2.2.1.2) were used in an attempt to 
protect lactone 267 (Scheme 100, table 22). 
NHO
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PhO
H
H
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NBocO
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PhO H
H
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OBoc
PhO H
267 280 281
 
Reagents and conditions: (a) conditions in table 22 
Scheme 100: Boc Protection Attempts 
 
Entry Conditions Equiv. Result 
1 Boc2O, DMAP, Et3N, DCM, R.T. 2 87% 281 
2 Boc-ON, DCM, LDA, 0 °C 1 42% 281 
 
Table 22: Boc Protection Attempts 
 
Using both reaction conditions the unwanted formation of enol carbamate 
281 was observed in high yields. This was disappointing as it was hoped that 
using the developed Boc-ON conditions would prevent enol carbonate formation. 
Attempts were also made to protect free amide 266 using the conditions 
detailed in table 23 (Scheme 101). 
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Reagents and conditions: (a) conditions in table 23 
Scheme 101: Boc Protection Attempts 
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Entry Conditions Equiv. Result 
1 Boc2O, DMAP, Et3N, DCM, R.T. 2 30% 283 
2 Boc-ON, DCM, LDA, 0 °C 1.5 52% 283 
 
Table 23: Boc Protection Attempts 
 
Using either standard Boc anhydride or Boc-ON conditions resulted in the 
formation of the undesired carbonate 283. Extended enol formation was causing 
the unwanted reaction and to avoid this, the conjugation was removed from enone 
104 and lactone 252 by hydrogenation (Scheme 102). 
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Reagents and conditions: (a) H2, 5% Pd/C, EtOAc; (b) TFA, reflux, 1 h;  (c) Boc2O (1 equiv.), DMAP (cat.), 
DCM, Et3N, 18h. 
Scheme 102: Synthesis of Saturated Bicycles 
 
Ketone 271 and lactone 254 were both successfully obtained in 85% and 
69% yield respectively from amides 284 and 285. As the unsaturation was 
essential for a regioselective Baeyer-Villiger oxidation, lactone 254 was used as 
an intermediate in the synthesis of the desired alkyne. 
2.3.3 Phenyl Oxidation. 
 
The phenyl oxidation reaction was attempted using Sharpless’s oxidation 
conditions on lactone 254 (Scheme 103). 
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Reagents and conditions: (a) i. RuCl3, NaIO4, EtOAc/H2O/CH3N; ii. TMS-CHN2, MeOH/toluene 
Scheme 103: Phenyl Oxidation Attempt 
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The reaction was unsuccessful and oxidation of the lactone ring was 
observed. Triester 286 was the only isolated product in 23% yield after 
esterification with TMS-diazomethane. 
2.3.4 Lactone Opening Studies. 
 
2.3.4.1 Unsaturated Lactone Opening. 
 
With the successful functionalisation of enone 104 using a Baeyer-Villiger 
oxidation reaction, research was carried out on the hydrolysis of the resulting 
lactones (251 and 252).  Studies were performed using unsaturated lactone 251 
(bearing a t-butyl group) to develop hydrolysis conditions (Scheme 104, table 24). 
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a
251 287
 
Reagents and conditions: (a) conditions in table 24 
Scheme 104: Lactone Hydrolysis 
 
Entry Conditions Temp. Time 
(hours) 
Result 
1 HCl aq./EtOH (2:1) R.T. 18 Trace 287 
2 Et3N, THF/EtOH R.T. 3 30% 287 
3 K2CO3, DCM/EtOH R.T. 2 Quant. 287 
4 Et3N, DCM/EtOH R.T. 18 Quant. 287 
 
Table 24: Lactone Hydrolysis Attempts 
 
Performing the reaction under basic conditions gave the desired product 287 
in 30% yield (entry 2). By changing the solvent to a DCM/ethanol mixture or by 
using potassium carbonate it was possible to obtain the desired aldehyde 287 in 
quantitative yield in 18 hours and 2 hours respectively (entry 3 and 4). These 
conditions were transferred to lactone 252 (bearing a cumyl group), with 
reproducible results (Scheme 105). 
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Reagents and conditions: (a) K2CO3. DCM/EtOH, 2 h; (b) TFA, reflux, 1h; (c) Boc2O, Et3N, DMAP, DCM, 
2h. 
Scheme 105: Lactone Hydrolysis 
 
Aldehyde 288 was considered as a possible intermediate for this synthesis 
and was successfully deprotected with TFA to give amide 289 in 71% yield. 
However, attempts to protect with a Boc group resulted in a complex mixture of 
products which were difficult to purify. 
2.3.4.2 Saturated Lactone Opening.  
 
Performing the lactone opening on saturated lactone 254 was the next step 
in the proposed synthesis (Step f, section 2.3, scheme 89). The synthesis of (–)-
kainic acid published by the Clayden group also involved a similar lactone 
opening reaction (Scheme 106).79 
a
74%
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O
CO2MeO H
NBoc
MeO2C
O
CO2MeH
H HHO
108 109
 
 
Reagents and conditions: (a) 1M NaOMe soln., MeOH, -78 °C, 2 h. 
Scheme 106: Lactone Opening Reaction Within the Group 
 
It was previously reported that using 1M sodium methoxide solution at -78 
°C for two hours gave the desired product 109.89 At -30 °C, Boc migration to the 
primary alcohol (291a) was reported in quantitative yield. At 0 °C, Boc migration 
occurs and epimerisation at the C4 position (291b) was observed (Scheme 107). 
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Reagents and conditions: (a) 1M NaOMe, -30 °C, 1 h; (b) 1M NaOMe, 0 °C, 1 h. 
Scheme 107: Observed By-Products from Lactone Opening Reactions 
 
With this information, attempts were made to open lactone 269 that 
contains a cumyl group, using 1M NaOMe at – 78 °C (Scheme 108). 
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H HHO
Ph Ph
269 292
 
Reagents and conditions: (a) 1M NaOMe, -78 °C, 2 h. 
Scheme 108: Model Lactone Opening 
 
At -78 °C the reaction successfully gave the desired primary alcohol 292 
in 94% yield. These conditions were transferred to the Boc protected lactone 254, 
resulting in 80% yield of the desired alcohol 293 (Scheme 109). 
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PhO H
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254 293
 
Reagents and conditions: (a) 1M NaOMe, -78 °C, 2 h 
Scheme 109: Lactone Opening 
 
Having synthesised primary alcohol 293 it was then necessary to protect 
the free alcohol as it would not be possible to perform the phenyl oxidation 
without unwanted over-oxidation. The decision to tackle the challenging phenyl 
oxidation prior to the lactam reduction was due to the problems previously 
observed with α oxidation using the ruthenium oxidation conditions (section 
2.2.6). 
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Scheme 110 shows the progress towards the alkyne intermediate and 
highlights the remaining steps. 
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Reagents and conditions: (a) benzyl bromide, K2CO3, DMF; (b) p-anisoyl chloride, DCM, Et3N; (c) i. LDA, 
THF 0 °C, 2 h; (d) mCPBA, DCM, 48 h; (e) i. H2, Pd/C, EtOAc; ii. TFA, reflux, 1h; iii. Boc2O, DMAP (cat.), 
Et3N, DCM, 18 h; (f) 1M NaOMe, -78 °C, 2 h 
Scheme 110: Summary of Progress and Remaining Steps 
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2.3.5 Alcohol Protection. 
 
Previous work within the Clayden group towards the synthesis of α-
methyl kainic acid (312) revealed that silyl protecting groups were too labile 
during the arene oxidation (Scheme 111).89 
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Reagents and conditions: (a) TIPS-OTf, Lutidine, DCM, 0 °C, MeOH; (b) SEMCl, DIPEA, DCM, 0 °C; (c) 
RuCl3, NaIO4, EtOAc/H2O/CH3CN, 4 h, ii. TMS-CHN2, toluene/methanol (low yields reported). 
Scheme 111: Previous Research into Stable Protecting Groups 
 
Protecting primary alcohol 299 with an acetate group resulted in a 
substrate that proved stable to the oxidation reaction and gave partial oxidation of 
the aromatic ring, which could be oxidised to the acid using hydrogen peroxide 
(Scheme 112). However, deprotecting the acetate group (304) caused 
epimerisation at the C4 position to give the more stable trans-trans epimer, 304a.  
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Reagents and conditions: (a) Ac2O, Et3N, DCM, DMAP (cat.). (b) i. RuCl3, NaIO4, EtOAc/H2O/CH3CN, 4 h; 
ii. H2O2, Na2CO3, dioxane, TMS-CHN2; (c) Et3N, H2O or K2CO3, MeOH, mixture of isomers, low yield. 
Scheme 112: Previous Research into Stable protecting Groups 
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It was reported that using trichloroacetate as the protecting group was 
stable enough to perform the partial oxidation of the aromatic ring, but labile 
under a second oxidation to give the desired alcohol 306 (Scheme 113). 
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35% NBocMeO2C
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Reagents and conditions: (a) Cl3CCOCl, Et3N, DCM, 0 °C; (b) i. RuCl3, NaIO4, EtOAc/H2O/CH3CN, 4h; ii. 
H2O2, Na2CO3, dioxane, TMS-CHN2 
Scheme 113: Previous Research into Stable Protecting Groups 
 
With this information, primary alcohol 293 was protected using 
trichloroacetyl chloride with triethylamine in DCM to give the desired product 
307 in quantitative yield (Scheme 114). 
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Reagents and conditions: (a) Cl3CCOCl, DCM, Et3N, R.T 
Scheme 114: Primary Alcohol Protection 
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2.3.6 Phenyl Oxidation. 
 
The next step in the synthesis was to perform the phenyl oxidation 
reaction on the newly protected lactam 307 (Scheme 115). 
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Reagents and conditions: (a) i. RuCl3, NaIO4, EtOAc/H2O/CH3N, 24 h; ii. TMS-CHN2, MeOH/toluene, 1 h 
Scheme 115: Phenyl Oxidation Reaction 
 
The oxidation was complete in 24 hours and after esterification gave 
methyl ester 308 in 38% yield and 19% recovered starting material. The 
trichloroacetate group remained and it was not necessary to perform a second 
oxidation to give the desired acid (that also cleaves the protection group, as 
discussed in section 2.3.5). 
2.3.7 Lactam Reduction Attempts. 
 
The final steps towards the desired alkyne 298 needed to include the 
reduction of the lactam and the conversion of a primary alcohol to the alkyne 
(Scheme 116). 
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Scheme 116: Remaining Transformation Towards the Desired Alkyne 
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The chemoselective lactam reduction was attempted on lactam 308 prior 
to the elimination reaction (Scheme 117, table 25). 
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Reagents and conditions: (a) conditions in table 25 
Scheme 117: Lactam Reduction Attempts 
 
Entry Reducing agent 
in THF (equiv.) 
Temp. Time 
(hours) 
Result/Comment 
1 BH3.THF (3) -78 °C 6 308 recovered 
2 BH3.THF (3) 0 °C 4 308 recovered 
3 BH3.THF (3) R.T. 4 308 recovered 
4 BH3.THF (3) Reflux 1 Complex mixture of products 
5 BH3. Me2S (2) -78 °C 6 308 recovered 
6 BH3. Me2S (2) 0 °C 4 308 recovered 
7 BH3. Me2S (2) R.T. 4 308 recovered 
9 DIBAlH (5) -78 °C 6 308 recovered 
10 DIBAlH (5) 0 °C 4 308 recovered 
11 DIBAlH (5) R.T. 4 Decomposition of 308 
 
Table 25: Carbamate Reduction Attempts 
 
Performing the reaction using borane complexes or DIBAlH at low 
temperatures was unsuccessful and only starting material was recovered. At 
reflux, borane dimethylsulfide gives a complex mixture of products (entry 4) and 
with DIBAlH the lactam 308 was resistant at room temperature but at reflux, 
reduction of the methyl ester was observed in the crude 1H NMR spectra. 
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2.3.8 Elimination Reaction Attempts. 
 
Due to the difficulty in performing a chemoselective reduction of lactam 
308, attempts were made to perform the elimination reaction. The elimination 
reaction has been previously applied in the synthesis of α-methyl kainic acid 
published by the Clayden group in 2003 (Scheme 118).113 
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H
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Reagents and conditions: (a) i. N-phenylselenylphthalimide, n-Bu3P, R.T., 2 h; ii. H2O2, pyridine (1 drop), 
THF, R.T., 12 h, 64% over 2 steps. 
Scheme 118: Previous Conditions Reported for the Elimination Reaction 
 
The trichloroacetate group in lactam 308 was removed using pyridine in 
THF/Methanol. The crude material was subjected to elimination conditions using 
N- phenylselenylphthalimide (Scheme 119). 
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Reagents and conditions: (a) i. pyridine, THF, MeOH, R.T., 1h; ii. N-phenylselenylphthalimide, n-Bu3P, 
R.T., 2 h; iii. H2O2, pyridine (1 drop), THF, R.T., 12 h. 
Scheme 119: Elimination Reaction Attempt 
 
The elimination reaction was unsuccessful giving a mixture of compounds 
in which alkene peaks were not observed in the crude 1H NMR spectrum.  
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2.3.9 Summary and Further Work. 
 
It was not possible to extensively research and develop conditions for the 
final stages of this route. Therefore the synthesis has yet to be defined as a viable 
route to the alkyne intermediate.  
In summary, it has been shown that a regioselective Baeyer-Villiger 
oxidation can be performed using enone 104 to generate a single lactone isomer 
252, but as a synthetic route to the target alkyne (298) suffers from reduction and 
oxidation complications (Scheme 120).  
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Reagents and conditions: (a) benzyl bromide, K2CO3, DMF; (b) p-anisoyl chloride, DCM, Et3N; (c) i. LDA, 
THF 0 °C, 2 h; (d) mCPBA, DCM, 48 h; (e) H2, Pd/C, EtOAc; (f) i. TFA, reflux, 1 h; ii. Boc2O, DMAP 
(cat.), Et3N, DCM, 18 h; (f) 1M NaOMe, -78 °C, 2 h; (g) Cl3CCOCl, Et3N, DCM; (h) i. RuCl3, NaIO4, 
EtOAc/H2O/CH3CN, 24 h; ii. TMS-CHN2, toluene/methanol, 1 h 
Scheme 120: Summary of Baeyer-Villiger Route 
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2.4 Silicon-Mediated Fragmentation Route. 
 
An alternative route to the desired alkyne was proposed by Dr. G. 
Lemière, who was associated to this project.  This was to utilise the Baeyer-
Villiger oxidation reaction and perform a Peterson olefination type fragmentation 
reaction to introduce alkene functionality (A). The retrosynthetic route is shown 
in scheme 121. 
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Scheme 121: Retrosynthetic Route  
 
The conversion of the alkene B to the alkyne A was not addressed in the 
Baeyer-Villiger route but this transformation could be performed directly using a 
halogenation reaction, followed by a double elimination using base.114 
Alternatively the alkene can be converted to the aldehyde and then using either 
the Corey-Fuchs reaction115 or the Seyferth-Gilbert homologation reaction116 to 
synthesise the alkyne. As the latter is more frequently used in organic synthesis, 
typically in natural product synthesis as it uses milder conditions, it was chosen as 
the primary sequence of steps to give the desired alkyne.117 Alkene B could be the 
product of a Peterson elimination type reaction of lactone C, which would be 
made from a regioselective Baeyer-Villiger oxidation reaction. The TMS group 
could be introduced by a silylcupration reaction on enone 104 which is the 
product of the dearomatising cyclisation with para-methoxy benzamide 92 
(section 2.1.2). 
Using a silicon-directed oxidative fragmentation reaction was previously 
studied within the Clayden group by B. Read, with the intension of incorporating 
a trisubstituted double bond in the isodomoic acid side chain stereospecifically.86, 
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118 Disappointingly, model studies proved poor yielding without adequate control 
of the alkene’s configuration. Fragmenation reactions using either 313a or 313b 
resulted in the formation of the cis alkene 314 (Scheme 122).. It was hoped that 
this methodology would enable the synthesis of both cis and trans alkenes.  
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Reagents and conditions: (a) PhI(OAc)2, I2, DCM, 0 °C, reflux, 2 - 3.5 h; sat. aq. Na2S2O3 soln.; (b) NaBH4, 
MeOH, 16 - 18 h;  
Scheme 122: Previous Work Involving Silicon-Directed Fragmentations 
 
Due to the poor reported yields for the model fragmenations, no further 
fragmentation attempts were made using silicon. The use of a Peterson type 
elimination reaction was not explored during the oxidative fragmentation research 
and so was considered as a potential step towards the synthesis of the desired 
alkyne. The proposed forward synthesis is shown in scheme 123. 
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Reagents and conditions: (a) 1,4-addition reaction; (b) protecting group removal and replacement; (c) arene 
oxidation; (d) Baeyer-Villiger oxidation; (e) silicon-mediated fragmentation; (f) lactam reduction; (g) alkyne 
formation. 
Scheme 123: Proposed Synthetic Route to the Desired Alkyne 
 
                                                      Chapter 2: Results and Discussion 
120 
This would be an attractive and concise route to the desired alkyne in 
which the TMS group indirectly protects the double bond in order to perform the 
aromatic oxidation reaction and is then reformed as a result of the fragmentation.  
2.4.1 Model Studies. 
 
The Peterson elimination reaction is a commonly used reaction in organic 
chemistry to form either a cis or trans alkene from a β-silylcarbanion.119 It was 
our aim to perform a similar type of reaction using a lactone to form the 
corresponding acid derivative and alkene. There are many examples of this type 
of fragmentation in the literature and a related reaction is shown in scheme 124.120  
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Reagents and conditions: (a) mCPBA, DCM; (b) HCl (cat.), MeOH 
Scheme 124: Related Fragmenation Reaction 
 
Grandi et. al. showed that it was possible to perform a regioselective 
Baeyer-Villiger oxidation to give lactone 323 in 86% yield.119(b) The formation of 
a single isomer was explained by the characteristic ability of silicon to stabilise a 
positive charge at the β position promoting preferential migration.121 The 
fragmentation reaction followed using acidic conditions to give alkene 324 in 
71% yield.  
This chemistry was transferred to a model lactone 325 to confirm that the 
fragmentation was viable in our bicyclic substrates (Scheme 125). 
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Reagents and conditions: (a) MeLi, CuCN, HMPA, HMD, -78 °C, THF, 2 h; (b) mCPBA, DCM, 48 h; (c) 
HCl (cat.), MeOH 
Scheme 125: Silicon-Mediated Fragmentation Model Studies 
 
                                                      Chapter 2: Results and Discussion 
121 
A 1,4-addition of a silylcuprate was performed on known enone 104 
(section 2.1.2) to give ketone 315 in 10% yield. It was thought that the cause for 
the poor yield was due to potential decomposition of the cuprate intermediate. 
The silylcupration reaction is discussed and optimised in section 2.4.2.  
As discussed in section 2.3.1, performing the Baeyer-Villiger oxidation 
reaction on a bicyclic substrate bearing a substitution in the β' position results in a 
regioselective oxidation. With this information and the additional stability gained 
from the presence of the silicon group, it was unsurprising to achieve a 
regioselective Baeyer-Villiger oxidation reaction on ketone 315 to give lactone 
325. The fragmentation was performed on the crude lactone 325 using 
HCl/methanol conditions to successfully give alkene 326 in 77% over two steps. 
2.4.2 Optimisation of the Silylcupration Reaction. 
 
Since the late 1950’s it has been known that silyl anions undergo smooth 
addition to a variety of electrophiles.122 Research by Fleming et. al has shown that 
it is possible to perform silyl conjugate addition efficiently using copper cyanide 
by transmetallation of the silyllithium species with copper (I) to form the more 
reactive cuprate.123 
In the model study shown in section 2.4.1, the 1, 4-addition reaction using 
a silyl cuprate resulted in a poor 10% yield, which was unacceptable for an early 
step in this total synthesis. Previous research by B. Read showed that it was 
possible to perform a 1,4-addition reaction using PhMe2SiLi in a one pot, two step 
protocol (Scheme 126).124, 86 
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Reagents and conditions: Method 1: Et2Zn, PhMe2SiLi, THF, 0 ºC, 10 min; 328, TMSCl, THF, –78 ºC, 1 h; 
R.T., 1.5 h; sat. aq. NH4Cl soln.; Method 2: Et2Zn, PhMe2SiLi, THF, 0 ºC, 5 min; 328, THF, –78 ºC, 40 min; 
TMSCl, –78 ºC, 30 min; R.T., 1.5 h; sat. aq. NH4Cl soln. 
Scheme 126: Previous 1,4-Addition Reactions 
 
The aim of this research was to isolate the silyl enol ether 330, but this 
proved unstable and susceptible to hydrolysis giving mixtures of 329 and 330. 
Attempts were not made to optimise a procedure for ketone 329, but this research 
highlighted the use of TMSCl to trap the cuprate intermediate in-situ in as the 
more stable silyl enol ether which could be hydrolysed to give the desired ketone 
315.  
The silylcupration reaction on enone 104 was performed with freshly 
distilled reagents, in the presence of TMSCl as the trapping agent (Scheme 127). 
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Reagents and conditions: (a) MeLi, CuCN, HMPA, HMD, -78 °C, THF, TMSCl, 2 h; (b) 3M HCl:THF 
Scheme 127: Optimised Silylcupration 
 
The reaction was cleaner by TLC analysis which identified two products. 
Using acidic conditions the crude intermediate was hydrolysed to give the desired 
product 315 in 86% after purification and a disilylated by-product 332 in 10% 
yield. It has been reported by Barrett et. al. that the formation of the disilylated 
product is as a result of an undesired reaction between newly formed Me3SiLi 
(337) and unreacted HMD, 335 (Scheme 128).  
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Scheme 128: Pentamethlydisilyl Anion Formation Mechanism 
 
The formation of the disilane can be suppressed by the use one equivalent 
of HMD. The importance of reaction stoichiometry on the balance between the 
formation of the pentamethyldisilyllithium and trimethylsilyllithium is consistent 
with the mechanism of lithiation in scheme 128. 
The addition of the TMS group to enone 104 was diastereoselective and 
the stereochemistry was confirmed by X-ray crystallography of the product 315 
(Fig 16). It was previously assumed that attack at this position was from the exo 
face which is caused by the ring junction stereochemistry.  
 
Figure 17: X-ray Crystal Structure 
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O
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2.4.3 Cumyl Removal and Boc Protection. 
 
In order to perform the phenyl oxidation reaction it was necessary to 
remove the cumyl protecting group and replace it with one which was stable to 
the oxidation conditions. Therefore the next step in the synthesis was to remove 
the cumyl group which was achieved quantitatively using TFA (Scheme 129). 
N
O
PhO
H
H Ph
Me3Si
a
quant.
NH
O
O
H
H Ph
Me3Si
315 341
 
Reagents and conditions: (a) TFA, reflux, 1 h. 
Scheme 129: Cumyl Removal 
 
It has been previously reported that performing the phenyl oxidation 
reaction on a free amide results in complex mixtures of products89 and so 
protection of the amide with a Boc group was necessary. 
Performing the Boc protection of amide 341 using Boc anhydride gave the 
desired product 316 in 77% yield. Enol carbonate formation was observed in two 
isomeric by-products 342a and 342b in a 2:1 ratio, as an inseparable mixture in 
9% yield (Scheme 130). 
a
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Reagents and conditions: (a) Boc2O, DCM, DMAP (cat.), Et3N, 18 h, 342a/342b 9%. 
Scheme 130: Boc Protection Reaction 
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2.4.4 Phenyl Oxidation. 
 
The phenyl oxidation was then carried out using Sharpless’s oxidation 
conditions (Scheme 131). 
NBoc
O
O
H
H Ph
Me3Si
a
76%
NBoc
O
O
H
H CO2Me
Me3Si
316 343
 
Reagents and conditions: (a) i. RuCl3, NaIO4, EtOAc/H2O/CH3CN, 24 h; ii. TMS-CHN2, MeOH/toluene, 1 h 
Scheme 131: Phenyl Oxidation Reaction 
 
The desired methyl ester 343 was successfully isolated in 76% yield over 
the two steps. Pleasingly, this was the highest reported yield within the Clayden 
group for an arene oxidation in these types of substrates. 
2.4.5 Baeyer-Villiger Oxidation of Methyl Ester 343. 
 
It has been discussed that it is possible to perform a regioselective Baeyer-
Villiger oxidation reactions in these types of bicyclic structures (sections 2.3.1 
and 2.4.1). The next step in the synthesis was to perform the Baeyer-Villiger 
oxidation on substrate 343 using mCPBA (Scheme 132). 
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Reagents and conditions: (a) mCPBA, DCM, 48 h 
Scheme 132: Baeyer-Villiger Oxidation Reaction 
 
The reaction successfully gave the desired lactone 344 in quantitative 
yield as a single regioisomer, which was identified by 1NMR analysis showing 
one set of product peaks that were assigned to isomer 344.  
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2.4.6 Silicon-Mediated Fragmentation of Lactone 344. 
 
The next step in the synthesis was to perform the fragmentation reaction 
on silylated lactone 344. There are several conditions available to perform the 
desired fragmentation, most commonly used are HCl/methanol119(b), boron 
trifluoride etherate119(c) or using a fluoride source (e.g. TBAF).119(e)   
Various conditions using boron trifluoride and fluoride sources were 
explored to develop conditions for the fragmentation (Scheme 133, table 26). 
NBocO
O
CO2MeO
H
H
a NBoc
O
CO2Me
MeO2C
H
H
Me3Si
NBoc
O
CO2Me
MeO2C
H
NH
O
CO2Me
MeO2C
H
H
344 345 346 347
 
Reagents and conditions: (a) i. conditions in table 26; ii. TMS-CHN2, methanol/toluene (step ii. not used in 
entry 7) 
Scheme 133: Silicon-Mediated Fragmentation Studies 
 
* no purification, single product by NMR analysis; ¥ single isomer obtained with undefined geometry 
 
 
 
 
 
 
Table 26: Silicon-Mediated Fragmentation Studies 
 
Fragmentation was observed using TBAF at room temperature but 
isomerisation of the desired product was the only product isolated as a single 
isomer (346, entry 1). Performing the reaction at a low temperature or using 
TBAT (a known non-basic fluoride source),124 also results in the formation of 
isomer 346 (entries 2 and 3). No fragmentation was observed using BF3.OEt2 at -
78 °C (entry 4), but allowing the reaction to warm to room temperature gave the 
Entry Reagent Temp. 345 346¥ 347 
1 TBAF, THF R.T. 0% quant. 0% 
2 TBAF, THF -78 °C 0% quant. 0% 
3 TBAT, THF125 -78 °C 0% 86% 0% 
4 BF3.OEt2, DCM -78 °C / / / 
5 BF3.OEt2, DCM -78 °C – R.T. 0% 0% quant. 
6 BF3.OEt2,DCM -30 °C 0% 0% quant.* 
7 HCl/MeOH R.T. 0% 0% 32% 
Si
Ph
Ph
Ph
F
F
TBAT, 348
Bu3N
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desired reaction with loss of the Boc protecting group (entry 5). To avoid the loss 
of the Boc group the reaction was performed at -30 °C but was unsuccessful and 
resulted in the formation of free amide 347 (entry 6). Under HCl/methanol 
conditions, loss of the Boc protecting group was observed and free amide 347 was 
isolated in 32% yield (entry 7). 
Protection of the free amide 347 was considered and attempted using 
either Boc
 
anhydride or Boc-ON conditions. The protection was successful, 
however isomerisation of the alkene was unavoidable and methyl ester 346 was 
formed as a single product (Scheme 134). 
NBoc
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CO2Me
MeO2C
NH
O
CO2Me
MeO2C
H
H
H
a
quant.
347 346
 
Reagents and conditions: (a) Boc2O, DMAP (cat.), Et3N, DCM, R.T., 18 h or Boc-ON, THF, LDA, 0 °C -
R.T., 2 h 
Scheme 134: Reprotection Attempts 
The unwanted isomerisation was rationalised by the formation of a stable 
enolate intermediate which can then promote isomerisation of the alkene for 
increased stabilisation through conjugation (Scheme 135). 
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Reagents and conditions: (a) i. TBAF, THF, -78 °C; ii. NH4Cl aq. 
Scheme 135: Possible Mechanism for Isomerisation 
 
The results of this research had shown that the fragmentation reaction was 
working well. However, due to the presence of the amide carbonyl, isomerisation 
of the alkene was unavoidable. 
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In order to prevent this undesired isomerisation, lactam reduction was 
considered prior to fragmentation. Performing the lactam reduction on lactone 
344 was deemed too difficult based on the similar attempts during the Baeyer-
Villiger oxidation route (section 2.3.2), so it was decided to open the lactone ring 
and then attempt the lactam reduction prior to performing a Peterson elimination 
(Scheme 136).118(a) 
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Scheme 136: Peterson Elimination Mechanism 
 
 Conditions to perform the methanolysis of lactone 344 were studied based 
on the previous work carried out in section 2.3.4 (Scheme 137). 
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Reagents and conditions: (a) conditions in table 27 
Scheme 137: Lactone Methanolysis 
 
* ratio determined by crude NMR analysis 
Table 27: Methanolysis Conditions 
 
Performing the reaction at -78 °C resulted in no reaction (entry 1). 
Allowing the reaction to warm to room temperature gave an inseparable mixture 
of products 352a and 352b as a result of Boc migration and epimerisation at the 
Entry Conditions Temp. 351 352a 352b 
1 NaOMe, MeOH, 2 h -78 °C / / / 
2 NaOMe, MeOH -78 °C – R.T. 0% 1* 1* 
3 NaOMe, MeOH, 2 h 0 °C 0% 1* 1* 
4 NaOMe, MeOH, 2 h -30 °C 0% 60% 0% 
5 NaOMe, MeOH, 2 h -60 °C 87% 0% 0% 
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C4 position (entry 2). At -30 °C the epimerisation was stopped and only Boc 
migration (352a) was observed in 60% yield (entry 4). Finally the desired product 
was obtained by performing the reaction at -60 °C giving alcohol 351 in 87% 
yield. 
2.4.7 Lactam Reduction. 
 
It has been discussed in both the Eschenmoser and the Baeyer-Villiger 
oxidation routes that the reduction of the lactam functionality is a challenging 
transformation. The target of this transformation was to reduce the, evidently 
resistant, lactam without the undesired ester reduction. A recent publication by 
Jung et. al. detailing the total synthesis of (–)-kainic acid and (–)-allokainic acid 
via a stereoselective C-H insertion, report a similar chemoselective lactam 
reduction using DIBAl-H at reduced temperature followed by hemiaminal 
cleavage using Et3SiH (Scheme 138).126 
NBoc
O
OHC
CO2Me
H
HMeO2C
NBoc
CO2Me
H
HMeO2C
MsO
(−)-kainic acid, 1
a
65%
353 354
 
Reagents and conditions: (a) i. DIBAlH, THF, -78 °C, 1 h; ii. MsCl, Et3N, iii. Et3SiH, BF3.OEt2, -78 °C, 2 h 
Scheme 138: Reported Lactam Reduction  
 
 The three step procedure was used to reduce alcohol 351, which resulted 
in a complex mixture of products that were difficult to purify (Scheme 139). 
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Reagents and conditions: (a) i. DIBAlH, THF, -78 °C, 1 h; ii. MsCl, TEA, iii. Et3SiH, BF3.OEt2, -78 °C, 2 h 
Scheme 139: Lactam Reduction Attempt 
 
Attempts to characterise any of the products proved difficult, however 
mass spectrometry data of the crude material suggested the formation of the 
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cyclised substrate 356 by intramolecular hemiaminal displacement. The formation 
of this bicycle could explain the failed mesylation and aminol cleavage attempts.  
An alternative stage in the route to perform the lactam reduction was in 
substrate 343, as the phenyl oxidation was already completed therefore avoiding α 
oxidation (see section 2.2.6). Various different reducting agents were used in an 
attempt to reduce lactam 343 chemoselectively (Scheme 140, table 28). 
a
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Reagents and conditions: (a) conditions in table 28 
Scheme 140: Amide Reduction Attempts 
 
* no purification, single product by NMR analysis 
Table 28: Amide Reduction Attempts 
 
Borane complexes at room temperature and DIBAlH at 0 °C gave only 
ketone reduction in alcohol 358 (entries 1 and 2) and decomposition under reflux. 
Diol 359 was observed when performing the reduction with LiAlH4 at -78 °C or 
DIBAlH at R.T. (entries 6 and 7). Using LiEt3BH (section 2.2.2) at 0 °C gave 
ketone reduction only (entry 8) and at room temperature resulted in a complex 
mixture of products which no longer contains the methyl ester by NMR analysis 
(entry 9). 
Entry Reducing Agent 
(equiv.) 
Temp. Time 
(hours) 
Result 
1 BH3. Me2S, THF R.T. 1 92% 358 
2 BH3, THF R.T. 1 88% 358 
3 BH3, THF Reflux 2 Complex mixture of 
products 
4 BH3. Me2S, THF Reflux 1 Complex mixture of 
products 
5 DIBAL, THF 0 °C 4 358* 
6 DIBAL, THF R.T. 2 359* 
7 LiAlH4, THF -78 ºC 6 47% 359 
8 LiEt3BH, THF 0 °C 2 358* 
9 LiEt3BH, THF R.T. 2 Complex mixture of 
products 
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The results in table 28 suggest that the conditions required to reduce the 
lactam will also result in the unwanted reduction the methyl ester (Fig. 18). 
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H CO2Me
Me3Si
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3
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343
 
Figure 18: Order of Carbonyl Susceptibility to Reduction 
 
Performing a global reduction followed by alcohol protection was 
considered but would have involved a number of additional steps. A possible 
solution would be to reduce the reactivity of the ester carbonyl, enabling the use 
of harsher reduction conditions. This could be achieved by synthesising a more 
hindered ester which would decrease the susceptibility of reduction. 
Literature searches revealed that performing a chemoselective lactam 
reduction in the presence of a tert-butyl ester group was commonly achieved.127 
Reducing agents for this reaction include LiEt3BH, DIBAlH and borane 
dimethylsulfide complex. 
The tert-butyl ester 361 was synthesised by esterification of the acid 
which was the product of the phenyl oxidation reaction. Various conditions were 
explored to obtain good yields for the esterification (Scheme 141, table 30). 
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Reagents and conditions: (a) i. RuCl3, NaIO4, EtOAc/H2O/CH3CN, R.T., 24 h; (b) conditions in table 29 
Scheme 141: tert-Butyl Esterification Attempts 
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* % yield over two steps 
Table 29: tert-Butyl Esterification Attempts 
 
The desired tert-butyl ester 361 was successfully synthesised using either 
Boc
 
anhydride or tert-butanol in 44% and 52% yield respectively (entries 1 and 
2). Using excess equivalents of tert-butanol gave the desired ester 361 in an 
improved 60 % yield over 2 step (entry 3). 
 
 
 
 
 
 
The tert-butyl ester 361 was subjected to various reduction conditions 
detailed in table 30 (Scheme 142). 
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Reagents and conditions: (a) conditions in table 2.29 
Scheme 142: Lactam Redution Attempts 
 
Entry Conditions Temp. Time 
(hours) 
Result* 
1 Boc2O, DMAP (cat.), Et3N, 
DCM128 
R.T. 18 44% 361 
2 tert-butanol (1 equiv.), DCC 
(1 equiv.), Et3N, DCM129 
0 °C 2 52% 361 
3 tert-butanol (2 equiv.), DCC 
(1 equiv.), Et3N, DCM 
0 °C – R.T. 18 60% 361 
4 2-methylpropene, H2SO4, 
DCM130 
-78 °C – R.T. 4 360 
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* ester reduction observed in crude 1H NMR ¥ mixture of diastereoisomers in 1H NMR 
Table 30: Lactam Reduction Attempts 
 
The lactam proved resistant to borane DMS complex, DIBAlH and 
LiEt3BH at low temperatures giving alcohol 363 (entries 1, 2, 4 and 6). At higher 
temperatures borane DMS and DIBAlH gave complex mixtures of products with 
observed ester reduction (entries 3 and 5). Pleasingly, using LiEt3BH at 0 °C 
resulted in the chemoselective reduction of the lactam giving a mixture of diol 
diastereoisomers 362. 
Due to purification difficulties it was not possible to purify the diol 
diastereoisomers 362 and so the crude material was subjected to the hemiaminal 
cleavage  and oxidation prior to purifying ketone 364 (Scheme 143) 
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Reagents and conditions: (a) i. LiEt3BH, THF, 0 °C; (b) i. Et3SiH, BF3.OEt2, THF, -78 °C, 2 h; ii. Dess-
Martin periodinane, DCM, R.T., 2 h 
Scheme 143: Optimised Reduction/Oxidation Reaction 
 
The desired amine 364 was isolated in 32% over the three step procedure. 
The reaction was repeated performing the LiEt3BH reduction at 0 °C with a 
hydrogen peroxide quench to remove all traces of the borane complex, which 
gave the desired amine 364 in an improved 50% yield over the 3 steps. 
Entry Conditions Temp. Equiv. Time 
(hours) 
Result/Comment 
1 BH3.DMS, THF 0 °C 3 4 quant 363 
2 BH3.DMS, THF R.T. 3 4 quant 363 
3 BH3.DMS, THF 50 °C 3 2 Complex mixture 
of products* 
4 DIBAlH, THF -78 °C 5 2 quant. 363 
5 DIBAlH, THF 0 °C 5 2 Complex mixture 
of products* 
6 LiEt3BH, THF -78 °C 3 3 quant. 363 
7 LiEt3BH, THF 0 °C 3 3 362¥ 
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2.4.8 Baeyer-Villiger Oxidation of Ester 364. 
 
The Baeyer-Villiger oxidation reaction was performed on amine 364 using 
mCPBA (Scheme 144). The desired lactone 365 was successfully isolated in 86% 
yield as a single regioisomer. The over-oxidised by-product 365b was also 
observed in 10% yield which was inseparable from 365.  
a
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365364
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Reagents and conditions: (a) mCPBA, DCM, R.T., 48 h 
Scheme 144: Baeyer-Villiger Oxidation 
 
2.4.9 Silicon-Mediated Fragmentation of Lactone 365. 
 
Having successfully synthesising lactone 365 without the lactam 
functionality, the product of the fragmentation reaction should not isomerise. The 
fragmentation reaction was performed on lactone 365 using TBAF (Scheme 145). 
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Reagents and conditions: (a) i. TBAF, THF, 0 °C, 1 h;  (b) Boc2O, DMAP, DCM, Et3N. 
Scheme 145: Silicon-Mediated Fragmentation Reaction 
 
The reaction gave the desired fragmentation without isomerisation and 
after tert-butyl esterification using Boc2O and DMAP, amine 367 was isolated in 
60% yield over two steps. The formation of the tert-butyl ester was introduced 
with the intention of performing a global acidic deprotection once the 
functionalisation of the alkyne was complete. 
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2.4.10 Ozonolysis of Alkene 367. 
 
The final stages of the route to the alkyne intermediate were to convert the 
alkene to the alkyne via the aldehyde (as discussed in section 2.4). The ozonolysis 
was performed on alkene 367 using ozone generated from oxygen in THF at -78 
°C (Scheme 146).131 
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98%
367 368
 
Reagents and conditions: (a) i. O3, DCM, -78 °C, 30 min; ii. DMS, R.T., 18 h. 
Scheme 146: Ozonolysis Reaction 
 
The reaction was complete in less than 30 minutes, indicated by the 
formation of a light blue solution. After the reductive quench of the trioxolane 
intermediate, aldehyde 368 was isolated in 98% yield.  
2.4.11 Alkyne Formation. 
 
The final step in the synthesis was to convert the aldehyde to the alkyne. 
Literature research highlighted two favourable reaction conditions to perform this 
transformation. The Corey-Fuchs reaction which uses triphenylphosphine and 
tetrabromomethane to make a dibromoalkene (376) that is then this is converted 
to the terminal alkyne (380) using butyllithium (Scheme 147).115 
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Scheme 147: Corey-Fuchs Reaction Mechanism 
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Alternatively, the Seyferth-Gilbert homologation reaction can be used to 
synthesis alkynes from aldehydes using dimethylphosphonodiazomethane with 
potassium tert-butoxide.116 These conditions generate the dimethyl 
(diazomethyl)phosphonate anion 382, which performs the transformation by an 
initial Horner-Wadworth Emmons reaction followed by α-elimination and 
carbene rearrangement to give the desired alkyne (Scheme 148). 
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Scheme 148: Seyferth-Gilbert Homologation Reaction Mechanism 
 
This procedure has been improved by the introduction of the more stable 
Ohira-Bestmann reagent 386, which generates anion 382 in-situ (Scheme 149).132 
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Scheme 149: Ohira-Bestmann Modification 
 
The main advantage of this reaction compared with the Corey-Fuchs 
procedure is that milder reaction conditions are used which tolerate a wider range 
of functional groups. Therefore, the Ohira-Bestmann conditions were chosen for 
the transformation using aldehyde 368 (Scheme 150).  
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Reagents and conditions: (a) dimethyl-1-diazo-2-oxopropylphosphonate 386, K2CO3, methanol, 0 °C,  1 h 
Scheme 150: Ohira-Bestmann Reaction Attempt 
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The reaction was complete in less than one hour and after purification 
alkyne 387 was isolated in 66% yield. Unfortunately, due to the presence of 
rotamers the characterisation proved difficult and so it was not possible to prove if 
epimerisation at the C4 position had occurred. Therefore, a global deprotection of 
387 was performed on a small scale to clarify the NMR spectrum (Scheme 151). 
 
 
 
 
 
Reagents and conditions: (a) TFA, H2O, R.T., 1 h 
Scheme 151: Global Deprotection Reaction 
 
The reaction was successful in giving alkyne 379 in quantitative yield. 
Disappointingly, NMR analysis showed two alkyne peaks at 2.79ppm and 
2.68ppm in a 57:43 ratio of epimers (Fig. 19).  
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Figure 19: Specific Epimer Alkyne Protons 
 
This confirmed the epimerisation at C4 had occurred and that new 
conditions were needed for the Ohira-Bestmann reaction.  
Gennari et. al. have also observed epimerisation in chiral aldehydes using 
the  Ohira-Bestmann reaction.133,134 In this article it describes that epimerisation 
was observed due to the presence of excess potassium carbonate. To avoid the 
epimerisation, sodium methoxide was used to form the (diazomethyl)phosphonate 
anion 382 at -78 °C prior to the addition of the chiral aldehyde. This procedure 
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was transferred to aldehyde 368 and performed using freshly prepared sodium 
methoxide (Scheme 152).  
 
Reagents and conditions: (a) dimethyl-1-diazo-2-oxopropylphosphonate 386 (5.2eq.), NaOMe (5 eq.), THF, -
78 °C, 1 h 
Scheme 152: Modified Ohira-Bestmann Reaction 
 
Pleasingly, this gave the desired alkyne 379a in 89% yield with no 
epimerisation (Fig. 20)  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20: 1H NMR Spectra of Alkyne Peaks Showing Epimerised and Non-Epimerised Products 
 
This data enabled the assignment of epimerised and the non-epimerised 
products, showing that epimerisation was favoured under previous conditions 
using potassium carbonate in methanol. 
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2.4.12 Enantioselective Synthesis. 
 
The enantioselective dearomatising cyclisation reaction using para-
methoxy benzamide 92 has previously been developed within the Clayden group 
for the total synthesis of (–)-kainic acid and (–)-isodomoic acid C.77,79 However, 
results from section 2.1.2 have shown the instability of the lithium enolate at high 
temperatures and so the procedure was modified to introduce the saturated 
ammonium chloride quench at 0 °C, increasing the overall yield (up to 66% after 
recrystalisation). The synthesis was repeated and enantiopure alkyne 379a was 
successfully obtained in 16 steps (Scheme 153).  
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Reagents and conditions: (a) benzyl bromide, K2CO3, DMF; (b) p-anisoyl chloride, DCM, Et3N; (c) i. amine 
112, THF , -78 °C - 0 °C; ii. 1M HCl aq.; (d) MeLi, CuCN, HMPA, HMD, -78 °C, THF, TMSCl, 2 h; ii. 1M 
HCl:THF; (e) i. TFA, reflux, 1 h; ii. Boc2O, DCM, DMAP (cat.), Et3N, 18 h; (f) i. RuCl3, NaIO4, 
EtOAc/H2O/CH3CN, R.T., 24 h; ii. tert-butanol (2 equiv.), DCC (1 equiv.), Et3N, DCM; (g) i. LiEt3BH, THF, 
0 °C, 2 h; ii. Et3SiH, BF3.OEt2, THF, -78 °C, 2 h; iii. Dess-Martin period inane, DCM, R.T., 2 h; (h) mCPBA, 
DCM, R.T., 48 h; (i) i. TBAF, 0 °C, THF, 1h; ii. Boc2O, DMAP, t-butanol; (j) i. O3, DCM, -78 °C; ii. DMS, 
R.T., 18 h; (k) dimethyl-1-diazo-2-oxopropylphosphonate 386 (5.2 eq.), NaOMe (5eq.), THF, -78 °C, 1 h 
Scheme 153: Enantioselective Synthesis of Alkyne Intermediate 
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387a
388a
388b
389a
389b
2.4.13 Further Work. 
 
Following the synthesis of enantiopure alkyne 387a (Scheme 153), the 
functionalisation was to be researched to synthesise the desired trisubstituted 
alkene using carbometallation chemistry (Scheme 154). 
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Scheme 154: Alkyne Functionalisation  
 
These studies have been conducted within the Clayden group by Dr. 
Toueg and Dr. Lemière. Initially carboalumination chemistry developed by 
Negishi was considered as this is commonly used to form a trisubstituted alkene 
stereo- and regioselectively.135 Reactions were conducted on a model alkyne 390 
to develop conditions prior to functionalising alkyne 387a (Scheme 155). 
N
Boc
N
Boc
390
a
391
 
Reagents and conditions: (a) i. AlMe3, Cp2ZrCl2 ii. H3O+ 
Scheme 155: Carboalumination of Model Alkyne 
 
The reactions were unsuccessful and the lack of success was thought be 
due to the presence of the carbamate interfering with the functionalisation as there 
are limited examples of carboalumination chemistry using nitrogen containing 
substrates. To examine this reactivity issue a known reaction using 1-octyne was 
performed which showed that in the precence of the carbamate there was no 
observed reaction (Scheme 156).136 
domoic acid,
isodomoic acid A and D
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Reagents and conditions: (a) i. AlMe3, Cp2ZrCl2, H2O, ii. HCl 
Scheme 156: Standard Reactions 
 
Carbomagnesiation catalysed by a Nickel complex developed by Snider 
was also considered for the functionalisation.137 However, the model alkyne 394 
proved resistant to these conditions and only starting material was recovered 
(Scheme 157). 
a
N
BocNBoc
TMS
TMS
394 395
 
Reagents and conditions: (a) Ni(acac)2, AlMe3, MeMgBr, THF, 0 °C – R.T 
Scheme 157: Carbomagnesiation Attempts 
  
Due to the little success in carbometallation with nitrogen containing 
compounds a procedure suitable to these substrates was explored. In 1989, 
Lipshutz et. al. reported a procedure for the formation of a trialkylstannylcuprate 
which can be used to functionalised alkynes.138 This procedure has since been 
applied to nitrogen protected alkynes by Capella et. al. in 1991.139 This 
publication states that it is possible to perform the cupration with a methyl iodide 
quench to give isomers 397 and 398 in a 95:5 ratio in 68% yield (Scheme 158). 
NHBoc
Bu3Sn NHBoca
89% SnBu3
NHBoc
396 397 398
 
Reagents and conditions: (a) i. Bu3Sn(Bu)Cu(CN)Li2, THF, -78°C; ii. MeI, 95:5 397:398 (68% isolated 397) 
Scheme 158: Regioselective Stannylcupration 
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This chemistry has been used in a number of different total synthesises to 
perform a regioselective addition of a methyl group forming a trisubstituted 
alkene.140 Therefore, attempts to functionalise model alkyne 390 were performed 
using Bu3Sn(Bu)Cu(CN)Li2 and quenching with methyl iodide (Scheme 159). 
a
90%
N
BocNBoc
Bu3Sn
390 399
 
Reagents and conditions: (a) i. Bu3Sn(Bu)Cu(CN)Li2, THF, -78 °C; ii. MeI 
Scheme 159: Stannylcupration Attempts 
 
Pleasingly, this resulted in a regioselective cis addition giving stannane 
399 as a single regioisomer in 90% yield after purification. With the success of 
this reaction it is envisaged to perform a Stille coupling with an appropriate halide 
partner (Scheme 160).  
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Reagents and conditions: (a) Pd catalyst 
Scheme 160: Stille Coupling Reactions with Potential Coupling Partners 
 
Initial model coupling reactions have looked promising giving the desired 
coupling in good yields. It is hoped that the success of the model studies can be 
transferred to enantiopure alkyne 387a and after a global deprotection complete 
the divergent synthesis to (–)-isodomoic acid B, E and F. 
Depending on the success of this strategy to obtain the trisubstituted 
alkene, further work would need to develop the functionalisation to obtain the E 
isomer in order to develop the total synthesis of domoic acid and (–)-isodomoic 
acids A and D.141 
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Appendix 1. 
 
A.1 Application of Flow Chemistry to the 
Dearomatising Cyclisation. 
 
Flow chemistry is a well established technique that is particularly used for 
large scale manufacture, in which a chemical reaction is run continuously using 
non-reactive tubing and pumps. There are many advantages of using flow 
chemistry compared to batch chemistry as reaction times and stoichiometries can 
be defined by the concentration of the reagents and the ratio of their flow rates. 
Within the field of research, Ley et. al have demonstrated the use of flow 
chemistry to complete the total synthesis of oxomaritidine in 40% yield in 5 
hours.142 
Within the Clayden group, the dearomatising cyclisation of para-methoxy 
benzamide 92 has been extensively researched. Based on the discovery that the 
cyclisation can be high yielding reaction if performed at a suitable temperature 
(section 2.1.2), it was applied to flow chemistry in an attempt to generate large 
quantities of pure dearomatised methyl ether 95 (Scheme 161). 
N
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H Ph
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PhMeO
N Ph
PhMeO
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92
95
 
Reagents and conditions: (a) LDA, THF 
Scheme 161: Dearomatising Cyclisation for Flow Chemistry 
 
The flow reactor was set-up using two syringe pumps containing cooled 
LDA in THF and benzamide 92 in THF (Fig. 21). These solutions were then 
pumped through a set length of stainless steel tubing at a controlled temperature 
(using a “cold finger”) and flow rate. Once the reaction was quenched with 
saturated ammonium chloride solution, the crude material was analyzed by LC-
MS. 
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Figure 21: Flow Reactor Set-up 
 
Table 31 shows the initial attempts to apply the cyclisation reaction to 
flow chemistry, using 5 feet of stainless steel coil (0.75 mm diameter) and 
performing the reaction at four different temperatures and three different flow 
rates.  
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Temperature: -20 °C 
 
Temperature: -10 °C 
 
Temperature: 0 °C 
 
Temperature: 10 °C 
* Actual % of SM not available  
Table 31: Flow Chemistry with 5 Foot Coil (0.75 mm Diameter) at Different Temps. and Flow Rates 
 
The initial results were not encouraging as large amounts of starting 
benzamide 92 was recovered with poor yields of the desired methyl ether 95. The 
results suggest that at higher temperatures with a slow flow rate would give an 
acceptable percentage of the desired product (entries 11, 12 and 13). Increasing 
the temperature further was considered but due to the instability of the 
intermediate lithium enolate 103, was avoided. In an attempt to increase the 
Entry Flow Rate 
(mg/ml) 
mg/ml Res. Time 
(mins) 
95 
(%) 
92 
(%) 
1 Fast (0.135) 2.39 2.5 15.35 79.14 
2 Mid (0.064) 2.64 5 16.91 93.68 
3 Slow (0.034) 2.44 10 15.63 85.11 
Entry Flow Rate 
(mg/ml) 
mg/ml Res. Time 
(mins) 
95 
(%) 
92 
(%) 
4 Fast (0.135) 1.94 2.5 12.44 80.37 
5 Mid (0.064) 1.92 5 12.31 83.38 
6 Slow (0.034) 2.10 10 13.47 84.15 
Entry Flow Rate 
(mg/ml) 
mg/ml Res. Time 
(mins) 
95 
(%) 
92 
(%) 
7 Fast (0.135) 1.97 2.5 12.64 78.80 
8 Mid (0.064) 2.15 5 13.77 82.05 
9 Slow (0.034) 2.06 10 13.21 85.04 
10 Very Slow 
(0.017) 
2.50 20.00 16.01 65.98 
Entry Flow Rate 
(mg/ml) 
mg/ml Res. Time 
(mins) 
95 
(%) 
92 
(%) 
11 Fast (0.067) 5.31 5 21.22 /* 
12 Mid (0.034) 6.52 10 26.09 /* 
13 Slow (0.017) 6.98 20 27.92 /* 
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percentage of product the coil length was increased to 15 foot (0.75 mm diameter) 
and the reaction performed with reduced flow rates. Table 32 shows the results 
from these experiments. 
Temperature: 0 °C 
 
Temperature: 10 °C 
 
 
 
 
 
 
 
Table 32: Flow Chemistry with 15 Feet of Coil (0.75 mm Diameter) 
 
These results suggest that by increasing the coil length the production of 
product 95 increases (entry 1). However, reducing the flow rate or increasing the 
temperature causes a decrease in the reported percentage yield (entries 4 and 5). 
The study has shown that the coil length of the reactor is a contributing 
factor to the amount of product produced. The reported poor conversion of 
benzamide 92 could be a result of a number of different factors of which the main 
concerns are listed below. 
1. Poor mxing: the turbulence in the reactor coil may not be high enough to 
force the LDA and the starting material to mix adequately and the results 
observed are that of a reaction at the interface of these two liquid as they 
pass through the coil. 
2. Incorrect residence time/coil length: the results suggest that a longer coil 
length promotes conversion and therefore 15 feet may be too short, as 
reducing the flow rate has proved unsuccessful. 
 
 
Entry Flow Rate 
(ml/min) 
mg/ml Res. Time 
(mins) 
95 
(%) 
1 Fast (0.203) 6.51 5 39.03 
2 Mid (0.101) 5.30 10 31.78 
3 Slow (0.050) 5.19 20 31.16 
Entry Flow Rate 
(ml/min) 
mg/ml Res. Time 
(mins) 
95 
(%) 
4 Fast (0.203) 4.55 5 27.32 
5 Mid (0.101) 4.20 10 25.18 
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Unfortunately, a micro-mixer was unavailable which would have 
eliminated the poor mixing theory, so increasing the coil length further was the 
only alternative. The flow reactor was altered to introduce a 33 foot Teflon tube 
of diameter 1.5 mm. The results are shown in table 33. 
Temperature: 0 °C 
 
 
 
 
 
 
 
Table 33: Flow Chemistry with 33 Foot Coil (1.5 mm Diameter) 
 
These results were more encouraging and showed that flow rate was 
having little affect on the conversion but by increasing the coil length had a major 
effect on the formation of the desired product 95, increasing the yield to 67% with 
<2% starting material. LC-MS data showed an increase in baseline impurities, 
which could be responsible for the moderate yields obtained.  
Due to time limitations it was not possible to attempt further runs at lower 
temperature using coil lengths between 15 and 33 feet. However, this study has 
shown that with the correct flow reactor set-up, the dearomatising cyclisation 
reaction can be applied to flow chemistry to generate pure material continuous.
Entry Flow Rate 
(ml/min) 
mg/ml Res. Time 
(mins) 
95 
(%) 
92 
(%) 
1 Fast (3.534) 7.12 5 66.50 1.80 
2 Mid (1.767) 7.19 10 67.18 1.73 
3 Slow (0.884) 7.07 20 66.04 3.00 
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Appendix 2. 
 
A.2 Alternative Approaches to the Desired Alkyne 
Intermediate. 
 
Three challenging routes to synthesise the desired alkyne have been 
discussed in sections 2.2, 2.3 and 2.4. Described in appendix 3 are alternative 
routes considered for the synthesis of the alkyne.  
A.2.1 Grignard Fragmentation Reaction. 
 
A recent publication by Dudley et.al. has shown the use of a Grignard 
reaction to perform a tandem carbanion addition which fragments to give alkyne 
403 (Scheme 162).143 
 
 
 
 
 
Reagents and conditions: (a) Tf2O (1.2 eq.), pyridine (2 eq.), DCM; (b) R-M, THF, -78 °C – R.T. 
Scheme 162: Grignard Fragmentation Reaction 
 
These conditions were used on enone 177 (bearing a t-butyl group) in an 
attempt to perform the fragmentation using phenyl magnesium bromide to initial 
the elimination of methoxide (Scheme 163). 
 
 
 
 
 
Reagents and conditions: (a) PhMgBr, THF, R.T. 18 h 
Scheme 163: Fragmentation Attempt 
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Subjecting enone 177 to phenyl magnesium bromide at room temperature 
resulted in the addition to the carbonyl group followed by enone formation to give 
enone 404 in 82% yield, which was thought to be a lower energy pathway 
compared to the fragmentation.  
No further attempts were made to complete the fragmentation reaction 
using a Grignard reagent on enone 177. Changing the leaving group to the 
reported triflate was considered but required a number of addition steps to make 
the precursor which was disfavoured for the synthesis. 
A.2.2 Cleavage of Enone 104. 
 
An alternative approach to the alkyne intermediate was to employ a diol 
cleavage reaction to give a functionalised intermediate. This reaction has been 
previous reported by Gonzalez et. al in the synthesis of (+)- and (–)-isocarvone 
(Scheme 164).144 
 
 
 
 
 
 
Reagents and conditions: (a) i. H+, THF/H2O; ii. NaIO4, 0 °C 
Scheme 164: Alternative Route to Aldehyde Intermediate 
 
Initial research into suitable conditions for the dihydroxylation of enone 
104 were explored using osmium tetroxide (Scheme 165, table 34). 
 
 
 
 
 
Reagents and conditions: (a) conditions in table 34 
Scheme 165: Dihyroxylation Attempts 
 
 
 
 
 
 
Table 34: Dihydroxylation Attempts 
Entry Conditions 407 408 
1 OsO4, NMO, Acetone/H2O (8:1) 0% 82% 
2 OsO4, Acetone/H2O (8:1) 48% 0% 
O O
HO
Oa
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Attempting the dihydroxylation using osmium tetroxide and NMO was 
unsuccessful, resulting in the formation of a mono-alcohol 408 which was thought 
to have been as a result of intermediate enolate hydroxylation. By removing the 
NMO from the reaction it was possible to obtain the desired diol 407 in 48% after 
purification. 
 The next step was to perform the diol cleavage using sodium periodate to 
give the desired aldehyde 409 (Scheme 164). 
 
 
 
 
 
Reagents and conditions: (a) NaIO4, 0 °C, H2O, MeOH 
Scheme 166: Diol Cleavage Attempts 
 
The reaction resulted in a mixture of products thought to be that of the 
desired aldehyde 409 and a cyclised product 410 by crude NMR analysis. 
Purification proved difficult and so it was not possible to confirm the presence of 
either product. It was thought that in solution there could be an equilibrium 
between the two products and so the crude material was subjected to esterification 
conditions using TMS-diazomethane to promote the formation of the desired 
aldehyde 409. Unfortunately, this was unsuccessful and caused decomposition of 
the material. 
Due to the little success in obtaining the desired aldehyde 409 and the 
concerns of epimerisation at the C4 position caused by increased acidity of the 
newly formed 1,3-dicarbonyl, this route was not researched further. 
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3.1 Experimental Procedures. 
 
3.1.1 General Procedures. 
 
Proton and carbon NMR spectra were recorded on Varian Unity 300, 
Bruker DPX 360, Varian Unity 400 or Bruker AMX 500 Fourier Transform 
instruments. Proton NMR data are presented as follows: chemical shift δ (in ppm 
relative to δTMS = 0), integration, multiplicity (s = singlet, d = doublet, t = triplet, 
q = quartet, qn = quintet, hept = heptet, m = multiplet, br = broad, obs = 
obscured), coupling constant J (in Hz, values rounded to nearest 0.5 Hz) and 
assignment (based on chemical shift, integration, coupling pattern and COSY, 
DEPT, HMQC and HMBC experiments where necessary). 
Infrared spectra were recorded on an ATi Matson Genesis Series Fourier 
Transform spectrophotometer. 
Low resolution electron impact and chemical ionisation mass spectra were 
recorded on a Waters Trio 2000 quadrupole mass spectrometer.  Low resolution 
electrospray mass spectra were recorded on a Micromass Platform II mass 
spectrometer.  High resolution mass spectra were recorded on a Thermo Finnigan 
MAT 95XP mass spectrometer. 
Melting points were determined using Electrothermal apparatus and are 
uncorrected. 
Analytical thin layer chromatography was carried out on pre-coated UV254 
plates, with visualisation by ultraviolet light at 254 nm, potassium permanganate,  
para-anisaldehyde or dodecamolybdophosphoric acid (PMA). 
Flash column chromatography145 was carried out using Fluorochem 
Davisil 40–63 µm 60 Å silica, under a positive pressure by means of compressed 
air. The use of the term in this report implies removal of the solvent under 
reduced pressure after purification. 
Reagents and solvents were purified by standard means.146  
Dichloromethane was distilled from calcium hydride and subsequently stored 
under a nitrogen atmosphere; tetrahydrofuran and diethyl ether were distilled from 
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sodium wire and benzophenone and subsequently stored under a nitrogen 
atmosphere. Triethylamine was distilled from and stored over potassium 
hydroxide. N, N′-Dimethyl-N, N′-propylene urea (DMPU) was distilled, under 
reduced pressure, from calcium hydride, and subsequently stored over molecular 
sieves. N, N-Dimethylformamide (DMF) was distilled from molecular sieves, and 
subsequently stored under a nitrogen atmosphere.  Chlorotrimethylsilane was 
distilled onto molecular sieves. ‘Petrol’ refers to the fraction of petroleum ether 
that boils between 40 ºC and 60 ºC, and was distilled before use.  All other 
chemicals were used as received, except where otherwise noted in the 
experimental text. 
All experiments were performed in anhydrous conditions under an 
atmosphere of nitrogen, unless otherwise noted in the experimental text.  
Apparatus was oven-dried and standard techniques were employed in handling 
air-sensitive materials. 
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3.1.2 Experimental Procedures for Section 2.1:  
 
 
N-Benzyl-N-tert butyl-2-methoxybenzamide 160. To a bi-phasic mixture of 
DCM (15 ml) and aq. sodium hydroxide (3M, 15ml), N-(tert-butyl) benzylamine 
(6.22 ml, 33.6 mmol) was added. o-Anisoyl chloride (5.73 g, 33.6 mmol) was 
added dropwise at 0 °C. The reaction was stirred overnight at room temperature, 
then extracted with DCM (2 x 20 ml). The combined organic fractions were dried 
over magnesium sulfate and the solvents evaporated under reduced pressure. 
Recrystallisation from hot ethyl acetate and petrol gave the title product (9.16 g, 
92 %) as a colourless solid, m.p 108-112 °C (lit.,147 109-111 °C); Rf 0.47 (1:1 
petrol/ethyl acetate); νmax 2963 and 1639 (film)/cm-1; 1H NMR (300MHz; 
CDCl3)  δH: 7.34-7.17 (7H, m, ArH), 6.86-6.82 (2H, m, ArH) 4.57-4.45 (2H, bm, 
H3, H3'), 3.81 (3H, s, OMe), 1.50 (9H, s, tBu). All data consistent with 
literature147 
 
 
 
N-benzyl-N-tert-butyl-4-methoxybenzamide 162. To a bi-phasic solution of 
DCM (15 ml) and aq. sodium hydroxide (3M, 15 ml), N-Benzyl-tert-butylamine 
166 (6.23 ml, 33.6 mmol) was added. The bi-phasic solution was stirred 
vigorously and cooled to 0 °C, then p-anisoyl chloride (4.55 ml, 33.6 mmol) was 
added dropwise. The reaction was left to stir overnight at room temperature and 
then extracted with DCM (2 x 100 ml). The combined organic fractions were 
washed with water (100 ml), dried over magnesium sulfate and the solvent 
removed under reduced pressure. Purification by crystallisation from ethyl acetate 
and petrol gave the title compound (7.29 g, 73 %) as a colourless solid, m.p 130-
132 °C (lit.,148 98-99 °C); Rf 0.70 (2:1 petrol/ethyl acetate); νmax (film)/cm-1 3000 
and 1609; 1H NMR (300MHz; CDCl3) δH: 7.45-7.22 (7H, m, ArH), 6.83 (2H, m, 
OMe
N
O
3 Ph
N
O
3 PhMeO
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ArH), 4.68 (2H, s, H3, H3'), 3.80 (3H, s, OMe), 1.51 (9H, s, tBu). All data 
consistent with literature.110(b), 148 
 
 
 
 
N-Benzyl-N-tert-butyl-2, 4-methoxybenzamide 165. To a round-bottom flask 
containing oxalyl chloride (20 ml), 2, 4-dimethoxybenzoic acid 163 (3.02 g, 16.7 
mmol) and a drop of DMF was added. The solution was stirred for 12 hours. The 
solvents were removed under reduced pressure. The remaining yellow solid (1.74 
g, 8.67 mmol) was dissolved in DCM with N-(tert-butyl) benzylamine (1.55 ml, 
7.72 mmol) and triethylamine (1.61 ml, 11.6 mmol). The solution was stirred for 
18 hours and then extracted with DCM (2 x 20 ml). The combined organic 
fractions were dried over magnesium sulfate and the solvents evaporated under 
reduced pressure. Purification by crystallisation from ethyl acetate and petrol (3:1 
petrol/ethyl acetate) gave the title compound (2.02 g, 67 %) as a colourless solid, 
m.p 106-108 °C, Rf 0.62 (1:1 petrol/ethyl acetate); νmax (film)/cm-1 2976 and 
1639; 1H NMR (500MHz; CDCl3) δH: 7.28-7.26 (2H, m, ArH), 7.21-7.17 (3H, m, 
ArH), 7.15-7.14 (1H, m, ArH), 6.38-6.36 (2H. m, ArH), 4.52-4.51 (2H, bm, H3, 
H3'), 3.79 (3H, s, OMe), 3.74 (3H, s, OMe) and 1.48 (9H, s, tBu); 13C NMR (75 
MHz, CDCl3) δC: 171.4 (C=O), 161.2 (COMe), 156.6 (COMe), 140.6 (Ar), 128.6 
(2xAr), 128.5 (2xAr), 126.9 (Ar), 126.6 (Ar), 122.1 (Ar), 104.7 (Ar), 98.9 (Ar), 
58.3 (C(CH3)3), 55.9 (OCH3), 55.6 (OCH3), 51.4 (C3) and 29.1 (C(CH3)3); m/z 
(Cl+) 328 (100%, MH+); Found MH+ 328.1906, C20H25NO3 requires MH+ 
328.1907. 
 
 
 
 
 
(3R,3aR,7aR)-2-tert-Butyl-3,3a-dihydro-7-methoxy-3-phenyl-2H-isoindol 
1(7aH)-one 166a.110(b) A solution of LDA was formed by addition of n-
butyllithium (1.7 M solution in diethyl ether, 2.92 ml, 5.04 mmol) to 
diisopropylamine (0.80 ml, 5.71 mmol) in THF (14 ml) at 0 °C. After twenty 
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minutes stirring at 0 °C, a yellow solution had formed and a solution of N-benzyl-
N-tert-butyl-2-methoxybenzamide 160 (1.00 g, 3.36 mmol) and DMPU (2.44 ml, 
20.2 mmol) in THF (16 ml) was added dropwise. The solution turned red. The 
reaction was quenched by addition of saturated aq. ammonium chloride solution 
after one hour of stirring at room temperature under nitrogen. The solution 
returned to pale yellow. The reaction was extracted with diethyl ether (3 x 20 ml), 
and the combined organics washed with brine (40 ml), dried over magnesium 
sulfate and concentrated under reduced pressure. Recrystallisation from hot ethyl 
acetate and petrol gave the title product (382 mg, 39 %) as a colourless solid, m.p. 
172-174 °C (lit.,148 171-172 °C), Rf 0.54 (1:1 petrol/ethyl acetate); νmax (film)/cm-1 
2963 and 1672; 1H NMR (300MHz; CDCl3) δH: 7.45-7.25 (5H, m, ArH), 5.98 
(1H, dd, J 6.0, 2.0, H8), 5.33 (1H, dd, J 10.0, 2.0, H9), 4.98 (1H, d, J 6.0, H7), 
4.81 (1H, s, H3), 3.72 (3H, s, OMe), 3.37 (1H, d, J 9.0, H5), 3.14 (1H, dt, J 9.0, 
2.0, H4) and 1.39 (9H, s, tBu). Also obtained (3R,3aS,7aS)-2-tert-butyl-3, 3a-
dihydro-7-methoxy-3-phenyl-2H-isoindol-1(7aH)-one 166b as a side product. 
Purification by recrystallisation of mother liquor of above crystallisation gave a 
colourless solid, m.p 102-106 °C; Rf 0.33 (1:1 petrol/ethyl acetate); νmax (film)/cm-
1
 2970 and 1687; 1H NMR (300MHz; CDCl3) δH: 7.30- 6.88 (5H, m, ArH), 5.43 
(1H, dd, J 9.0, 6.0, H8), 5.00 (1H, dd, J 9.0, 5.0, H9), 4.82 (1H, d, J 8.0, H7), 4.53 
(1H, dd, J 6.0, 2.0, H3), 3.54 (3H, s, OMe), 3.38 (1H, dd, J 13.0, 2.0, H5), 3.26 
(1H, dd, J 8.0, 5.0, H4) and 1.29 (9H, s, tBu). All data consistent with 
literature.110(b),148  
 
 
 
 
(3R, 3aR,7aR)-2-tert-Butyl-2, 3, 3a, 4-tetrahydro-3-phenyl-7aH-isoindole-1, 7-
dione 170. A solution of LDA was formed by addition of n-butyllithium (1 M 
solution in diethyl ether, 24.0 ml, 25.3 mmol) to diisopropylamine (3.93 ml, 28.6 
mmol) in THF (70 ml) at 0 °C. After twenty minutes stirring at 0 °C, a yellow 
solution had formed and a solution of N-benzyl-N-tert-butyl-2-
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methoxybenzamide 165 (5.00 g, 16.8 mmol) and DMPU (1.21 ml, 10.0 mmol) in 
THF (80 ml) was added dropwise. The solution turned red. The reaction was 
quenched by addition of saturated aq. ammonium chloride solution after one hour 
of stirring at room temperature under nitrogen. The solution returned to pale 
yellow. The reaction was extracted with diethyl ether (3 x 100 ml), and the 
combined organics washed with aq. 3M hydrochloric acid (200 ml) and brine 
(200 ml), dried over magnesium sulfate and concentrated under reduced pressure. 
Purification by flash column chromatography (1:1 petrol/ethyl acetate) gave the 
title compound (1.43 g, 36 %) as a colourless solid, m.p 118-122 °C (lit.,80,148 
119-120 °C); Rf 0.21 (1:1 petrol/ethyl acetate); νmax (film)/cm-1 2974 and 1694; 1H 
NMR (300MHz; CDCl3) δH: 7.45-7.25 (5H, m, ArH), 6.96 (1H, ddd, J 10.0, 6.0, 
3.0, H8), 6.13 (1H, dd, J 10.0, 3.0, H7), 4.60 (1H, s, H3), 3.64 (1H, d, J 7.0, H5), 
2.82-2.66 (2H, m, H9, H9'), 2.48-3.31 (1H, m, H4) and 1.42 (9H, s, tBu). All data 
consistent with literature.110(b),80,148 
 
 
  
 
((3S,3aS,7aR)-2-tert-butyl-3-phenyl-2,3,3a,4-tetrahydro-1H-isoindole-
1,5(7aH)-dione 171.110(b) A solution of LDA was formed by addition of n-
butyllithium (2.3 M solution in diethyl ether, 2.19 ml, 5.05 mmol) to a solution of 
diisopropylamine (0.80 ml, 5.72 mmol) in THF (14 ml) at 0 °C. The solution was 
left to stir for thirty minutes under an atmosphere of nitrogen. N-Benzyl-N-tert-
butyl-4-methoxybenzamide (1.00 g, 2.78 mmol) in THF (16 ml) was added 
slowly to the LDA solution by cannula at 0 °C. The reaction turned red. It was 
allowed to warm to room temperature, and left the stir for one hour. Addition of 
saturated aq. ammonium chloride solution quenched the reaction. The mixture 
was extracted with diethyl ether (2 x 50 ml). The combined organic fractions were 
washed with aq. 6M hydrochloric acid (50 ml) then saturated aq. sodium 
bicarbonate solution (50 ml), dried over magnesium sulfate and concentrated 
under reduced pressure. Purification by crystallisation from hot ethyl acetate and 
petrol gave the title compound (391 mg, 41 %) as a colourless solid, m.p 150-156 
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°C (lit.,148 151-154 °C); Rf 0.46 (2:1 petrol/ethyl acetate); νmax (film)/cm-1 2975 
and 1678; 1H NMR (300MHz; CDCl3) δH: 7.39-7.37 (2H, m, ArH), 7.32-7.29 
(1H, m, ArH), 7.26-7.24 (2H, m, ArH), 6.99 (1H, dd, J 5.5, 10.5, H6), 6.11 (1H, 
dd, J 1.5, 10.0, H7), 4.42 (1H, s, H3), 3.62-3.59 (1H, m, H5), 2.72-2.66 (2H, m, 
H4, H9), 2.54 (1H, dd, J 13.5, 17.0, H9') and 1.36 (9H, s, tBu). All data consistent 
with literature.110(b),148 (R)-2-tert-butyl-5-methoxy-3-phenylisoindolin-1-one 172 
was isolated as a minor impurity, m.p 148-152 °C, Rf 0.7 (1:1 petrol/ethyl 
acetate); νmax (film)/cm-1 1678 and 1364; (500 MHz, CDCl3) δH: 7.70 (1H, d, J 
10.5, ArH), 7.33-7.20 (5H, m, ArH), 6.88 (1H, dd, J 10.5, 3.0, ArH), 6.47 (1H, d, 
J 3.0, ArH), 5.59 (1H, s, H3), 3.72 (3H, s, OMe) and 1.44 (9H, s, tBu); (75 MHz, 
CDCl3) δC: 169.9 (NC=O), 162.7 (COMe), 148.8 (Ar), 141.1 (Ar), 129.0 (2xAr), 
127.8 (2xAr), 126.2 (Ar), 124.7 (Ar), 124.5 (Ar), 114.6 (Ar), 107.2 (Ar), 64.6 
(C3), 55.8 (OCH3), 55.5 (C(CH3)3) and 28.6 (C(CH3)3); m/z (EI) 318.2 (100 %, 
MH+); Found MH+ 318.1470, C19H21NO2 requires MNa+ 318.1475;  
 
 
 
 
Benzyl-(1-methyl-1-phenyl-ethyl)-amine 173.79 Benzyl bromide (3.29 ml, 27.7 
mmol), potassium carbonate (3.83 g, 27.7 mmol) and cumylamine (3.20 ml, 25.1 
mmol) were dissolved in dry DMF (25 ml) and left to stir for 18 hours under 
nitrogen. The reaction was diluted with diethyl ether (35 ml) and washed with 
water (2 x 35 ml). The layers were separated and the organic layer was dried over 
sodium sulfate and the solvents were removed under reduced pressure. 
Purification by flash chromatography (5:1→1:1 petrol/ethyl acetate) gave the title 
compound (4.17 g, 66 %) as clear oil, Rf 0.49 (3:1 petrol/ethyl acetate); νmax 
(film)/cm-1 3060, 3026 and 2971; 1H NMR (300MHz, CDCl3) δH: 7.64-7.24 (10H, 
m, ArH), 3.56 (2H, s, H1, H1') and 1.60 (6H, s, 2xMe). All data consistent with 
literature.79 
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N-benzyl-4-methoxy-N-(2-phenylpropan-2-yl)benzamide 92.77(a)  To a round-
bottom flash, 2, 4-Dimethoxybenzoic acid (3.02 g, 16.6 mmol) was dissolved in 
oxalyl chloride (14.4 ml, 165 mmol) with a drop of dry DMF added. The reaction 
was left to stir for twelve hours at room temperature under nitrogen. The oxalyl 
chloride was removed under reduced pressure and the resulting acid chloride was 
dried under high vacuum. The acid chloride (1.74 g, 8.67 mmol), amine 173 (1.55 
g, 7.72 mmol) and triethylamine (1.61 ml, 11.6 mmol) were dissolved in dry 
DCM (20 ml) and stirred for eighteen hours under nitrogen. The reaction was 
quenched by addition of water (20 ml). The mixture was extracted with DCM (2 x 
20 ml). The combined organic fraction were dried over magnesium sulfate and 
concentrated under reduced pressure to give the title compound (2.48 g, 80 %) as 
a colourless solid which was very unstable to acid conditions, m.p. 118-119 °C 
(lit.,79 118-119 °C); Rf 0.50 (2:1 petrol/ethyl acetate); νmax (film)/cm-1 1639 and 
1606; 1H NMR (300MHz, CDCl3) δH: 7.52-7.22 (12H, m, ArH), 6.85 (2H, d, J 
9.0, ArH), 4.85 (2H, s, H3, H3'), 3.81 (3H, s, OMe) and 1.75 (6H, s, 2xMe); All 
data consistent with literature.79 
 
 
 
 
 
(3S,3aS,7aR)-5-methoxy-3-phenyl-2-(2-phenylpropan-2-yl)-2,3,3a,7a-
tetrahydro-1H-isoindol-1-one 95. A solution of LDA was formed by addition of 
n-butyllithium (2.50 M solution in diethyl ether, 10.0 ml, 25.1 mmol) to 
diisopropylamine (4.0 ml, 28 mmol) in dry THF (120 ml) at -40 °C. The solution 
was left to stir of twenty minutes under nitrogen until a pale yellow colour had 
formed. A solution of benzamide 92 (6.00 g, 16.7 mmol) in THF (100 ml) was 
then added to the LDA, dropwise at -40 °C. The solution was allowed of stir 
under nitrogen for two hours, and then quenched by addition of saturated aq. 
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ammonium chloride solution, after which the pale yellow colour returned. The 
product was extracted with diethyl ether (150 ml). The aqueous layer was 
extracted with diethyl ether (2 x 100 ml) then the combined organic fractions 
were dried over magnesium sulfate and the solvents removed under reduced 
pressure. Purification by flash column chromatography (4:1 petrol/ethyl acetate) 
gave the title compound (4.75 g, 79 %) as a pale yellow amorphous solid, Rf 0.83 
(1:1 petrol/ethyl acetate); νmax (film)/cm-1 1688 and 1226; 1H NMR (400MHz, 
CDCl3) δH: 7.39-7.15 (10H, m, ArH), 5.89-5.81 (2H, m, H6, H7), 4.71 (1H, d, J 
3.0, H3), 4.54 (1H, m, H9), 3.60 (3H, s, OMe), 3.48 (1H, ddd, J 1.0, 4.5, 11.0, 
H5), 3.12 (1H, dt, J 3.0, 11.0, H4), 1.81 (3H, s, Me) and 1.38 (3H, s, Me); 13C 
NMR (75 MHz, CDCl3) δC: 175.0 (NC=O), 153.4 (COCH3), 147.2 (Ar), 143.7 
(Ar), 128.9 (2xAr), 128.0 (2xAr), 127.7 (Ar or C6), 126.4 (Ar or C6), 125.7 
(2xAr), 125.4 (2xAr), 124.9 (Ar), 124.2 (C7), 92.4 (C9), 60.1 (C3), 54.3 
(C(CH3)2Ph), 42.9 (C5), 41.2 (C4), 29.7 (C(CH3)2Ph) and 27.3 (C(CH3)2Ph); m/z 
(CI) 382.2 (100 %, MH+); Found MH+ 360.1954, C24H25NO2 requires MH+ 
360.1958 
 
 
 
 
 
(3S,3aS,7aR)-3-phenyl-2-(2-phenylpropan-2-yl)-2,3,3a,4-tetrahydro-1H-
isoindole-1,5(7aH)-dione 104.77(a)  
Method 1: A solution of LDA was formed by addition of n-butyllithium (2.40 M 
solution in diethyl ether, 4.8 ml, 11.5 mmol) to diisopropylamine (1.86 ml, 13.3 
mmol) in dry THF (80 ml) at 0 °C. The solution was left to stir of twenty minutes 
under nitrogen until a pale yellow colour had formed. A solution of amide 92 
(3.19 g, 8.87 mmol) in THF (70 ml) was then added to the LDA, dropwise at 0 
°C. A red colour formed. The solution was allowed of stir under nitrogen for one 
hour, then quenched by addition of saturated aq. ammonium chloride solution, 
after which the pale yellow colour returned. The product was extracted with 
diethyl ether (150 ml) and washed with hydrochloric acid (3M, 100 ml). The 
aqueous layer was extracted with diethyl ether (2 x 100 ml) then the combined 
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organic fractions were dried over magnesium sulfate and the solvents removed 
under reduced pressure. Purification by flash column chromatography (3:1 
petrol/ethyl acetate) gave the title compound (1.90 g, 62 %) as a pale yellow solid,  
Method 2: Amide 92 (0.25 g, 0.696 mmol) was added to a solution of chiral 
amide 111 (0.24 g, 0.90 mmol) and n-butyllithium (1.8 mmol) in THF (20 ml) at -
78 °C. The mixture was allowed to warm to room temperature and quenched with 
saturated ammonium chloride solution. The aqueous layer was extracted with 
diethyl ether. The combined organic layers were washed with 1M HCl solution 
and brine, dried over magnesium sulfate and the solvents removed under reduced 
pressure. Purification by flash column chromatography (3:1 petrol/ethyl acetate) 
gave the title compound (0.205 g, 85%). Analytical HPLC (β-Gem Regis), eluting 
with IPA and hexane (30:70) showed it to consist of 81% e.e of a mixture of two 
enantiomers, tR 8.16 and 8.95 mins. Recrystalisation from ethyl acetate gave the 
title compound (0.157 g, 66%) of e.e >99%; [α]D20 = -224 (c = 0.17, CHCl3); m.p. 
125-128 °C (lit.,149127-128 °C); Rf 0.63 (2:1 petrol/ethyl acetate); νmax (film)/cm-1 
1680; 1H NMR (300MHz, CDCl3) δH: 7.44-7.24 (10H, m, ArH), 6.92 (1H, dd, J 
10.0, 5.0, H6), 6.16 (1H, dd, J 10.0, 2.0, H7), 4.47 (1H, d, J 2.5, H3), 3.67 (1H, 
dd, J 7.0, 2.5, H17), 2.77-2.68 (1H, m, H4), 2.66 (1H, dd, J 20.0, 8.0, H9), 2.51 
(1H, dd, J 20.0, 12.0, H9'), 1.85 (3H, s, Me) and 1.52 (3H, s, Me); All data 
consistent with the literature.79 
 
 
 
 
 
(3S,3aS,7aS)-2-tert-butyl-2,3,3a,4-tetrahydro-7-methoxy-3-phenyl-7aH-
isoindole-1,5-dione 177. A solution of LDA was formed by addition of n-
butyllithium (2.2 M solution in diethyl ether, 2.09 ml, 4.59 mmol) to 
diisopropylamine (0.73 ml, 5.20 mmol) in THF (14 ml) at 0 °C. After twenty 
minutes stirring at 0 °C, a yellow solution had formed and a solution of N-benzyl-
N-tert-butyl-2- methoxybenzamide 165 (1.00 g, 3.06 mmol) in THF (16 ml) was 
added dropwise. The solution turned red. The reaction was quenched by addition 
of saturated aq. ammonium chloride solution after one hour of stirring at room 
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temperature under nitrogen. The solution returned to pale yellow. The reaction 
was extracted with diethyl ether (2 x 50 ml), and the combined organics washed 
with aq. 3M hydrochloric acid (50 ml) and brine (50 ml), dried over magnesium 
sulfate and concentrated under reduced pressure. Purification by flash column 
chromatography (1:1 petrol/ethyl acetate) gave the title compound (410 mg, 42 
%) as a colourless solid, Rf 0.48 (1:1 petrol/ethyl acetate); νmax (film)/cm-1 2963, 
1753 and 1639; m.p. 195-197 °C; 1H NMR (500MHz; CDCl3) δH: 7.39-7.36 (2H, 
m, ArH), 7.32-7.29 (1H, m, ArH) 7.26-7.25 (2H, m, ArH), 5.41 (1H, s, H7), 4.49 
(1H, s, H3), 3.80 (3H, s, OMe), 3.57 (1H, d, J 6.5, H5), 2.73-2.63 (2H, m, H9, 
H4), 2.47 (1H, dd, 12.0, 15.5, H9') and 1.38 (9H, s, tBu). All data consistent with 
literature.77(a) 
 
 
N-benzyl-2,4-dimethoxy-N-(2-phenylpropan-2-yl)benzamide 178. To a round-
bottom flash, 2, 4-Dimethoxybenzoic acid 163 (3.01 g, 16.6 mmol) was dissolved 
in oxalyl chloride (14.4 ml, 165 mmol) and a drop of dry DMF added. The 
reaction was left to stir for twelve hours at room temperature under nitrogen. The 
oxalyl chloride was removed under reduced pressure and the resulting acid 
chloride dried under high vacuum. The acid chloride 164 (1.74 g, 8.67 mmol), 
amine 166 (1.55 g, 7.72 mmol) and triethylamine (1.61 ml, 11.6 mmol) were 
dissolved in dry DCM (20 ml) and stirred for eighteen hours under nitrogen. The 
reaction was quenched by addition of water (20 ml). The mixture was extracted 
with DCM (2 x 20 ml). The combined organic fraction were dried over 
magnesium sulfate and concentrated under reduced pressure to give the title 
compound (2.02 g, 68%) as a colourless solid, m.p. 122-126 °C (lit.,89 122-123 
°C); νmax (film)/cm-1 2976 and 1639; 1H NMR (300MHz, CDCl3) δH: 7.52 (2H, d, 
J 8.0, ArH), 7.40-7.30 (9H, m, ArH), 6.44 (2H, m, ArH), 5.79 (2H, bs, H3, H3'), 
3.90 (3H, s, OMe), 3.79 (3H, s, OMe), 1.73 (3H, bs, Me) and 1.64 (3H, bs, Me); 
13C NMR (75 MHz, CDCl3) δC: 170.2 (NC=O), 161.1 (COMe), 156.4 (COMe), 
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148.9 (Ar), 139.8 (Ar), 129.1 (2xAr), 128.3 (2xAr), 127.9 (Ar), 126.9 (2xAr), 
126.8 (2xAr), 125.8 (Ar), 124.7 (Ar), 121.0 (Ar), 104.6 (Ar), 98.5 (Ar), 62.5 (C3), 
55.5 (OCH3), 55.3(OCH3), 51.5 (C(CH3)2Ph) and 29.6 (C(CH3)2Ph); m/z (CI) 390  
(MH+, 100 %), 272 (MH+ - cumyl, 95 %), Found M+ 389.1994; C25H27NO3 
requires M, 389.1991.  
 
 
 
 
(3S,3aS,7aS)-2,3,3a,4-tetrahydro-7-methoxy-3-phenyl-2-(2-phenylpropan-2-
yl)-7aH-isoindole-1,5-dione 180. A solution of LD was formed by addition of n-
butyllithium (2.2M solution in ether, 2.95 ml, 6.47 mmol) to a solution of 
diisopropylamine (1.05 ml, 7.47 mmol) in dry THF (30 ml) at 0°C and left to stir 
for twenty minutes under nitrogen. A solution of the amide 178 (2.00 g, 4.98 
mmol) in dry THF (30 ml) was added to the LDA dropwise at 0°C and stirred for 
one hour under nitrogen. The reaction was quenched by addition of saturated aq. 
ammonium chloride solution, then diluted with water (50 ml). The mixture was 
extracted with diethyl ether (2 x 50 ml) and the combined organic fractions were 
washed with hydrochloric acid (3M aq., 100 ml), dried over sodium sulfate then 
the solvents were removed under reduced pressure. Purification by flash 
chromatography (1:1, petrol/ethyl acetate) gave the title compound (1.11 g, 62%) 
as a colourless solid, m.p. 174-176 °C; νmax (film)/cm-1 2979, 1699, 1656 and 
1611; 1H NMR (300MHz, CDCl3) δH: 7.45-7.20 (10H, m, ArH), 5.40 (1H, s, H7), 
4.51 (1H, s, H3), 3.77 (3H, s, OMe), 3.68 (1H, d, J 6.0, H5), 2.67 (2H, m, H4, 
H9), 2.48 (1H, dd, J 17.0, 13.0, H9'), 1.88 (3H, s, Me) and 1.57 (3H, s, Me), 13C 
NMR (75 MHz, CDCl3) δC: 196.2 (C=O), 172.1 (NC=O), 169.5 (COMe), 145.4 
(Ar), 140.8 (Ar), 129.0 (Ar), 128.1 (2xAr), 128.0 (2xAr), 127.0 (Ar), 125.6 
(2xAr), 125.4 (2xAr), 102.9 (C7), 66.8 (C3), 59.6 (COMe), 56.3 (C(CH3)2Ph), 
44.7 (C5), 41.8 (C4), 38.9 (C9), 27.8 (C(CH3)2Ph) and 26.9 (C(CH3)2Ph); m/z (CI) 
375 (M+, 100 %) 119 (cumyl, 75 %); Found M+ 375.1834; C24H25NO3 requires 
M+ 375.1841. 
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3.1.3 Experimental Procedures for Section 2.2: 
Eschenmoser Fragmenation Route. 
 
 
 
 
 
 
(3S,3aS,7aS)-2-tert-butyl-3-phenylhexahydro-1H-isoindole-1,7(7aH)-dione 
195. Enone 170 (50 mg, 0.177 mmol) was dissolved in THF (2 ml) and cooled to 
-78 °C. Lithium aluminium hydride (2M in THF, 0.17 ml, 0.35 mmol), was added 
dripwise and the reaction was left to stir for 1 hour. It was quenched by dilution 
with ethyl acetate (1 ml) and Rochelle’s salt solution (1 ml) and left to stir for 15 
mins. The organic layer was extracted with ethyl acetate (2 x 10 ml). The 
combined organic fractions were washed with brine, dried over magnesium 
sulfate and concentrated under reduced pressure. Purification by flash column 
chromatography (1:1 petrol/ethyl acetate) gave the title compound (0.033 g, 66 
%) as an amorphous solid, Rf 0.8 (1:1 petrol/ethyl acetate); νmax (film)/cm-1 2940, 
1720 and 1680; 1H NMR (500MHz; CDCl3) δH: 7.36-7.33 (2H, m, ArH), 7.29-
7.26 (1H, m, ArH), 7.21-7.19 (2H, m, ArH), 4.54 (1H, s, H3), 3.58 (1H, d, J 7.0, 
H5), 2.42-2.37 (2H, m, H4, H7), 2.34-2.26 (1H, m, H7'), 2.19-2.16 (1H, bm, H8), 
2.07-2.01 (1H, bm, H8'), 1.67 (1H, qd, J 13.5, 3.0, H9), 1.57 (1H, qt, J 13.5, 3.5 
H9') and 1.38 (9H, s, tBu); 13C NMR (75 MHz, CDCl3) δC: 204.9 (C=O), 169.9 
(NC=O), 141.5 (Ar), 129.0 (2xAr), 127.8 (Ar), 125.4 (2xAr), 67.2 (C3), 55.7 
(C7), 55.3 (C(CH3)3), 46.3 (C5), 40.2 (C4), 28.9 (C9 or C8), 27.8 (C(CH3)3) and 
23.4 (C8 or C9); m/z (CI) 308.2 (100%, MNa+); Found MNa+ 308.1631, 
C18H23NO2 requires MNa+ 308.1621. 
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(3S,3aS,7aS)-2-tert-butyl-octahydro-7-hydroxy-3-phenylisoindol-1-one 196. A 
solution of enone 170 (50.0 mg, 0.17 mmol) in MeOH (4 ml) was cooled to 0 ºC. 
Sodium borohydride (19.7 mg, 0.52 mmol) was added slowly and the solution 
was allowed to stir for 2 hour. The reaction was quenched with water (2 ml). The 
mixture was extracted with DCM (10 ml) and washed with water (10 ml), dried 
over magnesium sulfate and concentrated under reduced pressure. Purification by 
flash chromatography eluting with 3:1 petrol-EtOAc afforded the title compound 
(44 mg, 90%) as an amorphous solid, Rf 0.26 (1:1 petrol/ethyl acetate);  νmax 
(film)/cm-1 2935, 1692; 1H NMR (400MHz; CDCl3) δH: 7.38-7.34 (2H, m, ArH), 
7.30-7.28 (1H, m, ArH), 7.23-21 (2H, m, ArH), 4.39 (1H, s, H3), 3.61-3.54 (1H, 
bm, H4), 3.11 (1H, dt, J 6.0, 6.0, H5), 2.05-1.93 (3H, m, H9, H6, H7), 1.76-1.71 
(1H, m, H7'), 1.36 (9H, s, tBu) and 1.31-1.12 (3H, m, H8', H8, H9'); 13C NMR 
(75MHz, CDCl3) δc: 177.5 (NC=O) 141.4 (Ar), 128.8 (2xAr), 127.5 (Ar), 125.3 
(2xAr), 69.9 (C6), 67.2 (C3), 54.9 (C(CH3)3), 44.2 (C5), 42.3 (C4), 33.0 (C7), 
29.2 (C8 or C9), 27.9 (C(CH3)3) and 22.6 (C9 or C8); m/z (ES+) 288.3, 310.1 
(100%, MH+, MNa+); Found MH+ 288.1969, C18H25NO2 requires MH+ 288.1958. 
 
 
 
 
(3S,3aS,7aS)-2-tert-butyl-5-hydroxy-7-methoxy-3-phenyl-2,3,3a,4,5,7a-
hexahydro-1H-isoindol-1-one 198. A solution of enone 176 (50 mg, 15 mmol) in 
THF (4 ml) was cooled to -78 ºC. Lithium aluminium hydride (18.2 mg, 47.9 
mmol) was added slowly and the solution was allowed to stir for 1 hour. The 
reaction was quenched with water (2 ml). The mixture was extracted with diethyl 
ether (10 ml) and washed with water (10 ml), dried over magnesium sulfate and 
concentrated under reduced pressure to give the title compound (49 mg, 97 %) as 
a thin-film, Rf 0.44 (1:1 petrol/ethyl acetate); νmax (film)/cm-1 3602 and 1666; 1H 
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NMR (300MHz; CDCl3) δH: 7.36-7.33 (2H, bs, ArH), 7.28-7.23 (3H, m, ArH), 
4.77 (1H, bs, H7), 4.46 (1H, s, H3), 4.35 (1H, bm, H8), 3.63 (3H, s, OMe), 3.24 
(1H, d, J 6.5, H5), 2.32 (1H, dt, J 12.0, 5.0, H9), 2.17 (1H, ddd , J 13.0, 6.5, 4.0, 
H4), 1.59 (1H, bs, OH), 1.51-1.44 (1H, m, H9') and 1.35 (9H, s, tBu); 13C NMR 
(75 MHz, CDCl3) δC: 172.7 (NC=O), 153.6 (C6), 142.2 (Ar), 128.9 (2xAr), 127.6 
(Ar), 125.2 (2xAr), 100.6 (C7), 66.5 (C3), 65.9 (C8), 55.0 (OCH3), 54.9 
(C(CH3)3), 43.7 (C5), 41.5 (C4), 36.9 (C9) and 27.8 (C(CH3)3); m/z (ES+) 338 
(100%, MNa+), Found MNa+ 338.1732, C19H25NO3 requires MNa+ 338.1732. 
 
 
 
 
 
 
(3S,3aS,7aS)-2-tert-butyl-3,3a,4,5-tetrahydro-7-methoxy-3-phenyl-2H-
isoindol-1(7aH)-one 199. A solution of enone 176 (50 mg, 0.15 mmol) in THF (4 
ml) was cooled to 0 ºC. Lithium aluminium hydride (30.3 mg, 0.799 mmol) was 
added slowly and the solution was allowed to stir for 2 hour. The reaction was 
quenched with water (2 ml). The mixture was extracted with diethyl ether (10 ml) 
and washed with water (10 ml), dried over magnesium sulfate and concentrated 
under reduced pressure. Purification by flash chromatography eluting with 3:1 
petrol-EtOAc afforded the title compound (15 mg, 32 %) as an amorphous solid, 
Rf 0.52 (1:1 petrol/ethyl acetate); νmax (film)/cm-1 1671; 1H NMR (300MHz; 
CDCl3) δH: 7.35-32 (2H, m, ArH), 7.27-7.24 (3H, m, ArH), 4.65 (1H, bd, J 4.0, 
H7), 4.43 (1H, s, H3), 3.59 (3H, s, OMe), 3.24 (1H, d, J 6.5, H5), 2.17–2.03 (3H, 
m, H8, H8', H4), 1.95-1.92 (1H, m, H9), 1.55 (1H, ddd, J 25.0, 12.5, 6.0, H9') and 
1.34 (9H, s, tBu); 13C NMR (75 MHz, CDCl3) δC: 174.2 (NC=O), 151.7 (COMe), 
143.1 (Ar), 129.1 (2xAr), 127.6 (Ar), 125.5 (2xAr), 95.1 (C7), 66.8 (C7), 54.8 
(OCH3), 54.8 (C(CH3)3), 43.9 (C5), 42.9 (C4), 28.1 (C(CH3)3), 26.8 (C8 or C9) 
and 22.5 (C9 or C8); m/z (ES+) 322 (100%, MNa+); Found MNa+ 322.1766, 
C19H25NO2 requires MNa+ 322.1778. 
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N-Benzyl-2-methoxybenzamide 202. To a round-bottom flask, N-Benzyl-N-tert-
butyl-2-methoxybenzamide 160 (50 mg, 0.16 mmol) was dissolved in CH3NO2 
(1.5 ml) and scandium triflate (0.10 g, 0.20 mmol) was added. The solution was 
stirred for 4 hours at 100 ºC. The reaction was allowed to cool to R.T. and the 
solvent removed under vacuum. The crude was dissolved in DCM and washed 
with water, dried over magnesium sulfate and the solvents were removed under 
reduced pressure. Purification by crystallisation from ethyl acetate and petrol (3:1 
petrol/ethyl acetate) gave the title compound (38 mg, 97 %) as a colourless solid, 
Rf 0.68 (1:1 petrol/ethyl acetate); m.p 98-102 °C (lit.,150 106-107 °C); νmax 
(film)/cm-1 3215, 2963 and 1686; 1H NMR (500MHz; CDCl3) δH: 8.15 (1H, d, J 
8.0, ArH), 8.12 (1H, bs, NH), 7.35 (1H, t, J 7.5, ArH), 7.27-7.23 (4H, m, ArH), 
7.18-7.16 (1H, m, ArH), 6.99 (1H, t, J 7.5, ArH), 6.87 (1H, d, J 8.5, ArH), 4.59 
(2H, d, J 5.0, H3, H3') and 3.81 (3H, s, OMe);  13C NMR (75 MHz, CDCl3) δC: 
165.2 (NC=O), 157.4 (COMe), 138.7 (Ar), 132.8 (Ar), 132.4 (Ar), 132.3 (Ar), 
128.6 (2xAr), 127.4 (Ar), 127.2 (2xAr), 121.3 (Ar), 111.2 (Ar), 55.8 (OCH3) and 
43.6 (C3); m/z (Cl+) 242 (100%, MH+); Found MNa+ 265.2858. C15H15NO2 
requires MNa+ 265.2851. 
 
 
 
 
7-Methoxy-3-phenyl-2,3,3a,4,5,7a-hexahydro-1H-1,5-isoindoledione 204.  
Method 1: Enone 180 (0.08 g, 0.32 mmol) was stirred in TFA at reflux for 3 h. 
TFA was evaporated under reduced pressure. Purification by flash 
chromatography, eluting with 1:2 petrol-EtOAc afforded the title compound (0.06 
g, 100 %) as a colourless solid, 
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Method 2: Enone 176 (0.10 g, 0.38 mmol) was stirred in conc. H2SO4 (10 ml) at 
55 ºC for 1 h. The reaction was quenched by transferring the crude to ice water 
(20 ml). The mixture was extracted with ethyl acetate and concentrated under 
reduced pressure. Purification by flash chromatography, eluting with 1:2 petrol-
EtOAc afforded the title compound (60 mg, 73 %) as a colourless film, Rf 0.16 
(1:1 petrol/ethyl acetate); υmax (film)/cm-1 3200, 1707, 1655 and 1603; 1H NMR 
(300MHz, CDCl3) δH: 7.40-7.32 (3H, m, ArH), 7.31-7.29 (2H, m, ArH), 6.40 (1H, 
b, NH), 5.56 (1H, s, H7), 4.38 (1H, d, J 6.5, H3), 3.79 (3H, s, OMe), 3.48 (1H, d, 
J 7.5, H5), 2.90-2.85 (1H, m, H4), 2.55 (1H, dd, J 17.0, 6.0, H9 [A of ABX]) and 
2.48 (1H, dd, J 17.0, 5.5, H9' [B of ABX]); 13C NMR (75 MHz, CDCl3) δC: 196.3, 
(C=O) 172.3 (NC=O), 170.1 (COMe), 139.1 (Ar), 129.5 (2xAr), 129.1 (Ar), 
126.4 (2xAr), 104.2 (C7), 61.8 (C3), 56.9 (OCH3), 45.0 (C5), 43.5 (C4) and 36.2 
(C9); m/z (ES-) 256.3 (M-, 100 %); Found MH+ 258.1121, C15H15NO3 requires 
MH+  258.1125. 
 
 
 
 
(1S,7aS)-tert-butyl 3-(tert-butoxycarbonyloxy)-4-methoxy-6-oxo-1-phenyl-
7,7a-dihydro-1H-isoindole-2(6H)-carboxylate 209. Amide 204 (0.043 g, 
0.0.1673 mmol) was dissolved in dry DCM (2 ml) and tert-butyl dicarboxylate 
(0.057 g, 0.0.201 mmol), DMAP (0.021g, 0.1673 mmol) and triethylamine (0.023 
ml, 0.1673 mmol) was added. The reaction was left the stir under nitrogen for 18 
hours, and then quenched by addition of saturated ammonium chloride solution. 
The mixture was extracted with DCM (2 x 10 ml) and the combined organic 
fractions were washed with water (30 ml), dried over magnesium sulfate and the 
solvents were removed under reduced pressure. Purification by flash column 
chromatography (2:1 petrol/ethyl acetate) gave the title compound (0.007 g, 9%), 
as a colourless solid, m.p 170–178 °C; Rf 0.66 (1:1 petrol/ethyl acetate); νmax 
(film)/cm-1 1793, 1732, 1665, 1610; 1H NMR (500MHz; CDCl3) δH: 7.34-7.25 
(5H, m, ArH), 5.60 (1H, s, H7), 4.22 (1H, d, J 9.0, H3), 3.75 (3H, s, OMe), 3.20 
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(1H, ddd, 8.0, 5.5, 2.0, 5.5, H4), 2.57 (1H, dd, J 17.5, 6.0, H9), 2.34 (1H, dd, J 
17.5, 2.0, H9'), 1.44 (9H, s, tBu) and 1.06 (9H, s, tBu); 13C NMR (75MHz, 
CDCl3); δC: 195.6 (C=O), 164.9 (COMe), 151.4 (NBoc), 148.5 (OBoc), 140.4 
(COBoc), 140.0 (Ar), 129.3 (2xAr), 128.7 (Ar), 126.3 (2xAr), 106.5 (C7),  99.6 
(C5), 85.0 (C(CH3)3), 84.2 (C(CH3)3), 63.5 (C3), 57.4 (OCH3), 42.0 (C4), 32.8 
(C9), 27.8 (C(CH3)3) and 27.2 (C(CH3)3); m/z (ES+) 480 (100%, M+Na); Found: 
M, 481.1474, C25H31NO7 requires M+, 481.1471. 
 
 
 
 
(1S,3aS,7aS)-tert-butyl 4-methoxy-3,6-dioxo-1-phenyl-3,3a,7,7a-tetrahydro-
1H-isoindole-2(6H)-carboxylate 208. A solution of LDA was formed by 
addition of n-butyllithium (2.3 M solution in diethyl ether, 0.44 ml, 1.01 mmol) to 
a solution of diisopropylamine (0.16 ml, 1.17 mmol) in THF (10 ml) at 0 °C. 
Amide 204  (0.20 g, 0.77 mmol) was added slowly and stirred for 20 mins. Boc-
ON (258 mg, 1.01 mmol) was then added and the mixture was stirred for two 
hours. The mixture was quenched with sat. ammonium chloride solution and 
extracted with diethyl ehter (2 x 10 ml) and the combined organic fractions were 
washed with water (20 ml), dried over magnesium sulfate and the solvents were 
removed under reduced pressure. Purification by flash column chromatography 
(2:1 petrol/ethyl acetate) gave the title compound (0.239 g, 86 %), as a colourless 
solid, m.p 160 – 164 °C; Rf 0.6 (ethyl acetate); νmax (film)/cm-1 2966, 1754, 1720 
and 1690; 1H NMR (300MHz; CDCl3) δH: 7.40-7.37 (2H, m, ArH), 7.34-7.31 
(1H, m, ArH), 7.22-7.21 (2H, m, ArH), 5.50 (1H, s, H7), 4.81 (1H, d, J 4.0, H3), 
3.79 (3H, s, OMe), 3.59 (1H, d J 7.0, H5), 2.83-2.77 (1H, m, H4), 2.68 (1H, dd, J 
17.0, 6.0, H9), 2.51 (1H, dd, J 17.0, 9.5, H9') and 1.29 (9H, s, tBu); 13C NMR 
(75MHz, CDCl3) δC: 195.5 (C=O), 169.7 (NC(O)O), 168.4 (NC=O), 149.3 
(COMe), 139.2 (Ar), 129.1 (2xAr), 128.2 (Ar), 125.1 (2xAr), 103.7 (C7), 83.9 
(C(CH3)3), 64.8 (C3), 56.6 (OCH3), 45.7 (C5), 39.6 (C4), 37.5 (C9) and 27.6 
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(C(CH3)3); m/z (ES+) 380.2 (100%, MNa+); Found MNa+ 380.1471, C20H23NO5 
requires MNa+ 380.1468.  
 
 
 
 
 
 
(1S,3aS,7aS)-tert-butyl 3,3a,7,7a-tetrahydro-6-hydroxy-4-methoxy-3-oxo-1-
phenyl-1H-isoindole-2(6H)-carboxylate 211. A solution enone 208 (50 mg, 15 
mmol) in THF (4 ml) was cooled to -78 ºC. Lithium aluminium hydride (18.2 mg, 
47.9 mmol) was added slowly and the solution was allowed to stir for 1 hour. The 
reaction was quenched with water (2 ml). The mixture was extracted with diethyl 
ether (10 ml) and washed with water (10 ml), dried over magnesium sulfate and 
concentrated under reduced pressure (47 mg, 96 %) as a colourless film, Rf 0.5 
(1:1 petrol/ethyl acetate); νmax (film)/cm-1 3604, 1748 and 1692; 1H NMR 
(300MHz; CDCl3) δH: 7.30-7.27 (2H, m, ArH), 7.22-7.19 (1H, m, ArH), 7.09-
7.08 (2H, m, ArH), 5.79 (1H, d, J 5.0, H7), 4.88 (1H, s, H3), 4.31 (1H, bm, H8), 
3.58 (3H, s, OMe), 2.87 (1H, bt, J 6.0, H5), 2.31-2.28 (1H, m, H9), 2.24-2.20 
(1H, m, H4), 2.07-1.93 (1H, m, H9'), 1.18 (9H, s, tBu); 13C NMR (75 MHz, 
CDCl3); m/z (ES+) 382.2 (MNa+, 100%), Found MNa+, 382.163, C19H25NO2 
requires MNa+, 382.1625. 
 
 
 
 
 
(3S, 3aS, 7aR)-7-methoxy-2-methyl-3-phenyl-2,3,3a,4,5,7a-hexahydro-1H-isoindol-5-
ol 213. Enone 208 (0.05 g, 0.14 mmol) was dissolved in THF and Lithium 
aluminium hydride solution (0.35 ml, 0.7 mmol) was added dropwise at -78 °C 
under a nitrogen atmosphere. After 30 min the cold bath was removed and the 
reaction mixture was stirred at R.T. for 5 h. It was then heated to 50 °C for 2 h. 
The reaction mixture was allowed to cool down and quenched by dropwise 
addition of NaHCO3 solution. The reaction mixture was then diluted with 
Rochelle’s salt and stirred vigorously for 1 h. The organic layer was then 
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extracted with EtOAc, and the combined organic extracts were washed with water 
and brine, dried with magnesium sulfate and evaporated. Purification by flash 
column chromatography (PE:EtOAc 1:1) afforded 17 mg (0.065 mmol, 47 %) of 
title compound as a single isomer and as a yellow oil, Rf 0.5 (1:2 PE/EtOAc); 1H 
NMR (CDCl3, 500 MHz) δH; 7.44-7.15 (5H, m, ArH), 4.81 (1H, d, J 3.5, H7), 
4.41-4.33 (1H, m, H8), 3.56 (3H, s, OMe), 3.49 (1H, dd, J 7.5, 9.0, H1'), 3.15 
(1H, d, J 7.0, H3), 3.01-2.86 (1H, m, H5), 2.43-2.25 (2H, m, H1', H4), 2.18 (3H, 
s, NMe), 2.01-1.89 (1H, m, H9) and 1.60-1.47 (1H, m, H9'); 13C NMR (CDCl3, 
125 MHz) δC: 158.9 (COMe), 128.6 (Ar), 128.6 (2xAr), 127.8 (Ar), 127.4 (2xAr), 
98.4 (C7), 77.4 (C8), 66.7 (C3), 60.8 (C1), 54.5 (OCH3), 45.1 (C5), 40.4 (NCH3), 
38.9 (C4) and 34.8; m/z (ES+) 366 (100 %, MNa+). 
 
 
 
tert-Butyl (1S, 3S, 3aR, 7aS)-3-Methoxy-4-oxo-1-phenyl-1,3,3a,4,7,7a-
hexahydroisoindole-2-carboxylate 214 and tert-Butyl (1S, 7aS)-4-oxo-1-
phenyl-1, 4,7,7a-tetrahydroisoindole-2-carboxylate 215. Enone 208 (0.1 g, 0.3 
mmol) was dissolved in THF and lithium aluminium hydride solution (0.8 ml, 1.5 
mmol) was added dropwise at 0 °C under a nitrogen atmosphere and the mixture 
was stirred for 8 h. The reaction was quenches by addition of water. 15 % wt 
NaOH aqueous solution was added followed by an equal volume of water. The 
resulting suspension was stirred at R.T. overnight. It was then filtered through a 
pad of celite, which was rinsed with Et2O. The filtrate was diluted with Et2O and 
water and the organic was extracted with Et2O. The combined organic layer was 
dried using magnesium sulfate and reduced under vacuum. The resulting light 
yellow residue was dissolved in (not anhydrous) THF (3 ml) and p-
toluenesulfonic acid (6 mg, 0.1 mmol) was added. The reaction mixture was 
allowed to stir at R.T. for 24 h. After this time further p-toluenesulfonic acid (0.03 
mmol, 0.1 equiv) was added and the reaction mixture was further stirred for 48 h. 
The reaction was quenched by addition of a saturated aqueous solution of 
3
NBoc
1∗7
8
9 PhH
4
H
5
O OMe
3
NBoc
1
7
8
9 PhH
4
O
                                                 Chapter 3: Experimental Procedures 
171 
NaHCO3 and extracted with Et2O. The combined organic layers were dried using 
magnesium sulfate and evaporated under reduced pressure. Purification by flash 
column chromatography (petro/ethyl acetate 75:25) afforded 12 mg (0.035 mmol, 
13 % over 2 steps) of title compound 214 as an unstable solid, and 17 mg (0.55 
mmol, 18 %) of compound 215 as a white solid. 
214: Rf 0.6 (7:3 PE/EtOAc); 1H NMR (CDCl3, 400 MHz) δH: 7.39-7.27 (5H, m, 
ArH), 7.02-6.89 (1H, m, H8), 6.24-6.10 (1H, bm, H7), 5.76-5.66 (1H, bs, H1), 
4.48-4.22 (1H, m, H3), 3.66-3.52 (3H, m, OMe), 3.11-3.00 (1H, bm, H4), 2.94 
(1H, d, J 6.5, H5), 2.56 (1H, dt, J 6.0, 2.5, H9), 2.52 (1H, dt, J 6.0, 2.5, H9'), 1.41 
(4.5H, bs, tBu) and 1.08 (4.5H, bs, tBu); m/z (CI) 366 (100 %, MNa+); Found 
MNa+ 366.16.76, C20H25NO4 requires MNa+ 366.1676.  
215: Rf 0.3 (7:3 PE/EtOAc); 1H NMR (CDCl3, 400 MHz) δH: 7.74-7.61 (1H, m, 
H18), 7.46-7.20 (5H, m, ArH), 6.80 (1H, ddd, J 2.0, 6.0, 10.0, H8), 6.15 (1H, dd, 
J 10.0, 2.0, H7), 4.94-4.74 (1H, bm, H3), 3.42-3.27 (1H, bm, H4), 2.64 (1H, dt, J 
17.5, 6.5, H9), 2.47-2.34 (1H, m, H9') and 1.57-1.04 (9H, m, tBu); 13C NMR 
(CDCl3, 75 MHz) δC: 184.8 (C=O), 151.8 (NBoc), 145.2 (C1), 136.0 (C8), 132.5 
(C7), 128.9 (Ar), 128.6 (2xAr), 127.8 (Ar), 125.7 (2xAr), 118.2 (C5), 82.4 
(C(CH3)3), 71.0 (C3), 50.7 (C4), 31.3 (C9) and 28.0 (C(CH3)3); m/z (CI) 312 (100 
%, MH+). 
 
 
 
 
 
tert-Butyl (1S, 3aS, 7aS)- 4-oxo-1-phenyl-1,3,3a,4,7,7a-hexahydroisoindole-2-
carboxylate 216. A 1.0 M Super-Hydride® solution (1.4 ml, 1.4 mmol) in THF 
was added dropwise to a solution of enone 208 (0.1 g, 0.3 mmol) in THF (1.4 ml) 
at -78 °C under a nitrogen atmosphere. After 15 min the cold bath was removed 
and the reaction mixture was allowed to warm up to R.T. overnight. It was then 
cooled to 0 °C and carefully quenched by dropwise addition of a saturated 
aqueous solution of NaHCO3. The reaction mixture was extracted with EtOAc, 
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and the combined organic layer was washed with water and brine, dried using 
magnesium sulfate and evaporated. The residue was then taken up in MeOH, 
filtered, and the filtrate was dried under vacuum. The resulting light yellow 
residue was dissolved in a 9:1 mixture of (not anhydrous) THF/MeOH (2.8 mL) 
and p-toluenesulfonic acid (16.0 mg, 0.08 mmol) was added. The reaction mixture 
was allowed to stir at R.T. for 2 h, quenched by addition of a saturated aqueous 
solution of NaHCO3 and extracted with EtOAc. The combined organic extracts 
were dried over magnesium sulfate and evaporated to afford solid 214 which was 
used without further purification in the next step. To a solution of the previsouly 
described residue in DCM (1.4 mL) at -78 °C under a nitrogen atmosphere was 
added dropwise (50 µL, 0.3 mmol) of triethylsilane and (40 µL, 0.3 mmol) of 
freshly distilled BF3.OEt2. After 15 min, another 50 µL of triethylsilane and 40 µL 
of BF3.OEt2 were added. This operation was repeated once again, and the reaction 
mixture was allowed to stir at -78 °C for another 1 h. The reaction was then 
quenched by addition of a saturated aqueous solution of NaHCO3 and extracted 
with EtOAc. The combined organic layers were dried over magnesium sulfate and 
evaporated. Purification by flash column chromatography (petrol/ethyl acetate 
7:3) afforded the title compound (28 mg, 32 % over 3 steps) as a white solid, Rf 
0.4 (7:3 petrol/ethyl acetate); νmax (film)/cm-1 1693 and 1677; m.p. 124-126 °C; 
1H NMR (CDCl3, 400 MHz) [2 rotamers] δH: 7.39-7.29 (3H, m, ArH), 7.23-7.12 
(2H, m, ArH), 7.00-6.90 (1H, m, H8), 6.20-6.08 (1H, m, H7), 4.62-4.60 (0.35H, 
m, H3), 4.35 (0.65H, bd, J 7.0, H3),  4.26-4.24 (0.65, m, H1), 4.10-4.07 (0.35H, 
bm, H1), 3.78 (1H, dd, J 10.5, 7.0, H1'), 2.96 (1H, td, J  11.0, 5.5, H5), 2.85-2.69 
(1H, m, H4), 2.69-2.56 (1H, m, H9), 2.49-2.31 (1H, m, H9'), 1.44 (3.5H, s, tBu) 
and 1.09 (5.5H, s, tBu); 13C NMR (CDCl3, 100 MHz) [2 rotamers] δC: 196.9 
(C=O), 154.1 (NBoc), 148.0 (0.5 C8), 147.6 (0.5 C8), 143.4 (Ar), 129.2 (0.5 C7), 
129.1 (0.5 C7), 128.7 (Ar), 128.5 (Ar), 127.3 (Ar), 126.0 (Ar), 125.6 (Ar), 79.7 
(C(CH3)3), 65.4 (C3), 48.8 (0.5 C1), 48.6 (0.5 C1), 47.3 (0.5 C4), 46.7 (0.5 C4), 
46.5 (0.5 C5), 46.1 (0.5 C5), 28.4 (1.5 C(CH3)3), 28.0 (1.5 C(CH3)3), 25.5 (0.5 
C9) and 25.0 (0.5 C9); m/z (ES+) 336 (100 %, MNa+); Found MNa+ 366.1570, 
C19H23NO3 requires MNa+ 336.1570.  
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tert-Butyl (1aS, 2aR, 5S, 5aS, 6aS)- 2-oxo-5-phenyloctahydro-1-oxa-4-
azacyclopropa[f]indene-4-carboxylate 217. To a solution of amine 216 (26 mg, 
0.1 mmol) in 0.4 mL of a 4:4:1 mixture of THF/MeOH/H2O under a nitrogen 
atmosphere at 0 °C, 35 % wt aqueous solution of H2O2 (0.01 ml, 0.16 mmol) and 
K2CO3 (12 mg, 0.1 mmol) was added. The reaction mixture was stirred for 45 
min, and then quenched by addition of a saturated aqueous solution of NH4Cl. It 
was extracted with EtOAc, and the combined organic layer was washed with 
water and brine, dried over sodium sulfate and evaporated. Purification by flash 
column chromatography (petrol/ethyl acetate 7:3) afforded the title compound (16 
mg, 59 %) as a yellow oil, Rf 0.5 (7:3 petrol/ethyl acetate); νmax (film)/cm-1 1693; 
m.p. 156-158 °C; 1H NMR (CDCl3, 400 MHz) δH: 7.36-7.28 (2H, m, ArH), 7.27-
7.21 (1H, m, ArH), 7.16-7.09 (2H, m, ArH), 4.85 (1H, dd, J 11.5, 9.5, H3), 3.89-
3.68 (2H, m, H1, H1'), 3.66-3.64 (1H, m, H8), 3.34 (1H, d, J  4.5, H7), 3.22-3.07 
(1H, m, H5), 2.68-2.77 (1H, m, H4), 2.60-2.46 (1H, m, H9), 1.99 (1H, dd, J 15.0, 
10.0, H9') and 1.60-1.05 (9H, m, tBu); 13C NMR (CDCl3, 100 MHz) δC: 205.8 
(0.5 C=O), 205.4 (0.5 C=O), 154.3 (NBoc), 142.2 (Ar), 128.7 (2xAr), 127.3 (Ar), 
125.3 (2xAr), 80.1 (C(CH3)3), 66.5 (C3), 55.8 (C7), 54.8 (C8), 47.0 (C5), 44.2 
(C4), 28.3 (C(CH3)3) and 25.4 (C9); m/z (CI) 352 (MNa+, 100 %); Found MNa+ 
352.1519, C19H23NO4 requires MNa+ 352.1520.  
 
 
 
 
 
 
(1aS,2aR,5S,5aS,6aS)-tert-butyl 2-ethoxy-5-phenyl-2-(2-
tosylhydrazinyl)hexahydro-1aH-oxireno[2,3-f]isoindole-4(2H)-carboxylate 
224. A mixture of 217 (10 mg, 0.03 mmol) and tosyl hydrazide (6.0 mg, 0.03 
mmol) in EtOH (0.3 ml) was stirred at R.T. for 30 min and then heated to 50 °C 
for 1 h 30 mins. The reaction mixture was then allowed to cool to R.T. and the 
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reaction mixture was diluted with EtOAc and brine. It was extracted with EtOAc, 
dried over magnesium sulfate and evaporated. Purification by flash column 
chromatography (petrol/ethyl acetate 7:3) afforded the title compound (9 mg, 55 
%) as yellow oil, Rf 0.3 (7:3 petrol/ethyl acetate); 1H NMR (CDCl3, 400 MHz) [2 
rotamers] δH: 7.88-7.72 (2H, m, ArH), 7.39-7.16 (5H, m, ArH), 7.16-7.04 (2H, m, 
ArH), 4.84 (0.35H, s, H3), 4.61 (0.65, s, H3), 4.11 (1H, dd, J 14.5, 7.0, H8), 3.84-
3.74 (1H, m, H1), 3.64 (1H, d, J 3.0, H7), 3.55-3.39 (1H, m, H1'), 3.18-3.16 (1H, 
bm, H5), 3.03-2.94 (1H, m, H9), 2.91-2.80 (1H, m, H9'), 2.58-2.49 (1H, m, H4), 
2.43 (3H, s, ArMe), 1.96-2.16 (2H, m, OCH2) and 1.50-1.16 (12H, m, tBu, 
CH2CH3); m/z (ES+) 566 (100 %, MNa+); Found MH+ 544.2476, C28H38N3O6S1 
requires MH+ 544.2476. 
 
 
 
1-tert-Butyl (2S, 3S, 4S)- 4-ethynyl-3-(2-oxoethyl)-2-phenylpyrrolidine-1-
carboxylate 223. A mixture of 217 (10.0 mg, 0.03 mmol) and mesitylsulfonyl 
hydrazide (7.0 mg, 0.1 mmol) in AcOH (0.3 mL) was stirred at R.T. for 36 h. The 
reaction mixture was diluted with EtOAc and carefully neutralized with a 
saturated aqueous solution of NaHCO3. It was extracted with EtOAc, dried over 
magnesium sulfate and evaporated. Purification by flash column chromatography 
(petrol/ethyl acetatev8:2) afforded the title compound (2 mg, <21 % [impure]) as 
a yellow oil, Rf 0.6 (7:3 PE/EtOAc); 1H NMR (CDCl3, 300 MHz) [2 rotamers] 
δH : 9.86-9.75 (1H, m, CHO), 7.38-7.15 (5H, m, ArH), 4.60 (0.35H, bs, H3), 4.39 
(0.65H, d, J 6.5, H3), 3.86-3.80 (1.65H, m, H1, H1'), 3.79-3.76 (0.35H, m, H1'), 
3.36-3.23 (1H, m, H5), 3.07-2.95 (1H, m, H9), 2.68-2.61 (2H, m, H4, H9'), 2.21 
(1H, s, H7), 1.44 (4H, bs, tBu) and 1.12 (5H, s, tBu); m/z (ES-) 312 (100 %, M-H). 
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N-(tert-Butyl)-N-(3-methoxyphenyl)-amine 231. Potassium carbonate (898 mg, 
6.50 mmol) was added to a solution of tert-butylamine (630 µl, 6.00 mmol,) and 
3-methoxybenzylbromide (700 µl, 5.01 mmol) in 25 ml of anhydrous DMF. The 
resulting solution was stirred overnight at R.T. under a nitrogen atmosphere. The 
reaction mixture was then quenched with water and extracted with Et2O. The 
combined organic extracts were washed with brine, dried over magnesium sulfate 
and evaporated. The resulting oil was then taken up in Et2O and washed 4 times 
with water. The organic layer was then dried over magnesium sulfate and 
evaporated to yield the title compound (822 mg, 85 %) as a yellow oil, Rf 0.65 
(4:1 petrol/ethyl acetate); 1H NMR (CDCl3, 400 MHz) δH: 7.24 (1H, t, J 8.0, 
ArH), 6.99-6.88 (2H, m, ArH), 6.82-6.75 (1H, m, ArH), 3.83 (3H, s, OMe), 3.72 
(2H, s, H9, H9') and 1.18 (9H, s, tBu); 13C NMR (CDCl3, 100 MHz); δC: 159.8 
(COMe), 143.3 (Ar), 129.5 (Ar), 120.6 (Ar), 113.9 (Ar), 112.3 (Ar), 55.3 (OCH3), 
50.8 (C(CH3)3), 47.4 (C9) and 29.3 (C(CH3)3); m/z 194 (100 %, MH+); all data 
consistent with literature.89  
 
 
 
 
 
 
 
2, 4-Dimethoxy-N-tert-butyl N-(3-methoxyphenyl)benzamide 232. To a round-
bottom flask, 2, 4-Dimethoxybenzoyl chloride (1.0 g, 5.1 mmol) was added N-
tert-butyl-N-(3-methoxyphenyl) amine (822 mg, 4.25 mmol) in DCM (20 ml) at 
R.T. under a nitrogen atmosphere. Triethylamine (0.9 ml, 6.4 mmol) was added to 
the reaction mixture, which was stirred overnight. It was then quenched by 
addition of water and extracted with DCM. The combined organic extracts were 
washed with brine, dried over magnesium sulfate and evaporated. Purification by 
flash column chromatography (petrol/ethyl acetate 7:3) yielded benzamide 232 
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(1.361 g, 90 %) as a colourless wax, Rf 0.55 (6:4 petrol/ethyl acetate); νmax 
(film)/cm-1 1633, 1605 and 1583; 1H NMR (CDCl3, 300 MHz) δH: 7.25-7.11 (1H, 
m, ArH), 6.89-6.68 (3H, m, ArH), 6.45-6.34 (2H, m, ArH), 4.61-4.35 (2H, m, H3, 
H3'), 3.80 (3H, s, OMe), 3.79 (3H, s, OMe), 3.76 (3H, s, OMe) and 1.51 (9H, s, 
tBu); 13C NMR (CDCl3, 75 MHz) δC: 171.2 (NC=O), 161.0 (Ar), 159.8 (Ar), 
156.4 (Ar), 142.2 (Ar), 129.4 (Ar), 128.3 (Ar), 122.0 (Ar), 118.7 (Ar), 112.2 (Ar), 
112.1 (Ar), 104.6 (Ar), 98.8 (Ar), 58.2 (C3), 55.7 (OCH3), 55.4 (OCH3), 55.3 
(OCH3), 51.2 (C(CH3)3) and 29.0 (C(CH3)3); m/z (ES+) 358 (100 %, MH+); Found 
M+ 358.2011, C21H28NO4 requires MH+ 358.2013. 
 
 
 
 
 
 
(3S, 3aS, 7aS)-2-(tert-Butyl)-7-methoxy-3-(3-methoxyphenyl)-2,3,3a,7a-
tetrahydro-4H-isoindole-1,5-dione 233. In a round-bottom flask, 2.1 M nBuLi 
(0.6 ml, 1.3 mmol) was added to a solution of DIPA (0.2 ml, 1.5 mmol) in THF (7 
ml) at 0 °C under a nitrogen atmosphere. Then a solution of benzamide 232 (357 
mg, 1.01 mmol) and DMPU (0.6 ml, 5.2 mmol) in THF (2 ml) was added 
dropwise via cannula to the reaction mixture at 0 °C. The reaction mixture, which 
turned to a deep orange colour, was stirred at 0 °C for another 1 h. It was 
quenched by addition of a saturated aqueous solution of NH4Cl. The reaction 
mixture was then diluted with water and extracted with Et2O. The combined 
organic extracts were washed with a 3M aqueous solution of HCl, dried over 
magnesium sulfate and evaporated. Purification by flash column chromatography 
(petrol/ethyl acetate 4:6) afforded  the title compound (108 mg, 31 %) as a white 
waxy solid, Rf 0.24 (4:6 petrol/ethyl acetate); νmax (film)/cm-1 1685, 1653 and 
1605; 1H NMR (CDCl3, 400 MHz) δH: 7.31 (1H, t, J 8.0, ArH), 6.86 (1H, d, J 2.0, 
ArH), 6.84 (1H, d, J 2.0, ArH), 6.79 (1H, t, J 2.0, ArH), 5.43 (1H , s, H7), 4.46 
(1H, s, H3), 3.82 (3H, s, OMe), 3.81 (3H, s, OMe), 3.61-3.56 (1H, m, H5), 2.75-
2.63 (2H, m, H9 H4), 2.54-2.41 (1H, m, H9') and 1.40 (9H, s, tBu); 13C NMR 
(CDCl3, 75 MHz) δC: 196.5 (C=O), 172.6 (NC=O), 170.0 (Ar), 160.4 (Ar), 142.6 
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(COMe), 130.4 (Ar), 117.6 (Ar), 113.2 (Ar), 111.3 (Ar), 103.1 (C7), 66.2 (C3), 
56.6 (OCH3), 55.7 (C(CH3)3), 55.4 (OCH3), 45.0 (C5), 42.2 (C4), 39.5 (C9) and 
27.9 (C(CH3)3); m/z 344 (100 %, MH+); Found MH+ 344.1864, C20H26NO7 
requires MH+ 344.1856. 
 
 
N-(3-Methoxyphenyl)-N-(1-methyl-1-phenylethyl)amine 235. Potassium 
carbonate (10.42 g, 75 mmol) was added to a solution of cumylamine (10 ml, 70 
mmol) and 3-methoxybenzylbromide (8.1 ml, 58 mmol) in 250 ml of anhydrous 
DMF. The resulting solution was stirred overnight at R.T. under a nitrogen 
atmosphere. The reaction mixture was then quenched with water and extracted 
with EtOAc. The combined organic extracts were washed with brine, dried over 
magnesium sulfate and evaporated. The resulting oil was purified by flash column 
chromatography (petrol/ethyl acetate4:1) to yield the title compound (14.09 g, 95 
%) as a colourless oil, Rf 0.6 (7:3 petrol/ethyl acetate). All spectroscopic data in 
accordance with the literature. 79 
 
 
 
 
 
 
 
2,4-Dimethoxy-N-(3-methoxyphenyl)-(1-methyl-1-phenylethyl)benzamide 
236. To a round-bottom flask, 2, 4-Dimethoxybenzoyl chloride (12 g, 61 mmol) 
was added to a solution of N-cumyl-N-(3-methoxyphenyl) amine 235 (14 g, 55 
mmol) in DCM (180 ml) at R.T. under a nitrogen atmosphere. Then triethylamine 
(11 ml, 83 mmol) was added to the reaction mixture, which was stirred at R.T. 
overnight. It was then quenched by addition of water and extracted with DCM. 
The combined organic extracts were washed with brine, dried over magnesium 
sulfate and evaporated. The resulting oil was dissolved in EtOAc and Et2O was 
added until a precipitate started to form. This suspension was then evaporated. 
N
O
3
Ph
MeO
OMe
OMe
OMe
9
N
H
Ph
                                                 Chapter 3: Experimental Procedures 
178 
The resulting solid was then recrystallized twice from EtOAc/Et2O to yield the 
title benzamide (19.95 g, 86 %) as a white crystalline solid, Rf 0.5 (6:4 
petrol/ethyl acetate); m.p. 108-110°C; 1H NMR (CDCl3, 400 MHz) δH: 7.52-7.44 
(2H, m, ArH), 7.32 (2H, t, J 8.0, ArH), 7.25-7.14 (3H, m, ArH), 6.86-6.80 (2H, 
m, ArH), 6.77 (2H, dd, J  8.0, 2.0, ArH), 6.43-6.35 (2H, m, ArH), 4.71 (2H, bs, 
H3, H3'), 3.86 (3H, s, OMe), 3.80 (3H, s, OMe), 3.76 (3H, s, OMe), 1.80 (3H, bs, 
Me) and 1.65 (3H, bs, Me); 13C NMR (CDCl3, 100 MHz) δC: 170.3 (NC=O), 
161.3 (Ar), 159.8 (Ar), 156.6 (Ar), 149.0 (Ar), 141.6 (Ar), 129.5 (Ar), 129.2 (Ar), 
128.0 (Ar), 126.0 (Ar), 124.8 (2xAr), 121.1 (Ar), 119.2 (Ar), 112.6 (Ar), 112.5 
(Ar), 104.7 (Ar), 98.7 (Ar), 62.6 (C(CH3)2Ph), 55.7 (OCH3), 55.4 (OCH3), 55.3 
(OCH3) and 51.6 (C3); m/z (ES-) 418 (100%, M-H); Found MH+ 420.2170, 
C26H30NO4 requires MH+ 420.2169. 
 
 
 
 
 
(3S, 3aS, 7aS)-7-Methoxy-3-(3-methoxyphenyl)-2-(1-methyl-1-phenylethyl)-
2,3,3a,7a-tetrahydro-4H-isoindole-1,5-dione 237 and 5,7-Dimethoxy-3-(3-
methoxyphenyl)-2-(1-methyl-1-phenylethyl)-2,3-dihydroxyisoindol-1-one 
237b.  
Method 1: A solution of LDA was formed by the addition of 2.2 M nBuLi (13.4 
mL, 29.5 mmol) to diisopropylamine (4.8 ml, 34.0 mmol) in THF (100 ml) at 0 
°C under a nitrogen atmosphere. Then a solution of benzamide 236 (9.50 mg, 23 
mmol) and DMPU (16.4 ml, 136 mmol) in THF (40 ml) was added dropwise via 
cannula at 0 °C over 30 min. The reaction mixture, which turned first to a deep 
green colour and then dark brown, was stirred for another 1 h at 0 °C. It was then 
quenched by addition of a saturated aqueous solution of NH4Cl. The reaction 
mixture was then diluted with water and extracted with Et2O. The combined 
organic extracts were then washed with a 3M aqueous solution of HCl, dried over 
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magnesium sulfate and evaporated. The resulting solid was recrystallised from 
EtOAc and EtOH. The white precipitate was filtered off and dried under vacuum. 
The mother liquors were evaporated again and purified by flash column 
chromatography (petrol/ethyl acetate 7:3 then 6:4) to yield the rearomatised 
product 237b (179 mg, 2 %) as an off-white solid and the title compound (5.81 g, 
64 %) as a colourless crystalline solid. 
Method 2: Amide 236 (0.50 g, 0.12 mmol) was added to a solution of chiral 
amide 112 (0.01 g, 0.059 mmol) and n-butyllithium (0.9 mmol) in THF (10 ml) at 
-30 °C. The mixture was allowed stir for 2 hours and then quenched with 
saturated ammonium chloride solution. The aqueous layer was extracted with 
diethyl ether. The combined organic layers were washed with 1M HCl solution 
and brine, dried over magnesium sulfate and the solvents removed under reduced 
pressure. Purification by flash column chromatography (3:1 petrol/ethyl acetate) 
gave the title compound (0.006 g, 12%). Analytical HPLC (β-Gem Regis), eluting 
with IPA and hexane (10:90) showed it to consist of 73% e.e of a mixture of two 
enantiomers, tR 17.89 and 20.41 mins. 
237b (rearomatised product): Rf 0.35 (6:4 petrol/ethyl acetate); νmax (film)/cm-1 
1682 and 1604; 1H NMR (CDCl3, 400 MHz) δH: 7.33-7.15 (5H, m, ArH), 6.83-
6.74 (2H, m, ArH), 6.60-6.45 (1H, m, ArH), 6.35 (1H, d J 1.5, ArH), 5.63 (1H, s, 
ArH), 3.89 (3H, s, OMe), 3.74 (3H, s, OMe), 3.73 (3H, s, OMe), 1.90 (3H, s, Me), 
1.61 (3H, s, Me); 13C NMR (CDCl3, 100 MHz) δC: 168.6 (NC=O), 164.4 (Ar), 
159.9 (Ar), 158.2 (Ar), 151.0 (Ar), 147.5 (Ar), 142.3 (Ar), 129.9 (Ar), 128.1 
(2xAr), 126.3 (Ar), 125.3 (Ar), 119.2 (Ar), 112.4 (Ar), 98.7 (Ar), 98.1 (Ar), 65.2 
(C3), 60.1 (C(CH3)2Ph), 55.7 (OCH3), 55.5 (OCH3), 55.2 (OCH3), 29.0 
(C(CH3)2Ph) and 28.5 (C(CH3)2Ph) (missing 2 Ar); m/z (ES+) 440 (100 %, 
MNa+). 
237: Rf 0.3 (6:4 petrol/ethyl acetate); νmax (film)/cm-1 1701, 1654, 1648 and 1610; 
m.p. 224 °C; 1H NMR (CDCl3, 500 MHz) δH: 7.41-7.36 (2H, m, ArH), 7.33-7.27 
(3H, m, ArH), 7.25-7.20 (1H, m, ArH), 6.89-6.82 (2H, m, ArH), 6.78-6.74 (1H, 
m, ArH), 5.38 (1H, s, H7), 4.47 (1H, s, H3), 3.82 (3H, s, OMe), 3.74 (3H, s, 
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OMe), 3.67 (1H, d, J 7.0, H5), 2.71-2.60 (2H, m, H9, H4), 2,45 (1H, dd, J 12.0, 
15.5, H9'), 1.87 (3H, s, Me), 1.56 (3H, s, Me); 13C NMR (CDCl3, 100 MHz) δC: 
196.4 (C=O), 172.2 (COMe), 169.7 (NC=O), 160.3 (Ar), 145.6 (Ar), 142.7 (Ar), 
130.3 (Ar), 128.3 (Ar), 127.2 (Ar), 125.6 (Ar), 117.9 (Ar), 113.4 (Ar), 111.6 (Ar), 
103.1 (C7), 67.0 (C3), 59.8 (C(CH3)2Ph), 56.5 (OCH3), 55.4 (OCH3), 44.9 (C5), 
42.0 (C4), 39.2 (C9), 28.1 (C(CH3)2Ph)  and 27.0 (C(CH3)2Ph); m/z (ES+) 428 
(100 %, MNa+); Found MNa+, 428.3384, C25H31N2O4 requires MNa+ 428.2278. 
 
 
 
 
2,4-Dimethoxy-N-tert-butyl N-(3,4-dimethoxyphenyl)benzamide 240. To a 
round-bottom flash, 3,4-dimethoxybenzaldehyde (1.0 g, 6.0 mmol) was added to a 
solution of tert-butylamine (760 µl, 7.20 mmol,) in DCM (30 ml) at R.T. under a 
nitrogen atmosphere. Then acetic acid (380 µL, 6.60 mmol) was added to the 
reaction mixture, and left to stir at R.T. for 2 h. NaBH(OAc)3 (1.9 g, 9.0 mmol) 
was added to the reaction mixture, which was left to stir for 3 days. The reaction 
was quenched by addition of a saturated aqueous solution of NaHCO3, extracted 
with DCM, and the combined organic layer were dried over magnesium sulfate 
and evaporated. The resulting crude amine (1.33 g, 99 %), as a colourless oil, was 
used in the next step without further purification. 2,4-Dimethoxybenzoyl chloride 
(1.32 g, 6.61 mmol) was added to a solution of  N-tert-butyl-N-(3,4-
dimethoxyphenyl)amine 239 (1.33 g, 6.0 mmol) in DCM (30 ml) at R.T. under a 
nitrogen atmosphere. Triethylamine (1.25 ml, 9.01 mmol) was added to the 
reaction mixture, and was stirred overnight. The reaction was quenched by 
addition of water and extracted with DCM. The combined organic layer was 
washed with brine, dried over magnesium sulfate and evaporated. Purification by 
flash column chromatography (petrol/ethyl acetate 45:55) yielded the title 
compound (859 mg, 2.22 mmol) as a colourless crystalline solid, Rf 0.3 (1:1 
petrol/ethyl acetate);  νmax (film)/cm-1 1626, 1607 and 1582; m.p. 116-118 °C; 1H 
NMR (CDCl3, 300 MHz) δH: 7.15 (1H, d, J 9.0, ArH), 6.82-6.70 (3H, m, ArH), 
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6.43-6.36 (2H, m, ArH), 4.59-4.40 (2H, m, H3, H3'), 3.87 (3H, s, OMe), 3.86 (3H, 
s, OMe), 3.81 (3H, s, OMe), 3.77 (3H, s, OMe) and 1.50 (9H, s, tBu); 13C NMR 
(CDCl3, 75 MHz) δC: 171.1 (NC=O), 161.1 (Ar), 156.5 (Ar), 148.9 (Ar), 147.9 
(Ar), 132.9 (Ar), 128.3 (Ar), 122.0 (Ar), 118.4 (Ar), 111.1 (Ar), 109.7 (Ar), 104.6 
(Ar), 98.9 (Ar), 58.1 (C(CH3)3), 56.0 (OCH3), 55.9 (OCH3), 55.8 (OCH3), 55.5 
(OCH3), 50.8 (C3) and 29.0 (C(CH3)3); m/z (ES+) 410 (100 %, MNa+); Found 
MNa+ 410.1929, C22H29NO5 requires MNa+ 410.1929. 
 
 
 
 
 
(3S, 3aS, 7aS)-2-(tert-Butyl)-7-methoxy-3-(3,4-dimethoxyphenyl)-2,3,3a,7a-
tetrahydro-4H-isoindole-1,5-dione 241. In a round-bottom flask, 2.0 M nBuLi 
(0.66 ml, 1.3 mmol) was added to a solution of DIPA (0.21 ml, 1.5 mmol, 1.5 
equiv) in THF (6 ml) at 0 °C under a nitrogen atmosphere. Then a solution of 
benzamide 240 (357 mg, 1.12 mmol) and DMPU (0.73 ml, 6 mmol) in THF (3 
ml) was added dropwise via cannula at -15 °C. The reaction mixture, which 
turned to a bright orange colour, was allowed to warm up to 0 °C over 2 h. It was 
quenched by addition of a saturated aqueous solution of NH4Cl. The reaction 
mixture was then diluted with water and extracted with Et2O. The combined 
organic layer was washed with a 3M aqueous solution of HCl, dried using 
magnesium sulfate and evaporated. Purification by flash column chromatography 
(petrol/ethylacetate 1:2) afforded 234 mg (0.6 mmol, 60 %) of starting material 
and  the title compound (52 mg, 14 %) as a colouless oil, Rf 0.23 (1:2 petrol/ethyl 
acetate); 1H NMR (CDCl3, 300 MHz) δH: 6.90-6.78 (2H, m, ArH), 6.75-6.69 (1H, 
m, ArH), 5.43 (1H, s, H7), 4.45 (1H, s, H3), 3.89 (6H, s, 2xOMe), 3.82 (3H, s, 
OMe), 3.60-3.57 (1H, m, H5), 2.74-2.62 (2H, m, H4, H9), 2.53-2.40 (1H, m, H9') 
and 1.40 (9H, s, tBu); 13C NMR (CDCl3, 75 MHz) δC: 196.5 (C=O), 172.5 
(NC=O), 169.9 (Ar or COMe), 149.6 (Ar or COMe), 148.8 (Ar or COMe), 133.3 
(Ar or COMe), 117.5 (Ar), 111.6 (Ar), 108.4 (Ar), 103.1 (C7), 65.9 (C3), 56.5 
(OCH3), 56.1 (OCH3), 55.6 (C(CH3)3), 45.0 (C5), 42.3 (C4), 39.4 (C9) and 27.9 
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(C(CH3)3); m/z (ES+) 374 (100%, MH+); Found MH+ 374.1966, C21H28NO5 
requires MH+ 374.1962. 
 
 
 
 
 
 
(3S, 3aS, 7aS)-7-Methoxy-3-(3-methoxyphenyl)-2,3,3a,7a-tetrahydro-4H-
isoindole-1,5-dione 242. Enone 237 (5.03 g, 12.4 mmol) was refluxed in TFA (31 
ml) for 1 h 30 mins under a nitrogen atmosphere. The reaction mixture was 
concentrated under reduced pressure and purification by flash column 
chromatography (ethyl acetate to ethyl acetate/methanol 9:1) afforded the title 
compound (3.61 g, quant.) as a colourless crystalline solid, Rf 0.2 (ethyl acetate); 
m.p. 158-160 °C; νmax (film)/cm-1 1701, 1648, 1638 and 1602; 1H NMR (CDCl3, 
400 MHz) δH: 7.31 (1H, t, J 7.9, ArH), 6.91-6.86 (2H, m, ArH), 6.85-8.83 (1H, m, 
ArH), 6.31 (1H, bs, NH), 5.58 (1H, s, H7), 4.36 (1H, d, J 5.0, H3), 3.82 (3H, s, 
OMe), 3.81 (3H, s, OMe), 3.49 (1H, d, J 7.0, H5), 2.94-2.85 (1H, m, H4), 2.58 
(1H, dd, J 17.0, 6.0, H9) and 2.50 (1H, dd, J 17.0, 6.0, H9'); 13C NMR (CDCl3, 
100 MHz) δC: 196.1 (C=O), 172.1 (NC=O), 170.0 (NBoc), 160.4 (Ar), 140.7 (Ar), 
130.4 (Ar), 118.6 (Ar), 114.2 (Ar), 111.7 (Ar), 104.0 (C7), 61.6 (C3), 56.8 
(OCH3), 55.5 (OCH3), 44.8 (C5), 43.2 (C4) and 36.2 (C9); m/z (ES+) 310 (100%, 
MNa+); Found MNa+ 310.1041, C16H17NO4 requires MNa+ 310.1050.  
 
 
 
 
 
 
tert-Butyl (3S, 3aS, 7aS)-7-Methoxy-3-(3-methoxyphenyl)-1,5-dioxo-
1,3,3a,4,5,7a-hexahydroisoindole-2-carboxylate 243. A suspension of 
compound 242 (3.61 g, 12.6 mmol) in THF (60 ml) was sonicated in a water bath. 
It was then cooled down to 0°C under a nitrogen atmosphere and (14.9 ml, 14.9 
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mmol) of a 1M solution of LDA in THF was added dropwise. The suspension 
then turned yellow. It was stirred at 0 °C for 20 min before a solution of Boc-ON 
(4.44 g, 15.5 mmol) in THF (15 ml) was added dropwise via cannula at 0 °C. The 
reaction mixture was stirred at this temperature for another 6 h. Over this time, the 
reaction turned to a deep brown solution. It was quenched by addition of a 
saturated aqueous solution of NH4Cl, extracted with EtOAc and the combined 
organic extracts were dried over magnesium sulfate and evaporated. Purification 
by flash column chromatography (petrol/ethyl acetate 1:1 to 1:2) yielded the title 
compound (3.69 g, 77 %) as a white solid, Rf 0.7 (ethyl acetate); m.p. 70-72°C; 
νmax (film)/cm-1 1785, 1757, 1656, 1647 and 1611; 1H NMR (CDCl3, 400 MHz) 
δH: 7.30 (1H, t, J 8.0, ArH), 6.86 (1H, dd, J 8.0, 2.0, ArH), 6.82-6.79 (1H, m, 
ArH), 6.76-6.73 (1H, m, ArH), 5.51 (1H, s, H7), 4.80 (1H, d, J 3.5, H3), 3.81 (3H, 
s, OMe), 3.79 (3H, m, OMe), 3.60 (1H, d, J 7.0, H5), 2.86-2.78 (1H, m, H4), 2.69 
(1H, dd, J 17.0, 6.0, H9), 2.52 (1H, dd, J 17.0, 9.5, H9') and 1.33 (9H, s, tBu); 13C 
NMR (CDCl3, 100 MHz) δC: 195.7 (C=O), 169.9 (NC=O), 168.5 (NBoc), 160.4 
(COMe), 149.5 (Ar), 140.9 (Ar), 130.3 (Ar), 117.4 (Ar), 113.6 (Ar), 111.0 (Ar), 
103.8 (C7), 84.0 (C(CH3)3), 64.8 (C3), 56.8 (OCH3), 55.4 (OCH3), 45.8 (C5), 
39.7 (C4), 37.7 (C9) and 27.8 (C(CH3)3); m/z (ES+) 410 (100%, MNa+); Found 
MNa+ 410.1570, C21H25NO6 requires MNa+ 410.1574.  
 
 
 
 
 
tert-Butyl (1S, 3aS, 7aS)-1-(3-methoxyphenyl)-4-oxo-1,3,3a,4,7,7a-
hexahydroisoindole-2-carboxylate 244. To a solution of 243 (1.51 g, 4.03 
mmol) in DCM (27 ml) at -78 °C under a nitrogen atmosphere, triethylsilane 
(0.71 ml, 4.41 mmol) and freshly distilled BF3.OEt2 (0.56 ml, 4.41 mmol) was 
added dropwise. After 20 min, a further 0.71 ml of triethylsilane and 0.56 ml of 
BF3.OEt2 were added. This operation was repeated again twice. The reaction 
mixture was then allowed to stir at -78 °C for another 2 h. It was quenched by 
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addition of a saturated aqueous solution of NaHCO3 and extracted with EtOAc. 
The combined organic layer was dried over magnesium sulfate and evaporated. 
Purification by flash column chromatography (petrol/ethyl acetate 7:3) afforded 
the title compound (1.09 g, 79 %) as a white solid, Rf 0.4 (7:3 petrol/ethyl 
acetate); νmax (film)/cm-1 1685, 1669 and 1599; 1H NMR (CDCl3, 400 MHz) [2 
rotamers] δH: 7.23 (1H, t, J 7.8, ArH), 6.98-6.89 (1H, m, H8), 6.84-6.64 (3H, m, 
ArH), 6.17-6.09 (1H, m, H7), 4.56 (0.35H, d, J 4.5, H3), 4.32 (0.65H, d, J 7.0, 
H3), 4.22 (0.65H, dd, J 11.0, 3.5, H1), 4.07 (0.35H, dd, J 11.0, 5.0, H1), 3.79 (3H, 
s, OMe), 3.79-3.70 (1H, m, H1'), 2.98-2.90 (1H, m, H5), 2.80-2.67 (1H, m, H4), 
2.67-2.55 (1H, m, H9), 2.50-2.33 (1H, m, H9'), 1.42 (4.0H, s, tBu) and 1.10 
(5.0H, s, H4); 13C NMR (CDCl3, 100 MHz) [2 rotamers] δC: 196.9 (C=O), 159.9 
(Ar [COMe]), 154.2 (NBoc), 147.6 (0.5 C8), 147.6 (0.5 C8), 145.1 (Ar), 129.8 
(0.5 Ar), 129.6 (0.5 Ar), 129.2 (0.5 C7), 129.1 (0.5 C7), 118.4 (Ar), 117.9 (Ar), 
112.5 (Ar), 111.7 (Ar), 80.1 (0.5 C(CH3)3), 79.8 (0.5 C(CH3)3), 65.4 (C3), 55.4 
(OCH3), 48.8 (0.5 C1), 48.5 (0.5 C1), 47.2 (0.5 C5), 46.7 (0.5 C5), 46.6 (0.5 C4), 
46.2 (0.5 C4), 28.5 (4.5 C(CH3)3), 28.1 (0.5 C9), 25.7 (0.5 C9) and 25.2 (0.5 C9); 
m/z (ES+) 366 (100%, MNa+); Found MH+ 344.1856, C20H23NO5 requires MH+ 
344.1857.  
 
 
 
tert-Butyl (1aS, 2aR, 5S, 5aS, 6aS)-5-(3-methoxyphenyl)-2-oxooctahydro-1-
oxa-4-azacyclopropa[f]indene-4-carboxylate 245. To a solution of 244 (1.14 g, 
3.32 mmol) in THF under a nitrogen atmosphere at 0 °C, 70 % wt aqueous 
solution of tert-BuOOH (1.1 ml, 6.6 mmol) and DBU (0.99 ml, 6.61 mmol) were 
added. The reaction mixture was stirred for 45 mins, and then quenched by 
addition of a saturated aqueous solution of sodium thiosulfate. It was extracted 
with EtOAc, and the combined organic extracts were washed with water and 
brine, dried over sodium sulfate and evaporated. Purification by flash column 
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chromatography (petrol/ethyl acetate 7:3) afforded the title compound (804 mg, 
68 %) as a white solid, Rf 0.5 (6:4 petrol/ethyl acetate); νmax (film)/cm-1 1695, 
1602 and 1586; 1H NMR (CDCl3, 400 MHz) δH: 7.24 (1H, t, J 8.0, ArH), 6.79 
(1H, dd, J 2.5, 8.0, ArH), 6.75-6.70 (1H, m, ArH), 6.68-6.65 (1H, m, ArH), 4.62-
4.44 (1H, bm, H3), 3.87-3.70 (5H, m, OMe, H1, H1'), 3.68-3.63 (1H, m, H8), 3.35 
(1H, d, J 4.0, H12), 3.20-3.15 (1H, m, H5), 2.77-2.69 (1H, m, H4), 2.60-2.48 (1H, 
bm, H9), 1.99 (1H, dd, J 15.0, 10.5, H9') and 1.56-1.13 (9H, m, tBu); 13C NMR 
(CDCl3, 100 MHz) δC: 205.6 (C=O), 202.0 (NBoc), 159.9 (Ar), 154.3 (Ar), 129.7 
(Ar), 117.6 (Ar), 112.3 (Ar), 111.3 (Ar), 80.1 (C(CH3)3), 66.4 (C3), 55.8 (C1), 
55.7 (C7), 55.3 (OCH3), 54.8 (C8), 47.1 (C5), 44.6 (C4), 28.3 (C(CH3)3) and 25.4 
(C9); m/z (ES+) 382 (100%, MNa+); Found MNa+ 382.1622, C20H25NO5 requires 
MNa+ 382.1622.  
 
 
 
 
4-tert-Butyl 5-methyl (1aS, 2aR, 5S, 5aS, 6aS)-2-oxooctahydro-1-oxa-4-
azacyclopropa[f]indene-4,5-dicarboxylate 218. In a round-bottom flash, 
RuCl3.xH2O (145 mg, 0.72 mmol) was dissolved in MeCN (11.5 ml). Then 
distilled water was added (23 ml), followed by NaIO4 (9.0 g, 42 mmol) of. This 
dark mixture was stirred vigorously at R.T. for 10 min. It was then cooled down 
to 0 °C, and a solution of compound 245 (837 mg, 2.33 mmol) in EtOAc (11.5 
ml) was slowly added dropwise. The reaction mixture turned light brown upon 
addition of the product. It was allowed to stir at 0 °C for 2 h. It was then filtered 
through a pad of celite. The filtrate was diluted with water and extracted with 
EtOAc. The combined organic layer was washed with brine, dried over 
magnesium sulfate, filtered through a pad of celite, evaporated and dried under 
vacuum. The dark residue was then dissolved in toluene (40 ml) at R.T. under a 
nitrogen atmosphere. Anhydrous methanol (20 ml) was added, followed by 2.0 M 
solution of (trimethylsilyl)diazomethane (1.75 ml, 3.55 mmol) in hexanes. The 
reaction mixture was stirred for 15 min, and quenched by careful addition of 2 
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drops of acetic acid. The reaction was concentrated under vacuum and 
purification by flash column chromatography (petrol/ethyl acetate 7:3) afforded 
the title compound (304 mg, 42 %) as a yellow oil, Rf 0.55 (6:4 petrol/ethyl 
acetate);  νmax (film)/cm-1 2367, 2340, 1747, 1707 and 1699; 1H NMR (CDCl3, 400 
MHz) [2 rotamers] δH: 4.14 (0.65H, s, H3), 3.99 (0.35H, s, H3), 3.90-3.77 (1H, m, 
H1), 3.75 (3H, s, OMe), 3.67-3.63 (1H, m, H1'), 3.63-3.55 (1H, m, H8), 3.37 (1H, 
d, J 4.0, H7), 3.19 (1H, td, J 10.0, 8.0, H5), 2.98-2.88 (1H, m, H4), 2.59-2.49 (1H, 
m, H9), 2.03-1.90 (1H, bm, H9') and 1.51-1.36 (9H, m, tBu); 13C NMR (CDCl3, 
75 MHz) [2 rotamers] δC: 205.2 (0.5 C=O), 204.6 (0.5 C=O), 172.1 (0.5 CO2Me), 
172.0 ((0.5 CO2Me), 154.4 (0.5 NBoc), 153.2 (0.5 NBoc), 80.4 (C(CH3)3), 66.4 
(C3), 64.3 (0.5 C7), 63.9 (0.5 C7), 55.2 (0.5 C8), 54.6 (0.5 C8), 52.3 (0.5 
CO2CH3), 52.2 (0.5 CO2CH3), 46.5 (0.5 C5), 46.3 (0.5 C5), 45.6 (0.5 C4), 44.6 
(0.5 C4), 37.9 (0.5 C1), 36.7 (0.5 C1), 28.1 (0.5 C(CH3)3), 28.1 (0.5 C(CH3)3), 
25.8 (0.5 C9) and 25.6 (0.5 C9); m/z (ES+) 344 (100%, MNa+); Found MH+ 
329.1709, C15H25NO5 requires MH+ 329.1709.  
 
 
 
 
1-tert-Butyl 2-methyl (2S, 3S, 4S)-4-ethynyl-3-(2-oxoethyl)-pyrrolidine-1,2-
dicarboxylate 247. A mixture of compound 218 (35 mg, 0.1 mmol) and 
mesitylsulfonyl hydrazide (25 mg, 0.1 mmol) in a 1:1 mixture of DCM/AcOH 
(1.1 ml) was heated to 40 °C for 2 h 30 mins. The reaction mixture was diluted 
with DCM and carefully neutralized with a saturated aqueous solution of 
NaHCO3. It was extracted with DCM, dried using magnesium sulfate and 
evaporated. Purification by flash column chromatography (petrol/ethyl acetate 
75:25) afforded the title compound (1 mg, <3 % [impure]) yellow oil, Rf 0.6 (7:3 
petrol/ethyl acetate); 1H NMR (CDCl3, 300 MHz) [rotamers present] δH: 9.87-
9.77 (1H, m, CHO), 4.11-3.93 (1H, m, H3), 3.88-3.67 (5H, m, Me, H1, H1'), 3.36-
3.26 (1H, m, H5), 3.12-2.97 (1H, m, H9), 2.88-2.71 (2H, m, H9', H4), 2.22 (1H, s, 
H7) and 1.53-1.36 (9H, m, tBu); m/z (ES+) 318 (100%, MNa+). 
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1-tert-Butyl 2-methyl (2S, 3S, 4S)-3-(2,2-diethoxyethyl)-4 
ethynylpyrrolidinedicarboxylate 248. A mixture of 218 (50 mg, 0.2 mmol) and 
mesitylsulfonyl hydrazide (36 mg, 0.2 mmol) in EtOH (1.6 ml) was refluxed for 4 
h. The reaction mixture was then allowed to cool down and volatiles were 
removed under vacuum. Purification by flash column chromatography 
(petrol/ethyl acetate 8:2) afforded the title compound (9 mg, 15 %) as a yellow 
oil, Rf 0.7 (7:3 petrol/ethyl acetate); νmax (film)/cm-1 3256, 2976, 2927, 2895, 
1747 and 1704; 1H NMR (CDCl3, 300 MHz) [2 rotamers] δH: 4.61 (1H, dd, J 6.0, 
11.5, H8), 4.13 (0.35H, d, J 7.0, H3), 4.03 (0.65H, d, J 8.0, H3), 3.80-3.39 (9H, 
m, OCH2, OCH2, Me, H1, H1'), 3.21-3.08 (1H, m, H5), 2.48-2.35 (1H, m, H4), 
2.19 (1H, d, J 2.5, H7), 2.18-2.03 (2H, m, H9), 1.92-1.77 (1H, m, H9'), 1.50-1.36 
(9H, m, tBu) and 1.29-1.14 (6H, t, J 7.0, 2xOCH2CH3); 13C NMR (CDCl3, 75 
MHz) [2 rotamers] δC: 173.1 (C=O), 154.3 (0.5 NBoc), 153.6 (0.5 NBoc), 101.2 
(C8), 81.4 (C(CH3)3 or C≡CH), 80.4 (C(CH3)3 or C≡CH), 72.9 (C7), 63.2 (0.5 
C3), 62.8 (0.5 C3), 61.8 (OCH2CH3), 61.5 (OCH2CH3), 52.3 (0.5 CO2CH3), 52.1 
(0.5 CO2CH3), 51.8 (0.5 C1), 51.6 (0.5 C1), 42.3 (0.5 C5), 42.3 (0.5 C5) , 33.5 
(C4), 32.9 (0.5 C9), 32.8 (0.5 C9), 28.5 (4.5 C(CH3)3), 28.3 (4.5 C(CH3)3) and 
15.4 (2xOCH2CH3); m/z (ES+) 392 (100%, MNa+); Found MH+ 370.2229, 
C19H32NO6 requires MH+ 370.2224.  
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3.1.4 Experimental Procedures for Section 2.3: 
Baeyer-Villiger Oxidation Route. 
 
 
 
   
(3S,3aS,8aS,Z)-2-tert-butyl-3-phenyl-2,3,3a,4-tetrahydro-1H-oxepino[4,5-
c]pyrrole-1,5(8aH)-dione 251. Enone 171 (0.100 g, 0.353 mmol) was dissolved 
in dry DCM (20 ml) and 3-chloroperoxybenzoic acid (0.079 g, 0.353 mmol) was 
added. The reaction was left the stir under nitrogen for 24 hours, then quenched 
by addition of saturated aq. sodium sulphite solution. The mixture was extracted 
with DCM (2 x 20 ml) and the combined organic fractions were washed with 
water (20 ml), dried over magnesium sulfate and the solvents were removed under 
reduced pressure. Purification by flash column chromatography (2:1 petrol/ethyl 
acetate) gave the title compound (0.045 g, 43 %) as a colourless solid, m.p 170-
172 °C; Rf 0.28 (1:1 petrol/ethyl acetate);  νmax (film)/cm-1 1728 and 1690; 1H 
NMR (500MHz; CDCl3) δH: 7.39-7.36 (2H, m, ArH), 7.33-7.30 (1H, m, ArH), 
7.22-7.20 (2H, m, ArH), 6.42 (1H, d, J 7.0, H7), 5.61 (1H, t, J 6.5, H6), 4.70 (1H, 
s, H3), 3.52 (1H, dd, J 7.5, 7.5 H5), 2.95 (1H, dd, J 12.5, 3.0, H9), 2.85 (1H, dd, J 
12.0, 8.5, H9'), 2.64 (1H, td, J 8.0, 3.0, H4) and 1.35 (9H, s, tBu); 13C NMR 
(75MHz, CDCl3) δC: 172.4 (C=O), 169.2 (NC=O), 142.2 (Ar), 139.8 (C7), 129.2 
(2xAr), 128.2 (2xAr), 125.2 (Ar), 111.7 (C6), 67.4 (C(CH3)3), 55.7 (C3), 42.2 
(C5), 38.3 (C4), 27.9 (C(CH3)3) and 27.7 (C9); m/z (ES+) 322 (100%, MNa+); 
Found MNa+ 322.1521, C18H21NO3 requires MNa+ 322.1521. 
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(1aS,4aS,5S,7aS,7bR)-6-tert-butyl-tetrahydro-5-phenyl-1aH-6,8-dioxa-
bicyclo[5.1.0]oct-1(7)-eno[3,2-c]pyrrole-3,7(7aH,7bH)-dione 265. Enone 171 
(0.100 g, 0.353 mmol) was dissolved in dry DCM (20 ml) and 3-
chloroperoxybenzoic acid (0.158 g, 0.706 mmol) was added. The reaction was left 
the stir under nitrogen for 24 hours, and then quenched by addition of saturated 
aq. sodium sulphite solution. The mixture was extracted with DCM (2 x 20 ml) 
and the combined organic fractions were washed with water (20 ml), dried over 
magnesium sulfate and the solvents were removed under reduced pressure. 
Purification by flash column chromatography (2:1 petrol/ethyl acetate) gave the 
title compound (0.092 g, 83 %)  as a colourless solid, m.p 178-182 °C; Rf 0.22 
(1:1 petrol/ethyl acetate); νmax (film)/cm-1 1728 and 1690; 1H NMR (500MHz; 
CDCl3) δH: 7.39-7.36 (2H, m, ArH), 7.33-7.30 (1H, m, ArH), 7.21-7.19 (2H, m, 
ArH), 5.22 (1H, d, J 2.5, H7), 4.48 (1H, s, H3), 3.62 (1H, dd, J 4.0, 2.5, H6), 3.48 
(1H, dd, J 7.5, 4.0, H5), 3.23 (1H, dd, J 14.0, 11.5, H9), 2.80 (1H, dd, J 14.0, 3.0, 
H9'), 2.42 (1H, ddd, J 11.0, 8.5, 3.0, 8.5, H4) and 1.36 (9H, s, tBu); 13C NMR 
(75MHz, CDCl3) δc; 171.8 (C=O), 168.7 NC=O), 142.1 (Ar), 129.6 (2xAr), 128.6 
92xAr), 125.4 (Ar), 79.4 (C7), 67.8 (C(CH3)3), 55.9 (C6), 55.5 (C3), 40.4 (C5), 
39.3 (C4), 38.9 (C9) and 27.8 (C(CH3)3); m/z (ES+) 316 (80%, MH+), 338 (100%, 
MNa+); Found MNa+, 338.1363. C18H21NO4 requires MNa+ 338.1363. 
 
 
 
 
(3S,3aS,7aR)-3-phenyl-2,3,3a,4-tetrahydro-1H-isoindole-1,5(7aH)-dione 266. 
Enone 104 (113 mg, 0.33 mmol) was dissolved in trifluoroacetic acid (5 ml) and 
heated at reflux for thirty minutes. The trifluoroacetic acid was removed under 
reduced pressure, then the compound was diluted with DCM (15 ml). The 
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solution was washed with saturated aq. sodium bicarbonate solution (15 ml). The 
organic fraction was dried over sodium sulfate then the solvent removed under 
reduced pressure. Purification by flash chromatography (1:1 petrol/ethyl acetate 
→ ethyl acetate) gave the title compound (59.5 mg, 80 %) as a colourless film, Rf 
0.44 (ethyl acetate); 1H NMR (300MHz, CDCl3) δH: 7.39-7.28 (5H, m, ArH), 6.81 
(1H, ddd, J 10.0, 3.0, 1.0, H6), 6.58 (1H, bs, NH), 6.24 (1H, dd, J 10.0, 3.0, H7), 
4.33 (1H, d, J 8.0, H3), 3.47 (1H, dt, J 8.0, 3.0, H5), 2.87-2.82 (1H, m, H4) and 
2.58-2.48 (2H, m, H9, H9'); 13C NMR (75 MHz, CDCl3) δC: 198.6 (C=O), 175.4 
(NC=O), 147.6 (C6), 143.2 (Ar), 128.8 (2xAr), 127.6 (2xAr), 126.6 (C7), 125.4 
(Ar), 47.9 (C3), 44.4 (C5), 42.6 (C4) and 28.9 (C9); m/z (CI) 228 (100%, MH+); 
Found MH+  227.0947, C14H13NO2 requires MH+ 227.0946. 
 
 
 
 
(3S,3aS,7aR)-3-phenyl-2-(2-phenylpropan-2-yl)hexahydro-1H-isoindole-
1,5(6H)-dione 268. Enone 104 (3.0 g, 8.7 mmol) and 5 % Pd/C (5 % w/v) was 
dissolved in ethyl acetate (100 ml) and placed into a hydrogenator® at 
atmospheric pressure. The reaction was left to stir under hydrogen for 1 hour. The 
reaction mixture was filtered and concentrated under reduce pressure to yield the 
title compound (2.9 g, 96 %) as a colourless solid, Rf 0.40 (1:1 petrol:ethyl 
acetate); νmax (film)/cm-1 1684 and 1696; 1H NMR (500MHz; CDCl3) δH: 7.37-
7.18 (10H, m, ArH), 4.40 (1H, s, H3), 3.11-3.07 (1H, m, H5), 2.61 (1H, dd J 7.0, 
15.5, H9), 2.57-2.52 (1H, m, H4), 2.38 (1H, dd, J 14.0, 8.0, H9'), 2.31-2.25 (1H, 
m, H6), 2.23-2.16 (2H, m, H7, H7'), 1.99-1.92 (1H, m, H6'), 1.80 (3H, s, Me) and 
1.50 (3H, s, Me); 13C NMR (75MHz, CDCl3) δc: 210.9 (C=O), 174.9 (NC=O), 
146.1 (Ar), 142.3 (Ar), 129.0 (2xAr), 128.1 (2xAr), 127.9 (2xAr), 126.9 (Ar), 
125.7 (2xAr), 125.4 (Ar), 68.3 (C(CH3)3), 59.4 (C3), 43.4 (C5), 42.4 (C4), 38.7 
(C7 or C9), 37.2 (C7 or C9), 27.9 (C(CH3)2Ph), 26.8 (C(CH3)2Ph), and 22.6 (C6); 
m/z (ES+) 370.2 (100%, MNa+); Found MNa+ 370.1778, C23H25NO2 requires 
MNa+ 370.1778. 
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(3S,3aS,7aR)-3-phenylhexahydro-1H-isoindole-1,5(6H)-dione 268b. Enone 
268 (0.082 g, 0.24 mmol) was stirred in TFA at reflux for 3 h. TFA was 
evaporated under reduced pressure. Purification by flash chromatography, eluting 
with 1:2 petrol-EtOAc afforded the title compound (0.071 g, quant.) as a 
colourless film, Rf 0.07 (1:1 petrol/ethyl acetate); νmax (film)/cm-1 1701; 1H NMR 
(400MHz; CDCl3) δH: 7.39-7.25 (5H, m, ArH), 6.28 (1H, bs, NH), 4.27 (1H, d, J 
5.0, H3), 2.91 (1H, dt, J 6.5, 9.0, H5), 2.82-2.76 (1H, m, H4), 2.62 (1H, dd, J 6.5, 
15.5, H9 [A of ABX]), 2.50 (1H, dd, J 6.5, 15.5, H9' [B of ABX]), 2.38-2.35 (2H, 
m, H7, H7') and 2.30-2.12 (2H, m, H6, H6'); 13C NMR (75MHz, CDCl3) δc: 210.3 
(C=O), 178.2 (NC=O), 140.7 (Ar), 129.1 (2xAr), 128.4 (2xAr), 125.6 (Ar), 62.8 
(C3), 43.8 (C5), 41.2 (C4), 38.7 (C7 or C9), 37.6 (C7 or C9) and 22.7 (C6); m/z 
(ES+) 252.2 (100%, M+Na+); Found MH+ 230.1178, C14H16NO2 requires MH+ 
230.1102. 
 
 
 
 
(3S,3aS,7aR)-tert-butyl 1,5-dioxo-3-phenylhexahydro-1H-isoindole-2(3H)-
carboxylate 271. Amide 271 (50 mg, 0.218 mmol), 4-dimethylaminopyridine 
(DMAP) (0.003 g, 0.022 mmol), and di-tert-butyl dicarbonate (0.057 g, 0.261 
mmol) were dissolved in dry acetonitrile (5 ml) and left to stir for eighteen hours. 
Water was added (5 ml) and the mixture extracted with ethyl acetate (3 x 5 ml). 
The combined organic fractions were washed with saturated aq. sodium 
bicarbonate solution (10 ml), and then dried over sodium sulfate and the solvents 
removed under reduced pressure. Purification by flash chromatography (2:1 
petrol/ethyl acetate→ethyl acetate) gave the title compound (0.060 mg, 85 %) as 
an colourless solid, Rf 0.5 (1:1 petrol/ethyl acetate); νmax (film)/cm-1 1782, 1742 
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and 1718; 1H NMR (400MHz; CDCl3) δH: 7.38-7.28 (3H, m, ArH), 7.19-7.17 
(2H, m, ArH), 4.75 (1H, d, J 1.5, H3), 3.04-2.99 (1H, m, H5), 2.71-2.62 (2H, m, 
H9, H4), 2.50-2.37 (3H, m, H9', H7. H6), 2.31-2.24 (1H, m, H7'), 2.08-1.99 (1H, 
m H6') and 1.30 (9H, s, H4); 13C NMR (75MHz, CDCl3) δc: 209.4 (C=O), 174.4 
(NC=O)), 149.5 (NBoc), 139.9 (Ar), 128.9 (2xAr), 127.9 (2xAr), 124.8 (Ar), 83.5 
(C(CH3)3), 65.8 (C3), 42.5 (C5), 41.6 (C4), 39.7 (C7 or C9), 37.5 (C7 or C9), 27.6 
(C(CH3)3) and 22.8 (C6); m/z (ES+) 352.2 (100%, MNa+); Found MH+ 330.1695, 
C19H24NO4 requires MH+ 330.1627. 
 
 
 
 
(3aR,7aS)-2-tert-butyl 1-methyl 3,6-dioxohexahydro-1H-isoindole-1,2(3H)-
dicarboxylate 273. Sodium periodate (11.7 g, 3.04 mmol) was added to a 
solution of H2O (40 ml)/acetonitrile (20 ml). RuCl3.xH2O (0.06 g, 0.32 mmol) 
was added and the mixture was stirred for 10 minutes. Lactam 271 (1.00 g, 3.04 
mmol) was dissolved in EtOAc (20 ml) and added dropwise to the reaction 
mixture and was allowed to stir for 24 hours. The solution was then filtered over 
celite and extracted with EtOAc. The combined organic layer was washed with 
water, dried using magnesium sulfate and concentrated under reduced pressure. 
Purification by column chromatography eluting with 2:1 petrol-EtOAc to yield 
the title compound (0.400 g, 39 %) as an amorphous solid, Rf 0.60 (1:1 
petrol/ethyl aceteate);  νmax (film)/cm-1 1732 and 1676; 1H NMR (400MHz; 
CDCl3) δH: 4.23 (1H, d, J 1.5, H3), 3.77 (3H, s, OMe), 3.00-2.96 (1H, m, H5), 
2.85-2.78 (1H, m, H4), 2.63 (1H, dd, J 15.0, 6.0, H9), 2.43-2.19 (4H, m, H6, H7, 
H7', H9'), 2.08-1.99 (1H, m, H6'), 1.48 (9H, s, H4); 13C NMR (75MHz, CDCl3) δc: 
208.4 (C=O), 184.7 (CO2Me), 173.0 (NC=O), 170.4 (NBoc), 84.2 (C(CH3)3), 63.0 
(C3), 52.8 (CO2CH3), 42.5 (C5), 40.4 (C4), 37.2 (C7 or C9), 35.9 (C7 or C9), 
27.8 (C(CH3)3) and 22.4 (C6); m/z (ES+) 334.1 (100%, MNa+); Found MNa+ 
334.1257, C15H21NO6 requires MNa+ 334.1267. 
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(3R,4S,5S)-1-tert-butyl-3,4-bis(2-hydroxyethyl)-5-phenylpyrrolidin-2-one 
278. A solution lactone 251 (50 mg, 0.2 mmol) in THF (4 ml) was cooled to -78 
ºC. DIBAL-H (1M solution in hexanes, 0.50 ml, 0.50 mmol) was added slowly 
and the solution was allowed to stir for 1 hour. The reaction was quenched with 
MeOH (2 ml). The mixture was extracted with diethyl ether (10 ml) and washed 
with water (10ml), dried over magnesium sulfate and concentrated under reduced 
pressure (32 mg, 63 %) as a colourless film, Rf 0.22 (1:1 petrol/ethyl acetate); νmax 
(film)/cm-1 3260 and 1652; 1H NMR (500MHz; CDCl3) δH: 7.38-7.35 (2H, m, 
ArH), 7.29-2.25 (3H, m, ArH), 4.84 (1H, s, H3), 3.95-3.90 (2H, m, H8 H8), 3.80 
(1H, dt, J 11.0, 8.0, 4.0, H7), 3.62 (1H, td, J 10.0, 2.0, H7'), 2.99-2.94 (1H, m, 
H5), 2.21-2.15 (1H, m, H4), 1.94-1.84 (1H, m, H6), 1.82-1.75 (1H, m, H9), 1.55-
1.47 (2H, m, H9, H6') and 1.36 (9H, s, tBu); 13C NMR (75MHz, CDCl3) δc: 174.1 
(NC=O), 140.6 (Ar), 129.2 (2xAr), 128.1 (2xAr), 125.3 (Ar), 67.1 (C7 & C8), 
65.9 (C3), 55.1 (C(CH3)3), 41.8 (C5), 40.7 (C4), 37.2 (C6 or C9), 30.9 (C6 or C9) 
and 27.9 (C(CH3)3); m/z (ES+) 328.6 (100%, MNa+); Found MH+ 306.2643, 
C18H27NO3 requires MH+ 306.2147. 
 
 
 
 
(3S,3aS,8aS,Z)-3-phenyl-2-(2-phenylpropan-2-yl)-2,3,3a,4-tetrahydro-1H-
oxepino[4,5-c]pyrrole-1,5(8aH)-dione 252. Enone 104 (3.00 g, 8.31 mmol) was 
dissolved in dry DCM (50 ml) and 3-chloroperoxybenzoic acid (1.45 g, 8.69 
mmol) was added. The reaction was left the stir under nitrogen for 24 hours, and 
then quenched by addition of saturated aq. sodium sulphite solution. The mixture 
was extracted with DCM (2 x 20 ml) and the combined organic fractions were 
washed with water (20 ml), dried over magnesium sulfate and the solvents were 
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removed under reduced pressure. Purification by flash column chromatography 
eluting with 2:1 petrol/ethyl acetate, gave the title compound (2.1 g, 67 %), as an 
amorphous solid, Rf 0.55 (1:1 petrol/ethyl acetate); νmax (film)/cm-1 1690 and 
1606; 1H NMR (400MHz; CDCl3) δH: 7.36-7.20 (8H, m, ArH), 7.12-7.10 (2H, m, 
ArH), 6.34 (1H, dd, J 8.0, 4.0, H7) 5.54 (1H, dd, J 8.0, 4.0, H6), 4.55 (1H, s, H3), 
3.62 (1H, ddd, J 8.0, 4.0, 2.5, H5), 2.94 (1H, dd, J 12.0, 10.5, H9), 2.87 (1H, dd, J 
17.5, 15.5, H9'), 2.64 (1H, td, J 12.5, 3.0, H4), 1.81 (3H, s, Me) and 1.54 (3H, s, 
Me); 13C NMR (75MHz, CDCl3) δc: 172.0 (C=O), 169.3 (NC=O), 145.6 (Ar), 
141.8 (Ar), 138.7 (C7), 129.1 (2xAr), 128.3 (2xAr), 128.1 (2xAr), 127.0 (2xAr), 
125.8 (2xAr), 110.9 (C6), 68.5 (C3), 59.86 (C(CH3)2Ph), 43.3 (C5), 42.7 (C4), 
38.5 (C9), 27.8 (Me) and 26.8 (Me); m/z (ES+) 384 (100%, MNa+); Found MNa+ 
384.1576, C23H23NO3 requires MNa+ 384.1576. (4aS,5S,7aS)-tetrahydro-5-
phenyl-6-(2-phenylpropan-2-yl)-1aH-6,8-dioxa-bicyclo[5.1.0]oct-1(7)-eno[3,2-
c]pyrrole-3,7(7aH,7bH)-dione 252b, was also isolated by flash chromatography 
as an amorphous solid (20 mg, 18 %), Rf 0.56 (1:1 petrol/ethyl acetate);  νmax 
(film)/cm-1 1685, 1607 and 1251; 1H NMR (400MHz; CDCl3) δH: 7.39-7.16 (8H, 
m, ArH), 7.15-7.10 (2H, m, ArH), 5.19 (1H, d, J 3.5, H6), 4.55 (1H, s, H3), 3.63 
(1H, dd, J 4.5, 4.5, H7), 3.49 (1H, dd, J 12.0, 6.0, H5), 3.35 (1H, dd, J 18.5, 18.5, 
H9), 2.68 (1H, dd, J 18.5, 2.5, H9'), 2.46-2.36 (1H, m, H4), 1.85 (3H, s, Me) and 
1.51 (3H, s, Me); 13C NMR (75MHz, CDCl3) δc: 171.9 (C=O), 168.2 (NC=O), 
145.7 (Ar), 141.6 (Ar), 129.1 (2xAr), 128.4 (Ar), 128.2 (Ar), 127.1 (Ar), 125.6 
(Ar), 125.5 (Ar), 125.4 (Ar), 79.2, (C7), 68.6 (C(CH3)2Ph), 55.8 (C6), 40.2 (C3), 
38.9 (C5), 38.5 (C4), 28.1 (C9) and 27.1 (C(CH3)2Ph); m/z (ES+) 400.6 (100%, 
MNa+); Found MH+ 378.1700, C23H23NO4 requires MH+ 378.1705. 
 
 
 
(3S,3aS,8aS,Z)-3-phenyl-2,3,3a,4-tetrahydro-1H-oxepino[4,5-c]pyrrole-
1,5(8aH)-dione 267. Lactone 252 (0.08 g, 0.22 mmol) was stirred in TFA at 
reflux for 3 h. TFA was evaporated under reduced pressure. Purification by flash 
chromatography, eluting with 1:2 petrol-EtOAc afforded the title compound as a 
3
NH
67
O
9O
OH
5
H
4
Ph
                                                 Chapter 3: Experimental Procedures 
195 
colourless film, Rf 0.23 (1:1 petrol/ethyl aceteate); νmax (film)/cm-1 3254, 1702 
and 1665; 1H NMR (400MHz; CDCl3) δH: 7.41-7.32 (3H, m, ArH), 7.27-7.25 
(2H, m, ArH), 6.65 (1H, bs, NH), 6.45 (1H, dd, J 7.0, 2.5, H7), 5.55 (1H, dd, J 
7.0, 5.0, H6), 4.47 (1H, d, J 4.0, H3), 3.55-3.51 (1H, m, H5), 3.02-2.92 (2H, m, 
H9, H4) and 2.85-2.76 (1H, m, H9'); 13C NMR (75MHz, CDCl3) δc: 175.9 (C=O), 
168.9 (NC=O), 140.5 (Ar), 140.1 (C7), 129.3 (2xAr), 128.8 (2xAr), 125.5 (Ar), 
110.5 (C6), 63.1 (C3), 46.5 (C5), 41.2 (C4) and 36.4 (C9); m/z (ES+) 266.8 
(100%, MNa+); Found MNa+ 266.0793, C14H13NO3 requires MNa+ 266.0793. 
 
 
 
 
(1S,8aS,Z)-tert-butyl 3-(tert-butoxycarbonyloxy)-7-oxo-1-phenyl-8,8a-
dihydro-1H-oxepino[4,5-c]pyrrole-2(7H)-carboxylate 281. Lactone 267 (70 
mg, 0.194), di-tert-butyl dicarbonate (47 mg, 0.213 mmol) and 4-
dimethylaminopyridine (DMAP) (2 mg, 0.019 mmol) were dissolved in dry DCM 
(3 ml) and stirred for 18 hours nitrogen. The reaction was quenched with water (5 
ml) and extracted with DCM (2 x 10 ml). The combined organic fractions were 
dried over sodium sulfate and the solvents were removed under reduced pressure. 
Purification by column chromatography (3:1 petrol/ethyl acetate) gave the title 
compound (52 mg, 60 %) as a colourless film, Rf 0.66 (1:1 petrol/ethyl acetate);  
νmax (film)/cm-1 1756, 1742 and 1639; 1H NMR (400MHz; CDCl3) δH: 7.42-7.32 
(5H, m, ArH), 6.49 (1H, d, J 7.0, H7), 5.65 (1H, d, J  7.0, H6), 4.64 (1H, d, J 7.0, 
H3), 3.30 (1H, ddd, J 10.5, 7.0, 3.5, H4), 2.92 (1H, dd, J 13.0, 11.0, H9 [A of 
ABX]), 2.82 (1H, dd, J 13.0, 3.5, H9' [B of ABX]), 1.42 (9H, s, tBu) and 1.20 
(9H, s, tBu); m/z (ES+) 466.3 (100%, MH+); Found MH+ 466.1832, C24H29NO7 
requires MH+ 466.1842. 
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tert-butyl (3S,3aS)-1-oxo-3-phenyl-2,3,3a,4-tetrahydro-1H-isoindol-5-yl 
carbonate 283. Amide 266 (138 mg, 0.608 mmol), di-tert-butyl dicarbonate (133 
mg, 0.61 mmol) and 4-dimethylaminopyridine (DMAP) (7.0 mg, 0.1 mmol) were 
dissolved in dry DCM (5 ml) and stirred for 18 hours nitrogen. The reaction was 
quenched with water (5 ml) and extracted with DCM (2 x 10 ml). The combined 
organic fractions were dried over sodium sulfate and the solvents were removed 
under reduced pressure. Purification by flash chromatography (2:1→1:2 
petrol/ethyl acetate with 1 % triethylamine) gave the title compound (45 mg, 23 
%) as a colourless solid, m.p. 154-157 °C; Rf 0.29 (1:1 petrol/ethyl acetate); νmax 
(film)/cm-1 3241, 2978, 1756 and 1692; 1H NMR (300MHz, CDCl3) δH: 7.39-7.31 
(5H, m, ArH), 6.75 (1H, dd, J 6.0, 3.5, H6), 6.47 (1H, bs, H4), 6.04 (1H, dd, J 6.0, 
3.0, H7), 4.31 (1H, d, J 7.0, H3), 3.00-2.92 (1H, m, H4), 2.68 (1H, dt, J 17.0, 2.5, 
H9), 2.49 (1H, dd, J 16.5, 9.5, H9') and 1.48 (9H, s, tBu); 13C NMR (75 MHz, 
CDCl3) δc: 169.4 (NC=O), 152.8 (COBoc), 150. 8 (OBoc), 140.2 (Ar), 130.0 
(C6), 129.3 (2xAr), 128.8 (C5), 126.4 (2xAr), 123.6 (Ar), 111.8 (C7), 84.2 
(C(CH3)3), 64.3 (C3), 44.3 (C4), 30.2 (C9) and 27.9 (C(CH3)3); m/z (CI) 328 
(20%, MH+), 228 (M-Boc); Found MH+ 328.1545, C19H21NO4 requires MH+ 
328.1543. 
 
 
 
 
(3S,3aS,8aR)-3-phenyl-2-(2-phenylpropan-2-yl)hexahydro-1H-oxepino[4,5-
c]pyrrole-1,5(7H)-dione 269. Lactone 252 (5.00 g, 13.9 mmol) and 5 % Pd/C (5 
% w/v) were dissolved in ethyl acetate (100 ml) and placed into a hydrogenator® 
at 10 bar. The reaction was left the stir under hydrogen for 3 hours. The reaction 
mixture was filtered and concentrated under reduce pressure to yield the title 
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compound (4.9 g, 97 %) as an amorphous solid, Rf 0.50 (1:1 petrol/ethyl acetate);  
νmax (film)/cm-1 1740 and 1690; 1H NMR (400MHz; CDCl3) δH: 7.38-7.16 (10H, 
m, ArH), 4.36 (1H, s, H3), 4.05 (1H, ddd, J 13.5, 5.0, 2.5, H7), 3.9 (1H, dd, J 
13.0, 11.5, H7'), 3.01 (1H, td, J 6.0, 2.5, H5), 2.7 (1H, dd, J 13.0, 13.0, H9), 2.61 
(1H, dd, J 13.0, 3.0, H9'), 2.4-2.31 (2H, m, H6, H4), 1.83 (3H, s, Me), 1.78-1.68 
(1H, m, H6') and 1.47 (3H, s, Me); 13C NMR (75MHz, CDCl3) δc: 174.1 (C=O), 
172.6 (NC=O), 145.6 (Ar), 140.5 (Ar), 129.1 (2xAr), 128.7 (2xAr), 128.2 (2xAr), 
127.3 (2xAr), 125.6 (Ar), 125.4 (Ar), 67.6 (C7), 65.9 (C3), 59.3 (C(CH3)2Ph), 
41.8 (C5), 40.6 (C4), 37.1 (C9), 27.8 (C6), 26.9 (C(CH3)2Ph) and 26.1 
(C(CH3)2Ph); m/z (ES+) 386 (100 %, MNa+); Found MNa+ 386.1732, C23H25NO3 
requires MNa+ 386.1732. 
 
 
 
 
(3S,3aS,8aR)-3-phenylhexahydro-1H-oxepino[4,5-c]pyrrole-1,5(7H)-dione 
285. Lactone 269 (0.08 g, 0.22 mmol) was stirred in TFA at reflux for 3 h. TFA 
was evaporated under reduced pressure. Purification by flash chromatography, 
eluting with 1:2 petrol/ethyl acetate afforded the title compound as an amorphous 
solid, Rf 0.42 (1:2 petrol/ethyl acetate); νmax (film)/cm-1 1752 and 1647; 1H NMR 
(400MHz; CDCl3) δH: 7.38-7.29 (5H, m, ArH), 7.19 (1H, bs, NH), 4.59 (1H, ddd, 
J 11.0, 7.0, 5.0, H7), 4.51-4.43 (2H, m, H3, H7'), 2.81-2.75 (2H, m, H5, H4), 2.58 
(2H, dd, J 16.5, 6.5, H9), 2.41 (1H, dd, J 16.5, 7.0, H9'), 2.15-2.07 (1H, m, H6) 
and 1.97-1.88 (1H, m, H6'); 13C NMR (75MHz, CDCl3) δc: 179.1 (C=O), 175.8 
(NC=O), 139.3 (Ar), 129.0 (2xAr), 128.4 (2xAr), 125.8 (Ar), 66.2 (C7), 61.3 
(C3), 44.3 (C5), 40.7 (C4), 32.7 (C9) and 24.2 (C6); m/z (ES+) 268.1 (100%, 
MNa+); Found MH+ 246.1323, C14H15NO3 requires MH+ 246.1132. 
 
 
 
 
3
NH
67
O
9O
OH
5
H
4
Ph
                                                 Chapter 3: Experimental Procedures 
198 
 
 
 
 
(3S,3aS,8aR)-tert-butyl 1,5-dioxo-3-phenylhexahydro-1H-oxepino[4,5-
c]pyrrole-2(7H)-carboxylate 254. Lactone 285 (3.00 g, 10.1 mmol), di-tert-butyl 
dicarbonate (2.4 g, 11 mmol) and 4-dimethylaminopyridine (DMAP) (123 mg, 
1.01 mmol) were dissolved in dry DCM (25 ml) and stirred for 18 hours nitrogen. 
The reaction was quenched with water (5 ml) and extracted with DCM (2 x 30 
ml). The combined organic fractions were dried over sodium sulfate and the 
solvents were removed under reduced pressure. Purification by flash 
chromatography (3:1 petrol/ethyl acetate) gave the title compound (2.86 g, 95 %) 
as a colourless solid, Rf  0.66 (1:1 petrol/ethyl acetate); νmax (film)/cm-11752, 1732 
and 1659; 1H NMR (400MHz; CDCl3) δH: 7.40-7.31 (3H, m, ArH), 7.19-7.17 
(2H, m, ArH), 4.88 (1H, s, H3), 4.26-4.21 (2H, m, H7, H7'), 3.04-2.98 (2H, m, 
H9, H5), 2.90 (1H, dd, J 13.5, 3.0, H9'), 2.61-2.56 (1H, m, H4), 2.54-2.49 (1H, m, 
H6), 1.98-1.89 (1H, m, H6') and 1.35 (9H, s, tBu); 13C NMR (75MHz, CDCl3) δc: 
173.3 (C=O), 172.2 (NC=O), 149.6 (NBoc), 138.6 (Ar), 128.6 (2xAr), 128.2 
(2xAr), 124.9 (Ar), 83.8 (C(CH3)3), 65.7 (C7), 65.6 (C3), 41.6 (C5), 39.8 (C4), 
36.8 (C9), 27.7 (C(CH3)3) and 25.9 (C6); m/z (ES+) 368.2 (100%, MNa+); Found 
MNa+ 368.1478, C19H23NO5 requires MNa+ 368.1468. 
 
 
 
 
(2S,3S,4R)-1-tert-butyl 2-methyl 3,4-bis(2-methoxy-2-oxoethyl)-5-
oxopyrrolidine-1,2-dicarboxylate 286. Sodium periodate (0.55 g, 2.61 mmol) 
was added to a solution of H2O (3 ml)/acetonitrile (1.5 ml). RuCl3.xH2O (3.00 
mg, 0.02 mmol) was added and the mixture was stirred for 10 minutes. Lactam 
254 (0.05 g, 0.15 mmol) was dissolved in EtOAc (20 ml) and added dropwise to 
the reaction mixture and was allowed to stir for 24 hours. The solution was then 
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filtered over celite and extracted with EtOAc. The combined organic layer was 
washed with water, dried using magnesium sulfate and concentrated under 
reduced pressure. Purification by column chromatography eluting with 2:1 petrol-
EtOAc to yield the title compound (0.025 g, 44 %) as a waxy film, Rf 0.34 (1:1 
petrol/ethyl aceteate);  νmax (film)/cm-1 1782, 1722 and 1642; 1H NMR (400MHz; 
CDCl3) δH: 4.45 (1H, d, J 1.0, H3), 3.82 (3H, s, OMe), 3.72 (3H, s, OMe), 3.70 
(3H, s, OMe), 3.33 (1H, ddd, J 10.0, 8.0, 4.5, H5), 3.07-3.01 (1H, m, H4), 2.91 
(1H, dd, J 17.5, 5.0, H6), 2.49 (1H, dd, J 16.0, 5.0, H9), 2.39 (1H, dd, J 17.5, 
10.5, H6'), 2.32 (1H, d, J 16.0, 9.0, H9') and 1.48 (9H, s, tBu); 13C NMR (75MHz, 
CDCl3) δc: 172.3 (C=O), 171.6 (C=O), 171.2 (C=O), 170.6 (NC=O), 149.4 
(NBoc), 84.1 (C(CH3)3), 61.9 (C3), 52.9 (OCH3), 52.3 (OCH3), 52.2 (OCH3), 41.8 
(C5), 34.7 (C4), 33.7 (C6 or C9), 30.2 (C6 or C9), and 27.9 (C(CH3)3); m/z (ES+) 
410.1 (100%, MNa+); Found MNa+ 410.1430, C17H25NO9 requires MNa+ 
410.1422. 
 
 
 
 
ethyl 2-((2S,3S,4R)-1-tert-butyl-5-oxo-4-(2-oxoethyl)-2-phenylpyrrolidin-3-
yl)acetate 287. Lactone 251 (0.05 g, 0.17 mmol) was dissolved in a 1:1 mixture 
of DCM:EtOH (6ml). Potassium carbonate (0.05 g, 0.33 mmol) was added and 
the mixture was stirred for 2 hours. The mixture was concentrated under reduced 
pressure and dissolved in DCM. The organic was washed with water (10 ml), 
dried over magnesium sulfate and concentrated under reduced pressure. 
Purification by flash chromatography eluting with 2:1 petrol/ethyl acetate, gave 
the title compound (0.045 g, 77 %) as an amorphous solid, Rf 0.53 (1:1 
petrol:ethyl acetate); νmax (film)/cm-1 1755 and 1684; 1H NMR (400MHz; CDCl3) 
δH: 9.81 (1H, s, CHO), 7.38-7.27 (5H, m, ArH), 4.70 (1H, s, H3), 4.24 (2H, q, J 
7.5, OCH2CH3), 3.40 (1H, dt, J 7.5, 7.5, H5) 2.93 (1H, dd, J 18.0, 6.0, H6), 2.64 
(1H, ddd, J 11.0, 7.0, 4.0, H4),  2.35 (1H, dd, J 18.0, 8.0, H6'), 2.33 (1H, dd, J 
16.0, 4.0, H9), 2.25 (1H, dd, J 16.0, 11.0, H9'), 1.35 (9H, s, tBu), 1.32 (3H, t, J 
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7.0, OCH2CH3); 13C NMR (75MHz, CDCl3) δc: 200.2 (CHO), 174.5 (C=O), 171.9 
(NC=O), 141.5 (Ar), 129.1 (2xAr), 128.8 (2xAr), 127.6 (Ar), 65.2 (OCH2CH3), 
60.9 (C3), 54.9 (C(CH3)3), 42.0 (C5), 40.0 (C4), 38.0 (C6), 34.4 (C9), 27.5 
(C(CH3)3) and 14.2 (OCH2CH3); m/z (ES+) 346.2 (100%, MNa+); Found MNa+ 
346.2000, C20H28NO4 requires MNa+ 346.2013. 
 
 
 
 
ethyl 2-((2S,3S,4R)-5-oxo-4-(2-oxoethyl)-2-phenyl-1-(2-phenylpropan-2-
yl)pyrrolidin-3-yl)acetate 288. Lactone 252 (0.10 g, 0.28 mmol) was dissolved 
in a 1:1 mixture of DCM:EtOH (10ml). Potassium carbonate (0.08 g, 0.55 mmol) 
was added and the mixture was stirred for 2 hours. The mixture was concentrated 
under reduced pressure and dissolved in DCM. The organic was washed with 
water (10 ml), dried over magnesium sulfate and concentrated under reduced 
pressure. Purification by flash chromatography eluting with 2:1 petrol/ethyl 
acetate, gave the title compound (0.101 g, 89 %) as an amorphous solid, Rf 0.44 
(1:1 petrol/ethyl acetate); νmax (film)/cm-1 1755 and 1684; 1H NMR (300MHz; 
CDCl3) δH: 9.69 (1H, s, CHO), 7.35-7.13 (10H, m, ArH), 4.65 (1H, s, H3), 4.14 
(2H, q, J 7.0, OCH2CH3), 3.40 (1H, dt, J 8.0, 6.0, H5), 2.79 (1H, dd, J 18.0, 6.0, 
H6), 2.65-2.54 (1H, m, H6'), 2.27-2.10 (3H, m, H9, H9', H4), 1.78 (3H, s, Me), 
1.41 (3H, s, Me) and 1.24 (3H, t, J 7.0, OCH2CH3); 13C NMR (75MHz, CDCl3) 
δc: 200.2 (CHO), 174.3 (C=O), 171.8 (NC=O), 146.0 (Ar), 141.6 (Ar), 128.8 
(2xAr), 128.1 (2xAr), 127.7 (2xAr), 126.9 (2xAr), 125.8 (Ar), 125.4 (Ar), 65.8 
(OCH2CH3), 60.9 (C3), 59.1 (C(CH3)2Ph), 41.9 (C5), 40.0 (C4), 37.9 (C6), 34.6 
(C9), 28.2 (C(CH3)2Ph), 26.7 (C(CH3)2Ph)) and 14.3 (OCH2CH3); m/z (ES+) 
430.3 (100%, MNa+); Found MH+ 407.2300, C25H29NO4 requires MH+ 407.2116. 
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ethyl 2-((2S,3S,4R)-5-oxo-4-(2-oxoethyl)-2-phenylpyrrolidin-3-yl)acetate 289. 
Aldehyde 288 (0.06 g, 0.15 mmol) was dissolved in trifluoroacetic acid (5 ml) and 
heated at reflux for thirty minutes. The trifluoroacetic acid was removed under 
reduced pressure and the compound diluted with DCM (15 ml). The solution was 
washed with saturated aq. sodium bicarbonate solution (15 ml). The organic 
fraction was dried over sodium sulfate then the solvent was removed under 
reduced pressure. Purification by flash chromatography (1:1 petrol/ethyl acetate 
→ ethyl acetate) gave the title compound (0.03 g, 71 %) as a waxy solid, Rf 0.55 
(ethyl acetate); 1H NMR (400MHz, CDCl3) δH: 9.79 (1H, s, CHO), 7.39-7.26 (5H, 
m, ArH), 6.50 (1H, bs, NH), 4.50 (1H, d, J 3.5, H3), 4.13 (2H, q, J 7.0, 
OCH2CH3), 3.22 ( 1H, td, J 9.0, 5.0, H5), 2.93-2.85 (2H, m, H6, H6'), 2.58 (1H, 
ddd, J 18.0, 8.5, 1.0, H4), 2.41 (1H, dd, J 16.5, 9.0, H9 [A of ABX]), 2.34 (1H, 
dd, J 16.5, 7.0, H9' [B of ABX]) and 1.22 (3H, t, J 7.0, OCH2CH3); 13C NMR 
(75MHz, CDCl3) δc: 199.9 (CHO), 177.7 (C=O), 171.6 (NC=O), 140.2 (Ar), 
128.9 (2xAr), 128.1 (2xAr), 125.8 (Ar), 61.1 (OCH2CH3), 60.9 (C3), 43.3 (C5), 
40.0 (C4), 33.7 (C6), 29.7 (C9) and 14.2 (OCH2CH3); m/z (ES-) 312 (100%, 
MNa+); Found MNa+ 312.1211, C16H19NO4 requires MNa+ 312.1212. 
 
 
 
 
methyl 2-((2S,3S,4R)-4-(2-hydroxyethyl)-5-oxo-2-phenyl-1-(2-phenylpropan-
2-yl)pyrrolidin-3-yl)acetate 292. Lactone 269 (100 mg, 0.28 mmol) was 
dissolved in a MeOH (10 ml) and cooled to -78 °C. Sodium methoxide (1M, 1.38 
mmol) was added dropwise and the mixture was stirred for 2 hours. The mixture 
was quenched with sodium bicarbonate solution. The mixture was extracted with 
EtOAc (2 x 10 ml). The organic was washed with water (10 ml), dried over 
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magnesium sulfate and concentrated under reduced pressure. Purification by flash 
chromatography eluting with 2:1 petrol/ethyl acetate, gave the title compound 
(102 mg, 94 %) as an amorphous solid, Rf 0.34 (1:1 petrol/ethyl acetate);  νmax 
(film)/cm-1 3266 and 1652; 1H NMR (400MHz; CDCl3) δH: 7.26-7.14 (10H, m, 
ArH), 4.57 (1H, s, H3), 3.63 (1H, s, OMe), 3.57 (1H, dt, J 11.0, 5.0, H7), 3.44 
(1H, td, J 9.5, 3.0, H7'), 2.91 (1H, ddd, J 9.5, 7.0, 4.5, H5), 2.47-2.37 (2H, m, H4, 
H9), 2.16 (1H, dd, J 12.0, 11.5, H9'), 1.78 (3H, s, Me), 1.71-1.62 (1H, m, H6), 
1.40 (3H, s, Me) and 1.38-1.31 (1H, m, H6'); 13C NMR (75MHz, CDCl3) δc: 176.7 
(C=O), 172.5 (NC=O), 145.5 (Ar), 141.0 (Ar), 128.5 (2xAr), 127.8 (2xAr), 127.4 
(2xAr), 126.6 (2xAr), 125.5 (Ar), 125.1 (Ar), 66.0 (C7), 61.7 (C3), 59.0 
(C(CH3)2Ph), 51.6 (OCH3), 43.1 (C5), 42.9 (C4), 33.6 (C9), 28.5 (C6), 27.9 
(C(CH3)2Ph) and  26.3 (C(CH3)2Ph); m/z (ES+) 396.4 (100%, MH+); Found MNa+ 
418.2086, C24H29NO4 requires MNa+ 418.2097. 
 
 
 
 
 
 
(3R,4S,5S)-tert-butyl 3-(2-hydroxyethyl)-4-(2-methoxy-2-oxoethyl)-2-oxo-5-
phenylpyrrolidine-1-carboxylate 293. Lactone 254 (0.20 g, 0.58 mmol) was 
dissolved in a MeOH (10 ml) and cooled to -78 °C. Sodium methoxide (1M, 2.89 
mmol) was added dropwise and the mixture was stirred for 2 hours. The mixture 
was quenched with sodium bicarbonate solution. The mixture was extracted with 
EtOAc (2 x 10 ml). The organic was washed with water (10 ml), dried over 
magnesium sulfate and concentrated under reduced pressure. Purification by flash 
chromatography eluting with 2:1 petrol/ethyl acetate, gave the title compound 
(0.174 g, 80 %) as a colourless film, Rf 0.45 (1:1 petrol/ethyl acetate); νmax 
(film)/cm-1 3643, 1752, 1732 and 1659; 1H NMR (400MHz; CDCl3) δH: 7.39-7.28 
(5H, m, ArH), 4.98 (1H, s, H3), 3.81-3.68 (5H, m, OMe, H7, H7'), 2.96 (1H, td J 
8.0, 6.0, H5), 2.75-2.69 (1H, m, H4), 2.58 (1H, dd J 17.0, 4.5, H9 [A of ABX]), 
2.41 (1H, dd J 17.0, 11.0, H9' [B of ABX]), 1.99-1.90 (1H, m, H6), 1.64-1.56 
(1H, m, H6') and 1.33 (9H, s, tBu); 13C NMR (75MHz, CDCl3) δc: 176.2 (C=O), 
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172.4 (NC=O), 149.6 (NBoc), 139.6 (Ar), 128.8 (2xAr), 127.8 (2xAr), 125.1 (Ar), 
83.6 (C(CH3)3), 64.7 (C7), 61.3 (C3), 52.1 (OCH3), 42.6 (C5), 41.1 (C4), 33.4 
(C9), 28.4 (C6) and 27.7 (C(CH3)3); m/z (ES+) 378.2 (100%, MH+); Found MH+ 
378.1823, C20H27NO6 requires MH+ 378.1838. 
 
 
 
 
 
(2S,3S,4R)-tert-butyl 3-(2-methoxy-2-oxoethyl)-5-oxo-2-phenyl-4-(2-(2,2,2-
trichloroacetoxy)ethyl)pyrrolidine-1-carboxylate 307. Alcohol 293 (0.100 g, 
0.265 mmol) was dissolved in DCM (5 ml). Triethylamine (0.05 ml, 0.318 mmol) 
and trichloroacetyl chloride (0.058 ml, 0.318 mmol) were added and the mixture 
was allowed to stir for 2 hours at R.T. The reaction was quenched with water (2 
ml) and extracted with DCM (2 x 10 ml). The combined organic layers was dried 
with magnesium sulfate and evaporated under reduced pressure. Purification by 
flash chromatorgraphy, eluting with 6:1 petrol-EtOAc afforded the title compound 
(0.135 g, 98 %) as a colourless oil, Rf 0.61 (1:1 petrol/ethyl acetate); νmax 
(film)/cm-1 1769, 1732 and 1659; 1H NMR (400MHz; CDCl3) δH: 7.37-7.27 (5H, 
m, ArH), 5.04 (1H, s, H3), 4.51 (1H, dt, J 6.0, 11.0, H7), 4.40 (1H, ddd, J 11.0, 
8.5, 5.5, H7'), 3.78 (3H, s, OMe), 2.91 (1H, dt, J 7.5, 7.0, H5), 2.78-2.73 (1H, m, 
H4), 2.60 (1H, dd, J 17.0, 3.5, H9 [A of ABX]), 2.41 (1H, dd, J 17.0, 11.5, H9' [B 
of ABX]), 2.29 (1H, dq, J 6.0, 5.5, H6), 1.86-1.77 (1H, m, H6') and 1.36 (9H, s, 
tBu); 13C NMR (75MHz, CDCl3) δc: 173.8 (C=O), 172.1 (NC=O), 161.6 
(CCl3C=O), 149.7 (NBoc), 139.4 (Ar), 128.8 (2xAr), 127.8 (2xAr), 124.9 (Ar), 
89.8 (CCl3), 83.5 (C(CH3)3), 67.5 (C7), 63.9 (C3), 52.1 (OCH3), 40.7 (C5), 40.5 
(C4), 33.1 (C9), 27.8 (C(CH3)3) and 23.9 (C6); m/z (ES+) 544.3 (100%, MNa+); 
Found MH+ 522.0853, C22H26Cl3NO7 requires MH+ 522.0853. 
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(3S,4R)-methyl 3-(2-methoxy-2-oxoethyl)-5-oxo-4-(2-(2,2,2-
trichloroacetoxy)ethyl)pyrrolidine-2-carboxylate 308. Sodium periodate (0.74 
g, 3.44 mmol) was added to a solution of H2O (12 ml)/acetonitrile (6 ml). 
RuCl3.xH2O (0.004 g, 0.019 mmol) was added and the mixture was stirred for 10 
minutes. Lactam 307 (0.1 g, 0.192 mmol) was dissolved in EtOAc (6 ml) and 
added dropwise to the reaction mixture and was allowed to stir for 24 hours. The 
solution was then filtered over celite and extracted with EtOAc. The combined 
organic layer was washed with water, dried using magnesium sulfate and 
concentrated under reduced pressure. Purification by column chromatography 
eluting with 2:1 petrol-EtOAc to yield the title compound (0.035 g, 36 %) and 
recovered starting material (10 mg, 10 %), Rf 0.45 (1:1 petrol/ethyl acetate); νmax 
(film)/cm-1 1752, 1732 and 1659; 1H NMR (400MHz; CDCl3) δH: 4.55 (1H, dt, 
11.0, 5.5, H7), 4.46-4.40 (2H, m, H7', H3), 3.79 (3H, s, OMe), 3.71 (3H, s, OMe), 
2.94-2.90 (2H, m, H5, H4), 2.59 (1H, dd, J 17.0, 4.0, H9), 2.35-2.21 (2H, m, H9', 
H6), 1.86-1.77 (1H, m, H6') and 1.47 (9H, s, tBu); 13C NMR (75MHz, CDCl3) δc: 
172.6 (C=O), 171.3 (C=O), 170.6 (NC=O), 161.8 (COCCl3), 148.4 (NBoc), 89.5 
(CCl3), 84.2 (C(CH3)3), 67.7 (C7), 61.8 (C3), 52.9 (OCH3), 52.3 (OCH3), 42.3 
(C5), 35.3 (C4), 33.3 (C9), 27.9 (C(CH3)3) and 22.4 (C6); m/z (ES+) 526.4 (100%, 
MH+); Found MH+ 526.0404, C22H26Cl3NO7 requires MH+ 526.0414. 
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3.1.5 Experimental Procedures for Section 2.4: 
Silicon-Mediated Fragmenation Route. 
 
 
 
 
(3S,3aS,7aR)-3-phenyl-2-(2-phenylpropan-2-yl)-7-(trimethylsilyl) hexahydro-
1H-isoindole-1,5(6H)-dione 315. A solution of HMPA (3.20 ml, 18.4 mmol) and 
HMDS (1.54 ml, 7.54 mmol) in THF (25 ml) was cooled to 0 °C. Methyllithium 
(3.99 ml, 6.38 mmol) was added dropwise and the reaction was left to stir for 15 
minutes. Copper cyanide (285 mg, 3.19 mmol) was then added in one portion and 
the reaction was left to stir for 30 minutes. After this time the reaction was cooled 
to -78 °C and a solution of enone 104 (1.00 g, 2.89 mmol) and TMSCl (1.07 ml, 
8.67 mmol) was added dropwise. The mixture was allowed to stir at -78 °C for 30 
minutes and then quenched with NH4OH/NH4Cl solution. The layers were 
separated and the organic was washed with water (30 ml), brine (30 ml), dried 
over magnesium sulfate and concentrated under reduced pressure. Purification by 
column chromatography (petrol/ethyl acetate 8:2) gave the title compound (1.05 
g, 86 %) as a colourless solid, Rf 0.8 (1:1 petrol/ethyl acetate); m.p. 119-121 °C; 
[α]D24 = 58.0 (c = 1 in CHCl3); νmax (film)/cm-1 2947, 1722, 1694, 1495, 1455 and 
1390; 1H NMR (400MHz; CDCl3) δH: 7.45-7.24 (10H, m, ArH), 4.43 (1H, s, H3), 
3.05 (1H, dd, J 4.0, 4.0, H5), 2.59 (1H, dd, J 12.0, 4.0, H9), 2.48-2.40 (1H, m, 
H4), 2.39-2.28 (2H, m, H9', H7), 2.15-2.04 (1H, m, H7'), 1.90 (3H, s, Me), 1.75-
1.69 (1H, m, H6), 1.55 (3H, s, Me) and 0.00 (9H, s, 3xSiMe); 13C NMR 
(100MHz, CDCl3) δc: 211.4 (C=O), 175.6 (NC=O), 146.1 (Ar), 141.8 (Ar), 129.1 
(2xAr), 128.2 (2xAr), 127.9 (2xAr), 127.0 (2xAr), 125.6 (Ar), 125.4 (Ar), 67.4 
(C3), 62.3 (C(CH3)2)Ph), 43.1 (C5), 42.9 (C4), 39.6 (C7), 38.7 (C9), 28.1 
(C(CH3)2)Ph), 27.1 (C(CH3)2)Ph), 19.9 (C6) and -2.5 (Si(CH3)3); m/z (ES+) 442.2 
(100%, MNa+); Found MH+ 420.2367, C26H33NO2Si requires MH+ 420.2353. 
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(3S,3aS,7aR)-7-(1,1,2,2,2-pentamethyldisilyl)-3-phenyl-2-(2-phenylpropan-2-
yl)hexahydro-1H-isoindole-1,5(6H)-dione 332 was isolated as a minor impurity 
(141 mg, 10 %) as a colourless oil, Rf 0.82 (1:1 petrol/ethyl acetate); νmax 
(film)/cm-1 2947, 1719, 1690; 1H NMR (400MHz; CDCl3) δH: 7.42-7.22 (10H, m, 
ArH), 4.37 (1H, s, H3), 3.01 (1H, dd,  J 7.0, 5.0, H5), 2.55 (1H, dd, J 15.0, 5.5, 
H9), 2.44-2.22 (3H, m, H4, H9', H7), 1.89-1.86 (4H, m, Me, H6), 1.53 (3H, s, 
Me) and 0.00 (15H, s, 5xSiMe); 13C NMR (100MHz, CDCl3) δc: 211.0 (C=O), 
175.3 (NC=O), 145.9 (Ar), 141.6 (Ar), 128.9 (2xAr), 128.1 (2xAr), 127.9 (2xAr), 
126.9 (2xAr), 125.5 (Ar), 125.4 (Ar), 67.2 (C3), 59.2 (C(CH3)2Ph), 43.3 (C5), 
42.9 (C7), 40.3 (C4), 39.4 (C7), 27.9 (C(CH3)2Ph), 27.0 (C(CH3)2Ph), 18.8 (C6) 
and -1.83 (Si(CH3)3); m/z (ES+) 500.3 (100%, MNa+); Found MH+ 478.2601, 
C28H39NO2Si2 requires MH+ 478.2592.  
 
 
 
 
(3S,3aS,8aR)-3-phenyl-2-(2-phenylpropan-2-yl)-8-(trimethylsilyl)hexahydro-
1H-oxepino[4,5-c]pyrrole-1,5(7H)-dione 325. Silylated ketone 315 (160 mg, 
0.38 mmol) was dissolved in DCM (5 ml). mCPBA (131 mg, 0.76 mmol) was 
added and the reaction was allowed to stir for 48 hours. The reaction was 
quenched with sodium sulfite solution and the organic was extracted with DCM 
(20 ml). The organic layer was washed with water (20 ml), brine (20 ml), dried 
over magnesium sulfate and concentrated under reduced pressure to yield a 
colourless oil. The crude was used without purification in the next step, Rf 0.44 
(7:3 petrol/ethyl acetate); νmax (film)/cm-1 1739 and 1691; 1H NMR (400MHz; 
CDCl3) δH: 7.46-7.22 (10H, m, ArH), 4.38 (1H, s, H3), 4.20 (1H, dd, J 13.5, 3.5, 
H7), 4.11 (1H, d, J 13.0, H7'), 2.98 (1H, d, J 6.5, H5), 2.83 (1H, dd, J 13.0, 13.0, 
H9 [A of ABX]), 2.64 (1H, dd, J 13.0, 3.0, H9' [B of ABX]), 2.40 (1H, ddd, J, 
13.0, 6.0, 3.0, H4), 1.88 (3H, s, Me), 1.85-1.82 (1H, m, H6), 1.53 (3H, s, Me) and 
0.00 (9H, s, 3xSiMe); 13C NMR (100MHz, CDCl3) δc: 174.5 (C=O), 172.7 
(NC=O), 145.5 (Ar), 140.6 (Ar), 129.1 (2xAr), 128.2 (2xAr), 127.3 (2xAr), 125.5 
3
N
O
Ph
H
4
Ph
H
5
6
7
O
9
Me3Si
O
                                                 Chapter 3: Experimental Procedures 
207 
(2xAr), 125.4 (2xAr), 68.4 (C7), 67.5 (C3), 59.3 (C(CH3)2Ph), 41.9 (C5), 41.8 
(C4), 37.2 (C9), 27.6 (C(CH3)2Ph), 27.1 (C(CH3)2Ph), 25.8 (C6) and -2.0 
(Si(CH3)3); m/z (ES+) 458 (100%, MNa+). 
 
 
 
 
Methyl 2-((2S,3S,4R)-5-oxo-2-phenyl-1-(2-phenylpropan-2-yl)-4-
vinylpyrrolidin-3-yl)acetate 326. Lactone 325 (crude) was dissolved in 2:1 
methanol/DCM. Two drops of concentrated HCl was added and the reaction was 
left to stir for 18 hours. The reaction was quenched with NaHCO3 solution and the 
organic was extracted with ethyl acetate. Purification by column chromatography 
(petrol/ethyl acetate 4:1) gave the title compound (110 mg, 77% over 2 steps) as a 
colourless oil, Rf 0.40 (7:3 petrol ethyl acetate); 1H NMR (300MHz; CDCl3) δH: 
7.36-7.18 (10H, m, ArH), 5.62 (1H, ddd, J 17.5, 10.5, 8.5, H6), 5.16 (2H, dd, J 
35.5, 10.5, H7), 4.61 (1H, s, H3), 3.70 (3H, s, OMe), 3.55 (1H, t, J 8.0, H5), 2.61-
2.46 (2H, m, H9, H4), 2.22 (1H, dd, J 16.0, 11.0, H9'), 1.83 (3H, s, Me) and 1.47 
(3H, s, Me); 13C NMR (75MHz, CDCl3) δc: 174.4 (C=O), 172.9 (NC=O), 146.1 
(Ar), 142.0 (Ar), 131.5 (C6), 128.9 (2xAr), 128.1 (2xAr), 127.7 (2xAr), 126.9 
(2xAr), 126.0 (Ar), 125.5 (Ar), 121.1 (C7), 65.8 (C3), 59.3 (C(CH3)2Ph), 51.9 
(OCH3), 47.5 (C5), 44.2 (C4), 34.3 (C9), 28.2 (C(CH3)2Ph) and 27.0 
(C(CH3)2Ph); m/z (ES+) 400 (100%, MNa+). 
 
 
 
 
(3S,3aS,7aR)-3-phenyl-7-(trimethylsilyl)hexahydro-1H-isoindole-1,5(6H)-
dione 341. Lactam 315 (1.23 g, 2.94 mmol) was dissolved in TFA (12 ml). The 
reaction was heated at reflux for 1 hour and then allowed to cool to R.T.. The 
TFA was removed under reduced pressure and the crude was dissolved in DCM 
(20 ml). The organic was washed with water (10 ml), brine (10 ml), dried over 
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magnesium sulfate and concentrated under reduced pressure. Purification by 
column chromatography (1:1 petrol/ethyl acetate) gave the title compound (0.819 
g, 92%) as a colourless solid, [α]D25 = 95.2 (c = 1 in CHCl3); m.p 99-101 °C; Rf 
0.13 (3:2 petrol/ethyl acetate);  νmax (film)/cm-1 3440, 2952, 1714, 1687 and 1651; 
1H NMR (400MHz; CDCl3) δH: 7.41-7.27 (5H, m, ArH), 6.92 (1H, bs, NH), 4.36 
(1H, d, J 3.0, H3), 2.80-2.69 (2H, m, H5, H4), 2.61 (1H, dd, J 16.0, 6.0, H9 [A of 
ABX]), 2.50 (1H, dd, J 16.0, 9.5, H9' [B of ABX]), 2.40 (1H, dd, J 15.5, 5.0, H7), 
2.15 (1H, dd, J 15.5, 10.5, H7'), 1.64 (1H, ddd, J 10.5, 7.5, 5.5, H6) and 0.00 (9H, 
s, 3xSiMe); 13C NMR (100MHz, CDCl3) δC: 211.1 (C=O), 178.6 (NC=O), 140.3 
(Ar), 128.8 (2xAr), 128.1 (2xAr), 125.5 (Ar), 61.8 (C3), 45.5 (C5), 41.7 (C4), 
39.7 (C7 or C9), 39.3 (C7 or C9), 20.7 (C6) and -2.5 (Si(CH3)3); m/z (ES+) 324 
(100%, MNa+); Found MNa+ 324.1389, C17H23NO2 requires MNa+ 324.1390. 
 
 
 
 
(1S,3aR,7aS)-tert-butyl 3,6-dioxo-1-phenyl-4-(trimethylsilyl)hexahydro-1H-
isoindole-2(3H)-carboxylate 316. Amide 316 (809 mg, 2.69 mmol) was 
dissolved in DCM (20 ml). Boc2O (762 mg, 3.49 mmol), triethylamine (0.37 ml, 
2.69 mmol) and DMAP (65.0 mg, 0.54 mmol) was added and the reaction was 
allowed to stir for 18 hours. The reaction was quenched with water (20ml) and 
extracted with DCM. The organic layer was washed with water (20 ml), brine (20 
ml), dried over magnesium sulfate and concentrated under reduced pressure. 
Purification by column chromatography (4:1 petrol/ethyl acetate) gave the title 
compound (830 mg, 77%) as a colourless solid, [α]D25 = + 93.6 [reading +0.234] 
(c = 1 in CHCl3); m.p 168 °C; Rf 0.71 (1:1 petrol/ethyl acetate);  νmax (film)/cm-1 
1782, 1751, 1716 and 1636; 1H NMR (400MHz; CDCl3) δH: 7.39-7.35 (2H, m, 
ArH), 7.32-7.28 (2H, m, ArH), 7.19-7.17 (2H, m, ArH), 4.79 (1H, s, H3), 2.92 
(1H, dd, J 6.5, 6.5, H5), 2.66 (1H, dd, J 15.0, 5.0, H7), 2.58-2.52 (1H, m, H4), 
2.46-2.38 (2H, m, H7', H9), 2.11 (1H, dd, J 15.5, 9.0, H9'), 1.73 (1H, dt, J 12.0, 
6.0, H6), 1.31 (9H, s, tBu) and 0.00 (9H, s, 3xSiMe); 13C NMR (100MHz, CDCl3) 
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δC: 210.0 (C=O), 174.9 (NC=O), 149.6 (NBoc), 139.8 (Ar), 128.9 (2xAr), 127.9 
(Ar), 124.7 (2xAr), 83.3 (C(CH3)3), 65.2 (C3), 42.5 (C5), 41.0 (C7), 40.8 (C4), 
38.5 (C9), 27.6 (C(CH3)3), 19.9 (C6) and -2.7 (Si(CH3)3); m/z (ES+) 424.3 (100%, 
MNa+); Found MNa+ 424.1927, C22H31NO4 requires MNa+ 424.1915. 
(1S,3aR,7aS)-tert-butyl 6-(tert-butoxycarbonyloxy)-3-oxo-1-phenyl-4-
(trimethylsilyl)-3a,4,7,7a-tetrahydro-1H-isoindole-2(3H)-carboxylate 342a 
and (3S,3aS,7aR)-tert-butyl 5-(tert-butoxycarbonyloxy)-1-oxo-3-phenyl-7-
(trimethylsilyl)-3,3a,7,7a-tetrahydro-1H-isoindole-2(6H)-carboxylate 342b 
were isolated as an inseparable 2:1 mixture (120 mg, 9 %) as a colourless solid, 
m.p 148-150 °C; Rf 0.75 (1:1 petrol/ethyl acetate);  νmax (film)/cm-1 2979, 1783, 
1749, 1721 and 1698; 1H NMR (500MHz; CDCl3) δH: 7.38-7.18 (7.5H, m, ArH), 
5.58 (1H, s, H9a), 5.49 (0.5H, d, J 4.0, H7b), 4.89 (1H, d, J 2.0, H3b), 4.86 (1H, s, 
H3a), 2.84 (1H, dd, J 2.5, 7.0, 7a), 2.81-2.76 (1H, bm, H4a), 2.70 (1H, dd, J 2.0, 
7.0, H9b), 2.54-2.45 (4H, m, H7a', H9b', H5b, H4b), 2.24-2.20 (1H, m, H6b), 2.06 
(1H, d, J 18.0, H5a), 1.80 (1H, d, J 8.2, H6a), 1.51 (3.5H, s, tBu[b]), 1.50 (9H, s, 
tBu[a]), 1.30 (18H, s, tBu[a+b]) and 0.00 (18H, s, 6xSiMe[a+b]) 13C NMR 
(125MHz, CDCl3) δC: 175.6 (NC=O), 175.3 (NC=O), 151.6 (OBoc), 150.7 
(OBoc), 149.9 (NBoc), 149.7 (NBoc), 142.7 (COBoc), 140.9 (2xAr), 129.0 
(4xAr), 128.7 (4xAr), 128.6 (4xAr), 125.2 (4xAr), 124.8 (2xAr), 114.1 (C7b or 
C9a), 113.6 (C9a or C7b), 83.1 (C(CH3)3), 82.9 (C(CH3)3), 65.9 (C3a or b), 65.8 
(C3a or b), 53.4 (, 40.4 (C5a or b), 40.2 (C5a or b), 39.5 (C4a or b), 39.1 (C4 a or 
b), 27.7 (C(CH3)3), 27.5 (C(CH3)3), 23.7 (C7a or C9b), 23.2 (C9b or C7a), 18.9 
(C6a and b), -2.5 (Si(CH3)3) and -2.6 (Si(CH3)3); m/z (ES+) 524 (100%, MNa+); 
Found MNa+ 524.2439, C27H39NO6 requires MNa+ 524.2439. 
 
 
 
 
(1S,3aR,7aS)-2-tert-butyl 1-methyl 3,6-dioxo-4-(trimethylsilyl)hexahydro-
1H-isoindole-1,2(3H)-dicarboxylate  343. To a solution of NaIO4 (7.79 g, 36.4 
mmol) in distilled water (30 ml) and acetonitrile (15 ml), RuCl3.xH2O (38 mg, 
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0.182 mmol) was added in one portion. A solution of lactam 316 (730 mg, 1.82 
mmol) in ethyl acetate (15 ml) was added dropwise. The reaction was allowed to 
stir for 24 hours. After this time the reaction was filtered over a bed of celite and 
the organic was extracted with ethyl acetate. The organic layer was washed with 
water (20 ml), brine (20 ml), dried over magnesium sulfate and concentrated 
under reduced pressure. The crude acid was used in the next step without 
purification. The crude acid was dissolved in 2:1 toluene/methanol (20 ml:10 ml). 
TMS-diazomethane (2M in hexanes, 1.82 ml, 3.64 mmol) was added dropwise 
and the reaction was allowed to stir for 30 minutes. At this time the reaction was 
quenched by 2 drops of acetic acid. The reaction was concentrated under reduced 
pressure. Purification by column chromatography (4:1 petrol/ethyl acetate) gave 
recovered starting material 316 (74 mg, 10 %) and the title compound (529 mg, 
76%) as a colourless oil, Rf 0.77 (1:1 petrol/ethyl acetate); νmax (film)/cm-1 1783, 
1744 and 1717; 1H NMR (400MHz; CDCl3) δH: 4.26 (1H, bs, H3), 3.81 (3H, s, 
OMe), 2.90 (1H, dd, J 7.0, 7.0, H5), 2.73 (1H, m, H4), 2.59 (1H, dd, J 16.0, 5.5, 
H9 [A of ABX]), 2.39 (1H, dd, J 16.0, 5.5, H7 [A of ABX]), 2.32 (1H, dd, J 16.0, 
12.5, H9' [B of ABX]), 2.14 (1H, dd, J 16.0, 9.5 [B of ABX], H7'), 1.68 (1H, dt, J 
9.5, 6.0 H6) and 1.51 (9H, s, tBu); 13C NMR (100MHz, CDCl3) δC: 209.1 (C=O), 
173.7 (CO2Me), 170.5 (NC=O), 149.5 (NBoc), 84.2 (C(CH3)3), 62.6 (C3), 52.9 
(OCH3), 42.0 (C5), 41.8 (C4), 38.4 (C9 or C7), 35.5 (C7 or C9), 27.9 (C(CH3)3), 
19.8 (C6) and -2.6 (Si(CH3)3); m/z (ES+) 406.1 (100%, MNa+); Found MNa+ 
406.1662, C18H21NO6Si requires MNa+ 406.1662. 
 
 
 
 
(1S,3aR,8aS)-2-tert-butyl 1-methyl 3,7-dioxo-4-(trimethylsilyl)hexahydro-
1H-oxepino[4,5-c]pyrrole-1,2(7H)-dicarboxylate 344. Lactam 343 (522 mg, 
1.36 mmol) was dissolved in DCM (10 ml). mCPBA (671 mg, 2.73 mmol) was 
added in one portion and the reaction was left to stir for 2 days. The reaction was 
quenched with sodium sulfite and extracted with DCM (10 ml). The organic layer 
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was washed with water (10 ml), brine (10 ml), dried over magnesium sulfate and 
concentrated under reduced pressure. Purification by column chromatography 
(3:1 petrol/ethyl acetate) gave the title compound (543 mg, quant.) as a colourless 
oil, Rf 0.66 (1:1 petrol/ethyl acetate); m.p. 159-161 °C; νmax (film)/cm-1 2954, 
1790 and 1732; 1H NMR (400MHz; CDCl3) δH: 4.32 (2H, m, H7, H7'), 4.25 (1H, 
s, H3), 3.82 (3H, s, OMe), 2.59 (1H, t, J 13.0,13.0, H9 [A of ABX]), 2.89 (1H, bd, 
J 6.5, H5), 2.77 (1H, ddd, J 13.0, 7.0, 3.0, H4), 2.70 (1H, dd, J 13.0, 2.5, H9' [B 
of ABX]), 1.95-1.91 (1H, bm, H6) and 1.51 (9H, s, tBu); 13C NMR (100MHz, 
CDCl3) δC: 172.7 (C=O), 171.5 (CO2Me), 169.9 (NC=O), 149.3 (NBoc), 84.5 
(C(CH3)3), 68.0 (C7), 63.1 (C3), 53.0 (OCH3), 44.9 (C5), 36.9 (C4), 34.6 (C9), 
27.8 (C(CH3)3), 25.6 (C6) and -1.9 (Si(CH3)3); m/z (ES+) 422.2 (100%, MNa+); 
Found MH+ 400.1777, C18H29NO7Si requires MH+ 400.1786. 
 
 
 
 
(2S,3S)-1-tert-butyl 2-methyl 4-ethylidene-3-(2-methoxy-2-oxoethyl)-5-
oxopyrrolidine-1,2-dicarboxylate 346. Lactone 344 (10.0 mg, 0.03 mmol) was 
dissolved in THF (1 ml). TBAF (1M in THF, 0.04 ml, 0.04 mmol) was added 
dropwise and the reaction was left to stir for 20 minutes. The reaction was 
quenched with water (1 ml) and extracted with ethyl acetate (5 ml). The organic 
was washed with brine (5 ml), dried over magnesium sulfate and concentrated 
under reduced pressure. The crude acid was dissolved in 2:1 toluene/methanol (1 
ml: 0.5 ml) and TMS-diazomethane (2M in hexanes, 0.02 ml, 0.05 mmol) was 
added dropwise. The reaction was allowed to stir for 30 minutes and then 
quenched with a drop of acetic acid. The reaction mixture was concentrated under 
reduced pressure to give the title compound (8 mg, quant.) as a colourless oil, Rf  
0.52 (1:1 petrol/ethyl acetate); νmax (film)/cm-1 2925, 2855, 1786, 1742, 1703, 
1677 and 1438; 1H NMR (400MHz; CDCl3) δH: 6.82 (1H, qd, J 7.5, 2.0, H6), 
4.46 (1H, d, J 1.5, H3), 3.77 (3H, s, OMe), 3.74 (3H, s, OMe), 3.34-3.31 (1H, bm, 
H4), 2.56-2.53 (2H, m, H9, H9'), 1.84 (3H, d, J 7.5, H7) and 1.51 (9H, s, tBu); 
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13C NMR (100MHz, CDCl3) δC: 171.3 (C=O), 170.7 (C=O), 165.2 (NC=O), 
150.0 (NBoc), 135.8 (C5), 132.6 (C6), 84.8 (C(CH3)3), 61.4 (C3), 52.8 (OCH3), 
52.2 (OCH3), 38.4 (C4), 34.6 (C9), 27.9 (C(CH3)3) and 15.2 (C7); m/z (ES+) 364.2 
(100%, MNa+); Found MNa+ 364.1360, C16H23NO7 requires MNa+ 364.1367. 
 
 
 
 
(2S,3S)-methyl 3-(2-methoxy-2-oxoethyl)-5-oxo-4-vinylpyrrolidine-2-
carboxylate 347. Lactone 344 (10.0 mg, 0.03 mmol) was dissolved in DCM (1 
ml) and cooled to -78 °C. Freshly distilled BF3.OEt2 (0.01 ml, 0.05 mmol) was 
added dropwise and the reaction was allowed to stir for 30 minutes. The reaction 
was quenched with water (1 ml) and allowed warm to room temperature. The 
organic was extracted with DCM (5 ml), washed with brine (5 ml), dried over 
magnesium sulfate and concentrated under reduced pressure. The crude acid was 
dissolved in 2:1 toluene/methanol (1.0 ml: 0.5 ml) and TMS-diazomethane (2M in 
hexanes, 0.018 ml, 0.038 mmol). The reaction was allowed to stir for 30 minutes 
and then a drop of acetic acid was added to quench. The crude was concentrated 
under reduced pressure to give the title compound (6 mg, quant.) as a colourless 
oil, Rf 0.15 (1:1 petrol/ethyl acetate); 1H NMR (400MHz; CDCl3) δH: 6.46 (1H, 
bs, NH), 5.66 (1H, dt, J 16.5, 10.0, H6), 5.36-5.28 (2H, m, H7), 4.01 (1H, d, J 6.0, 
H3), 3.79 (3H, s, OMe), 3.69 (3H, s, OMe), 3.38 (1H, t, J 8.5, 8.5, H5), 3.12-3.05 
(1H, m, H4), 3.66 (1H, dd, J 17.0, 7.0, H9 [A of ABX]) and 3.57 (1H, dd, J 17.0, 
8.0, H9' [B of ABX]); m/z (ES+) 242 (100%, MH+). 
 
 
 
 
(2S,3S,4R)-methyl 4-(2-(tert-butoxycarbonyloxy)-1-(trimethylsilyl)ethyl)-3-
(2-methoxy-2-oxoethyl)-5-oxopyrrolidine-2-carboxylate 352a. Lactone 344 
(50.0 mg, 0.13 mmol) was dissolved in MeOH (5 ml) and cooled to -30 °C. 
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NaOMe (1M, 0.25ml, 0.25 mmol) was added dropwise and the reaction was a 
llowed to stir for 1 hour. At this point the reaction was quenched with ammonium 
chloride solution (3 ml) and allowed to warm to R.T. The organic was extracted 
with ethyl acetate (2 x 10 ml), washed with water (10 ml), brine (10 ml), dried 
over magnesium sulfate and concentrated under reduced pressure. Purification by 
column chromatography (4:1 petrol/ethyl acetate) gave the title compound (32 
mg, 60 %) as a colourless oil, Rf 0.71 (1:1 petrol/ethyl acetate); νmax (film)/cm-1 
2957, 2922, 2854, 1766 and 1716; 1H NMR (400MHz; CDCl3) δH: 6.57 (1H, d, J 
9.5, NH), 5.59 (1H, dd, J 9.5, 4.0, H3), 4.45 (1H, t, J 9.0, 9.0, H7 [A of ABX]), 
4.19 (1H, dd, J 12.0, 9.5, H7' [B of ABX]), 3.75 (3H, s, OMe), 3.70 (3H, s, OMe), 
3.01-2.96 (1H, m, H5), 2.82 (1H, dd, J 10.0, 2.0, H4), 2.57 (1H, dd, J 16.5, 12.0, 
H9 [A of ABX]), 2.56 (1H, dd, J 16.5, 3.0, H9' [B of ABX]), 2.13-2.06 (1H, m, 
H6), 1.42 (9H, s, tBu) and 0.00 (9H, s, TMS); 13C NMR (75MHz, CDCl3) δC: 
179.5 (C=O), 172.1 (C=O), 171.1 (NC=O), 156.2 (OBoc), 79.7 (C(CH3)3), 71.5 
(C7), 55.7, (C3), 52.4 (OCH3), 52.2 (OCH3), 42.8 (C5), 37.3 (C4), 32.6 (C9), 28.2 
(C(CH3)3), 14.1 (C6) and -2.2 (Si(CH3)3); m/z (ES+) 454.2 (100%, MNa+); Found 
MNa+ 454.1871, C19H33NO8Si requires MNa+ 454.1868. 
 
 
 
 
(2S,3S,4R)-1-tert-butyl 2-methyl 4-(2-hydroxy-1-(trimethylsilyl)ethyl)-3-(2-
methoxy-2-oxoethyl)-5-oxopyrrolidine-1,2-dicarboxylate 351. Lactone 344 
(50.0 mg, 0.13 mmol) was dissolved in MeOH (5 ml) and cooled to -60 °C. 
NaOMe (1M, 0.25 ml, 0.25 mmol) was added dropwise and the reaction was a 
llowed to stir for 2 hour. At this point the reaction was quenched with ammonium 
chloride solution (3 ml) and allowed to warm to R.T. The organic was extracted 
with ethyl acetate (2 x 10 ml), washed with water (10 ml), brine (10 ml), dried 
over magnesium sulfate and concentrated under reduced pressure. Purification by 
column chromatography (4:1 petrol/ethyl acetate) gave the title compound (46 
mg, 87 %) as a colourless oil, Rf 0.48 (1:1 petrol/ethyl acetate); νmax (film)/cm-1 
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2982, 2901, 1768 and 1709; 1H NMR (400MHz; CDCl3) δH: 4.41 (1H, s, H3), 
3.79 (3H, s, OMe), 3.74-3.72 (5H, m, H7, H7', OMe), 3.19 (1H, t, J 7.5, 7.5, H5), 
2.98-2.92 (1H, m, H4), 2.62 (1H, dd, J 16.5, 3.5, H9 [A of ABX]), 2.37 (1H, dd, J 
16.5, 11.5, H9' [B of ABX]), 1.47 (9H, s, tBu) and 1.36-1.32 (1H, m, H8); 13C 
NMR (100MHz, CDCl3) δC: 175.7 (C=O), 172.7 (C=O), 171.5 (NC=O), 149.9 
(NBoc), 84.4 (C(CH3)3), 63.2 (C7), 62.5 (C3), 53.4 (OCH3), 52.8 (OCH3), 45.8 
(C5), 36.2 (C4), 33.8 (C9), 27.8 (C(CH3)3), 14.1 (C6) and -0.7 (Si(CH3)3); m/z 
(ES+) 454.4 (100%, MNa+); Found MNa+ 454.1879, C19H33NO8Si requires MNa+ 
454.1868. 
 
 
 
 
(1S,3aR,7aS)-2-tert-butyl 1-methyl 6-hydroxy-3-oxo-4-
(trimethylsilyl)hexahydro-1H-isoindole-1,2(3H)-dicarboxylate 358. Lactam 
343 (50 mg, 0.13 mmol) was dissolved in THF (5 ml) and cooled to 0 °C. 
BH3.DMS (2M in THF, 0.66 ml, 0.66 mmol) was added dropwise and the reaction 
was allowed to stir for 1 hour. The reaction was quenched with NaHCO3 solution 
and extracted with ethyl acetate (10 ml). The organic was washed with water (10 
ml), brine (10 ml) and dried over magnesium sulfate. Concentration under 
reduced pressure gave the title compound as a 1:0.8 mixture of diastereoisomers 
(46 mg, 92 %) as a colourless oil, Rf 0.67 (1:1 petrol/ethyl acetate); 1H NMR 
(400MHz; CDCl3) δH: 4.23 (1H, s, H3a), 4.21 (1H, d, J 3.0, H3b), 4.02-3.96 (1H, 
m, H8a), 3.79 (3H, s, OMe), 3.78 (3H, s, OMe), 3.64-3.55 (1H, m, H8b), 2.63-
2.56 (3H, bm, H4a, H5a, H5b), 2.46 (1H, qn, J 6.0, H4b), 2.29-2.17 (1H, m, H9b), 
1.93-1.86 (1H, m, H7b), 1.79-1.59 (3H, m, H7a, H9a, H9a'), 1.50 (9H, s, tBu), 
1.49 (9H, s, tBu), 1.44-1.18 (4H, m, H7a', H7b', H6b, H6a), 1.23 (1H, dt, J 12.0, 
11.5, H9b') and 0.05 (18H, s, Si(CH3)3) and 0.03 (9H, s, Si(CH3)3); 13C NMR 
(100MHz, CDCl3) δC: 174.5 (C=O), 174.0 (C=O), 171.1 (NC=O), 170.8 (N=CO), 
149.9 (NBoc), 83.7 (C(CH3)3), 83.5 (C(CH3)3), 66.4 (C8a or b), 65.8 (C8a or b), 
62.6 (C3a or b), 62.1 (C3a or b), 60.4, 52.7 (OCH3), 52.5 (OCH3), 42.9 (C5a or 
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b), 41.8 (C5a or b), 38.1 (C7a and b), 35.4 (C4 a or b), 34.2 (C4 a or b), 33.1 (C9a 
or b), 32.9 (C9a or b), 28.2 (C(CH3)3), 27.9 (C(CH3)3), 19.5 (C6a or b), 18.1 (C6 a 
or b), -1.4 (Si(CH3)3) and -1.9 (Si(CH3)3) ; m/z (ES+) 408 (100%, MNa+); Found 
MNa+ 408.1718, C18H31NO6Si requires MNa+ 408.1818.  
 
 
 
 
(1S,3aR,7aS)-tert-butyl 6-hydroxy-1-(hydroxymethyl)-3-oxo-4-
(trimethylsilyl)hexahydro-1H-isoindole-2(3H)-carboxylate 359. Lactam 343 
(50 mg, 0.13 mmol) was dissolved in THF (5 ml). BH3.DMS (2M in THF, 0.66 
ml, 0.66 mmol) was added dropwise and the reaction was heated to reflux and 
stirred for 24 hours. The reaction was quenched with NaHCO3 solution and 
extracted with ethyl acetate (10 ml). The organic was washed with water (10 ml), 
brine (10 ml) and dried over magnesium sulfate. Concentration under reduced 
pressure gave the title compound (21 mg, 47 %) as a colourless oil, Rf (1:1 
petrol/ethyl acetate); 1H NMR (500MHz; CDCl3) δH: 3.84-3.83 (2H, m, H20, H3), 
3.78-3.76 (1H, m, H20'), 3.61 (1H, tt, J 11.5, 4.0, H8), 2.76 (1H, d, J 7.0, H5), 
2.41 (1H, qn, J 6.0, H4), 2.25 (1H, bs, OH), 2.12-2.06 (1H, m, H9), 1.92-1.88 
(1H, m, H7), 1.77-1.75 (1H, m, H6), 1.46-1.39 (1H, m, H7), 1.09 (1H, q, J 12.5, 
H9'); 13C NMR (75MHz, CDCl3) δC: 175.1 (NC=O), 151.3 (NBoc), 83.5 
(C(CH3)3), 66.3 (C8), 63.1 (C20), 63.2 (C3), 41.9 (C5), 38.2 (C4), 34.5 (C7 or 
C9), 33.1 (C9 or C7), 28.0 (C(CH3)3), 19.8 (C6), and -1.4 (Si(CH3)3); m/z (ES+)  
380.2  (100%, MNa+); Found MNa+ 380.1859, C17H31NO5Si requires MNa+ 
380.1869. 
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(1S,3aR,7aS)-di-tert-butyl 3,6-dioxo-4-(trimethylsilyl)hexahydro-1H-
isoindole-1,2(3H)-dicarboxylate 361. To a solution of NaIO4 (0.48 g, 2.25 
mmol) in distilled water (4 ml) and acetonitrile (2 ml), RuCl3.xH2O (3.00 mg, 
0.02 mmol) was added in one portion. A solution of lactam 343 (50 mg, 0.13 
mmol) in ethyl acetate (2 ml) was added dropwise. The reaction was allowed to 
stir for 24 hours. After this time the reaction was filtered over a bed of celite and 
the organic was extracted with ethyl acetate (10 ml). The organic layer was 
washed with water (10 ml), brine (10 ml), dried over magnesium sulfate and 
concentrated under reduced pressure. Column chromatography (4:1 petrol/ethyl 
acetate then methanol) was performed to recover remaining starting material (12.5 
mg, 25 %). The crude acid was dissolved in DCM (2 ml). DCC (77 mg, 0.37 
mmol), DMAP (36 mg, 0.3 mmol) and tButanol (0.05 ml, 0.50 mmol) were added 
and the reaction was allowed to stir for 18 hours. After this time the reaction was 
quenched with water (2 ml) and extracted with DCM (2 x 10 ml). The organic 
layer was washed with brine (5 ml), dried over magnesium sulfate and 
concentrated under reduced pressure. Purification by column chromatography 
(4:1 petrol/ethyl acetate) gave the title compound (32 mg, 60%) as a colourless 
film, [α]D25 = 76.4 (c = 1 in CHCl3); Rf 0.71 (1:1 petrol/ethyl acetate); 1H NMR 
(400MHz; CDCl3) δH: 4.13 (1H, s, H3), 2.88 (1H, dd, J 7.0, 5.5, H5), 2.70 (1H, 
ddd, J 12.5, 7.0, 5.5, H4), 2.57 (1H, dd, J 16.0, 5.5, H9 [A of ABX]), 2.41 (1H, 
dd, J 15.5, 6.5, H7 [A of ABX]), 2.28 (1H, dd, J 16.0, 12.5, [B of ABX], H9'), 
2.17 (1H, dd, J 15.0, 8.0, H7' [B of ABX]) and 1.74 (1H, dt, J 7.5, 6.0, H6); 13C 
NMR (100MHz, CDCl3) δC: 209.4 (C=O), 173.9 (CO2tBu), 168.9 (NC=O), 149.5 
(NBoc), 83.8 (C(CH3)3), 82.9 (C(CH3)3), 63.5 (C3), 42.2 (C5), 41.8 (C4), 38.4 
(C9 or C7)), 36.1 (C9 or C7), 27.9 (C(CH3)3), 27.5 (C(CH3)3), 19.8 (C6) and -2.6 
(Si(CH3)3); m/z (ES+) 448.5 (100%, MNa+); Found MNa+ 448.2134, C21H35NO6Si 
requires MNa+ 448.2126. 
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(1S,3aR,7aS)-di-tert-butyl 6-hydroxy-3-oxo-4-(trimethylsilyl)hexahydro-1H-
isoindole-1,2(3H)-dicarboxylate 363. Lactam 361 (50.0 mg, 0.12 mmol) was 
dissolved in THF (5 ml) and cooled to -78 °C. BH3.DMS (2M in THF, 0.66 ml, 
0.66 mmol) was added dropwise and the reaction was allowed to stir for 1 hour. 
The reaction was quenched with NaHCO3 solution and extracted with ethyl 
acetate (10 ml). The organic was washed with water (10 ml), brine (10 ml) and 
dried over magnesium sulfate. Concentration under reduced pressure gave the title 
compound (48 mg, quant.) as a colourless oil, Rf  0.59 (1:1 petrol/ethyl acetate); 
1H NMR (400MHz; CDCl3) δH: 4.08 (1H, bs, H3), 3.57 (1H, tt, J 4.0, 11.5, H8), 
2.57 (1H, d, J 7.0, H5), 2.42 (1H, qn, J 6.0, H4), 2.19-2.15 (1H, m, H9), 1.91-1.88 
(1H, m, H7), 1.78 (1H, d, J 6.5, H6), 1.50 (3H, s, tBu), 1.47 (3H, s, tBu), 1.42-
1.32 (1H, m, H7') and 1.15-1.06 (1H, m, H9'); 13C NMR (75MHz, CDCl3) δC: 
175.7 (C=O), 170.8 (NC=O), 151.3 (NBoc), 84.8 (C(CH3)3), 83.9 (C(CH3)3), 67.9 
(C8), 64.8 (C3), 43.2 (C5), 39.5 (C4), 37.2 (C7 or C9), 34.3 (C9 or C7), 31.1 
(C(CH3)3), 29.3 (C(CH3)3), 20.8 (C6) and 0.00 (Si(CH3)3); m/z (ES+) 450.5 
(100%, MNa+); Found MNa+ 450.2276, C21H37NO6Si requires MNa+ 450.2277. 
 
 
 
 
(1S,3aR,7aS)-di-tert-butyl 6-oxo-4-(trimethylsilyl)hexahydro-1H-isoindole-
1,2(3H)-dicarboxylate 364. Lactam 361 (380 mg, 0.89 mmol) was dissolved in 
THF (9 ml) and cooled to 0 °C. Super-H (1M in THF, 3.5 ml, 3.7 ml) was added 
dropwise and the solution was allowed to stir for 1 hour. After this time the 
reaction was quenched with NaHCO3 solution and allowed to warm to R.T. The 
organic was extracted with ethyl acetate (2 x 10 ml). The combined layers were 
washed with water (10 ml), brine (10 ml), dried over magnesium sulfate and 
3
NBoc
67
9HO
Me3Si O
H
4
CO2tBu
H
5
*
8
3
NBoc
1
67
9O
Me3Si
H
4
CO2tBu
H
5
                                                 Chapter 3: Experimental Procedures 
218 
concentrated under reduced pressure.The crude aminol 362 was dissolved in 
DCM (6 ml) and cooled to -78 °C. BF3.OEt2 (125 µl, 0.98 ml) and Et3SiH (160 
µl, 0.98 ml) was added and the reaction was stirred for 30 minutes. After this time 
BF3.OEt2 (125 µl, 0.98 ml) and Et3SiH (160 µl, 0.98 ml) was added and the 
reaction was left to stir for 2 hours. After this time the reaction was quenched with 
NaHCO3 solution and allowed to warm to room temperature. The organic was 
extracted with DCM (2 x 5 ml). The combined organic layers were washed with 
water (10 ml), brine (10 ml), dried over magnesium sulfate and concentrated 
under reduced pressure. Purification of the alcohol was perform by column 
chromatography (5:3 petrol/ethyl acetate). The resulting alcohol (250 mg, 0.61 
mmol) was dissolved in DCM (2 ml). Dess-Martin periodinane (0.3M in 
methylene chloride, 4 ml, 1.2 mmol) was added dropwise and the reaction was 
allowed to stir for 2 hours. After this time the reaction was quenched with 
NaHCO3 solution and the organic was extracted with DCM (2 x 5 ml). The 
combined organic layers were washed with water (10 ml), brine (10 ml), dried 
over magnesium sulfate and concentrated under reduced pressure. Purification by 
column chromatography (3:1 petrol/ethyl acetate) gave the title compound (181 
mg, 50% over 3 steps) as a colourless oil, [α]D25 = 95.2 (c = 1 in CHCl3); Rf 0.55 
(1:1 petrol/ethyl acetate);  νmax (film)/cm-1 2978, 1738, 1733 and 1701; 1H NMR 
(400MHz; CDCl3) δH: 3.94 (0.3H, bs, H3), 3.84 (0.7H, dd, J 10.5, 8.0, H3), 3.78 
(0.7H, dd, J 10.5, 7.5, H9), 3.68 (0.3H, dd, J 10.5, 7.5, H9), 3.29-3.25 (1H, m, 
H9'), 2.60-2.53 (2H, m, H4, H5), 2.46-2.42 (2H, m, H13, H3’), 2.29 (1H, dd, J 
16.0, 4.5, H7 [A of ABX]), 2.10 (1H, dd, J 16.0, 12.5, H7' [B of ABX]), 1.46 (9H, 
bs, tBu) and 1.43 (9H, bs, tBu); 13C NMR (75MHz, CDCl3) δC: 211.6 (C=O), 
171.2 (C=O), 154.0 (NBoc), 81.6 (C(CH3)3), 80.3 (C(CH3)3), 64.8 (C3), 52.0 
(C1), 43.4 (C5), 41.0 (C4), 38.7 (C7 or C9), 35.3 (C9 or C7), 28.3 (C(CH3)3), 28.0 
(C(CH3)3), 23.9 (C6) and -2.9 (Si(CH3)3); m/z (ES+) 412 (80%, MH+), 434.4 
(100%, MNa+); Found MH+ 412.2505, C21H27NO5Si requires MH+ 412.2514. 
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(1S,3aR,4R,8aS)-di-tert-butyl hexahydro-4-(trimethylsilyl)-7-oxo-1H-
oxepino[4,5-c]pyrrole-1,2(7H)-dicarboxylate 365. Ketone 364 (288 mg, 0.71 
mmol) was dissolved in DCM (5 mL). mCPBA (240 mg, 1.42 mmol) was added 
in one portion and the reaction was left to stir for 2 days. The reaction was 
quenched with sodium thiosulfite and extracted with DCM. The organic layer was 
washed twice with NaHCO3 and brine, dried over magnesium sulfate and 
concentrated under reduced pressure to give 288 mg of an inseparable mixture of 
the title compound (86% yield) and the overoxidised product 365b (10% yield) as 
a colourless solid, m.p. 191-195 °C; [α]D25 = -4.4° (c = 1 in CHCl3); νmax 
(film)/cm-1 2979, 2936, 1733, 1728 and 1705; 1H NMR (400 MHz, CDCl3), [2 
rotamers] δH: 4.63-4.57 (1H, m, H7), 4.28-4.23 (1H, m, H7'), 3.99 (0.35, s, H3), 
3.84 (0.65, s, H3), 3.69 (0.65H, dd, J 10.5, 8.5, H1' [A of ABX]), 3.61 (0.35H, dd, 
J 10.5, 8.5, H1' [A of ABX]), 3.40 (0.65H, t, J 10.5, 10.5, H1 [B of ABX]), 3.36 
(0.35H, t, J 10.5, 10.5, H1 [B of ABX]), 2.99 (0.65H, t, J 13.5, 13.5, H9 [A' of 
A'B'X']), 2.95 (0.35H, t, J 13.5, 13.5, H9 [A' of A'B'X']), 2.75-2.69 (1H, m, H5), 
2.58 (1H, dd, J 13.5, 1.5, H9' [B' of A'B'X']), 2.52 (1H, dd, J 13.0, 5.5, H4), 1.47-
1.43 (18H, m, 2xtBu), 1.13 (0.65H, bs, H6) and 1.08 (0.35H, bs, H6) ; 13C NMR 
(100 MHz, CDCl3, [2 rotamers] δC : 173.2 (C=O), 173.1 (C=O), 170.5 (C=O), 
170.2 (C=O), 154.4 (NC=O), 154.1 (NC=O), 81.9 (C(CH3)3), 81.8 (C(CH3)3), 
80.4 (C(CH3)3), 80.2 (C(CH3)3), 66.9 (C3), 66.6 (C3), 66.1 (C7), 65.9 (C7), 48.5 
(C1), 48.3 (C1), 40.3 (C5), 39.3 (C5), 36.7 (4), 35.9 (C4), 35.6 (C9), 35.4 (C9), 
28.2 (C(CH3)3), 27.9 (C(CH3)3), 27.8 (C(CH3)3), 27.3 (C(CH3)3), 27.2 (C6) and -
2.0 (Si(CH3)3); m/z (ES+) 450 (100%, MNa+); Found MNa+ 450.2286, 
C21H37NO6Si requires MNa+ 450.2282. (1S,3aR,4R,8aS)-di-tert-butyl 
hexahydro-4-(trimethylsilyl)-3,7-dioxo-1H-oxepino[4,5-c]pyrrole-1,2(7H)-
dicarboxylate 364b was observed in trace amount that was inseparable from the 
desired product; 1H NMR (400MHz; CDCl3) δH: 4.31-4.30 (2H, m, H7, H7'), 4.14 
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(1H, s, H3), 2.93 (1H, t, J 12.5,12.5, H9), 2.88 (1H, bd, J 6.5, H5), 2.83-2.68 (2H, 
m, , H4, H9'), 1.92 (1H, bs, H6) 1.52 (9H, s, tBu) and 1.49 (9H, s, tBu); 13C NMR 
(100MHz, CDCl3) δC: 173.1 (C=O), 171.8 (C=O), 168.3 (NC=O), 149.3 (NBoc), 
84.1 (C(CH3)3), 83.3 (C(CH3)3),  68.0 (C7), 63.8 (C3), 44.8 (C5), 36.8 (C4), 34.9 
(C9), 28.2 (C(CH3)3), 27.8 (C(CH3)3), 25.4 (C6) and -2.0 (Si(CH3)3). 
 
 
 
 
(2S,3S,4R)-di-tert-butyl 3-((tert-butoxycarbonyl)methyl)-4-vinylpyrrolidine-
1,2-dicarboxylate 367. To a solution of lactone 365 (165 mg, 0.38 mmol) in dry 
THF (3.5 mL) was added Tetrabutylammonium fluoride dropwise at 0°C. The 
mixture was stirred for 5 min and then the cold bath was removedand stirring 
continued for 2 hours. The reaction was quenched with NH4Cl and extracted three 
times with ethyl acetate. The combined organic layers were washed with water 
and brine, dried over anhydrous magnesium sulfate and concentrated under 
reduced pressure to give the intermediate. To a solution of the intermediate acid in 
tert-butanol (4 mL) was added DMAP (14.0 mg, 0.11 mmol) and Boc2O (163 mg, 
0.76 mmol). The reaction was allowed to stir overnight at room temperature and 
the mixture was concentrated under reduced pressure. Purification by column 
chromatography (9:1 petrol/ ethyl acetate) gave the title compound (94 mg, 70 % 
yield over 2 steps) as a colourless oil, [α]D25 =  -3.6°  (c = 1 in CHCl3); Rf 0.4 (8:2 
petrol:ethyl acetate); νmax (film)/cm-1 2978, 2930, 1735, 1723 and 1700 ;1H NMR 
(400 MHz, CDCl3), [2 rotamers] δH : 5.68-5.59 (1H, m, H6), (1H, m, H7), (1H, m, 
H7'), 3.84 (0.35H, d, J  6.0, H3), 3.80 (0.65H, d, J 5.5, H3), 3.60 (0.65H, dd, J 
11.0, 6.5, H1 [A of ABX]), 3.56 (0.35H, dd, J 10.5, 6.5, H1 [A of ABX]), 3.43 
(0.65H, dd, J 11.0, 5.5, H1' [B of ABX]), 3.33 (0.35H, dd, J 10.5, 5.0, H1' [B of 
ABX]), 3.06-2.97 (1H, m, H19), 2.68-2.62 (1H, m, H17), 2.37-2.26 (2H, m, H9, 
H9') and 1.45-1.41 (27H, m, 3xtBu); 13C NMR (100 MHz, CDCl3), [2 rotamers] 
δC: 171.3 (C=O), 171.2 (C=O), 171.0 (C=O), 171.0 (C=O), 154.1 (NBoc), 153.8 
(NBoc), 134.9 (C6), 134.5 (C6), 117.8 (C7), 117.7 (C7), 81.3 (C(CH3)3), 81.2 
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(C(CH3)3), 80.7 (C(CH3)3), 80.7 (C(CH3)3), 79.9 (C(CH3)3), 79.7 (C(CH3)3), 63.7 
(C3), 63.7 (C3), 50.2 (C1), 49.5 (C1), 44.1 (C5), 44.0 (C5), 43.1 (C4), 43.0 (C4), 
35.0 (C9), 34.9 (C9), 28.3 (C(CH3)3), 28.2 (C(CH3)3), 28.0 (C(CH3)3) and 27.9 
(C(CH3)3); m/z (ES+) 434 (100%, MNa+); Found MH+ 412.2694, C22H35NO6 
requires MH+ 412.2694. 
 
 
 
 
(2S,3S,4R)-di-tert-butyl 3-((tert-butoxycarbonyl)methyl)-4-
formylpyrrolidine-1,2-dicarboxylate 368. In a three-neck round bottom flask, 
alkene 367 (130 mg, 0.32 mmol) was dissolved in dry DCM (5 mL). The solution 
was cooled down to -78 °C and O3 was bubbled through for 15 min. After the 
appearance of deep blue colour, the mixture was allowed to stir 5 more mins. 
Then O2 was bubbled for 5 min at the same temperature until the total 
disappearance of the blue colour. N2 was then flushed for 5 min and Me2S (1 mL, 
15.8 mmol) was added in once. The solution was then warmed up to room 
temperature and allowed to stir for 24 hours. The solvents were removed under 
reduced pressure to give the crude aldehyde 368 (128 mg, 98% yield) as a 
colourless oil, [α]D25 = - 3.8° (c = 1 in CHCl3); νmax (film)/cm-1 2977, 2930, 1735, 
1727 and 1703; 1H NMR (400 MHz, CDCl3), [2 rotamers] δH: 9.70 (1H, d, J 1.3, 
H6), 3.97 (0.35H, d, J 4.6, H3), 3.91 (0.65H, d, J 5.4, H3), 3.84 (0.65H, dd, J 
11.5, 5.5, H1 [A of ABX]), 3.76 (0.35H, dd, J 11.0, 6.5, H1 [A of ABX]), 3.60 
(0.65H, dd, J 11.5, 7.5, H1' [B of ABX]), 3.56 (0.35H, dd, J 11.0, 7.5, H1' [B of 
ABX]), 3.36-3.28 (1H, m, H5), 3.00-2.87 (1H, m, H4), 2.55-2.41 (2H, m, H9, 
H9') and 1.46-1.401 (27H, m, 3xtBu); 13C NMR (100 MHz, CDCl3), [2 rotamers] 
δC: 199.9 (CHO), 199.9 (CHO), 170.7 (C=O), 170.6 (C=O), 170.5 (C=O), 170.5 
(C=O), 154.0 (NBoc), 153.7 (NBoc), 81.8 (C(CH3)3), 81.8 (C(CH3)3), 81.5 
(C(CH3)3), 81.4 (C(CH3)3), 80.4 (C(CH3)3), 80.3 (C(CH3)3), 64.5 (C3), 64.3 (C3), 
51.6 (C1), 50.6 (C1), 44.9 (C5), 44.8 (C5), 42.0 (C4), 40.6 (C4), 35.1 (C9), 35.0 
(C9), 28.3 (C(CH3)3), 28.2 (C(CH3)3), 28. (C(CH3)3), 27.9 (C(CH3)3) and 27.9 
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(C(CH3)3); m/z (ES+) 436 (100%, MNa+), 468 (50%, M(MeOH)Na+); Found 
MNa+ 436.2308, C21H35NO7 requires MNa+ 436.2307. 
 
 
 
Dimethyl (1-diazo-2-oxopropyl)phosphonate (Bestmann Reagent) 386. A 
solution of dimethyl (2-oxopropyl)phosphonate (5.01 g, 30 mmol) and p-
acetamidobenznesulfonyl azide (7.96 g, 33.1 mmol, 1.1 eq) in anhydrous MeCN 
(100 mL) under a nitrogen atmosphere at 0°C was treated with K2CO3 (5.00 g, 36 
mmol, 1.2 equiv). The reaction mixture was allowed to warm up to R.T. and 
stirred overnight. The reaction mixture was then filtered to remove the salts. 
Volatiles were removed under vacuum, and the residue was dissolved in CHCl3 to 
recrystallize the p-acetamidobenznesulfonylamine. After stirring for 30 min, the 
suspension was filtered and the filtrate was evaporated. Purification by flash 
chromatography (Petrol/ethyl acetate 2:8) afforded 4.61 g (24 mmol, 82%) of the 
desired dimethyl (1-diazo-2-oxopropyl)phosphonate 386 right yellow oil; Rf: 0.3 
(ethyl acetate); 1H NMR (300 MHz, CDCl3); δH: 2.27 (s, 3H, CH3), 3.83 (s, 3H, 
OMe), 3.87 (s, 3H, OMe). Data consistent with the literature132 
 
 
 
 
(2S,3S,4S)-di-tert-butyl 3-((tert-butoxycarbonyl)methyl)-4-
ethynylpyrrolidine-1,2-dicarboxylate 387a. To a solution of Ohira-Bestmann 
reagent 386 (188 mg, 0.99 mmol) in dry THF (4 mL) at -78°C was added a 
solution of freshly prepared NaOMe (500 µL, 0.99 mmol, 2N in MeOH)  in dry 
THF (1 mL), the solution turned yellow. To this mixture, a solution of aldehyde 
368 (100 mg, 0.24 mmol) in dry THF (3 mL) was added dropwise. The reaction 
was allowed to stir 1 hour at the same temperature and then warmed up to room 
temperature over 1 hour. After this time, the reaction was quenched with NH4Cl 
and extracted twice with ethyl acetate. The combined organic layers were washed 
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with water and brine, dried over anhydrous magnesium sulfate and concentrated 
under reduced pressure. Purification by column chromatography (85:15 petrol/ 
ethyl acetate) gave the title compound 387a (88 mg, 89 % yield) as a colourless 
oil, [α]D25 = -4.1° (c = 1 in CHCl3); Rf 0.25 (8:2 petrol:ethyl acetate); νmax 
(film)/cm-1 3273, 2980, 2932, 1738, 1732 and 1700; 1H NMR (400 MHz, CDCl3), 
[2 rotamers] δH: 3.93 (0.35H, d, J  5.5, H3), 3.87 (0.65H, d, J 5.5, H3), 3.70-3.59 
(1.65H, m, H1, H1'), 3.53-3.49 (0.35H, m, H1), 3.32-3.23 (1H, m, H5), 2.77-2.72 
(1H, m, H9), 2.68-2.62 (1H, m, H4), 2-47-2.40 (1H, m, H9'), 2.17 (1H, d, J 2.5, 
H7) and 1.46-1.43 (27H, m, 3xtBu); 13C NMR (100 MHz, CDCl3), [2 rotamers] 
δC: 171.0 (C=O), 170.9 (C=O), 170.8 (C=O), 154.0 (NBoc), 153.7 (NBoc), 81.5 
(C(CH3)3), 81.0 (C(CH3)3), 80.8 (C(CH3)3), 80.3 (C(CH3)3), 80.0 (C(CH3)3), 77.9 
(C7), 72.9 (C6), 63.4 (C3), 63.3 (C3), 51.3 (C1), 50.8 (C1), 43.5 (C5), 42.3 (C5), 
35.5 (C4), 35.4 (C4), 32.7 (C9), 32.0 (C9), 28.3 (C(CH3)3), 28.3 (C(CH3)3), 28.0 
(C(CH3)3), 28.0 (C(CH3)3) and 27.9 (C(CH3)3); m/z (ES+) 432 (100%, MNa+); 
Found MNa+ 432.2371, C22H35NO6 requires MNa+ 432.2357. 
3.1.6 Experimental Procedures Appendix 2: 
 
 
 
 
(3S,3aS,7aS)-2-tert-butyl-2,3,3a,4-tetrahydro-3,5-diphenyl-7aH-isoindole-1,7-
dione 404. Enone 177 (100 mg, 0.32 mmol) was dissolved in dry THF (20 ml). 
Phenylmagnesium bromide was added dropwise at 0 ºC. The reaction was 
allowed to warm to rt and stirred for 30 minutes. The reaction was quenched with 
saturated ammonium chloride solution and extracted in with diethyl ether (2 x 20 
ml). The combined organic fractions were washed with water (20 ml), dried over 
magnesium sulfate and solvent removed under reduced pressure. Purification by 
flash column chromatography (2:1 petrol:ethyl acetate) gave the title compound 
(95 mg, 82 %) as a colourless film; Rf: 0.91 (1:1 petrol:ethyl acetate); νmax 
(film)/cm-1 1748 and 1642; 1H NMR (500MHz, CDCl3) δH: 7.54-7.53 (2H, m, 
ArH), 7.45-7.43 (3H, m, ArH), 7.40-7.37 (2H, m, ArH), 7.33-7.27 (3H, m, ArH), 
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6.46 (1H, d, J 2.5, H7), 4.66 (1H, m, H3), 3.65 (1H, d, J 6.5, H5), 3.19-3.15 (1H, 
m, H9), 2.84-2.74 (2H, m, H4, H9') and 1.40 (9H, s, tBu); (ES+) 360.2; Found: 
MNa+, 383.1547, C24H25NO2 requires MNa+ 383.1547. 
 
 
 
 
 
 
(3S,3aR,7aS)-7a-hydroxy-3-phenyl-2-(2-phenylpropan-2-yl)-2,3,3a,4-
tetrahydro-1H-isoindole-1,5(7aH)-dione 408. A solution of enone 104 (50.0 mg, 
0.15 mmol) was dissolve in an 8:1 (4.5 ml). NMO (16.9 mg, 0.15 mmol) and 
osmium tetroxide (2.5 % in tert-butanol) (0.030 ml, 0.001 mmol) was added and 
allowed to stir for 18 hours. The mixture was quenched with 40 % w/v sodium 
hydrogen sulphate solution at 0 ºC. The acetone was removed under reduced 
pressure and extracted with ethyl acetate. Purification by flash chromatography 
afforded the title compound as an amorphous solid, Rf 0.52 (1:2 petrol:ethyl 
acetate); νmax (film)/cm-1 3615 and 1684; 1H NMR (300MHz, CDCl3) δH: 7.33-
7.04 (10H, m, H13, H16), 6.41 (1H, dd, J 10.5, 2.0, H7), 6.41 (1H, dd, J 10.5, 2.0, 
H7), 6.24 (1H, d, J 10.0, H6), 4.24 (1H, d, J 8.0, H3), 2.73-2.64 (2H, m, H9, H4), 
2.39-2.30 (1H, m, H9'), 1.74 (3H, s, Me) and 1.34 (3H, s, Me); 13C NMR (75 
MHz, CDCl3) δC: 196.6 (C=O), 174.6 (NC=O), 145.9 (Ar), 143.5 (Ar), 139.6 
(C6), 130.7 (C7), 128.7 (2xAr), 128.3 (2xAr), 128.0 (2xAr), 127.4 (2xAr), 126.8 
(Ar), 125.0 (Ar), 71.4 (C5), 66.4 (C(CH3)2Ph), 61.3 (C3), 47.8 (C4), 33.0 (C9), 
28.7 (C(CH3)2Ph) and 27.6 (C(CH3)2Ph); m/z (ES+) 384 (100 %, MNa+); Found 
MNa+ 384.1576, C23H23NO3 requires MNa+ 384.1576. 
 
 
 
 
(3S,3aS,7aS)-6,7-dihydroxy-3-phenyl-2-(2-phenylpropan-2-yl)hexahydro-1H-
isoindole-1,5(6H)-dione 407. A solution of enone 104 (50.0 mg, 0.15 mmol) was 
dissolve in an 8:1 (4.5 ml). Osmium tetroxide (2.5 % in tert-butanol) (3.00 ml, 
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0.15 mmol) was added and allowed to stir for 18 hours. The mixture was 
quenched with 40 % w/v sodium hydrogen sulphate solution at 0 ºC. The acetone 
was removed under reduced pressure and extracted with ethyl acetate. Purification 
by flash chromatography afforded the title compound as an amorphous solid, Rf 
0.32 (1:2 petrol/ethyl acetate); νmax (film)/cm-1 3622, 1752 and 1680; 1H NMR 
(500MHz; CDCl3) δH: 7.46-7.21 (10H, m, ArH), 4.65 (1H, t, J 1.0, H6), 4.39 (1H, 
s, H3), 4.14-4.09 (1H, m, H7), 3.68 (1H, s, OH), 3.39 (1H, dd, J 6.0, 2.0, H5), 
2.76 (1H, dd, J 10.0, 6.0, H9), 2.68-2.63 (1H, qd, J 10.0, 7.0, H4), 2.18 (1H, dd, 
13.5, 11.0, H9'), 1.92 (3H, s, Me) and 1.55 (3H, s, Me); 13C NMR (75MHz, 
CDCl3) δc: 207.90 (C=O), 172.53 (NC=O), 145.37 (Ar), 140.25 (Ar), 129.03 
(2xAr), 128.25 (2xAr), 128.12 (2xAr), 127.32 (2xAr), 125.66 (Ar), 125.47 (Ar), 
74.63 (C7), 72.51 (C6), 67.54 (C(CH3)2Ph), 59.41 (C3), 45.00 (C5), 43.16 (C4), 
41.20 (C9), 27.73 (C(CH3)2Ph) and 27.11 (C(CH3)2Ph); m/z (ES+) 402.2 (100%, 
MNa+); Found MNa+ 402.1681, C23H25NO4 requires MNa+ 402.1681. 
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3.2 Detailed X-Ray Crystallographic Data. 
 
3.2.1 Data for Epoxyketone 217. 
 
Empirical formula        C19H23NO4  
Formula weight           329.38  
Crystal size             0.30 x 0.20 x 0.10 mm  
      
Temperature              100(2)K    
X-Ray Wavelength         0.71073Å  
Ө Range     2.03 to 28.34º 
Limiting indices         -12≤h≤24;-11≤k≤11;-24≤l≤26  
Refinement method        Full-matrix least-squares on F2 
R Factor    0.1149 
 
Crystal System   Orthorhombic 
Space Group        Pbcn  
Unit cell dimensions     a = 18.768(2) Å   α = 90º  
                         b = 9.0367(12) Å  β = 90º 
                         c = 20.034(3) Å   γ = 90º  
Unit Cell Volume         3397.8(8) Å3  
Z     8 
Calculated density       1.288 Mg/m-3  
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Atomic Labels 
 
 
 
Atomic Coordinates 
 
                x             y             z            
C(1)          868(1)       4674(2)       3684(1)        
C(2)          852(1)       5823(2)       3109(1)        
C(3)         1075(1)       7355(2)       3347(1)        
C(4)         1180(1)       8399(2)       2772(1)        
C(5)         1514(1)       7865(2)       2158(1)      
C(6)         1753(1)       6294(2)       2141(1)       
C(7)         1343(1)       5191(2)       2565(1)      
C(8)         1860(1)       4144(2)       2923(1)      
C(9)          177(1)       3816(2)       3737(1)      
C(10)          51(1)       2540(2)       3376(1)      
C(11)        -616(1)       1848(3)       3403(1)     
C(12)       -1150(1)       2451(3)       3790(1)    
C(13)       -1021(1)       3714(3)       4162(1)      
C(14)        -362(1)       4378(2)       4134(1)     
C(15)        1741(1)       2671(2)       3934(1)      
C(16)        1432(1)       1341(2)       4959(1)      
C(17)         859(1)       1646(2)       5470(1)       
C(18)        1267(1)        -66(2)       4576(1)       
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C(19)        2163(1)       1317(2)       5276(1)        
N(1)         1483(1)       3735(2)       3528(1)        
O(1)          757(1)       8117(2)       2187(1)      
O(2)         2273(1)       5933(2)       1824(1)       
O(3)         2244(1)       1877(2)       3786(1)      
O(4)         1367(1)       2629(1)       4508(1)     
 
Bond Lengths (Å) 
 
C(1)-N(1)                     1.465(2)  
C(1)-C(9)                     1.514(3)  
C(1)-C(2)                     1.552(2)  
C(1)-H(1)                     1.0000  
C(2)-C(3)                     1.522(2)  
C(2)-C(7)                     1.537(2)  
C(2)-H(2)                     1.0000  
C(3)-C(4)                     1.501(2)  
C(3)-H(3A)                    0.9900  
C(3)-H(3B)                    0.9900  
C(4)-O(1)                     1.439(2)  
C(4)-C(5)                     1.463(3)  
C(4)-H(4)                     1.0000  
C(5)-O(1)                     1.440(2)  
C(5)-C(6)                     1.489(3)  
C(5)-H(5)                     1.0000  
C(6)-O(2)                     1.209(2)  
C(6)-C(7)                     1.519(3)  
C(7)-C(8)                     1.533(3)  
C(7)-H(7)                     1.0000  
C(8)-N(1)                     1.452(2)  
C(8)-H(8A)                    0.9900  
C(8)-H(8B)                    0.9900  
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C(9)-C(10)                    1.381(3)  
C(9)-C(14)                    1.384(3)  
C(10)-C(11)                   1.400(3)  
C(10)-H(10)                   0.9500  
C(11)-C(12)                   1.379(3)  
C(11)-H(11)                   0.9500  
C(12)-C(13)                   1.384(3)  
C(12)-H(12)                   0.9500  
C(13)-C(14)                   1.377(3)  
C(13)-H(13)                   0.9500  
C(14)-H(14)                   0.9500  
C(15)-O(3)                    1.222(2)  
C(15)-O(4)                    1.348(2)  
C(15)-N(1)                    1.349(2)  
C(16)-O(4)                    1.478(2)  
C(16)-C(17)                   1.510(3)  
C(16)-C(19)                   1.512(3)  
C(16)-C(18)                   1.516(3)  
C(17)-H(17A)                  0.9800  
C(17)-H(17B)                  0.9800  
C(17)-H(17C)                  0.9800  
C(18)-H(18A)                  0.9800  
C(18)-H(18B)                  0.9800  
C(18)-H(18C)                  0.9800  
C(19)-H(19A)                  0.9800  
C(19)-H(19B)                  0.9800  
C(19)-H(19C)                  0.9800  
 
Bond Angles (°) 
 
N(1)-C(1)-C(9)              113.10(16)  
N(1)-C(1)-C(2)              104.14(16)  
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C(9)-C(1)-C(2)              112.15(17)  
N(1)-C(1)-H(1)              109.1  
C(9)-C(1)-H(1)              109.1  
C(2)-C(1)-H(1)              109.1  
C(3)-C(2)-C(7)              113.32(17)  
C(3)-C(2)-C(1)              111.78(16)  
C(7)-C(2)-C(1)              105.43(16)  
C(3)-C(2)-H(2)              108.7  
C(7)-C(2)-H(2)              108.7  
C(1)-C(2)-H(2)              108.7  
C(4)-C(3)-C(2)              111.58(17)  
C(4)-C(3)-H(3A)             109.3  
C(2)-C(3)-H(3A)             109.3  
C(4)-C(3)-H(3B)             109.3  
C(2)-C(3)-H(3B)             109.3  
H(3A)-C(3)-H(3B)            108.0  
O(1)-C(4)-C(5)              59.48(13)  
O(1)-C(4)-C(3)              116.13(18)  
C(5)-C(4)-C(3)              119.64(18)  
O(1)-C(4)-H(4)              116.5  
C(5)-C(4)-H(4)              116.5  
C(3)-C(4)-H(4)              116.5  
O(1)-C(5)-C(4)               59.42(13)  
O(1)-C(5)-C(6)              116.70(17)  
C(4)-C(5)-C(6)              117.50(19)  
O(1)-C(5)-H(5)              116.9  
C(4)-C(5)-H(5)              116.9  
C(6)-C(5)-H(5)              116.9  
O(2)-C(6)-C(5)              120.8(2)  
O(2)-C(6)-C(7)              121.7(2)  
C(5)-C(6)-C(7)              117.42(19)  
C(6)-C(7)-C(8)              110.22(18)  
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C(6)-C(7)-C(2)              117.13(18)  
C(8)-C(7)-C(2)              106.10(16)  
C(6)-C(7)-H(7)              107.7  
C(8)-C(7)-H(7)              107.7  
C(2)-C(7)-H(7)              107.7  
N(1)-C(8)-C(7)              103.82(16)  
N(1)-C(8)-H(8A)             111.0  
C(7)-C(8)-H(8A)             111.0  
N(1)-C(8)-H(8B)             111.0  
C(7)-C(8)-H(8B)             111.0  
H(8A)-C(8)-H(8B)            109.0  
C(10)-C(9)-C(14)            118.8(2)  
C(10)-C(9)-C(1)             122.57(19)  
C(14)-C(9)-C(1)             118.57(19)  
C(9)-C(10)-C(11)            120.5(2)  
C(9)-C(10)-H(10)            119.8  
C(11)-C(10)-H(10)           119.8  
C(12)-C(11)-C(10)           119.6(2)  
C(12)-C(11)-H(11)           120.2  
C(10)-C(11)-H(11)           120.2  
C(11)-C(12)-C(13)           120.1(2)  
C(11)-C(12)-H(12)           119.9  
C(13)-C(12)-H(12)           119.9  
C(14)-C(13)-C(12)           119.6(2)  
C(14)-C(13)-H(13)           120.2  
C(12)-C(13)-H(13)           120.2  
C(13)-C(14)-C(9)            121.4(2)  
C(13)-C(14)-H(14)           119.3  
C(9)-C(14)-H(14)            119.3  
O(3)-C(15)-O(4)             126.4(2)  
O(3)-C(15)-N(1)             123.3(2)  
O(4)-C(15)-N(1)             110.3(2)  
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O(4)-C(16)-C(17)            102.23(16)  
O(4)-C(16)-C(19)            110.01(17)  
C(17)-C(16)-C(19)           111.35(19)  
O(4)-C(16)-C(18)            109.56(16)  
C(17)-C(16)-C(18)           110.51(19)  
C(19)-C(16)-C(18)           112.68(18)  
C(16)-C(17)-H(17A)          109.5  
C(16)-C(17)-H(17B)          109.5  
H(17A)-C(17)-H(17B)         109.5  
C(16)-C(17)-H(17C)          109.5  
H(17A)-C(17)-H(17C)         109.5  
H(17B)-C(17)-H(17C)         109.5  
C(16)-C(18)-H(18A)          109.5  
C(16)-C(18)-H(18B)          109.5  
H(18A)-C(18)-H(18B)         109.5  
C(16)-C(18)-H(18C)          109.5  
H(18A)-C(18)-H(18C)         109.5  
H(18B)-C(18)-H(18C)         109.5  
C(16)-C(19)-H(19A)          109.5  
C(16)-C(19)-H(19B)          109.5  
H(19A)-C(19)-H(19B)         109.5  
C(16)-C(19)-H(19C)          109.5  
H(19A)-C(19)-H(19C)         109.5  
H(19B)-C(19)-H(19C)         109.5  
C(15)-N(1)-C(8)             120.62(18)  
C(15)-N(1)-C(1)             124.52(18)  
C(8)-N(1)-C(1)              114.49(16)  
C(4)-O(1)-C(5)              61.11(12)  
C(15)-O(4)-C(16)            120.06(16)  
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Hydrogen Coordinates 
 
                  x             y             z           
H(1)          958          5199          4116          
H(2)          356          5881          2929         
H(3A)         704          7756          3648           
H(3B)        1524          7277          3603            
H(4)         1263          9461          2888          
H(5)         1803          8594          1898          
H(7)         1043          4580          2258          
H(8A)        1963          3262          2646           
H(8B)        2313          4652          3029            
H(10)         418          2130          3108          
H(11)        -700           967          3156          
H(12)       -1607          1999          3800            
H(13)       -1386          4120          4434          
H(14)        -275          5239          4393            
H(17A)        979          2546          5719          
H(17B)        825           809          5779          
H(17C)        401          1782          5243          
H(18A)        820            58          4329          
H(18B)       1220          -892          4890          
H(18C)       1655          -273          4262          
H(19A)       2523          1129          4932          
H(19B)       2182           533          5613          
H(19C)       2257          2275          5488          
 
Torsion Angles (°) 
   
N(1)-C(1)-C(2)-C(3)            -108.60(18)  
C(9)-C(1)-C(2)-C(3)             128.76(18)  
N(1)-C(1)-C(2)-C(7)                14.9(2)  
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C(9)-C(1)-C(2)-C(7)            -107.70(19)  
C(7)-C(2)-C(3)-C(4)                51.2(2)  
C(1)-C(2)-C(3)-C(4)             170.20(17)  
C(2)-C(3)-C(4)-O(1)                29.1(3)  
C(2)-C(3)-C(4)-C(5)               -39.0(3)  
C(3)-C(4)-C(5)-O(1)               104.6(2)  
O(1)-C(4)-C(5)-C(6)              -106.3(2)  
C(3)-C(4)-C(5)-C(6)                -1.7(3)  
O(1)-C(5)-C(6)-O(2)               145.2(2)  
C(4)-C(5)-C(6)-O(2)              -147.2(2)  
O(1)-C(5)-C(6)-C(7)               -37.9(3)  
C(4)-C(5)-C(6)-C(7)                29.8(3)  
O(2)-C(6)-C(7)-C(8)                39.9(3)  
C(5)-C(6)-C(7)-C(8)            -137.05(19)  
O(2)-C(6)-C(7)-C(2)               161.2(2)  
C(5)-C(6)-C(7)-C(2)               -15.7(3)  
C(3)-C(2)-C(7)-C(6)               -24.9(3)  
C(1)-C(2)-C(7)-C(6)            -147.48(18)  
C(3)-C(2)-C(7)-C(8)              98.59(19)  
C(1)-C(2)-C(7)-C(8)               -24.0(2)  
C(6)-C(7)-C(8)-N(1)             151.21(17)  
C(2)-C(7)-C(8)-N(1)                23.5(2)  
N(1)-C(1)-C(9)-C(10)              -30.1(3)  
C(2)-C(1)-C(9)-C(10)               87.3(2)  
N(1)-C(1)-C(9)-C(14)            153.48(18)  
C(2)-C(1)-C(9)-C(14)              -89.1(2)  
C(14)-C(9)-C(10)-C(11)              1.3(3)  
C(1)-C(9)-C(10)-C(11)          -175.20(19)  
C(9)-C(10)-C(11)-C(12)              0.4(3)  
C(10)-C(11)-C(12)-C(13)            -1.6(3)  
C(11)-C(12)-C(13)-C(14)             1.2(3)  
C(12)-C(13)-C(14)-C(9)              0.5(3)  
                                                 Chapter 3: Experimental Procedures 
235 
C(10)-C(9)-C(14)-C(13)             -1.7(3)  
C(1)-C(9)-C(14)-C(13)           174.87(19)  
O(3)-C(15)-N(1)-C(8)               -9.2(3)  
O(4)-C(15)-N(1)-C(8)            170.89(17)  
O(3)-C(15)-N(1)-C(1)              178.1(2)  
O(4)-C(15)-N(1)-C(1)               -1.8(3)  
C(7)-C(8)-N(1)-C(15)            171.88(18)  
C(7)-C(8)-N(1)-C(1)               -14.8(2)  
C(9)-C(1)-N(1)-C(15)              -65.0(3)  
C(2)-C(1)-N(1)-C(15)            173.01(18)  
C(9)-C(1)-N(1)-C(8)             121.95(19)  
C(2)-C(1)-N(1)-C(8)                -0.1(2)  
C(3)-C(4)-O(1)-C(5)              -110.5(2)  
C(6)-C(5)-O(1)-C(4)               107.7(2)  
O(3)-C(15)-O(4)-C(16)             -14.7(3)  
N(1)-C(15)-O(4)-C(16)           165.20(16)  
C(17)-C(16)-O(4)-C(15)         -172.14(17)  
C(19)-C(16)-O(4)-C(15)             69.5(2)  
C(18)-C(16)-O(4)-C(15)            -54.9(2)  
3.2.2 Data for Lactone 251. 
 
Empirical formula  C18H21NO3  
Formula weight   299.36  
Crystal size   0.30 x 0.28 x 0.08 mm  
 
Temperature   100(2) K    
X-Ray Wavelength  0.71073 Å 
Ө Range        2.49 to 28.28º 
Limiting Indices  -19≤h≤18;-8≤k≤7;-22≤l≤14  
Refinement method  Full-matrix least-squares on F2 
R Factor        0.0594 
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Crystal System   Monoclinic 
Space Group   P21/n  
Unit cell Dimensions a = 15.051(2) Å α = 90º  
b = 6.738(10)Å β =113.949(3)º                               
c = 16.592(2)Å  γ = 90º 
Unit Cell Volume         1537.9(4)Å3 
Z     4 
Calculated density       1.293 Mg/m-3 
 
Atomic Labels 
 
 
 
Atomic Coordinates 
                x             y             z              
C(1)         3685(1)       2409(2)       2481(1)         
C(2)         2640(1)       1759(3)       2264(1)         
C(3)         2565(1)       5113(3)       1852(1)         
C(4)         3625(1)       4672(3)       2504(1)         
C(5)         3828(1)       5409(3)       3438(1)        
C(6)         4896(2)       5596(3)       3984(1)        
C(7)         5092(2)       2004(3)       4003(1)        
C(8)         4379(1)       1360(3)       3281(1)        
C(9)          958(1)       3209(3)       1614(1)        
C(10)         694(1)       2592(3)       2375(1)        
C(11)         560(2)       1696(3)        860(1)       
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C(12)         503(1)       5240(3)       1279(1)       
C(13)        2461(1)       5487(3)        914(1)       
C(14)        2505(1)       3977(3)        365(1)      
C(15)        2431(1)       4392(3)       -478(1)         
C(16)        2292(1)       6322(3)       -794(1)         
C(17)        2251(1)       7839(3)       -250(1)         
C(18)        2337(1)       7428(3)        599(1)         
N(1)         2039(1)       3332(2)       1938(1)        
O(1)         5449(1)       3934(2)       4226(1)        
O(3)         5319(1)       7152(2)       4206(1)   
      
       
Bond Lengths (Å) 
C(1)-C(8)                     1.492(2)  
C(1)-C(4)                     1.529(2)  
C(1)-C(2)                     1.529(3)  
C(1)-H(1)                     1.0000  
C(2)-O(2)                     1.232(2)  
C(2)-N(1)                     1.356(2)  
C(3)-N(1)                     1.477(2)  
C(3)-C(13)                    1.520(2)  
C(3)-C(4)                     1.550(2)  
C(3)-H(3)                     1.0000  
C(4)-C(5)                     1.535(2)  
C(4)-H(4)                     1.0000  
C(5)-C(6)                     1.496(3)  
C(5)-H(5A)                    0.9900  
C(5)-H(5B)                    0.9900  
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C(6)-O(3)                     1.204(2)  
C(6)-O(1)                     1.356(2)  
C(7)-C(8)                     1.316(3)  
C(7)-O(1)                     1.398(2)  
C(7)-H(7)                     0.9500  
C(8)-H(8)                     0.9500  
C(9)-N(1)                     1.494(2)  
C(9)-C(10)                    1.527(2)  
C(9)-C(12)                    1.530(2)  
C(9)-C(11)                    1.535(2)  
C(10)-H(10A)                  0.9800  
C(10)-H(10B)                  0.9800  
C(10)-H(10C)                  0.9800  
C(11)-H(11A)                  0.9800  
C(11)-H(11B)                  0.9800  
C(11)-H(11C)                  0.9800  
C(12)-H(12A)                  0.9800  
C(12)-H(12B)                  0.9800  
C(12)-H(12C)                  0.9800  
C(13)-C(14)                   1.385(2)  
C(13)-C(18)                   1.393(2)  
C(14)-C(15)                   1.385(2)  
C(14)-H(14)                   0.9500  
C(15)-C(16)                   1.386(2)  
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C(15)-H(15)                 0.9500  
C(16)-C(17)                 1.381(2)  
C(16)-H(16)                 0.9500  
C(17)-C(18)                 1.390(2)  
C(17)-H(17)                 0.9500  
C(18)-H(18)                 0.9500  
Bond Angles (°) 
C(8)-C(1)-C(4)              118.52(16)  
C(8)-C(1)-C(2)              110.87(15)  
C(4)-C(1)-C(2)              103.08(14)  
C(8)-C(1)-H(1)              108.0  
C(4)-C(1)-H(1)              108.0  
C(2)-C(1)-H(1)              108.0  
O(2)-C(2)-N(1)              126.39(18)  
O(2)-C(2)-C(1)              124.57(17)  
N(1)-C(2)-C(1)              109.04(15)  
N(1)-C(3)-C(13)             113.41(15)  
N(1)-C(3)-C(4)              102.54(14)  
C(13)-C(3)-C(4)             113.35(14)  
N(1)-C(3)-H(3)              109.1  
C(13)-C(3)-H(3)             109.1  
C(4)-C(3)-H(3)              109.1  
C(1)-C(4)-C(5)              111.00(14)  
C(1)-C(4)-C(3)              103.20(14)  
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C(5)-C(4)-C(3)              111.64(14)  
C(1)-C(4)-H(4)              110.3  
C(5)-C(4)-H(4)              110.3  
C(3)-C(4)-H(4)              110.3  
C(6)-C(5)-C(4)              111.28(15)  
C(6)-C(5)-H(5A)             109.4  
C(4)-C(5)-H(5A)             109.4  
C(6)-C(5)-H(5B)             109.4  
C(4)-C(5)-H(5B)             109.4  
H(5A)-C(5)-H(5B)            108.0  
O(3)-C(6)-O(1)              116.36(19)  
O(3)-C(6)-C(5)              124.30(18)  
O(1)-C(6)-C(5)              119.29(17)  
C(8)-C(7)-O(1)              129.15(18)  
C(8)-C(7)-H(7)              115.4  
O(1)-C(7)-H(7)              115.4  
C(7)-C(8)-C(1)              132.16(18)  
C(7)-C(8)-H(8)              113.9  
C(1)-C(8)-H(8)              113.9  
N(1)-C(9)-C(10)             109.17(15)  
N(1)-C(9)-C(12)             110.01(15)  
C(10)-C(9)-C(12)            108.37(15)  
N(1)-C(9)-C(11)             109.75(14)  
C(10)-C(9)-C(11)            110.30(15)  
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C(12)-C(9)-C(11)            109.22(16)  
C(9)-C(10)-H(10A)           109.5  
C(9)-C(10)-H(10B)           109.5  
H(10A)-C(10)-H(10B)         109.5  
C(9)-C(10)-H(10C)           109.5  
H(10A)-C(10)-H(10C)         109.5  
H(10B)-C(10)-H(10C)         109.5  
C(9)-C(11)-H(11A)           109.5  
C(9)-C(11)-H(11B)           109.5  
H(11A)-C(11)-H(11B)         109.5  
C(9)-C(11)-H(11C)           109.5  
H(11A)-C(11)-H(11C)         109.5  
H(11B)-C(11)-H(11C)         109.5  
C(9)-C(12)-H(12A)           109.5  
C(9)-C(12)-H(12B)           109.5  
H(12A)-C(12)-H(12B)         109.5  
C(9)-C(12)-H(12C)           109.5  
H(12A)-C(12)-H(12C)         109.5  
H(12B)-C(12)-H(12C)         109.5  
C(14)-C(13)-C(18)           118.57(17)  
C(14)-C(13)-C(3)            122.60(16)  
C(18)-C(13)-C(3)            118.82(16)  
C(15)-C(14)-C(13)           120.64(17)  
C(15)-C(14)-H(14)           119.7  
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C(13)-C(14)-H(14)           119.7  
C(14)-C(15)-C(16)           120.63(17)  
C(14)-C(15)-H(15)           119.7  
C(16)-C(15)-H(15)           119.7  
C(17)-C(16)-C(15)           119.14(18)  
C(17)-C(16)-H(16)           120.4  
C(15)-C(16)-H(16)           120.4  
C(16)-C(17)-C(18)           120.31(18)  
C(16)-C(17)-H(17)           119.8  
C(18)-C(17)-H(17)           119.8  
C(17)-C(18)-C(13)           120.69(17)  
C(17)-C(18)-H(18)           119.7  
C(13)-C(18)-H(18)           119.7  
C(2)-N(1)-C(3)              112.13(15)  
C(2)-N(1)-C(9)              123.55(15)  
C(3)-N(1)-C(9)              124.01(15)  
C(6)-O(1)-C(7)              124.53(16)  
Hydrogen Coordinates        
              x             y             z                  
H(1)         3847          2036          1973           
H(3)         2322          6298          2064           
H(4)         4094          5285          2289           
H(5A)        3513          6716          3401           
H(5B)        3542          4468          3725           
H(7)         5410          1019          4433           
H(8)         4290           -38          3265           
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H(10A)        963          1274          2586           
H(10B)        -15          2552          2170           
H(10C)        964          3553          2857           
H(11A)        756          2081           386           
H(11B)       -151          1662           632           
H(11C)        822           378          1080           
H(12A)        746          6204          1762           
H(12B)       -206          5142          1063           
H(12C)        678          5673           799           
H(14)        2586          2643           568           
H(15)        2477          3344          -842           
H(16)        2226          6598         -1377           
H(17)        2164          9169          -458           
H(18)        2311          8483           969           
 
Torsion Angles (º)  
 
N(1)-C(1)-C(2)-C(3)           -108.60(18)  
C(9)-C(1)-C(2)-C(3)              128.76(18)  
N(1)-C(1)-C(2)-C(7)                 14.9(2)  
C(9)-C(1)-C(2)-C(7)             -107.70(19)  
C(7)-C(2)-C(3)-C(4)                 51.2(2)  
C(1)-C(2)-C(3)-C(4)              170.20(17)  
C(2)-C(3)-C(4)-O(1)                 29.1(3)  
C(2)-C(3)-C(4)-C(5)                -39.0(3)  
C(3)-C(4)-C(5)-O(1)                104.6(2)  
O(1)-C(4)-C(5)-C(6)               -106.3(2)  
C(3)-C(4)-C(5)-C(6)                 -1.7(3)  
O(1)-C(5)-C(6)-O(2)                145.2(2)  
C(4)-C(5)-C(6)-O(2)               -147.2(2)  
O(1)-C(5)-C(6)-C(7)                -37.9(3)  
C(4)-C(5)-C(6)-C(7)                 29.8(3)  
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O(2)-C(6)-C(7)-C(8)                 39.9(3)  
C(5)-C(6)-C(7)-C(8)             -137.05(19)  
O(2)-C(6)-C(7)-C(2)                161.2(2)  
C(5)-C(6)-C(7)-C(2)                -15.7(3)  
C(3)-C(2)-C(7)-C(6)                -24.9(3)  
C(1)-C(2)-C(7)-C(6)             -147.48(18)  
C(3)-C(2)-C(7)-C(8)               98.59(19)  
C(1)-C(2)-C(7)-C(8)                -24.0(2)  
C(6)-C(7)-C(8)-N(1)              151.21(17)  
C(2)-C(7)-C(8)-N(1)                 23.5(2)  
N(1)-C(1)-C(9)-C(10)               -30.1(3)  
C(2)-C(1)-C(9)-C(10)                87.3(2)  
N(1)-C(1)-C(9)-C(14)             153.48(18)  
C(2)-C(1)-C(9)-C(14)               -89.1(2)  
C(14)-C(9)-C(10)-C(11)               1.3(3)  
C(1)-C(9)-C(10)-C(11)           -175.20(19)  
C(9)-C(10)-C(11)-C(12)               0.4(3)  
C(10)-C(11)-C(12)-C(13)             -1.6(3)  
C(11)-C(12)-C(13)-C(14)              1.2(3)  
C(12)-C(13)-C(14)-C(9)               0.5(3)  
C(10)-C(9)-C(14)-C(13)              -1.7(3)  
C(1)-C(9)-C(14)-C(13)            174.87(19)  
O(3)-C(15)-N(1)-C(8)                -9.2(3)  
O(4)-C(15)-N(1)-C(8)             170.89(17)  
O(3)-C(15)-N(1)-C(1)               178.1(2)  
O(4)-C(15)-N(1)-C(1)                -1.8(3)  
C(7)-C(8)-N(1)-C(15)             171.88(18)  
C(7)-C(8)-N(1)-C(1)                -14.8(2)  
C(9)-C(1)-N(1)-C(15)               -65.0(3)  
C(2)-C(1)-N(1)-C(15)             173.01(18)  
C(9)-C(1)-N(1)-C(8)              121.95(19)  
C(2)-C(1)-N(1)-C(8)                 -0.1(2)  
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C(3)-C(4)-O(1)-C(5)               -110.5(2)  
C(6)-C(5)-O(1)-C(4)                107.7(2)  
O(3)-C(15)-O(4)-C(16)              -14.7(3)  
N(1)-C(15)-O(4)-C(16)            165.20(16)  
C(17)-C(16)-O(4)-C(15)          -172.14(17)  
C(19)-C(16)-O(4)-C(15)              69.5(2)  
C(18)-C(16)-O(4)-C(15)             -54.9(2) 
 
3.2.3 Data for Silylated Ketone 315. 
 
Crystal Data and Structure Refinement  
 
Empirical Formula  C26H34NO2Si  
Formula Weight   428.63  
Crystal Size   0.60 x 0.20 x 0.20 mm  
 
Temperature   100(2)K       
X-Ray Wavelength  0.71073Å  
Ө Range    1.76 to 25.03º 
Limiting Indices  -13≤h≤11;-15≤k≤18;15≤l≤15  
Refinement Method  Full-matrix least-squares on F2  
R Factor     0.0693 
 
Crystal System        Monoclinic 
Space Group     P21/n  
Unit cell dimensions a = 11.549(3)Å α = 90º 
b = 15.630(4)Å β = 90.792(5)º  
c = 13.138(4)Å γ = 90º  
Unit Cell Volume         2371.4(11) Å3  
Z     4 
Calculated density       1.201 Mg/m-3        
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Atomic Labels 
          
 
Atomic Coordinates   
 
 
x             y             z         
Si(1)       10418(1)       6811(1)     1845(1)   
O(1)         7489(1)       7884(1)      2461(1)   
O(2)         7406(2)       5036(1)       -88(2)   
N(1)         6603(2)       8216(1)       935(1)        
C(1)         7466(2)       7873(1)      1526(2)        
C(2)         8366(2)       7478(1)       831(2)        
C(3)         8932(2)       6645(1)      1256(2)        
C(4)         8965(2)       5946(2)       429(2)        
C(5)         7776(2)       5759(2)        14(2)        
C(6)         7040(2)       6527(1)      -213(2)        
C(7)         7694(2)       7380(1)      -174(2)        
C(8)         6840(2)       8140(1)      -158(2)        
C(9)         5615(2)       8704(1)      1369(2)        
C(10)        4958(2)       8141(2)      2131(2)        
C(11)        4657(2)       7311(2)      1854(2)        
C(12)        3955(2)       6818(2)      2464(2)   
C(13)        3537(2)       7143(2)      3366(2)        
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C(14)        3839(2)       7965(2)      3654(2)        
C(15)        4545(2)       8459(2)      3039(2)        
C(16)        6064(2)       9540(1)      1834(2)        
C(17)        4746(2)       8915(2)       509(2)        
C(18)       10333(2)       7622(2)      2884(2)        
C(19)       10922(2)       5770(2)      2395(2)        
C(20)       11405(2)       7168(2)       818(2)        
C(21)        7311(2)       8952(1)      -646(2)        
C(22)        8077(2)       9498(2)      -130(2)        
C(23)        8500(2)      10227(2)      -609(2)        
C(24)        8167(2)      10415(2)     -1597(2)        
C(25)        7416(2)       9880(2)     -2117(2)        
C(26)        6989(2)       9150(2)     -1637(2)        
O(1S)        5054(5)       4656(3)      -688(4) 
 
Bond Lengths (Å)             
  
Si(1)-C(20)                   1.864(3)  
Si(1)-C(18)                   1.866(3)  
Si(1)-C(19)                   1.870(2)  
Si(1)-C(3)                    1.890(2)  
O(1)-C(1)                     1.229(3)  
O(2)-C(5)                     1.216(3)  
N(1)-C(1)                     1.365(3)  
N(1)-C(8)                     1.470(3)  
N(1)-C(9)                     1.493(3)  
C(1)-C(2)                     1.524(3)  
C(2)-C(7)                     1.531(3)  
C(2)-C(3)                     1.557(3)  
C(2)-H(2)                     1.0000  
C(3)-C(4)                     1.543(3)  
C(3)-H(3)                     1.0000  
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C(4)-C(5)                     1.498(3)  
C(4)-H(4A)                    0.9900  
C(4)-H(4B)                    0.9900  
C(5)-C(6)                     1.499(3)  
C(6)-C(7)                     1.532(3)  
C(6)-H(6A)                    0.9900  
C(6)-H(6B)                    0.9900  
C(7)-C(8)                     1.544(3)  
C(7)-H(7)                     1.0000  
C(8)-C(21)                    1.525(3)  
C(8)-H(8)                     1.0000  
C(9)-C(16)                    1.530(3)  
C(9)-C(17)                    1.537(3)  
C(9)-C(10)                    1.539(3)  
C(10)-C(15)                   1.384(4)  
C(10)-C(11)                   1.390(3)  
C(11)-C(12)                   1.382(4)  
C(11)-H(11)                   0.9500  
C(12)-C(13)                   1.383(4)  
C(12)-H(12)                   0.9500  
C(13)-C(14)                   1.383(4)  
C(13)-H(13)                   0.9500  
C(14)-C(15)                   1.389(4)  
C(14)-H(14)                   0.9500  
C(15)-H(15)                   0.9500  
C(16)-H(16A)                  0.9800  
C(16)-H(16B)                  0.9800  
C(16)-H(16C)                  0.9800  
C(17)-H(17A)                  0.9800  
C(17)-H(17B)                  0.9800  
C(17)-H(17C)                  0.9800  
C(18)-H(18A)                  0.9800  
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C(18)-H(18B)                  0.9800  
C(18)-H(18C)                  0.9800  
C(19)-H(19A)                  0.9800  
C(19)-H(19B)                  0.9800  
C(19)-H(19C)                  0.9800  
C(20)-H(20A)                  0.9800  
C(20)-H(20B)                  0.9800  
C(20)-H(20C)                  0.9800  
C(21)-C(26)                   1.384(3)  
C(21)-C(22)                   1.398(3)  
C(22)-C(23)                   1.393(3)  
C(22)-H(22)                   0.9500  
C(23)-C(24)                   1.380(4)  
C(23)-H(23)                   0.9500  
C(24)-C(25)                   1.379(4)  
C(24)-H(24)                   0.9500  
C(25)-C(26)                   1.397(3)  
C(25)-H(25)                   0.9500  
C(26)-H(26)                   0.9500  
O(1S)-H(1O)                   0.871(19)  
 
Bond Angles (º) 
 
C(20)-Si(1)-C(18)           111.41(12)  
C(20)-Si(1)-C(19)           110.46(12)  
C(18)-Si(1)-C(19)           109.09(13)  
C(20)-Si(1)-C(3)            107.82(11)  
C(18)-Si(1)-C(3)            109.64(11)  
C(19)-Si(1)-C(3)            108.37(11)  
C(1)-N(1)-C(8)              112.33(18)  
C(1)-N(1)-C(9)              122.59(19)  
C(8)-N(1)-C(9)              124.66(18)  
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O(1)-C(1)-N(1)              124.7(2)  
O(1)-C(1)-C(2)              126.8(2)  
N(1)-C(1)-C(2)              108.5(2)  
C(1)-C(2)-C(7)              102.42(18)  
C(1)-C(2)-C(3)              114.2(2)  
C(7)-C(2)-C(3)              115.53(18)  
C(1)-C(2)-H(2)              108.1  
C(7)-C(2)-H(2)              108.1  
C(3)-C(2)-H(2)              108.1  
C(4)-C(3)-C(2)              110.73(19)  
C(4)-C(3)-Si(1)             110.79(16)  
C(2)-C(3)-Si(1)             113.95(15)  
C(4)-C(3)-H(3)              107.0  
C(2)-C(3)-H(3)              107.0  
Si(1)-C(3)-H(3)             107.0  
C(5)-C(4)-C(3)              111.3(2)  
C(5)-C(4)-H(4A)             109.4  
C(3)-C(4)-H(4A)             109.4  
C(5)-C(4)-H(4B)             109.4  
C(3)-C(4)-H(4B)             109.4  
H(4A)-C(4)-H(4B)            108.0  
O(2)-C(5)-C(4)              122.7(2)  
O(2)-C(5)-C(6)              121.7(2)  
C(4)-C(5)-C(6)              115.5(2)  
C(5)-C(6)-C(7)              114.4(2)  
C(5)-C(6)-H(6A)             108.7  
C(7)-C(6)-H(6A)             108.7  
C(5)-C(6)-H(6B)             108.7  
C(7)-C(6)-H(6B)             108.7  
H(6A)-C(6)-H(6B)            107.6  
C(2)-C(7)-C(6)              111.07(19)  
C(2)-C(7)-C(8)              103.13(18)  
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C(6)-C(7)-C(8)              110.85(18)  
C(2)-C(7)-H(7)              110.5  
C(6)-C(7)-H(7)              110.5  
C(8)-C(7)-H(7)              110.5  
N(1)-C(8)-C(21)             114.61(19)  
N(1)-C(8)-C(7)              101.71(17)  
C(21)-C(8)-C(7)             113.77(19)  
N(1)-C(8)-H(8)              108.8  
C(21)-C(8)-H(8)             108.8  
C(7)-C(8)-H(8)              108.8  
N(1)-C(9)-C(16)             109.41(19)  
N(1)-C(9)-C(17)             108.84(19)  
C(16)-C(9)-C(17)            108.94(19)  
N(1)-C(9)-C(10)             110.03(18)  
C(16)-C(9)-C(10)            113.4(2)  
C(17)-C(9)-C(10)            106.14(19)  
C(15)-C(10)-C(11)           118.1(2)  
C(15)-C(10)-C(9)            122.3(2)  
C(11)-C(10)-C(9)            119.2(2)  
C(12)-C(11)-C(10)           121.0(3)  
C(12)-C(11)-H(11)           119.5  
C(10)-C(11)-H(11)           119.5  
C(11)-C(12)-C(13)           120.5(3)  
C(11)-C(12)-H(12)           119.8  
C(13)-C(12)-H(12)           119.8  
C(14)-C(13)-C(12)           119.0(3)  
C(14)-C(13)-H(13)           120.5  
C(12)-C(13)-H(13)           120.5  
C(13)-C(14)-C(15)           120.3(3)  
C(13)-C(14)-H(14)           119.8  
C(15)-C(14)-H(14)           119.8  
C(10)-C(15)-C(14)           121.0(3)  
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C(10)-C(15)-H(15)           119.5  
C(14)-C(15)-H(15)           119.5  
C(9)-C(16)-H(16A)           109.5  
C(9)-C(16)-H(16B)           109.5  
H(16A)-C(16)-H(16B)         109.5  
C(9)-C(16)-H(16C)           109.5  
H(16A)-C(16)-H(16C)         109.5  
H(16B)-C(16)-H(16C)         109.5  
C(9)-C(17)-H(17A)           109.5  
C(9)-C(17)-H(17B)           109.5  
H(17A)-C(17)-H(17B)         109.5  
C(9)-C(17)-H(17C)           109.5  
H(17A)-C(17)-H(17C)         109.5  
H(17B)-C(17)-H(17C)         109.5  
Si(1)-C(18)-H(18A)          109.5  
Si(1)-C(18)-H(18B)          109.5  
H(18A)-C(18)-H(18B)         109.5  
Si(1)-C(18)-H(18C)          109.5  
H(18A)-C(18)-H(18C)         109.5  
H(18B)-C(18)-H(18C)         109.5  
Si(1)-C(19)-H(19A)          109.5  
Si(1)-C(19)-H(19B)          109.5  
H(19A)-C(19)-H(19B)         109.5  
Si(1)-C(19)-H(19C)          109.5  
H(19A)-C(19)-H(19C)         109.5  
H(19B)-C(19)-H(19C)         109.5  
Si(1)-C(20)-H(20A)          109.5  
Si(1)-C(20)-H(20B)          109.5  
H(20A)-C(20)-H(20B)         109.5  
Si(1)-C(20)-H(20C)          109.5  
H(20A)-C(20)-H(20C)         109.5  
H(20B)-C(20)-H(20C)         109.5  
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C(26)-C(21)-C(22)           118.6(2)  
C(26)-C(21)-C(8)            119.3(2)  
C(22)-C(21)-C(8)            122.1(2)  
C(23)-C(22)-C(21)           120.2(2)  
C(23)-C(22)-H(22)           119.9  
C(21)-C(22)-H(22)           119.9  
C(24)-C(23)-C(22)           120.3(3)  
C(24)-C(23)-H(23)           119.8  
C(22)-C(23)-H(23)           119.8  
C(25)-C(24)-C(23)           120.1(3)  
C(25)-C(24)-H(24)           120.0  
C(23)-C(24)-H(24)           120.0  
C(24)-C(25)-C(26)           119.7(3)  
C(24)-C(25)-H(25)           120.1  
C(26)-C(25)-H(25)           120.1  
C(21)-C(26)-C(25)           121.0(2)  
C(21)-C(26)-H(26)           119.5  
C(25)-C(26)-H(26)           119.5  
            
   
Hydrogen Bond Length (Å) 
 
O(1S)-H(1O)...O(2)  0.871    O(1S)...O(2)    2.880 
H(1O)...O(2)    2.05 
 
Hydrogen Bond Angles (º) 
 
O(1S)-H(1O)...O(2) 158(4)  
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